CN100432103C - 有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽 - Google Patents
有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽 Download PDFInfo
- Publication number
- CN100432103C CN100432103C CNB028183320A CN02818332A CN100432103C CN 100432103 C CN100432103 C CN 100432103C CN B028183320 A CNB028183320 A CN B028183320A CN 02818332 A CN02818332 A CN 02818332A CN 100432103 C CN100432103 C CN 100432103C
- Authority
- CN
- China
- Prior art keywords
- leu
- ser
- gly
- pro
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明涉及用于治疗需要除去或破坏患者的有害细胞或不想要的组织的疾病的肽,组合物和方法,该方法采用含有衍生自神经丝状蛋白至少一种氨基酸序列和其它相关分子的蛋白质,和衍生自该蛋白质氨基酸序列的肽进行治疗。
Description
本申请要求2001年7月19日提交的题为“有效治疗肿瘤和其它需要除去或破坏细胞的疾病的蛋白质和肽”的临时申请序列号60/306,161的优先权,2001年7月19日提交的题为“有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽”的临时专利申请序列号60/306,150的优先权,以及2001年11月16日提交的题为“有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽”的临时专利申请序列号60/331,477的优先权,在此将它们全文并入以供参考。
发明领域
本发明涉及用含有对应于、相似于或同源于神经丝状蛋白的部分氨基酸序列的氨基酸序列的蛋白质和肽化合物治疗疾病的方法,这类疾病需要除去或破坏细胞成分,如良性或恶性肿瘤。该方法包括但不限于肌肉内、口服、静脉内、鞘内、肿瘤内、鼻内、局部、透皮等给所述化合物,或单独或偶联于载体的所述化合物。
发明背景
许多医学治疗和过程包括除去或破坏有害或不想要的组织。这种重要治疗的例子包括手术除去癌性生长物、通过化疗破坏转移性肿瘤和减少腺体(如前列腺)增生。其它例子包括除去不想要的面部毛发、疣、皮下组织、淋巴组织或脂肪组织。
需要有效的制剂来破坏从而便于除去有害或不想要的细胞和组织或抑制其进一步生长,主要是局部作用而全身毒性最小或没有。神经丝状蛋白及其相关分子是2002年3月8日提交的题为“用神经丝状蛋白治疗肿瘤和相关疾病的方法”的待审批美国专利申请序列号10/092,934所描述的这类制剂之一,其公布的内容全部纳入本文供参考。含有与神经丝状蛋白部分氨基酸序列相对应的氨基酸序列的肽,AD7c-NTP也是这类试剂。这些肽可参见2002年5月24日提交的题为“有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽”的待审批美国专利申请序列号10/153,334中的描述,其公布的内容全部纳入本文供参考。
癌是细胞内部调节机制发生的异常,导致不受控制的细胞生长和繁殖。正常细胞构成组织,当这些细胞失去作为特定、受控制和协同单元的能力(去分化)时,这种缺陷会导致细胞群发生混乱。当它发生时,即形成肿瘤。
组织的良性过度生长是异常情况,此时需要从机体中除去细胞。良性肿瘤是不会全身转移但能引起疾病症状的细胞增殖。如果这种肿瘤位于器官如脑中难以到达的区域,它们可能是致命的。良性肿瘤存在于许多器官中,包括肺、脑、皮肤、垂体、甲状腺、肾上腺皮质和肾上腺髓质、卵巢、子宫、睾丸、结缔组织、肌肉、肠、耳、鼻、喉、扁桃腺、口、肝脏、胆囊、胰、前列腺、心和其它器官。
在癌症治疗中手术通常是第一步。手术的目的不同。有时用手术的除尽可能多的明显肿瘤,或至少使它“除块”(节除主要的肿瘤块从而减少对其它方法治疗的需要)。取决于癌种类和位置,手术也可为病人提供一些症状缓解。例如,如果手术切除了大部分扩增的脑肿瘤,颅内压将减少,使病人的症状改善。
不是所有的肿瘤都可以手术切除。一些肿瘤可能位于使它们不能完全被切除的身体部位。这些肿瘤例子是脑干中的肿瘤(控制呼吸的脑部分)或生长在主要血管中和周围的肿瘤。在这些情况中,由于肿瘤切除相关的高风险,手术的实施受到限制。
在一些情况中,由于不需要,不能用手术切除肿瘤块。一个例子是何杰金淋巴瘤,这是一种对化疗和放射治疗相联合有良好反应的淋巴结癌症。在何杰金淋巴瘤中,很少需要手术来达到治愈,而手术几乎都是用于确定诊断。
化疗是癌治疗的一种常用形式,包括使用能特异性攻击全身中快速分裂细胞(如肿瘤中所见的细胞)的药物(通常通过口服或注射给予)。这使化疗可用于治疗转移癌以及有很高机会通过血液和淋巴系统扩散但尚未明显超过原发性肿瘤部位的肿瘤。化疗也可用于提高局部肿瘤对手术和放疗的反应。例如对于一些头部和颈部的癌症。
不幸的是,人体中正常快速分裂的其它细胞(如胃的内皮层和毛发)也会受到化疗影响。由于这个原因,许多化疗剂会导致不良副作用如恶心、呕吐、贫血、脱发或其它症状。这些副作用是暂时性的,目前的药物可帮助减轻许多这些副作用。随着我们的知识持续增长,学者们设计了更加新的化疗剂,它们不仅能更好地杀死癌细胞且对病人的副作用更小。
化疗药物可以多种方式给予病人。一些是药丸,一些通过静脉内或其它部位注射给药。就可注射的化疗药物而言,病人须到医生诊所或医院接受治疗。其它化疗剂需要一天24小时连续输入血流中。对于这些类型的化疗药物,可进行小手术给病人植入小泵。用泵慢慢给药。在许多情况中,须在病人静脉中安置永久性输液管口以消除反复针刺的需要。
放疗是另一种抗癌的常用武器。放射线通过破坏肿瘤细胞内的DNA来杀死癌。放疗可用不同方式传送。最普通的方法包括以高度精确方式使放射线束指向病人,集中照射在肿瘤上。为此,病人须躺在台上光束围绕他/她周围移动。此可程持续几分钟,但可每天进行,连续数周(取决于肿瘤类型)以达到具体的总处方放射量。
有时采用称为近程治疗的另一种放射方法,包括采用放射性小丸(“辐射盒”)或电线,将它们植入身体的肿瘤区域中。植入物可以是暂时或永久性的。就永久性植入而言,辐射盒中的射线在几天或几周中“衰变”从而病人不会有放射性。就暂时性植入而言,总放射剂量通常须在数天中输入,病人在此时间中必须住院。对于这两种近程治疗,一般须将放射线准确关至肿瘤区域以获得对癌症的局部控制(此与全身治疗相反,如化疗)。
一些高度选择的病人可求助于骨髓移植。通常进行此种治疗是因为病人患有显著的攻击性癌或因为他们经常规疗法治疗后癌症复发。骨髓移植是一种复杂的过程。有许多种类且它们引起副作用和治愈的可能性不同。大多数移植须在特殊的医疗中心进行,在许多情况中采用移植认为是研究性的。
有一些其它治疗方法,尽管大部分仍在临床考核中探索,未成为标准治疗方法。例子包括免疫治疗、单克隆抗体、抗血管生成因子和基因治疗。
免疫治疗:设计了多种技术以促进病人自身免疫系统抵抗癌症,这与放射治疗或化疗完全不同。通常为达到此目的,学者们用特制疫苗给病人注射。单克隆抗体:设计用于攻击癌细胞(不攻击正常细胞)的抗体,利用癌和非癌细胞之间抗原性或/或其它特征的差异。抗体可单独给予病人,或与各种细胞毒化合物偶联或采用放射性形式,使抗体优先靶向癌性细胞,从而将毒性剂或放射剂递送给需要的细胞。
抗血管生成因子:由于癌细胞迅速分裂和肿瘤生长,它们可能很快长得比其血液供应还快。为补偿这点,一些肿瘤可分泌协助诱导其周围血管生长的物质,从而向癌细胞提供血管输送的营养物。已设计了实验性疗法以阻止血管长入肿瘤。
基因疗法:癌是一系列突变的产物,最终导致癌细胞产生和其过度增殖。治疗癌可将能控制或停止癌增殖的基因引入癌细胞、开启细胞的程序性细胞(死亡)机制破坏癌细胞、提高细胞的免疫识别、或表达能转变成毒性代谢物的前体药物或抑制肿瘤生长的细胞因子。
良性肿瘤和畸形也可通过多种方法治疗,包括手术、放射治疗、药物治疗、热和电烧灼、冷冻疗法等。尽管良性肿瘤不转移,它们可长大且可复发。手术根除良性肿瘤通常有困难和手术副作用,而一些良性肿瘤须要反复进行手术,如垂体腺瘤、脑膜瘤、前列腺增生等。
还有其它一些疾患包含不想要的细胞成分,需要选择性去除这些细胞。例如心脏病和中风一般由动脉粥样硬化所引起,而动脉粥样硬化是纤维脂肪和平滑肌成分的增殖性损伤而致使血管壁扭曲、血管腔狭窄、血流收缩、易发病灶性血栓并最终导致阻塞和梗塞。治疗动脉粥样硬化的各种方法包括:旁路移植;人工移植;采用血管再通、刮除、放射、激光或其它去除阻塞的血管成形术;通过脂质减少抑制动脉粥样硬化的药物疗法;抗血凝治疗;和饮食、锻炼及生活方式的全身疗法。仍需要一种除去动脉粥样硬化性损伤而无风险和副作用的方法。
其它需要选择性去除不想要的细胞丰分例子,包括病毒诱导的生长物如疣。另一个例子是炎症情况中所见的肥大炎性块和肥大疤痕或瘢痕疙瘩。其它例子见于化妆美容时例如除去不想要的毛发如面部汗毛,或为美容目的须除去面部皮肤和结缔组织或四肢皮肤和结缔组织中的皱缩的不需要的组织区域。
其它例子是此领域一般技术人员知道的。在所有或大部分这些例子中,都需要能除去或破坏不想要的细胞成分进行治疗,而无常规疗法的风险和副作用,和需要更精确除去不想要的细胞成分的方法。
神经丝状蛋白(NTP)是最近才鉴定的一个脑蛋白质家族。此家族成员之一AD7c-NTP是41kD功能与神经芽生相关的膜结合磷蛋白(de la Monte等,J.Clin.Invest.,100:3093-3104(1997);de la Monte等,Alz.Rep.,2:327-332(1999);de la Monte SM和Wands JR,Journal of Alzheimer’s Disease,3:345-353(2001))。已鉴定和报道了编码AD7c-NTP的基因和AD7c-NTP的预测蛋白质序列(de laMonte等,J.Clin.Invest.,100:3093-3104(1997))。除了41kD种类外,其它种类的神经丝状蛋白(约26kD、约21kD、约17kD和约15kD)也已鉴定并与神经外胚层瘤、星形细胞瘤和成胶质细胞瘤以及缺氧、局部缺血或脑梗塞引起的损伤相关联(Xu等,Cancer Research,53:3823-3829(1993);de la Monte等,J.Neuropathol.Exp.Neurol.,55(10):1038-50(1996),de la Monte等,J.Neurol.Sci.,138(1-2):26-35(1996);de la Monte等,J.Neurol.Sci.,135(2):118-25(1996);de la Monte等,J.Clin.Invest.,100:3093-3104(1997);de la Monte等,Alz.Rep.,2:327-332(1999))。
对神经丝状蛋白的种类已有描述和权利要求,见美国专利号5,948,634;5,948,888和5,830,670中所有关于“阿尔茨海默氏病的神经丝状蛋白基因表达和检测”和美国专利号6,071,705关于“检测神经疾病或功能不良的方法”。这些专利所披露内容特别地全部纳入本文供参考。如其中所述,NTP在细胞死亡期间上调和产生。因此,报道认为死亡和垂死的神经细胞系过度产生NTP而致,因而它的存在表明神经细胞死亡和阿尔茨海默氏病(AD)发作。
已将其它种类的神经丝状蛋白鉴定为AD7c-NTP基因的其它产物(如描述于NCBI Entrez-蛋白质数据库登录号#XP_032307 PID g15928971的一种112个氨基酸的蛋白质)或类似于神经丝状蛋白(如描述于NCBI Entrez-蛋白质数据库登录号#AAH14951 PID g15928971的一种106个氨基酸的蛋白质,描述于NCBI Entrez-蛋白质数据库登录号#XP_039102 PID g18599339的另一种106个氨基酸的蛋白质和描述于NCBI Entrez-蛋白质数据库登录号#AAH02534 PID g12803421的一种61个氨基酸的蛋白质)。
与AD和NTP相关的神经丝状蛋白在AD的细胞死亡中上调。与对照相比AD7c-NTP mRNA在AD大脑中上调;AD中大脑和CSF中的AD7c-NTP蛋白水平高于对照;AD7c-NTP的免疫反应性发现于AD和唐氏综合症大脑中的老年斑、神经纤维缠结(NFT)、变性神经元、神经毡丝(neuropil thread)和营养不良性神经芽生中(Ozturk等,Proc.Natl.Acad.Sci.USA,86:419-423(1989);de la Monte等,J.Clin.Invest.,86(3):1004-13(1990);de la Monte等,J.Neurol.Sci.,113(2):152-64(1992);de la Monte等,Ann.Neurol.,32(6):733-42(1992);de la Monte等,J.Neuropathol.Exp.Neurol.,55(10):1038-50(1996),de la Monte等,J.Neurol.Sci.,138(1-2):26-35(1996);de la Monte等,J.Neurol.Sci.,135(2):118-25(1996);de la Monte等,J.Clin.Invest.,100:3093-3104(1997);de la Monte等,Alz.Rep.,2:327-332(1999))。NTP定位于细胞内、神经毡内的精细加工中,或AD和唐氏综合症大脑中的细胞外。de la Monte等,Ann.Neurol.,32(6):733-42(1992)。
在AD病人的CSF和尿中都发现AD7c-NTP蛋白水平升高(de la Monte和Wands,Front Biosci 7:989-96(2002);de la Monte和Wands,Journal of Alzheimer’sDisease,3:345-353(2001);Munzar等,Alzheimer’s Reports 4:61-65(2001);Kahle等,Neurology 54:1498-1504(2000);Munzar等,Alzheimer’s Reports 3:155-159(2000);de la Monte等,Alzheimer’s Reports 2:327-332(1999);和de la Monte等,J Clin Invest 100:3093-3104(1997)。
过度表达NTP也与阿尔茨海默氏病中的细胞死亡过程相联系(de la Monte和Wands,J.Neuropathol Exp.Neurol.,60:195-207(2001);de la Monte和Wands,CellMol Life Sci 58:844-49(2001)。也在唐氏综合症大脑组织中鉴定到AD7c-NTP(Wands等,国际专利出版号WO 90/06993;de la Monte等,J Neurol Sci 135:118-25(1996);de la Monte等,Alz.Rep.,2:327-332(1999))。有一些证据表明过度表达NTP也可能与正常张力青光眼相关联(Golubnitschaja-Labudova等,Curr Eye Res21:867-76(2000))。
已证明NTP是在体外神经胶质瘤和成神经细胞瘤的细胞培养物,体内正常啮齿动物肌肉组织、皮下结缔组织和真皮中,以及多种不同人和非人来源的肿瘤(包括乳腺癌、皮肤癌和乳头状瘤、结肠癌、脑胶质瘤和啮齿动物模型中的其它肿瘤)中,能导死细胞死亡的一种有效制剂。参见2002年3月8日提交的待审批美国专利申请序列号10/092,934;题为“用神经丝状蛋白治疗肿瘤和相关疾病的方法”。
此描述中包括上述相关领域的描述、任何和所有本文所述公开的文献,包括任何和所有的美国专利全部纳入本文供参考。上述相关领域的描述不意味着以任何方式承认包括待审批美国专利申请的任何本文所述文献是本发明的现有技术。
* * * *
此领域仍需要新的、毒性较弱的治疗不需要的细胞成分的方法。本发明可满足这些需求。
发明概述
本发明一部分包括本发明者发现AD7c-NTP中所含的肽序列,及其变体或同系物,包括其人和其它哺乳动物等生物的其它蛋白质中发现的肽序列是破坏或除去有害细胞或不想要细胞的有效制剂,。一旦发现了此种肽序列,此领域的一般技术人员就可通过利用广泛存在的公众或商业蛋白质数据库如国家生物技术信息中心的蛋白质数据库(National Center Biotechnology Information′s Protein database)和检索程序如(局部序列比对基本检索工具)找到这些蛋白质。参见Altschul,Stephen F.,Thomas L.Madden,Alejandro A.Jinghui Zhang,ZhengZhang,Webb Miller和David J.Lipman(1997),“缺口BLAST和PSI-BLAST:新一代蛋白质数据库检索程序(Gapped BLAST and PSI-BLAST:a new generation of proteindatabase search programs)”,Nucleic Acids Res.25:3389-3402。
此领域的一般技术人员然后可以用这里描述的测定方法来筛选这些蛋白质,以确定它们作为破坏或除去不需要的或有害细胞的制剂的效力。发现一种或多种这类有效制剂后,此领域的一般技术人员然后可以确定那些制剂中,包含与这里所述或2002年5月24日提交的题为“有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽”的待审批美国专利申请序列号10/153,334所述的AD7c-NTP肽序列同源或类似的序列,这些制剂可用此领域技术人员已知的方法合成,并测试合成的制剂作为破坏或除去不需要或有害细胞的制剂的效力。此外,此领域的一般技术人员还可所发现的此类蛋白质的氨基酸序列,来确定与本文所述以及2002年5月24日提交的题为“有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽”的美国专利申请序列号10/153,334所述的AD7c-NTP肽序列不类似或不同源,和同源或类似的其它肽序列。然后可测试这些新合成的序列作为破坏或除去不需要的或有害细胞的制剂的效力。
本发明涉及治疗不需要的细胞增殖的肽、组合物和方法,如良性或恶性肿瘤、腺体(如前列腺)增生、不需要的面部汗毛、疣和不需要的脂肪组织。这种方法包括将治疗有效量的相关蛋白、已知是能导致细胞死亡的有效制剂的相关肽或NTP肽,给予需要的哺乳动物,。“相关蛋白”、“相关肽”和“NTP肽”的定义如下。
本发明的肽具有至少一段与神经丝状蛋白的部分氨基酸序列相对应的氨基酸序列。本发明的组合物包括这种肽和药学上可接受的载体。本发明的肽或蛋白质(“细胞死亡肽”)可单独或者与载体或抗体偶联后施用。施用此细胞死亡肽可通过肌肉内、口服、静脉内、腹膜内、脑内(实质内)、脑室内、肿瘤内、病灶内、皮内、鞘内、鼻内、眼内、动脉内、局部、透皮、通过气雾剂、灌输、推注、植入装置、缓释系统等,或单独或运载体偶联。另外,此细胞死亡肽可通过给予表达此肽的基因来体内表达、通过给予能诱导导入此基因的细胞、细菌或病毒体内表达此肽的疫苗,或导致基因修饰等来产生此肽。
此外,此细胞死亡肽可结合其它疗法用于来治疗良性或恶性肿瘤和其它不想要的或有害的细胞生长。以上一般描述和下列详细描述是示范性和说明性的,将为本发明的权利要求提供进一步说明。从本发明的详细描述中,本领域技术人员不难了解本发明的其它目标、优点和新特征。
附图简述
图1:显示AD7c-NTP基因的完整氨基酸序列和核酸序列以及该基因的AD7c-NTP蛋白产物(获自美国专利号5,830,670、5,948,634和5,948,888的序列120和121;de la Monte等,J.Clin.Invest.,100:3093-3104(1997);NCBI Entrez-蛋白质数据库登录号#AAC08737;PID g3002527)[SEQ ID NO.1]。
图2:显示122个氨基酸的神经丝状蛋白的完整氨基酸序列(获自美国专利号5,830,670、5,948,634和5,948,888的序列40;NCBI Entrez-蛋白质数据库登录号#AAE25447 PID g10048540)[SEQ ID NO.2](“NTP-122”)。
图3:显示112个氨基酸的神经丝状蛋白的完整氨基酸序列(NCBI Entrez-蛋白质数据库登录号#XP_032307 PID g15928971)[SEQ ID NO.3](“NTP-112”)。
图4:显示106个氨基酸的神经丝状蛋白样蛋白质的完整氨基酸序列(NCBIEntrez-蛋白质数据库登录号#AAH14951 PID g15928971)[SEQ ID NO.4](“NTP-106A”)。
图5:显示106个氨基酸的神经丝状蛋白样蛋白质的完整氨基酸序列(NCBIEntrez-蛋白质数据库登录号#XP_039102 PID g18599339)[SEQ ID NO.5](“NTP-106B”)。
图6:显示98个氨基酸的神经丝状蛋白的完整氨基酸序列(获自美国专利号5,830,670、5,948,634和5,948,888的序列30;NCBI Entrez-蛋白质数据库登录号#AAE25445,PID g10048538)[SEQ ID NO.6](“NTP-98”)。
图7:显示75个氨基酸的神经丝状蛋白的完整氨基酸序列(获自美国专利号5,830,670、5,948,634和5,948,888的序列48;NCBI Entrez-蛋白质数据库登录号#AAE25448,PID g10048541)[SEQ ID NO.7](“NTP-75”)。
图8:显示68个氨基酸的神经丝状蛋白的完整氨基酸序列(获自美国专利号5,830,670、5,948,634和5,948,888的序列36;NCBI Entrez-蛋白质数据库登录号#AAE25446,PID g10048539)[SEQ ID NO.8](“NTP-66”)。
图9:显示61个氨基酸的神经丝状蛋白样蛋白质的完整氨基酸序列(NCBIEntrez-蛋白质数据库登录号#AAH02534,PID g12803421)[SEQ ID NO.9](“NTP-61”)。
优选实施方案的详细说明
除非另有说明,本文使用的术语和词组按如下定义。
术语“AD7c-NTP”指约41kD蛋白质和基因以及编码它的核酸序列,描述是de la Monte等,J.Clin.Invest.,100:3093-104(1997),美国专利号5,948,634;5,948,888和5,830,670的序列120和121以及GenBank#AF010144中,其核酸和氨基酸序列示于图1。术语“AD7c-NTP”也包括AD7c-NTP的生物活性片段、变体、衍生物、同源物和模拟物。
术语“NTP”或“神经丝状蛋白”指神经丝状蛋白和相关分子(包括胰丝状蛋白)和编码这些蛋白质的核酸序列,且包括(但不限于)下列蛋白质和编码这些蛋白质的氨基酸序列的核酸序列:
(a)AD7c-NTP;
(b)~42、~26、~21、~17、~14和~8kD种类的神经丝状蛋白,描述见于美国专利号5,948,634;5,948,888;5,830,670和6,071,705和de la Monte等,J.Neuropathol.Exp.Neurol.,55(10):1038-50(1996),de la Monte等,J.Neurol.Sci.,138(1-2):26-35(1996);de la Monte等,J.Neurol.Sci.,135(2):118-25(1996);de la Monte等,J.Clin.Invest.,100:3093-3104(1997);de la Monte等,Alz.Rep.,2:327-332(1999);
(c)单克隆抗体#2特异性识别的蛋白质保存于美国典型培养物保藏所,Manassas,Va.,登录号HB-12546,或单克隆抗体#5特异识别的蛋白质保存于美国典型培养物保藏所,Manassas,Va.,登录号HB-12545;
(d)由AD7c-NTP基因所编码的蛋白质;
(e)122个氨基酸神经丝状蛋白,描述见美国专利号5,830,670、5,948,634和5,948,888的序列40,并在NCBI Entrez-蛋白质登录号#AAE25447,PID g10048540中列出,其氨基酸序列示于图2(“NTP-122”);
(f)NCBI Entrez-蛋白质登录号#XP_032307,PID g14725132中列出的122个氨基酸神经丝状蛋白,其氨基酸序列示于图3(“NTP-112”);
(g)NCBI Entrez-蛋白质登录号#AAH14951 PID g15928971中列出的106个氨基酸神经丝状蛋白,其氨基酸序列示于图4(“NTP-106A”);
(h)NCBI Entrez-蛋白质登录号#XP_039102 PID g18599399中列出的106个氨基酸神经丝状蛋白,其氨基酸序列示于图5(“NTP-106B”);
(i)98个氨基酸神经丝状蛋白,描述见美国专利号5,830,670、5,948,634和5,948,88的序列30,并在NCBI Entrez-蛋白质登录号#AAE25445,PIDg10048538中列出,其氨基酸序列示于图6(“NTP-98”);
(j)75个氨基酸神经丝状蛋白,描述见美国专利号5,830,670、5,948,634和5,948,888的序列48,并在NCBI Entrez-蛋白质登录号#AAE25448,PIDg10048541中列出,其氨基酸序列示于图7(“NTP-75”);
(k)68个氨基酸神经丝状蛋白,描述见美国专利号5,830,670、5,948,634和5,948,888的序列36,并在NCBI Entrez-蛋白质登录号#AAE25446,PIDg10048539中列出,其氨基酸序列示于图8(“NTP-68”);
(l)在NCBI Entrez-蛋白质登录号#AAH02534,PID g12803421中列出的61个氨基酸的神经状蛋白样蛋白质,其氨基酸序列示于图9(“NTP-61”);
(m)胰丝状蛋白;
(n)在美国专利号6,071,705中描述的神经胰丝状蛋白(nPTP);
(o)杂交瘤产生的抗体特异性识别的蛋白质,这些杂交瘤为保存于美国典型培养物保藏所的HB 9934、HB 9935和HB 9936。
术语“NTP肽”所指的肽包括对应于NTP的至少一部分氨基酸序列或NTP片段的氨基酸序列,除非另有说明,还包括这些肽的同源物、衍生物、变体、融合蛋白和肽模拟物。术语“NTP肽”还包括(但不限于)美国专利申请序列号10/092,934个10/153334中特别列出的肽。术语“NTP肽”优选包括(但不限于)NTP的以下氨基酸序列:
a)NTP肽#1[SEQ ID NO.10],AD7c-NTP p239-243
SSWDY
Ser-Ser-Trp-Asp-Tyr
b)NTP肽#2[SEQ ID NO.11],AD7c-NTP p31-39
PASASPVAG
Pro-Ala-Ser-Ala-Ser-Pro-Val-Ala-Gly
c)NTP肽#3[SEQ ID NO.12],AD7c-NTP p14-24
GAISAHRNLRL
Gly-Ala-Ile-Ser-Ala-His-Arg-Asn-Leu-Arg-Leu
d)NTP肽#4[SEQ ID NO.13],AD7c-NTP p53-58
FFLVEM
Phe-Phe-Leu-Val-Glu-Met
e)NTP肽#5[SEQ ID NO.14],AD7c-NTP p208-216
SVTQAGVQW
Ser-Val-Thr-Gln-Ala-Gly-Val-Gln-Trp
f)NTP肽#6[SEQ ID NO.15],NTP-122p106-122
IDQQVLSRIKLEIKRCL
Ile-Asp-Gln-Gln-Val-Leu-Ser-Arg-Ile-Lys-Leu-Glu-Ile-Lys-Arg-Cys-Leu
g)NTP肽#7[SEQ ID NO.16],NTP-122p111-119
LSRIKLEIK
Leu-Ser-Arg-Ile-Lys-Leu-Glu-Ile-Lys
并包括这些特别列出的NTP肽的同源物、衍生物、变体、片段、融合蛋白和肽模拟物。
术语“相关蛋白”指含有一种或多种与一种或多种NTP肽相同、非常类似或同源的氨基酸序列的蛋白质。
表述“相关肽”指由与所述相关蛋白的至少一部分氨基酸序列相对应的氨基酸序列构成的肽,并包括这种肽的同源物、变体、融合蛋白、反-D肽和肽模拟物。表述“相关肽”还优选包括(但不限于)所述相关蛋白的以下氨基酸序列:
(a)相关肽#1[SEQ ID NO.17],暂时的受体潜在通道6,δ变体(NCBI登录号CAC01686,PID g9716913),p356-377
GDHGRPNLSRLKLAIKYEVKKM
Gly-Asp-His-Gly-Arg-Pro-Asn-Leu-Ser-Arg-Leu-Lys-Leu-Ala-Ile-Lys-Tyr-Glu-Val-Lys-Lys-Met
(b)相关肽#2[SEQ ID NO.18],假定的钙通道(NCBI登录号NP_065122,PIDg9966865),p345-360
QQSIAVKFLAVFGVSI
Gln-Gln-Ser-Ile-Ala-Val-Lys-Phe-Leu-Ala-Val-Phe-Gly-Val-Ser-Ile
(c)相关肽#3[SEQ ID NO.19],trp-相关蛋白4截短的γ变体(NCBI登录号AF063825_1,PID g6665596),p337-357
GLLFPVFSVCYLIAPKSPLGL
Gly-Leu-Leu-Phe-Pro-Val-Phe-Ser-Val-Cys-Tyr-Leu-Ile-Ala-Pro-Lys-Ser-Pro-Leu-Gly-Leu
并包括这些特别列出的相关肽的同源物、衍生物、变体、片段、融合蛋白和肽模拟物。
表述“细胞死亡肽”指已证明是造成细胞死亡的有效制剂的相关蛋白或相关肽。
术语“片段”指由NTP蛋白、NTP肽、相关蛋白或相关肽的氨基酸序列的连续亚序列构成的蛋白质或多肽,包括天然产生的片段,如剪接变体和体内由于蛋白酶水解活性天然产生的片段。这种片段可在氨基末端、羧基末端和/或中间(如自然剪接)截短。这种片段可以用或不用氨基末端甲硫氨酸制备。术语“片段”包括相同NTP蛋白或NTP肽,或相关蛋白或相关肽的片段,可以相同或不同,共有或没有毗连的氨基酸序列,直接或通过接头连接在一起。
术语“变体”指蛋白质或多肽,其中与NTP蛋白、NTP肽、相关蛋白或相关肽的氨基酸序列相比,存在一个或多个氨基酸取代、缺失和/或插入,包括天然产生的NTP蛋白、NTP肽、相关蛋白或相关肽的等位基因变体或者交替剪接变体。术语“变体”包括在肽序列中的一个或多个氨基酸用类似或同源氨基酸或不相似氨基酸的置换。氨基酸可在许多等级上分为类似或同源氨基酸(Gunnar von Heijne,《分子生物学的序列分析》(Sequence Analysis in Molecular Biology),123-39页Academic Press,纽约,NY 1987.)优选的变体包括一个或多个氨基酸位置的丙氨酸取代。其它优选的取代包括对蛋白质的整体净电荷、极性或疏水性影响小或没有影响的保守性取代。保守性取代列于下表2中。
表2
保守性氨基酸取代
碱性: 精氨酸
赖氨酸
组氨酸
酸性: 谷氨酸
天冬氨酸
无电荷极性: 谷氨酰胺
天冬酰胺
丝氨酸
苏氨酸
酪氨酸
非极性: 苯丙氨酸
色氨酸
半胱氨酸
甘氨酸
丙氨酸
缬氨酸
脯氨酸
甲硫氨酸
亮氨酸
异亮氨酸
表3列出氨基酸取代的另一种方案:
表3
原来的残基 取代
丙氨酸 甘氨酸;丝氨酸
精氨酸 赖氨酸
天冬酰胺 谷氨酰胺;组氨酸
天冬氨酸 谷氨酸
半胱氨酸 丝氨酸
谷氨酰胺 天冬酰胺
谷氨酸 天冬氨酸
甘氨酸 丙氨酸;脯氨酸
组氨酸 天冬酰胺;谷氨酰胺
异亮氨酸 亮氨酸;缬氨酸
亮氨酸 异亮氨酸;缬氨酸
赖氨酸 精氨酸;谷氨酰胺;谷氨酸
甲硫氨酸 亮氨酸;酪氨酸;异亮氨酸
苯丙氨酸 甲硫氨酸;亮氨酸;酪氨酸
丝氨酸 苏氨酸
苏氨酸 丝氨酸
色氨酸 酪氨酸
酪氨酸 色氨酸;苯丙氨酸
缬氨酸 异亮氨酸;亮氨酸
其它变体可由保守性较小的氨基酸取代组成,如选择的残基更显著的不同在于它们对维持(a)取代区域中多肽主链结构的作用,例如片层或螺旋构型,(b)靶位点分子的电荷或疏水性,(c)侧链大小。预期通常对功能有更显著作用的取代是(a)甘氨酸和/或脯氨酸被另一种氨基酸取代或缺失或插入;(b)亲水性残基如丝氨酰或苏氨酰取代(或被)疏水性残基,如亮氨酰、异亮氨酰、苯丙氨酰、缬氨酰或丙氨酰;(c)半胱氨酸残基取代(或被)任何其它残基;(d)具有正电侧链的残基如赖氨酰、精氨酰或组氨酰取代(或被)具有负电荷的残基如谷氨酰或天冬氨酰;或(e)具有大侧链的残基如苯丙氨酸取代(或被)没有这种侧链的残基如甘氨酸。其它变体包括设计为产生新的糖基化和/或磷酸化位点的,或设计为缺失现有糖基化和/或磷酸化位点的残基。变体包括糖基化位点、蛋白水解切割位点和/或半胱氨酸残基上的至少一个氨基酸取代。变体还包括在接头肽上NTP蛋白、NTP肽、相关蛋白或相关肽氨基酸序列之前或之后具有其它氨基酸残基的NTP蛋白、NTP肽、相关蛋白或相关肽。例如,可将半胱氨酸残基加在相关肽的氨基和羧基末端通过形成二硫键使相关肽环化。术语“变体”还包括具有相关蛋白或相关肽的氨基酸序列的多肽,它们在相关蛋白或相关肽的3′或5′末端侧接有至少1个和多达25个或更多额外的氨基酸。
术语“衍生物”指化学修饰的蛋白质或多肽,它们通过天然过程如加工和其它翻译后修饰而被化学修饰,也可通过化学修饰技术加入一个或多个聚乙二醇分子、糖、磷酸盐和/或其它这类分子,其中这类分子不是天然结合于野生型NTP蛋白或肽的分子。衍生物包括盐。这种化学修饰描述可见基础教材和更详细的专论以及大量研究文献中,它们是本领域技术人员所熟知的。将会理解的是,相同类型的修饰可能以相同或不同程度存在于某给定蛋白质或多肽的一些位点上。同样,给定蛋白质或多肽可包含许多种类的修饰。这些修饰可发生在蛋白质或多肽的任何地方,包括肽主链、氨基酸侧链和氨基或羧基末端。这些修饰包括例如乙酰化、酰化、ADP-核糖基化、酰胺化、黄素的共价结合、血红素部分的共价结合、核苷酸或核苷酸衍生物的共价结合、脂质或脂质衍生物的共价结合、磷脂酰肌醇的共价结合、交联、环化、二硫键形成、脱甲基化、形成共价交联、形成半胱氨酸、形成焦谷氨酸、甲酰化、γ-羧基化、糖基化、GPI锚形成、羟基化、碘化、甲基化、豆蔻酰化、氧化、蛋白酶解加工、磷酸化、异戊二烯化、外消旋化、糖基化、脂质结合、硫酸化、谷氨酸残基的γ-羧基化、羟基化和ADP-核糖基化、硒基化(selenoylation)、转运RNA介导的氨基酸加入蛋白质,如精氨酰化和泛素化。参见例如《蛋白质-结构和分子性质》(Proteins-Structure And Molecular Properties),第二版,T.E.Creighton,W.H.Freeman和Company,纽约(1993)和Wold,F.,“翻译后蛋白质修饰:观点和前景”(Posttranslational Protein Modifcation:Perspective andProspects),《蛋白质的翻译后共价修饰》(Posttranslational Convalent Modification ofProteins),1-12页,B.C.Johnson编,Academic Press,纽约(1983);Seifter等,Meth.Enzymol.182:626-646(1990)和Rattan等,“蛋白质合成:翻译后修饰和衰老”(Posttranslational Modifcation and Aging),Ann.N.Y.Acad.Sci.663:48-62(1992)。术语“衍生物”包括化学修饰导致蛋白质或多肽变成分支状或者有或没有分支的环状。环状、分支状和分支环状蛋白质或多肽可能由翻译后的天然加工产生并也可完全由合成方法产生。
术语“同源物”指蛋白质,其与NTP蛋白、NTP肽、相关蛋白或相关肽的氨基酸序列,根据常用于比较两种多肽的氨基酸位置相似性的标准方法测定至少有60%相同。两种蛋白质之间的相似性或相同性程度可用已知方法计算,包括但不限于以下所描述的那些方法:《计算分子生物学》(Computational Molecular Biology),Lesk,A.M.编,牛津大学出版社,纽约,1988;《生物计算:信息学和基因组计划》(Biocomputing:Informatics and Genome Projiects),Smith,D.W.编,Academic Press,纽约,1993;《序列数据的计算机分析》(Computer Analysis of Sequence Data),第I部分,Griffin,A.M.和Griffin,H.G.编,Humana Press,新泽西州,1994);《分子生物学序列分析》(Sequence analysis in Molecular Biology),von Heinje,G.,AcademicPress,纽约,1987);《序列分析引物》(Sequence analysis Primery),Gribskov,M.和Devereux,J.编,M Stockton Press,纽约,1991;Carillo H.和Lipman,D.,SIAM,J.Applied Math.,48:1073(1988)。设计了确定相同性的优选方法来给出测试序列之间的最大匹配。在公众可得到的计算机程序中编纂了确定相同性和相似性的方法。
用于确定两种序列之间相同性和相似性的优选计算机程序方法,包括但不限于GCG程序包(Devereux,J.等,Nucleic Acids Research,12(1):387(1984)),BLASTP,BLASTN和FASTA,Atschul,S.F.等,J.Molec.Biol.,215:403-410(1990)。BLASTX程序公众可从NCBI和其它来源获得(BLAST手册,Altschul,S.等,NCBI NLM NIHBethesda,Md.20894;Altschul,S.等,J.Mol.Biol.,215:403-410(1990)。例如采用计算机算法如GAP(遗传学计算机组,University of Wisconsin,Madison,Wis.),排列对比两种待测定的蛋白质或多肽的序列相同性百分比用于最佳匹配它们各自的氨基酸(“匹配范围”通过算法确定)。
空隙开放罚分(gap opening penalty)(计算为3x倍平均对角线;“平均对角线”是所用比较矩阵的对角线平均值;“对角线”是通过具体比较矩阵赋予各优选氨基酸的评分或数值)和空隙延伸罚分(gap extension penalty)(通常是空隙开放罚分的1/10倍)以及比较矩阵例如PAM250或BLOSUM 62可与此算法结合使用。此算法也可使用标准的比较矩阵(PAM250比较矩阵参见Dayhoff等,《蛋白质序列和结构图谱集》(Atlas ofProtein Sequence and Structure),第5卷,增补本3[1978];BLOSUM62比较矩阵参见Henikoff等,Proc.Natl.Acad.Sci.USA,89:10915-10919[1992])。然后用该算法计算相同性百分比。同源物与NTP蛋白、NTP肽、相关蛋白或相关肽相比,通常具有一个或多个氨基酸取代、缺失和/或插入。
术语“肽模拟物”或“模拟物”指能模拟肽或蛋白质的生物活性但在化学性质上不再是肽的生物活性化合物,即它们不再含任何肽键(即氨基酸间的酰胺键)。这里术语肽模拟物用于更广泛含义,包括性质上不再完全是肽的分子如假肽、半肽和拟肽(peptoid)。此广泛含义上的肽模拟物的例子(其中肽的一部分被缺乏肽键的结构取代)在下面描述。无论完全是或部分是非肽,本发明的肽模拟物提供了反应性化学组成成分的空间排列,肽模拟物所依据的这种排列非常类似于NTP肽相关蛋白或相关肽中活性基团的三维排列。由于这种相似的活性位点的几何结构,肽模拟物对生物系统的作用类似于NTP肽、相关蛋白或相关肽的生物活性。
本发明的肽模拟物优选在三维形状和生物活性上基本上类似于本文所述的NTP肽、相关蛋白或相关肽。本领域已知的结构上修饰肽以产生肽模拟物的方法的例子,包括倒置主链手性中心产生D-氨基酸残基结构,具体是在N-末端,使对蛋白酶降解的稳定性提高而对活性没有不利地影响。在论文“含氚D-丙氨酸1-肽T结合”,Smith C.S.等,Drug DevelopmentRes.,15,371-379页(1988)中描述了一个例子。第二种方法是改变稳定性所需的环状结构,如N到c的链间二酰亚胺和内酰胺(Ede等,Smith和Rivier编,《肽:化学和生物学》(Peptides:Chemistry andBiology),Escom,Leiden,1991,268-270页)。例子见构型限制的胸腺五肽样化合物,如美国专利号4,457,489(1985),Goldstein,G.等所公开的那样,其内容全部纳入本文供参考。第三种方法是用对蛋白水解有抗性的假肽键替换相关蛋白或相关肽中的肽键。
已报道了一些假肽键一般不影响肽的结构和生物活性。此方法的一个例子是取代逆一反转假肽键(“胸腺五肽的生物活性逆反转同源物”)(Biologically activeretroinverso analogue of thymopentin),Sisto A等,Rivier,J.E.和Marshall,G.R.编,“肽、化学、结构和生物学”(Peptides,Chemistry,Structure and Biology),Escom,Leiden,1990,722-773页)和Dalpozzo等(1993),Int.J.Peptide Protein Res.,41:561-566,纳入本文供参考)。根据此修饰,肽的氨基酸序列可能与上述NTP肽、相关蛋白或相关肽的序列相同,除了一个或多个肽键被逆转化假肽键所取代。优选大部分N-末端肽键被取代,由于这种取代将赋于N-末端对抗外肽酶的蛋白水解抗性。也可用其它类似结构的化学基团替代氨基酸的化学基团进行修饰。另一种已知可提高对抗酶裂解的稳定性而生物活性没有或很少损失的合适假肽键,是还原型电子等排物(isostere)假肽键(Couder等(1993),Int.J.Peptide Protein Res.,41:181-184,全部纳入本文供参考)。
因此,这些肽的氨基酸序列可能与NTP肽、相关蛋白或相关肽的序列相同,除了一个或多个肽键被电子等排物假肽键替代外。本文所用术语“氨基酸序列”优选指至少2个氨基酸的序列,优选至少4个,更优选至少5个。优选大部分N-末端肽键被取代,因为这种取代可赋予N-末端对抗外肽酶的蛋白水解抗性。合成具有一个或多个还原型电子等排的假肽键的肽是本领域已知的(Couder等,上面所引用)。另一个例子包括导入酮亚甲基键或甲硫键来替代肽键。
NTP肽、相关蛋白或相关肽的拟肽衍生物代表了另一类肽模拟物,它们保留了生物活性的重要结构决定簇,但去除了肽键,从而赋予对蛋白水解的抗性(Simon等,1992,Proc.Natl.Acad.Sci.USA,89:9367-9371,全部纳入本文供参考)。拟肽是N-取代的甘氨酸的寡聚物。已报道了一些N-烷基基团,各对应于天然氨基酸的侧链(Simon等,1992,见上面所引用)。NTP肽、相关蛋白或相关肽的一些或所有的氨基酸可用对应于被替代氨基酸的N-取代甘氨酸所替代。
术语“肽模拟物”或“模拟物”还包括反-D肽和下面定义的对映异构体。
术语“反-D肽”指与NTP肽、相关蛋白或相关肽的L-氨基酸序列相比,由反向顺序排列的D-氨基酸组成的生物活性蛋白质或肽。因此,L-氨基酸NTP肽、相关蛋白或相关肽的羧基末端残基成为D-氨基酸肽的氨基末端。例如,NTP肽、SSWDY变成TdDdWdSdSd,其中Dd、Sd、Wd和Yd是分别对应于L-氨基酸D、S、W和Y的D-氨基酸。
术语“对映异构体”指一种生物活性蛋白质或肽,其中NTP肽、相关蛋白或相关肽的氨基酸序列中一个或多个L-氨基酸残基被相应的D-氨基酸残基替代。
本文所描述的氨基酸和氨基酸残基可参考下表提供的公众接受的单字母或三字母码。
表1
氨基酸 单字母符 三字母符
丙氨酸 A Ala
精氨酸 R Arg
天冬酰胺 N Asn
天冬氨酸 D Asp
半胱氨酸 C Cys
谷氨酰胺 Q Gln
谷氨酸 E Glu
甘氨酸 G Gly
组氨酸 H His
异亮氨酸 I Ile
亮氨酸 L Leu
赖氨酸 K Lys
甲硫氨酸 M Met
苯丙氨酸 F Phe
脯氨酸 P Pro
丝氨酸 S Ser
苏氨酸 T Thr
色氨酸 W Trp
酪氨酸 Y Tyr
缬氨酸 V Val
本发明涉及含有如本发明以上定义的细胞死亡肽的组合物。优选的细胞死亡肽与NTP肽类似或同源。然而,使用基于相关蛋白的部分或片段的细胞死亡肽也包括在本发明范围之内。例如,在许多人类和非人蛋白质(“相关蛋白”)中也发现了AD7c-NTP肽序列和类似的变体和同源物。特别是,AD7c-NTP基因含有Alu-型序列,它与那些也在人类和其它灵长类基因组的其它基因中发现的序列非常类似。
因此,可以理解,一些(如果不是全部)相关蛋白也将被证明是造成细胞死亡的有效制剂,因为它们含有肽序列与AD7c-NTP肽同源或非常类似(“相关肽”)。同样,此领域的一般技术人员可以基于任何相关蛋白的氨基酸序列来合成特定的相关肽,这些相关蛋白质是造成细胞死亡的有效制剂,并测试它们作为造成细胞死亡制剂的效力。
衍生自相关蛋白(它们被发现是造成细胞死亡的有效制剂)的其它肽序列也是可造成细胞死亡的有效制剂。此领域的一般技术人员无需过多实验就可合成跨越所述蛋白质整个氨基酸序列的有效相关蛋白的片段,以便鉴定其它有效的肽序列。
一些相关蛋白包括以下已知含有与NTP肽序列相同、非常类似或同源的氨基酸的蛋白质。
蛋白质 序列 蛋白质的氨基酸序列
鉴定编号 编号
(PID)
g10121865 20 MEVSPLQPVNENMQVN KIKKNEDAKKRLSVER IYQKKTQLEHILLRPD
TYIGSVELVTQQMWVY DEDVGINYREVTFVPG LYKIFDEILVNAADNK
QRDPKMSCIRVTIDPE NNLISIWNNGKGIPVV EHKVEKMYVPALIFGQ
LLTSSNYDDDEKKVTG GRNGYGAKLCNIFSTK FTVETASREYKKMFKQ
TWMDNMGRAGEMELKP FNGEDYTCITFQPDLS KFKMQSLDKDIVALMV
RRAYDIAGSTKDVKVF LNGNKLPVKGFRSYVD MYLKDKLDETGNSLKV
IHEQVNHRWEVCLTMS EKGFQQISFVNSIATS KGGRHVDYVADQIVTK
LVDVVKKKNKGGVAVK AHQRELCNGAILAHCN LRLMGSSDSPASASRV
AGIAGGCHHTQLIFVF LVETGFHHVGQAGLER LTSGDPPASASQSSGI
TDVKVKNHWMIFVNAL IENPTFDSQTKENMTL QPKSFGSTCQLSEKFI
KAAIGCGIVESILNWV KFKAQVQLNKKCSAVK HNRIKGIPKLDDANDA
GGRNSTECTLILTEGD SAKTLAVSGLGVVGRD KYGVFPLRGKILNVRE
ASHKQ
g10257409 21 MTGDKGPQRLSGSSYG SISSPTSPTSPGPQQA PPRETYLSEKIPIPDT
KPGTFSLRKLWAFTGP GFLMSIAFLDPGNIES DLQAGAVAGFKLLWVL
LWATVLGLLCQRLAAR LGVVTGKDLGEVCHLY YPKSESRSVAQSGVQW
CDVSSLQPLPPRCPAP SSG
g10433567 22 MMLSVQENVHRCICKH YAPPTAPHLFFETESH SVTQAGVQWCDLGSLQ
PSPPGFKQFSCLSLSR SWDYRRVPLCLANFIV FLVETGFCRVGQAGLK
LLTSSDLPASACQSAG DYRHEPLRLALTLCHF ISRTCTSVDFYICRDL
ERIPHGH
g10434441 23 MISAHRNLHLPGSSNS PASAFLSSWDYRHVPP CPANVVFLVEMGFLHV
GQAGLELPTSDDPPTL ASQSAGITGVSHRTWQ EFASLTVSQAVLRMLV
WGPQFENHCSKLLMAS EGDSSLVFFLYPLSNL N
g10436387 24 MQGSHSAVQAGVWWCH HDSLQPWPPGLRRSSC LSLQSLWDYRSLALSL
RLACNGTTSAHCDLCL LSSSDSPASASQVAGI TGEKTAEPHKAHAAQG
ERHLSSHMSPDENMTE KFCPGPRASFHLRILA ASRHLVKRLLNEYTVT
VLRDKSYLRNN
g10437485 25 MKNYYYFLGQGLTLSP RLECSSTISAHCNLHL LGSSNSPVAASPVAGT
TGTCHHDWLIFVFLVE TGFHHIGQTGLEFLTS GDPPTLASKSAGITGV
SHCAWPTFLLNDMRHS FNKNLVIIFYVPAIS
g10441986 26 MRRELLAGILLRITFN FFLFFFLPFPLVVFFI YFYFYFFLEMESHYVA
QAGLELLGSSNPPASA SLVAGTLSVHHCACFE SFTKRKKKLKKAFRFI
QCLLLGLLKVRPLQHQ GVNSCDCERGYFQGIF MQAAPWEGT
g10945428 27 MSKTLKKKKHWLSKVQ ECAVSWAGPPGDFGAE IRGGAERGEFPYLGRL
REEPGGGTCCIVSGKA PNPSDVLLEVNGTPVS GLTNRDTLAVIRHFRE
PIRLKTVKPGKVINKD LRHYLSLQFQKGSIDH KLQQVIRDNLYLRTIP
CTTRAPRDGEVPGVDY NFISVEQFKALEESGA LLESGTYDGNFYGTPK
PPAEPSPFQPDPVDQV LFDNEFDAESQRKRTT SVSKMERMDSSLPEEE
EDEDKGAINGSGNAEN RERHSESSDWMKTVPS YNQTNSSMDFRNYMMR
DETLEPLPKNWEMAYT DTGMIYFIDHNTKTTT WLDPRLCKKAKAPEDC
EDGELPYGWEKIEDPQ YGTYYVDFTLVAQAGV QWHDLGSLQPPPPGFN
HLNQKTQFENPVEEAK RKKQLGQVEIGSSKPD MEKSHFTRDPSQLKGV
LVRASLKKSTMGFGFT IIGGDRPDEFLQVKNV LKDGPAAQDGKIAPGD
VIVDINGNCVFGHTHA DVVQMFQLVPVNQYVN LTLCRGYPLPDDSEDP
VVDIVAATPVINGQSL TKGETCMNPQDFKPGA MVLEQNGKSGHTSTGD
GLNGPSDASEQRVSMA SSGSSQPELVTIPLIK GPKGFGFAIADSPTGQ
KVKMILDSQWCQGLQK EDIIKEIYHQNVQNLT HLQVVEVLKQFPVGAD
VPLLILRGGPPSTTKT AKMKTDKKENAGSLEA INEPIPQPMPFPPSII
RSGSPKLDPSEVYLKS KTLYEDKPPNTKDLDV FLRKQESGFGFRVLGG
DGPDQSIYIGAIIPLG AAEKDGRLRAADELMC IDGIPVKGKSHKQVLD
LMTTAARNGHVLLTVR RKIFYGEKQPEDDSSQ AFISTQNGSPRLNRAE
VPARPAPQEPYDVVLQ RKENEGFGFVILTSKN KPPPGVIPHKIGRVIE
GSPADRCGKLKVGDHI SAVNGQSIVELSHANI VQLIKDAGVTVTLTVI
AEEEHHGPPSGTNSAR QSPALQHRPMGQSQAN HIPGDRSALEGEIGKD
VSTSYRHSWSDHKHLA QPDTAVISVVGSRHNQ NLGCYPVELERGPRGF
GFSLRGGKEYNMGLFI LRLAEDGPAIKDGRIH VGDQIVEINGEPTQGI
THTRAIELIQAGGNKV LLLLRPGTGLIPDHGL APSGLCSYVKPEQH
g1117849 28 MADDQGCIEEQGVEDS ANEDSVDAKPDRSSFV PSLFSKKKKNVTMRSI
KTTRDRVPTYQYNMNF EKLGKCIIINNKNFDK VTGMGVRNGTDKDAEA
LFKCFRSLGFDVIVYN DCSCAKMQDLLKKASE EDHTNAACFACILLSH
GEENMESCSVTQAGVQ RRDLGRLQPPPPRLAE GPSLMMASRPTRGPSM
TQMLILDTRSQWKLTS SSPIPRFQAITRGGAQ EEAPGLCKPSAPSWRS
TEKTWKSCRSSPG
g11493409 29 MGLSIASHFGLLIKKV ERNILFFFRRSLALCQ AGVQWRYLSQLTAASA
SWVQAILCLSLPSSWD YRHMPPRPANFCILSR DGISPCWPGWSRSLDL
VIRPPRPPKVLRLQA
g11493483 30 MQIIFFFLFLRWSFTL VAQAGVQWRDLSSPQP PPPRFKRFSCLSPPSS
WDYRHAPPHPANFVFL VETGFLRVGQAGLELL TSGDPPASASQSAGIT
GVSHHTQPDANNFLRK LFQKLF
g12654881 31 MGHPRAIQPSVFFSPY DVHFLLYPIRCPYLKI GRFHIKLKGLHFLFSF
LFFFFETQSHSVTRLE CSGTISAHCNLCLPGS SNSPASASQVAGTTGT
CHHAQLIFVFLAEMGF HHIGQDGLDLNLVIHP PRSPKALGLQA
g12803929 32 MPNHYSFCFCFCFCFR RSLALSPRLECSGAIL AHGKLHLPGSRHSPAS
ASPVAGTKGARHHARL IFLYF
g13359183 33 LFTNSPFSLLSPAQWL CFGTHLGHVQSVSHLQ WEGSVQESLRSVRNSR
CALPMLSAPCSLSLHF LLFSLSPFFFFEIRVL LYRQAGVQWCYLGSLQ
PLPPGFKQFSCLSYPS SWDYRRPPPRQANFCI FSTDGVSPCWPRWSLS
LDLMIRPPQPPEVLGL QV
g13375624 34 MGRLVLLWGAAVFLLG GWMALGQGGAEGVQIQ IIYFNLETVQVTWNAS
KYSRTNLTFHYRFNGD EAYDQCTNYLLQEGHT SGCLLDAEQRDDILYF
SIRNGTHPVFTASRWM VYYLKPSSPKHVRFSW HQDAVTVTCSDLSYGD
LLYEVQYRSPFDTEWQ TQSRSVTQAGVQWCDL CLLQPSPPRFKRFSCL
SLPSSWDYRHPPPRLA NFCIISRDGVSPCWPG WSRTCDLR
g13376528 35 MEFLKVARRNKREQLE QIQKELSVLEEDIKRV EEMSGLYSPVSEDSTV
PQFEAPSPSHSSIIDS TEYSQPPGFSGSSQAG VQWRYLGSLQPPPPRY
KRFSCLTLPSSWDYRR LPPHLTKKQPWYNSTL ASRRKRLTAHFEDLEQ
CYFSTRMSRISDDSRT ASQLDEFQECLSKFTR YNSVRPLATLSYASDL
YNGSSIVSSIEFDRDC DYFAIAGVTKKIKVYE YDTVIQDAVDIHYPEN
EMTCNSKISCISWSSY HKNLLASSDYEGTVIL WDGFTGQRSKVYQEHE
KRCWSVDFNLMDPKLL ASGSDDAKVKLWSTNL DNSVASIEAKANVCCV
KFSPSSRYHLAFGCAD HCVHYYDLRNTKQPIM VFKGHRKAVSYAKFVS
GEEIVSASTDSQLKLW NVGKPYCLRSFKGHIN EKNFVGLASNGDYIAC
GSENNSLYLYYKGLSK TLLTFKFDTVKSVLDK DRKEDDTNEFVSAVCW
RALPDGESNVLIAANS QGTIKVLELV
g13376550 36 MGSYFVARAGCKLLGL KGTSHFSLPKCRNCRR EPLPGLFFLFFVFFFL
RRSLALSPRLECSGAI VAHCKLGLPGSLHSPA SASQVAGTIGTCHNTR
IIFCILVETGFHRVSQ DGVDLLTL
g13430856 37 MDCGSVGGQRTQRLPG RQRLLFLPVGLSGRPG GSETSARRCPSALSDG
LGALRPRAPAARGGVS RASPLLLLLLVPSPRL AAAAPRRQLGDWERSR
LGYAAPPAGRSGAWRC SPGVAAAAGALPQYHG PAPALVSCRRELSLSA
GSLQLERKRRDFTSSG SRKLYFDTHALVCLLE DNESHSFIQAGVQWHS
LGLLQPPPPGFKRSSH LILLSSWDYRHAPPHL DNFSVFLLETGFHHVG
QAGLKLLTSSDPPTLA S
g13431835 38 MSPATTGTFLLTVYSI FSKVHSDRNVYPSAGV LFVHVLEREYFKGEFP
PYPKPGEISNDPITFN TNLMGYPDRPGWLRYI QRTPYSDGVLYGSPTA
ENVGKPTIIEITAYNR RTFETARHNLIINIMS AEDFPLPYQAEFFIKN
MNVEEMLASEVLGDFL GAVKNVWQPERLNAIN ITSALDRGGRVPLPIN
DLKEGVYVMVGADVPF SSCLREVENPQNQLRC SQEMEPVITCDKKFRT
QFYIDWCKISLVDKTK QVSTYQEVIRGEGILP DGGEYKPPSDSLKSRD
YYTDFLITLAVPSAVA LVLFLILAYIMCCRRE GVEKRNMQTPDIQLVH
HSAIQKSTKELRDMSK NREIAWPLSTLPVFHP VTGEIIPPLHTDNYDS
TNMPLMQTQQWSFAPV AQAGVQWRDLGSLQPP PPRNLPHQTQIPQQQT
TGKWYP
g13435153 39 MLGLRKAAAISLLLRN VGLQLATLLMSQKKLG FCGNFLFLNLAIIQTK
ISSSFFFFLRQSLTLS PRLECNGAISAHCHLR LPDSSNSPASASQVTG
ITGSHHHAWLIFVFLV ETGFCHVGQDGLELLT SGDPPASASQSAGITG
MSHHTWPTDLFFKTVL PARLGLWDSSV
g13489079 40 MHAVPRGFGKKVRVGV QSCPSPFSGQACPQPS SVFWSLLKNLPFLEHL
ELIGSNFSSAMPRNEP AIRNSLPPCSRAQSVG DSEVAAIGQLAFLRHL
TLAQLPSVLTGSGLVN IGPQCQQLRSLSLANL GMMGKVVYMPALSDML
KHCKRLRDLRLEQPYF SANAQFFQALSQCPSL QRLCLVSRSGTLQPDA
VLAFMARCLQVVMCHL FTGESLATCKSLQQSL LRRWGEVTGRRPQLFT
ELREEPSARTSRATGR RQPCLPDSGVVCCPCG RPLAVSGIILVGVSPS
LVVKTTCVYRVLFKNL DYASIFFLVCLFETES HSVVQAGVQWRDLSSL
QPLLSGLQPQPPEQLE NELEIGFSYCFVI
g13489081 41 MEEDEFIGEKTFQRYC AEFIKHSQQIGDSWEW RPSKDCSDGYMCKIHF
QIKNGSVMSHLGASTH GQTCLPMEVKSCSVTQ AGVQLRDLSSLQPPPS
GFKQFSCLSLPSNWDY RGSPLHLANFLYF
g13540498 42 MTTCEFEFIFLKEQVT RICNIAPLKAYFSVHK MGKILKKLSNFSFLTH
RQSLTLSPRLECSGAI SAHCNLHLLGSSNSAA SASRVAGTTGACHHAQ
LIFVFLVETGFHHVGQ DGLGLLTS
g13543287 43 MSCNPSFGGIGKGHLM REVDALDGLCSRICDQ SGVHYKVLNRRKGPAV
WGLRAQIDRKLYKQNM QKEILNTPLLTVQEGA VEDLILTEPEPEHTGK
CRVSGVVLVDGSTVYA ESVILTTGTFLRGMIV IGLETHPAGRLGDQPS
IGLAQTLEKLGFVVGR LKTGTPPRIAKESINF SILNKHIPDNPSIPFS
FTNETVWIKPEDQLPC YLTHTNPRVDEIVLKN LHLNSHVKETTRGPRY
CPSIESKVLRFPNRLH QVWLEPEGMDSDLIYP QGLSMTLPAELQEKMI
TCIRGLEKAKVIQPDG VLLLLPRMECNGAISA HHNLPLPGYGVQYDYL
DPRQITPSLETHLVQR LFFAGQINGTTGYEEA AAQGVIAGINASLRVS
RKPPFVVSRTEGYIGV LIDDLTTLGTSEPYRM FTSRVEFRLSLRPDNA
DSRLTLRGYKDAGCVS QQRYERACWMKSSLEE GISVLKSIEFLSSKWK
KLIPEASISTSRSLPV RALDVLKYEEVDMDSL AKAVPEPLKKYTKCRE
LAERLKIEATYESVLF HQLQEIKGVQQDEALQ LPKDLDYLTIRDVSLS
HEVREKLHFSRPQTIG AASRIPGVTPAAIINL LRFVKTTQRRQSAMNE
SSKTDQYLCDADRLQE REL
g13569856 44 MPFLYDISSCWTSFCF LFFSPLDGVLLCFPGW NAVARSQLTATSASQV
QAILLVSASGVAGIIG TCHHAQPIFVFLVEMG FHHVGQACLKLLNSGD
PPASASQSAGITGMSH HARPFFFFFSF
g13591868 45 MSEAENEFINWVATAA IEANCSQCWLCVELPE AAGNGLPWRIVPANIS
EWICQYQWEWDNTWFC FDFLSQSVSLSPRLEC SGTILAQCNLCLLGSS
DSPASASQVAGIIGAC RHAWLIFCIFSRDGVS PYCPG
g13591870 46 MALFLDKMGSLQKGNY SSQSGMIPGSWQHKMK LQLILKSSKAYYVLSD
AAMSLQKYGRALRYIK LALQSHDTYCCLCTNM LSEVLLFLSQYLTLCG
DIQLMLAQNANNRAAH LEEFHYQTKEDQEILH SLHRESSCQGVPQAWT
TWFTVGLCSLAHAYLS IQKRGRNIRVLIFALY LFIYFLRRSFALVAQA
GVQWCNLGSLKPPPPG FKQFSCLSLPSSWNYR HAPPCPASPPWPPKVL
GLQV
g1362993 47 RSLTLWPSLEYSGTIS AHCNLRLPGSSDSRAS ASRAAGITGVSHCARP
CMLFDPEFDLLAGVQL LPFEPPTGKALSRKD
g13631907 48 MEFRKLRGMETRPPAN TARLQPPRDLRSSSPR KQLSESSDDDYDDVDI
PTPAEDTPPPLPPKPK FRSPSDEGPGSMGDDG QLSPGVLVRCASGPPP
NSPRPGPPPSTSSPHL TAHSEPSLWNPPSREL DKPPLLPPKKEKMKRK
GCALLVKLFNGCPLRI HSTAAWTHPSTKDQHL LLGAEEGIFILNRNDQ
EATLEMLFPSRTTWVY SINNVLMSLSGKTPHL YSHSILGLLERKETRA
GNPIAHISPHRLLARK NMVSTKIQDTKGCRAC CVAEGASSGGPFLCGA
LETSVVLLQWYQPMNK FLLVRQVLFPLPTPLS VFALLTGPGSELPAVC
IGVSPGRPGKSVLFHT VRFGALSCWLGEMSTE HRGPVQVTQVEEDMVM
VLMDGSVKLVTPEGSP VRGLRTPEIPMTEAVE AVAMVGGQLQAFWKHG
VQVWALGSDQLLQELR DPTLTFRLLGSPRLEC SGTISPHCNLLLPGSS
NSPASASRVAGITGL
g13644612 49 MSMVLGGPFSKGHTAS DEYFQIFHNISFFETE SCSVAQAGVQWCNLGS
LQALPPRFTPFSCLSL PSSWDYRHPPPCPDNV FVFSVETGLHCVSQDG
LNLLTL
g13646055 50 MDCGSVGGQRTQRLPG RQRLLFLPVGLSGRPG GSETSARRCLSALSDG
LGALRPRAPAARGGVS RASPLLLLLLVPSPRL AAAAPRRQLGDWERSR
LGYAAPPAGRSSAWRC SPGVAAAAGALPQYHG PAPALVSCRRELSLSA
GSLQLERKRRDFTSSG SRKLYFDTHALVCLLE DNESHSFIQAGVQWHS
LGLLQPPPPGFKRSSH LILLSSWDYRHAPPHL DNFSVFLLETGFHHVG
QAGLKLLTSSDPPTLA S
g13646423 51 MNFFFKTEFLSVTQAG MQWHNFSSLQPLPPGF KQFSCLSLLSSWDYRH
TPPCPANFCIFSRGGV SPCWSGWSRTPDFMIH PPRPPKVLRLQK
g13648611 52 MPLAAYCYLRVVGKGS YGEVTLVKHRRDGKQY VIKKLNLRNASSRERR
AAEQEAQLLSQLKHPN IVTYKESWEGGDGLLY IVMGFCEGGDLYRKLK
EQKGQLLPENQVVEWF VQIAMALQYLHEKHIL HRDLKTQNVFLTRTNI
IKVGDLGIARVLENHC DMASTLIGTPYYMSPE LFSNKPYNYKSDVWAL
GCCVYEMATLKHAFNA KDMNSLVYRIIEGKLP PMPRDYSPELAELIRT
MLSKRPEERPSVRSIL RQPYIKRQISFFLEAT KIKTSKNNIKNGDSQS
KPFATVVSGEAESNHE VIHPQPLSSEGSQTYI MGEGKCLSQEKPRASG
LLKSPASLKAHTCKQD LSNTTELATISSVNID ILPAKGRDSVSDGFVQ
ENQPRYLDASNELGGI CSISQVEEEMLQDNTK SSAQPENLIPMWSSDI
VTGEKNEPVKPLQPLI KEQKPKDQSLALSPKL ECSGTILAHSNLRLLG
SSDSPASASRVAGITG VCHHAQDQVAGECIIE KQGRIHPDLQPHNSGS
EPSLSRQRRQKRREQT EHRGEKRQVRRDLFAF QESPPRFLPSHPIVGK
VDVTSTQKEAENQRRV VTGSVSSSRSSEMSSS KDRPLSARERRRLKQS
QEEMSSSGPSVRKASL SVAGPGKPQEEDQPLP ARRLSSDCSVTQERKQ
IHCLSEDELSSSTSST DKSDGDYGEGKGQTNE INALVQLMTQTLKLDS
KESCEDVPVANPVSEF KLHRKYRDTLILHGKV AEEAEEIHFKELPSAI
MPGSEKIRRLVEVLRT DVIRGLGVQLLEQVYD LLEEEDEFDREVRLRE
HMGEKYTTYSVKARQL KFFEENMNF
g13651342 53 MFISFGRLIFSFFLTW SLSLSPRLECSGTILA HCNPTSQVQAILPASA
SRVAGITGMHHHTCLI FVLLVKMGFCHVGHAG LELVT
g13652010 54 MESGQPSLSFYFLFIY FFEIGSHFVTQAGVQW HNLDSLQLSLASAPQV
AGTTGACHHARLIFGV FCRDWVLPC
g13653409 55 MLLVDADQPEPMRSGA RELALFLTPEPGAEAK EVEETIEGMLLRLEEF
CSLADLIRSDTSQILE ENIPVLKAKLTEMRGI YAKVDRLEAFVKMVGH
HVAFLEADVLQAERDH GAFPQALRRWLGSAGL PSFRNVECSGTIPARC
NLRLPGSSDSPASASQ VAGIPEVTCTGARDVR AAHTV
g13699916 56 MSRGNENRLTHRRQTV LREKGRRLANRGPAYM FNDHSTSLSIEEERFL
DAAEYGNIPVVRKMLE ECLSLNVNCVDYMGQN ALQLAVANEHLEITEL
LLKKENLSRVGDALLL AISKGYVRIVEAILNH PAFAEGKRLATSPSQS
ELQQDDFYAYDEDGTR FSHDVTPIILAAHCQE YEIVHTLLRKGARIER
PHDYFCKCTECSQKQK HDSFSHSRSRINAYKG LASPAYLSLSSEDPVM
TALELSNELAVLANIE KEFKNDYRKLSMQCKD FVVGLLDLCRNTEEVE
AILNGDAETRQPGDLA RPNLSRLKLAIKYEVK KFVAHPNCQQQLLSIW
YENLSGLRQQTMAVKF LVVLAVAIGLPFLALI YWCAPCSKMGKILRGP
FMKFVAHAASFTIFLG LLVMNAADRFEGTKLL PNETSTDNARQLFRMK
TSCFSWMEMLIISWVI GMIWAECKEIWTQGPK EYLFELWNMLDFGMLA
IFAASFIARFMAFWHA SKAQSIIDANDTLKDL TKVTLGDNVKYYNLAR
IKWDPTDPQIISEGLY AIAVVLSFSRIAYILP ANESFGPLQISLGRTV
KDIFKFMVIFIMVFVA FMIGMFNLYSYYIGAK QNEAFTTVEESFKTLF
WAIFGLSEVKSVVINY NHKFIENIGYVLYGVY NVTMVIVLLNMLIAMI
NSSFQEIEDDADVEWK FARAKLWFSYFEEGRT LPVPFNLVPSPKSLLY
LLLKFKKWMSELIQGH KKGFQEDAEMNKRNEE KKFGILGSHEDLSKFS
LDRNQLAHNKQSSTRS SEDFHLNSFSNPPRQY QKIMKRLIKRYVLQAQ
IDKESDEVNEGELKEI KQDISSLRYELLEEKS QNTEDLAELIRKLGER
LSLESKQEESRR
g13702149 57 MSRGNENRLTHRRQTV LREKGRRLANRGPAYM FNDHSTSLSIEEERFL
DAAEYGNIPVVRKMLE ECLSLNVNCVDYMGQN ALQLAVANEHLEITEL
LLKKENLSRVGDALLL AISKGYVRIVEAILNH PAFAEGKRLATSPSQS
ELQQDDFYAYDEDGTR FSHDVTPIILAAHCQE YEIVHTLLRKGARIER
PHDYFCKCTECSQKQK HDSFSHSRSRINAYKG LASPAYLSLSSEDPVM
TALELSNELAVLANIE KEFKNDYRKLSMQCKD FVVGLLDLCRNTEEVE
AILNGDAETRQPGDLA RPNLSRLKLAIKYEVK KFVAHPNCQQQLLSIW
YENLSGLRQQTMAVKF LVVLAVAIGLPFLALI YWCAPCSKMGKILRGP
FMKFVAHAASFTIFLG LLVMNAADRFEGTKLL PNETSTDNARQLFRMK
TSCFSWMEMLIISWVI GMIWAECKEIWTQGPK EYLFELWNMLDFGMLA
IFAASFIARFMAFWHA SKAQSIIDANDTLKDL TKVTLGDNVKYYNLAR
IKWDPTDPQIISEGLY AIAVVLSFSRIAYILP ANESFGPLQISLGRTV
KDIFKFMVIFIMVFVA FMIGMFNLYSYYIGAK QNEAFTTVEESFKTLF
WAIFGLSEVRSVVINY NHKFIENIGYVLYGVY NVTMVIVLLNMLIAMI
NSSFQEIERNEEKKFG ILGSHEDLSKFSLDRN QLAHNKQSSTRSSEDF
HLNSFSNPPRQYQKIM KRLIKRYVLQAQIDKE SDEVNEGELKEIKQDI
SSLRYELLEEKSQNTE DLAELIRRLGERLSLE SKQEESRR
g14043238 58 MESRSVAQAGVQWPDL GSLQPLPPRFKRFFCL SLQSSWDYRHAPPRPA
NFVFLVETGFCHVSQA GLELLTSSDPPPRPPK VLR
g14192931 59 MISVHCNLCLPGSSDP PASASQVAGITGVRHC MASGAVLNKVRRHQCS
GDLEVRGSHGSLGEAP WGKSVPGRGTASRKGP GAGVIGNSKEASTGRA
QWSAPVIPATQEAKAG GLLEPRSLISAWATYQ DLISINKLKEKRG
g14198309 60 MTRSLFKGNFWSADIL STIGYDNIIQHLNNGR KNCKEFEDFLKERAAI
EERYGKDLLNLSRKKP CGQSEINTLKRALEVF KQQVDNVAQCHIQLAQ
SLREEARKMEEFREKQ KLQRKKMESHSVTQAG AQWHDLGSLQALPPGF
MPFSCLSLPSSWNYRL PPPPRLAEPRNQDHGV A
g14249973 61 MESHSVTQAGVQWRDL GSLQPLPPGFKQFSHL SLPSSWDYRRVPPYLG
NFCIFSGEGVSPCWPG WS
g16226025 62 MGSLSTANVEFCLDVF KELNSNNIGDNIFFSS LSLLYALSMVLLGARG
ETAEQLEKVLHFSHTV DSLKPGFKDSPKCSQA GRIHSEFGVEFSQINQ
PDSNCTLSIANRLYGT KTMAFHQQYLSCSEKW YQARLQTVDFEQSTEE
TRKTINAWVENKTNGK VANLFGKSTIDPSSVM VLVNTIYFKGQRQNKF
QVRETVKSPFQLSEGK NVTVEMMYQIGTFKLA FVKEPQMQVLELPYVN
NKLSMIILLPVGIANL KQIEKQLNSGTFHEWT SSSNMMEREVEVHLPR
FKLEIKYELNSLLKPL GVTDLFNQVKADLSGM SPTKGLYLSKAIHKSY
LDVSEEGTEAAAATGD SIAVKSLPMRAQFKAN HPFLFFIRHTHTNTIL
FCGKLASP
g16517174 63 MAQFYYKRNVNAPYRD RIPLRIVRAESELSPS EKAYLNAVEKGDYASV
KKSLEEAEIYFKININ CIDPLGRTALLIAIEN ENLELIELLLSFNVYV
GDALLHAIRKEVVGAV ELLLNHKKPSGEKQVP PILLDKQFSEFTPDIT
PIILAAHTNNYEIIKL LVQKGVSVPRPHEVRC NCVECVSSSDVDSLRH
SRSRLNIYKALASPSL IALSSEDPFLTAFQLS WELQELSKVENEFKSE
YEELSRQCKQFAKDLL DQTRSSRELEIILNYR DDNSLIEEQSGNDLAR
LKLAIKYRQKEFVAQP NCQQLLASRWYDEFPG WRRRHWAVKMVTCFII
GLLFPVFSVCYLIAPK SPLGLFIRKPFIKFIC HTASYLTFLFLLLLAS
QHIDRSDLNRQGPPPT IVEWMILPWVLGFIWG EIKQMWDGGLQDYIHD
WWNLMDFVMNSLYLAT ISLKIVAFVKYSALNP RESWDMWHPTLVAEAL
FAIANIFSSLRLISLF TANSHLGPLQISLGRM LLDILKFLFIYCLVLL
AFANGLNQLYFYYEET KGLTCKGIRCEKQNNA FSTLFETLQSLFWSIF
GLINLYVTNVKAQHEF TEFVGATMFGTYNVIS LVVLLNMLIAMMNNSY
QLIADHADIEWKFART KLWMSYFEEGGTLPTP FNVIPSPKSLWYLIKW
IWTHLCKKKMRRKPES FGTIGVRTQHRRAADN LRRHHQYQEVMRNLVK
RYVAAMIRDAKTEEGL TEENFKELKQDISSFR FEVLGLLRGSKLSTIQ
SANASKESSNSADSDE KSDSEGNSKDKKKNFS LFDLTTLIHPRSAAIA
SERHNISNGSALVVQE PPREKQRKVNFVTDIK NFGLFHRRSKQNAAEQ
NANQIFSVSEEVARQQ AAGPLERNIQLESRGL ASRGDLSIPGLSEQCV
LYDHRERNTDTLGLQV GKRVCPFKSEKVVVED TVPIIPKEKHAKEEDS
SIDYDLNLPDTVTHED YVTTRL
g16517176 64 MAQFYYKRNVNAPYRD RIPLRIVRAESELSPS EKAYLNAVEKGDYASV
KKSLEEAEIYFKININ CIDPLGRTALLIAIEN ENLELIELLLSFNVYV
GDALLHAIRKEVVGAV ELLLNHKKPSGEKQVP PILLDKQFSEFTPDIT
PIILAAHTNNYEIIKL LVQKGVSVPRPHEVRC NCVECVSSSDVDSLRH
SRSRLNIYKALASPSL IALSSEDPFLTAFQLS WELQELSKVENEFKSE
YEELSRQCKQFAKDLL DQTRSSRELEIILNYR DDNSLIEEQSGNDLAR
LKLAIKYRQKEASYGE KLNRCGMADFRTTSMI GGI
g16758330 65 MSQSPGFVTRRGGSPK AAPGAGARRNESQDYL LMDELGDDGYPQLQQP
PYGYYPSFRGNENRLT HRRQTVLREKGRRLAN RGPAYMFNDHSTSLSI
EEERFLDAAEYGNIPV VRKMLEECLSLNVNCV DYMGQNALQLAVANEH
LEITELLLKKENLSRV GDALLLAISKGYVRIV EAILNHPAFAEGKRLA
TSPSQSELQQDDFYAY DEDGTRFSHDVTPIIL AAHCQEYEIVHTLLRK
GARIERPHDYFCKCTE CSQKQKHDSFSHSRSR INAYKGLASPAYLSLS
SEDPVMTALELSNELA VLANIEKEFKNDYRKL SMQCKDFVVGLLDLCR
NTEEVEAILNGDAETR QPGDLARPNLSRLKLA IKYEVKKFVAHPNCQQ
QLLSIWYENLSGLRQQ TMAVKFLVVLAVAIGL PFLALIYWCAPCSKMG
KILRGPFMKFVAHAAS FTIFLGLLVMNAADRF EGTKLLPNETSTDNAR
QLFRMKTSCFSWMEML IISWVIGMIWAECKEI WTQGPKEYLFELWNML
DFGMLAIFAASFIARF MAFWHASKAQSIIDAN DTLKDLTKVTLGDNVK
YYNLARIKWDPTDPQI ISEGLYAIAVVLSFSR IAYILPANESFGPLQI
SLGRTVKDIFKFMVIF IMVFVAFMIGMFNLYS YYIGAKQNEAFTTVEE
SFKTLFWAIFGLSEVK SVVINYNHKFIENIGY VLYGVYNVTMVIVLLN
MLIAMINSSFQEIEDD ADVEWKFARAKLWFSY FEEGRTLPVPFNLVPS
PKSLLYLLLKFKKWMS ELIQGHKKGFQEDAEM NKRNEEKKFGILGSHE
DLSKFSLDRNQLAHNK QSSTRSSEDFHLNSFS NPPRQYQKIMKRLIKR
YVLQAQIDKESDEVNE GELKEIKQDISSLRYE LLEEKSQNTEDLAELI
RKLGERLSLESKQEES RR
g1710216 66 MGHPRAIQPSVFFSPY DVHFLLYPIRCPYLKI GRFHIKLKGLHFLFSF
LFFFFETQSHSVTRLE CSGTISAHCNLCLPGS SNSPASASRVAGTAGT
CRRAQLIFVFLAEMGF HHVGRDGLDLNLVIHP PRSPKALGLQA
g17978303 67 MGSLSTANVEFCLDVF KELNSNNIGDNIFFSS LSLLYALSMVLLGARG
ETAEQLEKVLHFSHTV DSLKPGFKDSPKCSQA GRIHSEFGVEFSQINQ
PDSNCTLSIANRLYGT KTMAFHQQYLSCSEKW YQARLQTVDFEQSTEE
TRKMINAWVENKTNGK VANLFGKSTIDPSSVM VLVNTIYFKGQRQNKF
QVRETVKSPFQLSEGK NVTVEMMYQIGTFKLA FVKEPQMQVLELPYVN
NKLSMIILLPVGIANL KQIEKQLNSGTFHEWT SSSNMMEREVEVHLPR
FKLEIKYELNSLLKPL GVTDLFNQVKADLSGM SPTKGLYLSKAIHKSY
LDVSEEGTEAAAATGD SIAVKSLPMRAQFKAN HPFLFFIRHTHTNTIL
FCGKLASP
g18376629 68 MLRNSTFKNMQRRHTT LREKGRRQAIRGPAYM FNEKGTSLTPEEERFL
DSAEYGNIPVVRKMLE ESKTLNFNCVDYMGQN ALQLAVGNEHLEVTEL
LLKKENLARVGDALPL AISKGYVRIVEAILNH PAFAQGQRLTLSPLEQ
ELRDDDFYAYDEDGTR FSHDITPIILAAHCQE YEIVHILLLKGARIER
PHDYFCKCNECTEKQR KDSFSHSRSRMNAYKG LASAAYLSLSSEDPVL
TALELSNELARLANIE TEFKNDYRKLSMQCKD FVVGVLDLCRDTEEVE
AILNGDVNFQVWSDHH RPSLSRIKLAIKYEVK KFVAHPNCQQQLLTMW
YENLSGLR(QQSIAVKF LAVFGVSI)GLPFLAIA YWIAPCSKLGRTLRSP
FMKFVAHAVSFTIFLG LLVVNASDRFEGVKTL PNETFTDYPKQIFRVK
TTQFSWTEMLIMKWVL GMIWSECKEIWEEGPR EYVLHLWNLLDFGMLS
IFVASFTARFMAFLKA TEAQLYVDQHVQDDTL HNVSLPPEVAYFTYAR
DKWWPSDPQIISEGLY AIAVVLSFSRIAYILP ANESFGPLQISLGRTV
KDIFKFMVIFIMVFVA FMIGMFNLYSYYRGAK YNPAFTTVEESFKTLF
WSIFGLSEVISVVLKY DHKFIENIGYVLYGVY NVTMVVVLLNMLIAMI
NNSYQEIEEDADVEWK FARAKLWLSYFDEGRT LPAPFNLVPSPKSFYY
LIMRIKMCLIKLCKSK AKSCENDLEMGMLNSK FKKTRYQAGMRNSENL
TANNTLSKPTRYQKIM KRLIKRYVLKAQVDRE NDEVNEGELKEIKQDI
SSLRYELLEEKSQATG ELADLIQQLSEKFGKN LNKDHLRVNKGKDI
g1843388 69 MKVRLLRQLSAAAKVK APSGLQGPPQAHQFIS LLLEEYGALCQAARSI
STFLGTLENEHLKKFQ VTWELHNKHLFENLVF SEPLLQSNLPALVSQI
RLGTTTHDTCSEDTYS TLLQRYQRSEEELRRV AEEWLECQKRIDAYVD
EQMTMKTKQRMLTEDW ELFKQRRFIEEQLTNK KAVTGENNFTDTMRHV
LSSRLSMPDCPNCNYR RRCACDDCSLSHILTC GIMDPPVTDDIHIHQL
PLQVDPAPDYLAERSP PSVSSASSGSGSSSPI TIQQHPRLILTDSGSA
PTFCSDDEDVAPLSAK FADIYPLSNYDDTEVV ANMNGIHSELNGGGEN
MALKDESPQISSTSSS SSEADDEEADGESSGE PPGAPKEDGVLGSRSP
RTEESKADSPPPSYPT QQAEQAPNTCECHVCK QEASGLTPSAMTAGAL
PPGHQFLSPEKPTHPA LHLYPHIHGHVPLHTV PHLPRPLIHPTLYATP
PFTHSKALPPAPVQNH TNKHQVFNASLQDHIY PSCFGNTPEWNSSKFI
SLWGSEVMNDKNWNPG TFLPDTISGSEILGPT LSETRPEALPPPSSNE
TPAVSDSKEKKNAAKK KCLYNFQDAFMEANKV VMATSSATSSVSCTAT
TVQSSNSQFRVSSKRP PSVGDVFHGISKEDHR HSAPAAPRNSPTGLAP
LPALSPAALSPAALSP ASTPHLANLAAPSFPK TATTTPGFVDTRKSFC
PAPLPPATDGSISAPP SVCSDPDCEGHRCENG VYDPQQDDGDESADED
SCSEHSSSTSTSTNQK EGKYCDCCYCEFFGHG GPPAAPTSRNYAEMRE
KLRLRLTKRKEEQPKK MDQISERESVVDHRRV EDLLQFINSSETKPVS
STRAAKRARHKQRKLE EKARLEAEARAREHLH LQEEQRRREEEEDEEE
EEDRFKEEFQRLQELQ KLRAVKKKKKERPSKD CPKLDMLTRNFQAATE
SVPNSGNIHNGSLEQT EEPETSSHSPSRHMNH SEPRPGLGADGDAADP
VDTRDSKFLLPKEVNG KQHEPLSFFFDIMQHH KEGNGKQKLRQTSKAS
SEPARRPTEPPKATEG QSKPRAQTESKAKVVD LMSITEQKREERKVNS
NNNNKKQLNHIKDEKS NPTPMEPTSPGEHQQN SKLVLAESPQPKGKNK
KNKKKKGDRVNNSIDG VSLLLPSLGYNGAILA HCNLRLPGSSDCAASA
SQVVGITDDVFLPKDI DLDSVDMDETEREVEY FKRFCLDSARQTRQRL
SINWSNFSLKKATFAA H
g20140144 70 MGSLSTANVEFCLDVF KELNSNNIGDNIFFSS LSLLYALSMVLLGARG
ETAEQLEKVLHFSHTV DSLKPGFKDSPKCSQA GRIHSEFGVEFSQINQ
PDSNCTLSIANRLYGT KTMAFHQQYLSCSEKW YQARLQTVDFEQSTEE
TRKMINAWVENKTNGK VANLFGKSTIDPSSVM VLVNIIYFKGQRQNKF
QVRETVKSPFQLSEGK NVTVEMMYQIGTFKLA FVKEPQMQVLELPYVN
NKLSMIILLPVGIANL KQIEKQLNSGTFHEWT SSSNMMEREVEVHLPR
FKLEIKYELNSLLKPL GVTDLFNQVKADLSGM SPTKGLYLSKAIHKSY
LDVSEEGTEAAAATGD SIAVKSLPMRAQFKAN HPFLFFIRHTHTNTIL
FCGKLASP
g20476660 71 MMAALYPSTDLSGASS SSLPSSPSSSSPNEVM ALKDVREVKEENTLNE
KLFLLACDKGDYYMVK KILEENSSGDLNINCV DVLGRNAVTITIENEN
LDILQLLLDYGCQSAD ALLVAIDSEVVGAVDI LLNHRPKRSSRPTIVK
LMERIQNPEYSTTMDV APVILAAHRNNYEILT MLLKQDVSLPKPHAVG
CECTLCSAKNKKDSLR HSRFRLDIYRCLASPA LIMLTEEDPILRAFEL
SADLKELSLVEVEFRN DYEELARQCKMFAKDL LAQARNSRELEVILNH
TSSDEPLDKRGLLEER MNLSRLKLAIKYNQKE FVSQSNCQQFLNTVWF
GQMSGYRRKPTCKKIM TVLTVGIFWPVLSLCY LIAPKSQFGRIIHTPF
MKFIIHGASYFTFLLL LNLYSLVYNEDKKNTM GPALERIDYLLILWII
GMIWSDIKRLWYEGLE DFLEESRNQLSFVMNS LYLATFALKVVAHNKF
HDFADRKDWDAFHPTL VAEGLFAFANVLSYLR LFFMYTTSSILGPLQI
SMGQMLQDFGKFLGMF LLVLFSFTIGLTQLYD KGYTSKEQKDCVGIFC
EQQSNDTFHSFIGTCF ALFWYIFSLAHVAIFV TRFSYGEELQSFVGAV
IVGTYNVVVVIVLTKL LVAMLHKSFQLIANHE DKEWKFARAKLWLSYF
DDKCTLPPPFNIIPSP KTICYMISSLSKWICS HTSKGKVKRQNSLKEW
RNLKQKRDENYQKVWC CLVHRYLTSMRQKMQS TDQATVENLNELRQDL
SKFRNEIRDLLGFRTS KYAMFYPRN
g20546044 72 MAQFYYKRNVNAPYRD RIPLRIVRAESELSPS EKAYLNAVEKGDYASV
KKSLEEAEIYFKININ CIDPLGRTALLIAIEN ENLELIELLLSFNVYV
GDALLHAIRKEVVGAV ELLLNHKKPSGEKQVP PILLDKQFSEFTPDIT
PIILAAHTNNYEIIKL LVQKGVSVPRPHEVRC NCVECVSSSDVDSLRH
SRSRLNIYKALASPSL IALSSEDPFLTAFQLS WELQELSKVENEFKSE
YEELSRQCKQFAKDLL DQTRSSRELEIILNYR DDNSLIEEQSGNDLAR
LKLAIKYRQKEFVAQP NCQQLLASRWYDEFPG WRRRHWAVKMVTCFII
GLLFPVFSVCYLIAPK SPLGLFIRKPFIKFIC HTASYLTFLFLLLLAS
QHIDRSDLNRQGPPPT IVEWMILPWVLGFIWG EIKQMWDGGLQDYIHD
WWNLMDFVMNSLYLAT ISLKIVAFVKYSALNP RESWDMWHPTLVAEAL
FAIANIFSSLRLISLF TANSHLGPLQISLGRM LLDILKFLFIYCLVLL
AFANGLNQLYFYYEET KGLTCKGIRCEKQNNA FSTLFETLQSLFWSIF
GLINLYVTNVKAQHEF TEFVGATMFGTYNVIS LVVLLNMLIAMMNNSY
QLIADHADIEWKFART KLWMSYFEEGGTLPTP FNVIPSPKSLWYLIKW
IWTHLCKKKMRRKPES FGTIGVRTQHRRAADN LRRHHQYQVIMRNLVK
RYVAAMIRDAKTEEGL TEENFKELKQDISSFR FEVLGLLRGSKLSTIQ
SANASKESSNSADSDE KSDSEGNSKDKKKNFS LFDLTTLIHPRSAAIA
SERHNISNGSALVVQE PPREKQRKVNFVTDIK NFGLFHRRSKQNAAEQ
NANQIFSVSEEVARQQ AAGPLERNIQLESRGL ASRGDLSIPGLSEQCV
LVDHRERNTDTLGLQV GKRVCPFKSEKVVVED TVPIIPKEKHAKEEDS
SIDYDLNLPDTVTHED YVTTRL
g20881287 73 MSQSPRFVTRRGGSLK AAPGAGTRRNESQDYL LMDELGDDGYPQLPLP
PYGYYPSFRGNENRLT HRRQTILREKGRRLAN RGPAYMFNDHSTSLSI
EEERFLDAAEYGNIPV VRKMLEECHSLNVNCV DYMGQNALQLAVANEH
LEITELLLKKENLSRV GDALLLAISKGYVRIV EAILNHPAFAEGKRLA
TSPSQSELQQDDFYAY DEDGTRFSHDVTPIIL AAHCQEYEIVHTLLRK
GARIERPHDYFCKCTE CSQKQKHDSFSHSRSR INAYKGLASPAYLSLS
SEDPVMTALELSNELA VLANIEKEFKNDYRKL SMQCKDFVVGLLDLCR
NTEEVEAILNGDAETR QPGDFGRPNLSRLKLA IKYEVKKFVAHPNCQQ
QLLSIWYENLSGLRQQ TMAVKFLVVLAVAIGL PFLALIYWCAPCSKMG
KILRGPFMKFVAHAAS FTIFLGLLVMNAADRF EGTKLLPNETSTDNAR
QLFRMKTSCFSWMEML IISWVIGMIWAECKEI WTQGPKEYLFELWNML
DFGMLAIFAASFIARF MAFWHASKAQSIIDAN DTLKDLTKVTLGDNVK
YYNLARIKWDPTDPQI ISEGLYAIAVVLSFSR IAYILPANESFGPLQI
SLGRTVKDIFKFMVIF IMVFVAFMIGMFNLYS YYIGAKQNEAFTTVEE
SFKTLFWAIFGLSEVK SVVINYNHKFIENIGY VLYGVYNVTMVIVLLN
MLIAMINSSFQEIEDD ADVEWKFARAKLWFSY FEEGRTLPVPFNLVPS
PKSLLYLLLKFKKWMC ELIQGQKQGFQEDAEM NKRNEEKKFGISGSHE
DLSKFSLDKNQLAHNK QSSTRSSEDYHLNSFS NPPRQYQKIMKRLIKR
YVLQAQIDKESDEVNE GELKEIKQDISSLRYE LLEEKSQNTEDLAELI
RKLGERLSLEPKLEES RR
g2105420 74 PSGLPLLPVLFALGGL LLLSNASCVGGVLWQR RLRRLAEALNFPPHLH
PGRSEEDRVRNEYEES QWTGERDTQSSTVSTT EAEPYYRSLRDFSPQL
PPTQEEVSYSRGFTGE DEDMAFPGHLYDEVER TYPPSGAWGPLYDEVQ
MGPWDLHWPEDTYQDP RGIYDQVAGDLDTLEP DSLPFELRGHLVWGFN
HVSQAGLKLLASSDPP ASASQSAEITESHSVV QVGVQWRYFGSLHPLP
PGSRDSLASASRIAGI TAPWEAEVSRSPQGTQ DSPVTRSGPPSRGWQS
LSFDGGAFHLKGTGEL TRALLVLRLCAWPPLV THGLLLQAWSRRLLGS
RLSGAFLRASVYGQFV AGETAEEVKGCVQQLR TLSLRPLLAVPTEEEP
DSAAKRMRLHHVGQAG LELLTPAASGSVAQAG VQWRQSSDRGGGNQAA
ASRSSLLQEAAFSPPC GRLQLPAQPASRHGAR GRGSMKAKSLTSRHLL
ASQGQETIIKTKVRIP ALWKAEPGQHSKTPSQ QNKSQYVTTLWEADVG
RSLENLQVSCLNAEQN QHLRASLSRLHRVTPP AGTSTSGPPSAACIGW
HSRLHRVAQYARAQHV RLLVDAEYTSLNPALS LLVAALAVRWNSPGEG
GPWVWNTYQACLKDTF ERLGRDAEAAHRAGLA FGVKLVRGAYLDKERA
VAQLHGMEDPTQPDYE ATSELNRASPFSYSRC LELMLTHVARHGPMCH
LMVASHNEESVRQATK RMWELGIPLDGTVCFG QLLGMCDHVSLALGQA
GYVVYKSIPYGSLEEV IPYLIRRAQENRSVLQ GARREQELLSQELWRR
LLPGCRRIPH
g2119643 75 SCSVTLAGVQWRDLGL LQPLPPKFKRFSCLSF PSSWDYR
g2119644 76 EMEFNCESCSVTLAGV QWRDLGLLQPLPPKFK RFSCLSFPSSWDYR
g2136328 77 MCPGIPGPRAEAAVGT THPFSSPGAWLGSGSG SGPVGAPPPSPGLPPS
WAAMMAALYPSTDLSG ASSSSLPSSPSSSSPN EVMALKDVREVKEENT
LNEKLFLLACDKGDYY MVKKILEENSSGDLNI NCVDVLGRNAVTITIE
NENLDILQLLLDYGCQ KLMERIQNPEYSTTMD VAPVILAAHRNNYEIL
TMLLKQDVSLPKPHAV GCECTLCSAKNKKDSL RHSRFRLDIYRCLASP
ALIMLTEEDPILRAFE LSADLKELSLVEVEFR NDYEELARQCKMFAKD
LLAQARNSRELEVILN HTSSDEPLDKRGLLEE RMNLSRLKLAIKYNQK
EFVSQSNCQQFLNTVW FGQMSGYRRKPTCKKI MTVLTVGIFWPVLSLC
YLIAPKSQFGRIIHTP FMKFIIHGASYFTFLL LLNLYSLVYNEDKKNT
MGPALERIDYLLILWI IGMIWSDIKRLWYEGL EDFLEESRNQLSFVMN
SLYLATFALKVVAHNK FHDFADRKDWDAFHPT LVAEGLFAFANVLSYL
RLFFMYTTSSILGPLQ ISMGQMLQDFGKFLGM FLLVLFSFTIGLTQLY
DKGYTSKEQKDCVGIF CEQQSNDTFHSFIGTC FALFWYIFSLAHVAIF
VTRFSYGEELQSFVGA VIVGTYNVVVVIVLTK LLVAMLHKSFQLIANH
EDKEWKFARAKLWLSY FDDKCTLPPPFNIIPS PKTICYMISSLSKWIC
SHTSKGKVKRQNSLKE WRNLKQKRDENYQKVM CCLVHRYLTSMRQKMQ
STDQATVENLNELRQD LSKFRNEIRDLLGFRT SKYAMFYPRN
g3766191 78 MSRGNENRLTHRRQTI LREKGRRLANRGPAYM FNDHSTSLSIEEERFL
DAAEYGNIPVVRKMLE ECHSLNVNCVDYMGQD ALQLAVANEHLEITEL
LLKKENLSRVGDALLL AISKGYVRIVEAILNH PAFAEGKRLATSPSQS
ELQQDDFYAYDEDGTR FSHDVTPIILAAHCQE YEIVHTLLRKGARIER
PHDYFCKCTECSQKQK HDSFSHSRSRINAYKG LASPAYLSLSSEDPVM
TALELSNELAVLANIE KEFKNDYRKLSMQCKD FVVGLLDLCRNTEEVE
AILNGDAETRQPGDFG RPNLSRLKLAIKYEVK KFVAHPNCQQQLLSIW
YENLSGLRQQTMAVKF LVVLAVAIGLPFLALI YWCAPCSKMGKILRGP
FMKFVAHAASFTIFLG LLVMNAADRFEGTKLL PNETSTDNARQLFRMK
TSCFSWMEMLIISWVI GMIWAECKEIWTQGPK EYLFELWNMLDFGMLA
IFAASFIARFMAFWHA SKAQSIIDANDTLKDL TKVTLGDNVKYYNLAR
IKWDPTDPQIISEGLY AIAVVLSFSRIAYILP ANESFGPLQISLGRTV
KDIFKFMVIFIMVFVA FMIGMFNLYSYYIGAK QNEAFTTVEESFKTLF
WAIFGLSEVKSVVINY NHKFIENIGYVLYGVY NVTMVIVLLNMLIAMI
NSSFQEIEDDADVEWK FARAKLWFSYFEEGRT LPVPFNLVPSPKSLLY
LLLKFKKWMCELIQGQ KQGFQEDAEMNKRNEE KKFGISGSHEDLSKFS
LDKNQLAHNKQSSTRS SEDYHLNSFSNPPRQY QKIMKRLIKRYVLQAQ
IDKESDEVNEGELKEI KQDISSLRYELLEEKS QNTEDLAELIRKLGER
LSLEPKLEESRR
g403460 79 DRLSLLSPRLECNGMI LAHCKLRLPGFKRFSC LSLPSSWDYRHVPPRQ
VHFVFSVETGFHRAGQ AGLELLTSSVPPTSAF PKCWDYRRDDQAWPTL
SSFRGLNKFAFLPKFF AHPISQFQRVECNVGC PILLAMKYLAYSSLPG
ADTMLYFYFYEQEASL AVCNICRQKFHWVLYQ ISHLYRGVIVDNFLLH
PDGRFTWTIFFLSWVK QNSLYDFFFGTESRSV ALLPRLECSGAMSTLH
TVLRPAYSHIYHPDVK EKTHFLGNVFNKRKLQ KKILKTPNPLCALHSA
PSPSLPPFLRCTGRLP FYLGLDDFLFVAGALM FLPVSFLNPHTLTWPP
QCCTRSDCNPLRGQRE ISALSHSLPTGLSMPL
g4200234 80 MAALYACTKCHQRFPF EALSQGQQLCKECRIA HPVVKCTYCRTEYQQE
RLECNGTISAHCNLHL PGSSDSPASSSRVAGI TGIKTNTICKKCAQNV
QLYGTPKPCQYCNIIA AFIGNKCQRCTNSEKK YGPPYSCEQCKQQCAF
DRKDDRKKVDGKLLCW LCTLSYKRVLQKTKEQ RKHLSSSSRAGHQEKE
QYSRLSGGGHYNSQKT LSTSSIQNEIPKKKSK FESITTNGDSFSPDLA
LDSPGTDHFVIIAQLK EEVATLKKMLHQKDQM ILEKEKKITELKADFQ
YQESQMRAKMNQMEKT HKEVTEQLQAKNRELL KQAAALSKSKKSEKSG
AITSP
g4200238 81 MAALYACTKCHQRFPF EALSQGQQLCKECRIA HPVVKCTYCRTEYQQE
RLECNGTISAHCNLHL PGSSDSPASSSRVAGI TGIKTNTICKKCAQNV
QLYGTPKPCQYCNIIA AFIGNKCQRCTNSEKK YGPPYSCEQCKQQCAF
DRKDDRKKVDGKLLCW LCTLSYKRVLQKTKEQ RKHLSSSSRAGHQEKE
QYSRLSGGGHYNSFSP DLALDSPGTDHFVIIA QLKEEVATLKKMLHQK
DQMILEKEKKITELKA DFQYQESQMRAKMNQM EKTHKEVTEQLQAKNR
ELLKQAAALSKSKKSE KSGAITSP
g423149 82 FFFFFFETESCSVAEA GVQWCDLGSLKSPPPG SSDSPASASRVAGITG
MHHHTQLIFVFLVETG SHMQLSDSTLVITTAQ NAKITARAPRDLFFFF
FFFF
g4336401 83 LPLLPRMECRGMISAH CNLCRSGSSDSPASAS RVAGITGTCHHAQLSF
PFFLFMRW
g4336402 84 LPLLPRMECRGMISAH CNLCRSGSSDSPASAS RVAGITGTCHHAQL
g4379098 85 MDIEDEENMSSSSTDV KENRNLDNVSPKDGST PGPGEGSQLSNGGGGG
PGRKRPLEEGSNGHSK YRLKKRRKTPGPVLPK NALMQLNEIKPGLQYT
LLSQTGPVHAPLFVMS VEVNGQVFEGSGPTKK KAKLHAAEKALRSFVQ
FPNASEAHLAMGRTLS VNTDFTSDQADFPDTL FNGFETPDKAEPPFYV
GSNGDDSFSSSGDLSL SASPVPASLAQPPLPV LPPFPPPSGKNPVMIL
NELRPGLKYDFLSESG ESHAKSFVMSVVVDGQ FFEGSGRNKKLAKARA
AQSALAAIFNLHLDQT PSRQPIPSEGLQLHLP QVLADAVSRLVLGKFG
DLTDNFSSPHARRKVL AGVVMTTGTDVKDAKV ISVSTGTKCINGEYMS
DRGLALNDCHAEIISR RSLLRFLYTQLELYLN NKDDQKRSIFQKSERG
GFRLKENVQFHLYIST SPCGDARIFSPHEPIL EGSRSYTQAGVQWCNH
GSLQPRPPGLLSDPST STFQGAGTTEPADRHP NRKARGQLRTKIESGE
GTIPVRSNASIQTWDG VLQGERLLTMSCSDKI ARWNVVGIQGSLLSIF
VEPIYFSSIILGSLYH GDHLSRAMYQRISNIE DLPPLYTLNKPLLSGI
SNAEARQPGKAPNFSV NWTVGDSAIEVINATT GKDELGRASRLCKHAL
YCRWXaAACARQGSLPLT TLQDYQAQRVP
g4504601 86 MLLSQNAFIVRSLNLV LMVYISLVFGISYDSP DYTDESCTFKISLRNF
RSILSWELKNHSIVPT HYTLLYTIMSKPEDLK VVKNCANTTRSFCDLT
DEWRSTHEAYVTVLEG FSGNTTLFSCSHNFWL AIDMSFEPPEFEIVGF
TNHINVMVKFPSIVEE ELQFDLSLVIEEQSEG IVKKHKPEIKGNMSGN
FTYIIDKLIPNTNYCV SVYLEHSDEQAVIKSP LKCTLLPPGQESESAE
SAKIGGIITVFLIALV LTSTIVTLKWIGYICL RNSLPKVLRQGLTKGW
NAVAIHRCSHNALQSE TPELKQSSCLSFPSSW DYKRASLCPSD
g4507277 87 MPLAAYCYLRVVGKGS YGEVTLVKHRRDGKQY VIKKLNLRNASSRERR
AAEQEAQLLSQLKHPN IVTYKESWEGGDGLLY IVMGFCEGGDLYRKLK
EQKGQLLPENQVVEWF VQIAMALQYLHEKHIL HRDLKTQNVFLTRTNI
IKVGDLGIARVLENHC DMASTLIGTPYYMSPE LFSNKPYNYKSDVWAL
GCCVYEMATLKHAFNA KDMNSLVYRIIEGKLP AMPRDYSPELAELIRT
MLSKRPEERPSYRSIL RQPYIKRQISFFLEAT KIKTSKNNIKNGDSQS
KPFATVVSGEAESNHE VIHPQPLSSEGSQTYI MGEGKCLSQEKPRASG
LLKSPASLKAHTCKQD LSNTTELATISSVNID ILPAKGRDSVSDGFVQ
ENQPRYLDASNELGGI CSISQVEEEMLQDNTK SSAQPENLIPMWSSDI
VTGEKNEPVKPLQPLI KEQKPKDQSLALSPKL ECSGTILAHSNLRLLG
SSDSPASASRVAGITG VCHHAQDQVAGECIIE KQGRIHPDLQPHNSGS
EPSLSRQRRQKRREQT EHRGEKRQVRRDLFAF QESPPRFLPSHPIVGK
VDVTSTQKEAENQRRV VTGSVSSSRSSEMSSS KDRPLSARERRRLKQS
QEEMSSSGPSVRKASL SVAGPGKPQEEDQPLP ARRLSSDCSVTQERKQ
IHCLSEDELSSSTSST DKSDGDYGEGKGQTNE INALVQLMTQTLKLDS
KESCEDVPVANPVSEF KLHRKYRDTLILHGKV AEEAEEIHFKELPSAI
MPGSEKIRRLVEVLRT DVIRGLGVQLLEQVYD LLEEEDEFDREVRLRE
HMGEKYTTYSVKARQL KFFEENMNF
g4507685 88 MMAALYPSTDLSGASS SSLPSSPSSSSPNEVM ALKDVREVKEENTLNE
KLFLLACDKGDYYMVK KILEENSSGDLNINCV DVLGRNAVTITIENEN
LDILQLLLDYGCQKLM ERIQNPEYSTTMDVAP VILAAHRNNYEILTML
LKQDVSLPKPHAVGCE CTLCSAKNKKDSLRHS RFRLDIYRCLASPALI
MLTEEDPILRAFELSA DLKELSLVEVEFRNDY EELARQCKMFAKDLLA
QARNSRELEVILNHTS SDEPLDKRGLLEERMN LSRLKLAIKYNQKEFV
SQSNCQQFLNTVWFGQ MSGYRRKPTCKKIMTV LTVGIFWPVLSLCYLI
APKSQFGRIIHTPFMK FIIHGASYFTFLLLLN LYSLVYNEDKKNTMGP
ALERIDYLLILWIIGM IWSDIKRLWYEGLEDF LEESRNQLSFVMNSLY
LATFALKVVAHNKFHD FADRKDWDAFHPTLVA EGLFAFANVLSYLRLF
FMYTTSSILGPLQISM GQMLQDFGKFLGMFLL VLFSFTIGLTQLYDKG
YTSKEQKDCVGIFCEQ QSNDTFHSFIGTCFAL FWYIFSLAHVAIFVTR
FSYGEELQSFVGAVIV GTYNVVVVIVLTKLLV AMLHKSFQLIANHEDK
EWKFARAKLWLSYFDD KCTLPPPFNIIPSPKT ICYMISSLSKWICSHT
SKGKVKRQNSLKEWRN LKQKRDENYQKVMCCL VHRYLTSMRQKMQSTD
QATVENLNELRQDLSK FRNEIRDLLGFRTSKY AMFYPRN
g4507687 89 MEGSPSLRRMTVMREK GRRQAVRGPAFMFNDR GTSLTAEEERFLDAAE
YGNIPVVRKMLEESKT LNVNCVDYMGQNALQL AVGNEHLEVTELLLKK
ENLARIGDALLLAISK GYVRIVEAILNHPGFA ASKRLTLSPCEQELQD
DDFYAYDEDGTRFSPD ITPIILAAHCQKYEVV HMLLMKGARIERPHDY
FCKCGDCMEKQRHDSF SHSRSRINAYKGLASP AYLSLSSEDPVLTALE
LSNELAKLANIEKEFK NDYRKLSMQCKDFVVG VLDLCRDSEEVEAILN
GDLESAEPLEVHRHKA SLSRVKLAIKYEVKKF VAHPNCQQQLLTIWYE
NLSGLREQTIAIKCLV VLVVALGLPFLAIGYW IAPCSRLGKILRSPFM
KFVAHAASFIIFLGLL VFNASDRFEGITTLPN ITVTDYPKQIFRVKTT
QFTWTEMLIMVWVLGM MWSECKELWLEGPREY ILQLWNVLDFGMLSIF
IAAFTARFLAFLQATK AQQYVDSYVQESDLSE VTLPPEIQYFTYARDK
WLPSDPQIISEGLYAI AVVLSFSRIAYILPAN ESFGPLQISLGRTVKD
IFKFMVLFIMVFFAFM IGMFILYSYYLGAKVN AAFTTVEESFKTLFWS
IFGLSEVTSVVLKYDH KFIENIGYVLYGIYNV TMVVVLLNMLIAMINS
SYQEIEDDSDVEWKFA RSKLWLSYFDDGKTLP PPFSLVPSPKSFVYFI
MRIVNFPKCRRRRLQK DIEMGMGNSKSRLNLF TQSNSRVFESHSFNSI
LNQPTRYQQIMKRLIK RYVLKAQVDKENDEVN EGELKEIKQDISSLRY
ELLEDKSQATEELAIL IHKLSEKLNPSMLRCE
g4885373 90 MSETVPPAPAASAAPE KPLAGKKAKKPAKAAA ASKKKPAGPSVSELIV
QAASSSKERGGVSLAA LKKALAAAGYDVEKNN SRIKLGIKSLVSKGTL
VQTKGTGASGSFKLNK KASSVETKPGASKVAT KTKATGASKKLKKATG
ASKKSVKTPKKAKKPA ATRKSSKNPKKPKTVK PKKVAKSPAKAKAVKP
KAAKARYTKPKTAKPK KAAPKKK
g5730102 91 MSQSPAFGPRRGSSPR GAAGAAARRNESQDYL LMDSELGEDGCPQAPL
PCYGYYPCFRGSDNRL AHRRQTVLREKGRRLA NRGPAYMFSDRSTSLS
IEEERFLDAAEYGNIP VVRKMLEECHSLNVNC VDYMGQNALQLAVANE
HLEITELLLKKENLSR VGDALLLAISKGYVRI VEAILSHPAFAEGKRL
ATSPSQSELQQDDFYA YDEDGTRFSHDVTPII LAAHCQEYEIVHTLLR
KGARIERPHDYFCKCN DCNQKQKHDSFSHSRS RINAYKGLASPAYLSL
SSEDPVMTALELSNEL AVLANIEKEFKNDYKK LSMQCKDFVVGLLDLC
RNTEEVEAILNGDVET LQSGDHGRPNLSRLKL AIKYEVKKFVAHPNCQ
QQLLSIWYENLSGLRQ QTMAVKFLVVLAVAIG LPFLALIYWFAPCSKM
GKIMRGPFMKFVAHAA SFTIFLGLLVMNAADR FEGTKLLPNETSTDNA
KQLFRMKTSCFSWMEM LIISWVIGMIWAECKE IWTQGPKEYLFELWNM
LDFGMLAIFAASFIAR FMAFWHASKAQSIIDA NDTLKDLTKVTLGDNV
KYYNLARIKWDPSDPQ IISEGLYAIAVVLSFS RIAYILPANESFGPLQ
ISLGRTVKDIFKFMVI FIMVFVAFMIGMFNLY SYYIGAKQNEAFTTVE
ESFKTLFWAIFGLSEV KSVVINYNHKFIENIG YVLYGVYNVTMVIVLL
NMLIAMINSSFQEIED DADVEWKFARAKLWFS YFEEGRTLPVPFNLVP
SPKSLFYLLLKLKKWI SELFQGHKKGFQEDAE MNKINEEKKLGILGSH
EDLSKLSLDKKQVGHN KQPSIRSSEDFHLNSF NNPPRQYQKIMKRLIK
RYVLQAQIDKESDEVN EGELKEIKQDISSLRY ELLEEKSQNTEDLAEL
IRELGEKLSMEPNQEE TNR
g5802234 93 SRDPPASASQVTGIR
g6005868 94 MASLSRALRVAAAHPR QSPTRGMGPCNLSSAA GPTAEKSVPYQRTLKE
GQGTSVVAQGPSRPLP STANVVVIGGGSLGCQ TLYHLAKLGMSGAVLL
ERERLTSGTTWHTAGL LWQLRPSDVEVELLAH TRRVVSRELEEETGLH
TGWIQNGGLFIASNRQ RLDEYKRLMSLGKAYG VESHVLSPAETKTLYP
LMNVDDLYGTLYVPHD GTMDPAGTCTTLARAA SARGAQVIENCPVTGI
RVWTDDFGVRRVAGVE TQHGSIQTPCVVNCAG VWASAVGRMAGVKVPL
VAMHHAYVVTERIEGI QSFTLLPTLEYSGTVS AHCNLRLPGSSNSRAS
ASHVAGIKCARHHTRL IFFCILVETEFHHVAK AGLELLSSGNPPISDF
QSARITGVSHHA
g604969 95 LLWVLLWATVLGLLCQ RLAARLGVVTGKDLGE VCHLYYPKSESRSVAQ
SGVQWCDVSSLQPLPP RCPAPSSG
g6650810 96 METESGSVAQAGVQWH NLGSLQPPPSRLKQLS YLSLPSSWDYRCTPPH
PANFLYFNRDGISPCC PGWSPTPKLTQSTHLG LSKC
g6665594 97 MAQFYYKRNVNAPYRD RIPLRIVRAESELSPS EKAYLNAVEKGDYASV
KKSLEEAEIYFKININ CIDPLGRTALLIAIEN ENLELIELLLSFNVYV
GDALLHAIRKEVVGAV ELLLNHKKPSGEKQVP PILLDKQFSEFTPDIT
PIILAAHTNNYEIIKL LVQKGVSVPRPHEVRC NCVECVSSSDVDSLRH
SRSRLNIYKALASPSL IALSSEDPFLTAFQLS WELQELSKVENEFKSE
YEELSRQCKQFAKDLL DQTRSSRELEIILNYR DDNSLIEEQSGNDLAR
LKLAIKYRQKEFVAQP NCQQLLASRWYDEFPG WRRRHWAVKMVTCFII
GLLFPVFSVCYLIAPK SPLGLFIRKPFIKFIC HTASYLTFLFLLLLAS
QHIDRSDLNRQGPPPT IVEWMILPWVLGFIWG EIKQMWDGGLQDYIHD
WWNLMDFVMNSLYLAT ISLKIVAFVKYSALNP RESWDMWHPTLVAEAL
FAIANIFSSLRLISLF TANSHLGPLQISLGRM LLDILKFLFIYCLVLL
AFANGLNQLYFYYEET KGLTCKGIRCEKQNNA FSTLFETLQSLFWSIF
GLINLYVTNVKAQHEF TEFVGATMFGTYNVIS LVVLLNMLIAMMNNSY
QLIADHADIEWKFART KLWMSYFEEGGTLPTP FNVIPSPKSLWYLIKW
IWTHLCKKKMRRKPES FGTIGRRAADNLRRHH QYQEVMRNLVKRYVAA
MIRDAKTEEVARQQAA GPLERNIQLESRGLAS RGDLSIPGLSEQCVLV
DHRERNTDTLGLQVGK RVCPFKSEKVVVEDTV PIIPKEKHAKEEDSSI
DYDLNLPDTVTHEDYV TTRL
g6665596 98 MAQFYYKRNVNAPYRD RIPLRIVRAESELSPS EKAYLNAVEKGDYASV
KKSLEEAEIYFKININ CIDPLGRTALLIAIEN ENLELIELLLSFNVYV
GDALLHAIRKEVVGAV ELLLNHKKPSGEKQVP PILLDKQFSEFTPDIT
PIILAAHTNNYEIIKL LVQKGVSVPRPHEVRC NCVECVSSSDVDSLRH
SRSRLNIYKALASPSL IALSSEDPFLTAFQLS WELQELSKVENEFKSE
YEELSRQCKQFAKDLL DQTRSSRELEIILNYR DDNSLIEEQSGNDLAR
LKLAIKYRQKEFVAQP NCQQLLASRWYDEFPG WRRRHWAVKMVTCFII
GLLFPVFSVCYLIAPK SPLGLFIRKPFIKFIC HTASYLTFLFLLLLAS
QHIDRSDLNRQGPPPT IVEWMILPWVLGFIWG EIKQMWDGGLQDYIHD
WWNLMDFVMNSLYLAT ISLKIVAFVKYSALNP RESWDMWHPTLVAEAL
FAIANIFSSLRLISLF TANSHLGPLQISLGRM LLDILKFLFIYCLVLL
AFANGLNQLYFYYEET KGLTCKGIRCEKQNNA FSTLFETLQSLFWSIF
GLINLYVTNVKAQHEF TEFVGATMFGTYNVIS LVVLLNMLIAMMNNSY
QLIARRAADNLRRHHQ YQEVMRNLVKRYVAAM IRDAKTEEGLTEENFK
ELKQDISSFRFEVLGL LRGSKLSTIQSANASK ESSNSADSDEKSDSEE
EVARQQAAGPLERNIQ LESRGLASRGDLSIPG LSEQCVLVDHRERNTD
TLGLQVGKRVCPFKSE KVVVEDTVPIIPKEKH AKEEDSSIDYDLNLPD
TVTHEDYVTTRL
g6690167 99 MRTKSEREIHLCVLGF FXFFFETGSRSVAQAG VQRHSHGSLQPRPPGL
IQFSHLSLPSSWDYRH APPHLVNFL
g6690252 100 RFFFFFFFEESRSFAQ AGVQWRYLGSLQPPPP GFTRFSCLSLLSSWDY
RRPPPRPANFLYF
g7243280 101 ELSFPLLSLDFGAHQG LGSADMGDMKTPDFDD LLAAFDIPDIDANEAI
HSGPEENEGPGGPGKP EPGVGSESEDTAAASA GDGPGVPAQASDHGLP
PPDISVVSVIVKNTVC PEQSEALAGGSAGDGA QAAGVTKEGPVGPHRM
QNGFGSPEPSLPGTPH SPAPPSGGTWKEKGME GKTPLDLFAHFGPEPG
DHSDPLPPSAPSPTRE GALTPPPFPSSFELAQ ENGPGMQPPVSSPPLG
ALKQESCSPHHPQVLA QQGSGSSPKATDIPAS ASPPPVAGVPFFKQSP
GHQSPLASPKVPVCQP LKEEDDDEGPVDKSSP GSPQSPSSGAEAADED
SNDSPASSSSRPLKVR IKTIKTSCGNITRTVT QVPSDPDPPAPLAEGA
FLAEASLLKLSPATPT SEGPKVVSVQLGDGTR LKGTVLPVATIQNAST
AMLMAASVARKAVVLP GGTATSPKMIAKNVLG LVPQALPKADGRAGLG
TGGQKVNGASVVMVQP SKTATGPSTGGGTVIS RTQSSLVEAFNKILNS
KNLLPAYRPNLSPPAE AGLALPPTGYRCLECG DAFSLEKSLARHYDRR
SMRIEVTCNHCARRLV FFNKCSLLLHAREHKD KGLVMQCSHLVMRPVA
LDQMVGQPDITPLLPV AVPPVSGPLALPALGK GEGAITSSAITTVAAE
APVLPLSTEPPAAPAT SAYTCFRCLECKEQCR DKAGMAAHFQQLGPPA
PGATSNVCPTCPMMLP NRCSFSAHQRMHKNRP PHVCPECGGNFLQANF
QTHLREACLHVSRRVG YRCPSCSVVFGGVNSI KSHIQTSHCEVFHKCP
ICPMAFKSGPSAHAHL YSQHPSFQTQQAKLIY KCAMCDTVFTHKPLLS
SHFDQHLLPQRVSVFK CPSCPLLFAQKRTMLE HLKNTHQSGRLEETAG
KGAGGALLTPKTEPEE LAVSQGGAAPATEESS SSSEEEEVPSSPEPPR
PAKRPRRELGSKGLKG GGGGPGGWTCGLCHSW FPERDEYVAHMKKEHG
KSVKKFPCRLCERSFC SAPSLRRHVRVNHEGI KRVYPCRYCTEGKRTF
SSRLILEKHVQVRHGL QLGAQSPGRGTTLARG SSARAQGPGRKRRQSS
DSCSEEPDSTTPPAKS PRGGPGSGGHGPLRYR SSSSTEQSLMMGLRVE
DGAQQCLDCGLCFASP GSLSRHRFISHKKRRG VGKASALGLGDGEEEA
PPSRSDPDGGDSPLPA SGGPLTCKVCGKSCDS PLNLKTHFRTHGMAFI
RARQGAVGDN
g7305597 102 MSQSPRFVTRRGGSLK AAPGAGTRRNESQDYL LMDELGDDGYPQLPLP
PYGYYPSFRGNENRLT HRRQTILREKGRRLAN RGPAYMFNDHSTSLSI
EEERFLDAVEYGNIPV VWKMLEECHSLNVNCV DYMGQNALQLAVANEH
LEITELLLKKENLSRV GDALLLAISKGYVRIV EAILNHPSFAEGKRLA
TSPSQSELQQDDFYAY DEDGTRFSHDVTPIIL AAHCQEYEIVHTLLRK
GARIERPHDYFCKCTE CSQKQKHDSFSHSRSR INAYKGLASPAYLSLS
SEDPVMTALELSNELA VLANIEKEFKNDYRKL SMQCKDFVVGLLDLCR
NTEEVEAILNGDAETR QPGDFGRPNLSRLKLA IKDEVKKFVAHPNCQQ
QLLSIWYENLSGLRQQ TMAVKFLVVLAVAIGL PFLALIYWCAPCSKMG
KILPRPFMKFVAHAAS FTIFLGLLVMNAADRF EGTKLLPNETSTDNAR
QLFRMKTSCFSWMEML IISWVIGMIWAECKEI WTQGPKEYLFELWNML
DFGMLAIFAASFIARF MAFWHASKAQSIIDAN DTLKDLTKVTLGDNVK
YYNLARIKWDPTDPQI ISEGLYAIAVVLSFSR IAYILPANESFGPLQI
SLGRTVKDIFKFMVIF IMVFVAFMIGMFNLYS YYIGAKQNEAFTTVEE
SFKTLFWAIFGLSEVK SVVINYNHKFIENIGY VLYGVYNVTMVIVLLN
MLIAMINSSFQEIEDD ADVEWKFARAKLWFSY FEEGRTLPVPFNLYPS
PKSLLYLLLKFKKWMC ELIQGQKQGFQEDAEM NKRNEEKKFGISGSHE
DLSKFSLDKNQLAHNK QSSTRSSEDYHLNSFS NPPRQYQKIMKRLIKR
YVLQAQIDKESDEVNE GELKEIKQDISSLRYE LLEEKSQNSEDLAELI
RKLGERLSLEPKLEES RR
g7512448 103 GFLPATKNLLNEKNHG VLHTSVVLLTEMCERS PDMLAHFRENEKLVPQ
LVRILKNLIMSGYSPG HDVSGISDPFLQVRIL RLLRILGRNDDDSSEA
MNDILAQVATNTETSK NVGNAILYETVLTIMD IKSESGLRVLAINILG
RFLLNNDKNIRYVALT SLLKTVQTDHNAVQRH RSTIVDCLKDLDVSIK
RRAMELSFALVNGNNI RGMMKELLYFLDSCEP EFKADCASGIFLAAEK
YAPSKRWHIDTIMRVL TTAGSYVRDDAVPNLI QLITNSVEMHAYTVQR
LYKAILGDYSQQPLVQ VAAWCIGEYGDLLVSG QCEEEEPIQVTEDEVL
DILESVLISNMSTSVT RGYALTAIMKLSTRFT CTVNRIKKVVSIYGSS
IDVELQRRAVEYNALF KKYDHMRSALLERMPV MEKVTTNGPTEIVQTN
GETEPAPLETKPPPSG PQPTSQANDLLDLLGG NDITPVIPTAPTSKPS
SAGGELLDLLGDINLT GSHSVSQAGVQWDYLG SLQPLPPAFR
g7522630 104 MWPNGSSLGPCFRPTN ITLEERRLIASPWFAA SFCVVGLASNLLALSV
LAGARQGGSHTRSSFL TFLCGLVLTDFLGLLV TGTIVVSQHAALFEWH
AVDPGCRLCRFMGVVM IFFGLSPLLLGAAMAS ERYLGITRPFSRPAVA
SQRRAWATVGLVWAAA LALGLLPLLGVGRYTV QYPGSWCFLTLGAESG
DVAFGLLFSMLGGLSV GLSFLLNTVSVATLCH VYHGQEAAQQRPRDSE
VEMMAQLLGIMVVASV CWLPLLVFIAQTVLRN PPAMSPAGQLSRTTEK
ELLIYLRVATWNQILD PWVYILFRRAVLRRLQ PRLSTRPRRSLTLWPS
LEYSGTISAHCNLRLP GSSDSRASASRAAGIT GVSHCARPCMLFDPEF
DLLAGVQLLPFEPPTG KALSRKD
g7669477 105 MDIEDEENMSSSSTDV KENRNLDNVSPKDGST PGPGEGSQLSNGGGGG
PGRKRPLEEGSNGHSK YRLKKRRKTPGPVLPK NALMQLNEIKPGLQYT
LLSQTGPVHAPLFVMS VEVNGQVFEGSGPTKK KAKLHAAEKALRSFVQ
FPNASEAHLAMGRTLS VNTDFTSDQADFPDTL FNGFETPDKAEPPFYV
GSNGDDSFSSSGDLSL SASPVPASLAQPPLPV LPPFPPPSGKNPVMIL
NELRPGLKYDFLSESG ESHAKSFVMSVVVDGQ FFEGSGRNKKLAKARA
AQSALAAIFNLHLDQT PSRQPIPSEGLQLHLP QVLADAVSRLVLGKFG
DLTDNFSSPHARRKVL AGVVMTTGTDVKDAKV ISVSTGTKCINGEYMS
DRGLALNDCHAEIISR RSLLRFLYTQLELYLN NKDDQKRSIFQKSERG
GFRLKENVQFHLYIST SPCGDARIFSPHEPIL EGSRSYTQAGVQWCNH
GSLQPRPPGLLSDPST STFQGAGTTEPADRHP NRKARGQLRTKIESGE
GTIPVRSNASIQTWDG VLQGERLLTMSCSDKI ARWNVVGIQGSLLSIF
VEPIYFSSIILGSLYH GDHLSRAMYQRISNIE DLPPLYTLNKPLLSGI
SNAEARQPGKAPNFSV NWTVGDSAIEVINATT GKDELGRASRLCKHAL
YCRWMRVHGKVPSHLL RSKITKPNVYHESKLA AKEYQAAKARLFTAFI
KAGLGAWVEKPTEQDQ FSLTP
g7669479 106 MDIEDEENMSSSSTDV KENRNLDNVSPKDGST PGPGEGSQLSNGGGGG
PGRKRPLEEGSNGHSK YRLKKRRKTPGPVLPK NALMQLNEIKPGLQYT
LLSQTGPVHAPLFVMS VEVNGQVFEGSGPTKK KAKLHAAEKALRSFVQ
FPNASEAHLAMGRTLS VNTDFTSDQADFPDTL FNGFETPDKAEPPFYV
GSNGDDSFSSSGDLSL SASPVPASLAQPPLPV LPPFPPPSGKNPVMIL
NELRPGLKYDFLSESG ESHAKSFVMSVVVDGQ FFEGSGRNKKLAKARA
AQSALAAIFNLHLDQT PSRQPIPSEGLQLHLP QVLADAVSRLVLGKFG
DLTDNFSSPHARRKVL AGVVMTTGTDVKDAKV ISVSTGTKCINGEYMS
DRGLALNDCHAEIISR RSLLRFLYTQLELYLN NKDDQKRSIFQKSERG
GFRLKENVQFHLYIST SPCGDARIFSPHEPIL EGSRSYTQAGVQWCNH
GSLQPRPPGLLSDPST STFQGAGTTEPADRHP NRKARGQLRTKIESGE
GTIPVRSNASIQTWDG VLQGERLLTMSCSDKI ARWNVVGIQGSLLSIF
VEPIYFSSIILGSLYH GDHLSRAMYQRISNIE DLPPLYTLNKPLLSGI
SNAEARQPGKAPNFSV NWTVGDSAIEVINATT GKDELGRASRLCKHAL
YCRWMRVHGKVPSHLL RSKITKPNVYHESKLA AKEYQAAKVH
g7770147 107 MEVLLFLFIFETESCS VIRLECSGSLQPPPPR FKQFSCLSLPSSWDYR
CPPPCPINFCIFGTDR VSPCWPGWSRSR
g7706747 108 MAQFYYKRNVNAPYRD RIPLRIVRAESELSPS EKAYLNAVEKGDYASV
KKSLEEAEIYFKININ CIDPLGRTALLIAIEN ENLELIELLLSFNVYV
GDALLHAIRKEVVGAV ELLLNHKKPSGEKQVP PILLDKQFSEFTPDIT
PIILAAHTNNYEIIKL LVQKGVSVPRPHEVRC NCVECVSSSDVDSLRH
SRSRLNIYKALASPSL IALSSEDPFLTAFQLS WELQELSKVENEFKSE
YEELSRQCKQFAKDLL DQTRSSRELEIILNYR DDNSLIEEQSGNDLAR
LKLAIKYRQKEFVAQP NCQQLLASRWYDEFPG WRRRHWAVKMVTCFII
GLLFPVFSVCYLIAPK SPLGLFIRKPFIKFIC HTASYLTFLFLLLLAS
QHIDRSDLNRQGPPPT IVEWMILPWVLGFIWG EIKQMWDGGLQDYIHD
WWNLMDFVMNSLYLAT ISLKIVAFVKYSALNP RESWDMWHPTLVAEAL
FAIANIFSSLRLISLF TANSHLGPLQISLGRM LLDILKFLFIYCLVLL
AFANGLNQLYFYYEET KGLTCKGIRCEKQNNA FSTLFETLQSLFWSIF
GLINLYVTNVKAQHEF TEFVGATMFGTYNVIS LVVLLNMLIAMMNNSY
QLIADHADIEWKFART KLWMSYFEEGGTLPTP FNVIPSPKSLWYLIKW
IWTHLCKKKMRRKPES FGTIGRRAADNLRRHH QYQEVMRNLVKRYVAA
MIRDAKTEEGLTEENF KELKQDISSFRFEVLG LLRGSKLSTIQSANAS
KESSNSADSDEKSDSE GNSKDKKKNFSLFDLT TLIHPRSAAIASERHN
ISNGSALVVQEPPREK QRKVNFVTDIKNFGLF HRRSKQNAAEQNANQI
FSVSEEVARQQAAGPL ERNIQLESRGLASRGD LSIPGLSEQCVLVDHR
ERNTDTLGLQVGKRVC PFKSEKVVVEDTVPII PKEKHAKEEDSSIDYD
LNLPDTVTHEDYVTTR L
g8922960 109 MESYSVTQAGVQWHEL CSLQPSPPRFREMCIE QDGRVHLTVVYFGKEE
INEVKGVLENTSKAAN FRNFTFIQLNGEFSRG KGLDVGARFWKGSNVL
LFFCDVDIYFTSEFLN TCRLNTQPGKKVFYPV LFSQYNPGIIYGHHDA
VPPLEQQLVIKKETGF WRDFGFGMTCQYRSDF INIGGFDLDIKGWGGE
DVHLYRKYLHSNLIVV RTPVRGLFHLWHEKRC MDELTPEQYKMCMQSK
AMNEASHGQLGMLVFR HEIEAHLRKQKQKTSS KKT
g8923251 110 MDITLVRKELQELQNL YKQNSTHTAQQAELIQ QLQVLNMDTQKVLRNQ
EDVHTAESISYQKLYN ELHICFETTKSNEAML RQSVTNLQDQLLQKEQ
ENAKLKEKLQESQGAP LPLPQESDPDYSAQVP HRPSLSSLETLMVSQK
SEIEYLQEKLKIANEK LSENISANKGFSRKSI MTSAEGKHKEPPVKRS
RSLSPKSSFTDSEELQ KLRKAERKIENLEKAL QLKSQENDELRDAHEK
RKERLQMLQTNYRAVK EQLKQWEEGSGMTEIR KIKRADPQQLRQEDSD
AVWNELAYFKRENQEL MIQKMNLEEELDELKV HISIDKAAIQELNRCV
AERREEQLFRSGEDDE VKRSTPEKNGKEMLEQ TLQKVIELENRLKSFE
KRSRKLKEGNKKLMKE NDFLKSLLKQQQEDTE TREKELEQIIKGSKDV
EKENTELQVKISELET EVTSLRRQVAEANALR NENEELINPMEKSHQS
ADRAKSEMATMKVRSG RYDCKTTMTKVKFKAA KKNCSVGRHHTVLNHS
IKVMSNVFENLSKDGW EDVSESSSDSEAQTSQ TLGTIIVETSQKISPT
EDGKDQKESDPTEDSQ TQGKEIVQTYLNIDGK TPKDYFHDKNAKKPTF
QKKNCKMQKSSHTAVP TRVNREKYKNITAQKS SSNIILLRERIISLQQ
QNSVLQNAKKTAELSV KEYKEVNEKLLHQQQV SDQRFQTSRQTIKKLN
LDLAGLRKEKEDLLKK LESSSEITSLAEENSQ VTFPRIQVTSLSPSRS
MDLEMKQLQYKLKNAT NELTKQSSNVKTLKFE LLAKEEHIKEMHEKIS
RMERDITMKRHLIEDL KFRQKVNLESNKSFSE MLQNLDKKVKTLTEEC
SNKKVSIDSLKQRLNV AVKEKSQYEQMYQKSK EELEKKDLKLTLLVSR
ISETESAMAEIETAAS KQLQELALQSEQVLEG AQKTLLLANEKVEEFT
TFVKALAKELQNDVHV VRRQIRELKKMKKNRD ACKTSTHKAQTLAASI
LNISRSDLEEILDTED QVEIEKTKIDAENDKE WMLYIQKLLEGQSLTL
SPRLKCNGAIMAHQNL RLPDSSSSASAS
g8923273 111 MKVVPEKNAVRILWGR ERGARAMGAQRLLQEL VEDKTRWMKWEGKRVE
LPDSPRSTFLLAFSPD RTLLASTHVNHNIYIT EVKTGKCVHSLIGHRR
TPWCVTFHPTISGLIA SGCLDGEVRIWDLHGG SESWFTDSNNAIASLA
FHPTAQLLLIATANEI HFWDRSRREPFAVVKT ASEMERVRLVRFDPLG
HYLLTAIVNPSNQQGD DEPEIPIDGTELSHYR QRALLQSQPVRRTPLL
HNFLHMLSSRSSGIQT EPFHPPEQASSTQQDQ GLLNRPSAFSTVQSST
AGNTLRNLSLGPTRRS LGGPLSSHPSRYHREI APGLTGSEWTRTVLSL
NSRSEAESMPPPRTSA SSVSLLSVLRQQEGGS QASVYTSATEGRGFPA
SGLATESDGGNGSSQN NSGSIRHELQCDLRRF FLEYDRLQELDQSLSG
EAPQTQQAQEMLNNNI ESERPGPSHQPTPHSS ENNSNLSRGHLNRCRA
CHNLLTFNNDTLRWER TTPNYSSGEASSSWQV PSSFESVPSSGSQLPP
LERTEGQTPSSSRLEL SSSASPQEERTVGVAF NQETGHWERIYTQSSR
SGTVSQEALHQDMPEE SSEEDSLRRRSLALSP RLEYSGAILAHCKLRL
PGSCHSPASASQVAGT TGAHHHARLIFAFLVE MEFHHVSQAGLELLTS
GDLPTSASQVLGLQA
g8923360 112 MVHSPRSLVANPSQVL FFLSFLFFFFLRQSFA LVAQAGVQWRNLGSLQ
PPPPGFKQFSCLSLLS SWDYRHAPPCPAYFVF LVDMGFPHVGQTGLEL
LTSGDPPASASQSAGI TGGSHRAQPTSSNPYG IVFFFLPVKTFSGMSQ
EAGDCRET
g8923452 113 MPTATGLTLLTSASSA ISDPGGEVSAPWGGLR TWTQPLRCWERLLPPP
GDPRTVAENTQQDECG LPGSCPARPLSRKPEC GREGILPCCSSSAWPE
GSFRPFQMNLFSFLSF FFLFFFFLRWSLTLSP RLECSSAISAHCNLRL
PGSSNSPALASQVAGI TGICHHARQIFVFLVE TGFCHVGQAGLELLIS
GDSPASAFQSAGIIGV SHRARPGSVFLARSEE SLYLRPGQQSQEVKV
g8923454 114 MLLVDADQPEPMRSGA RELALFLTPEPGAEAK EVEETIEGMLLRLEEF
CSLADLIRSDTSQILE ENIPVLKAKLTEMRGI YAKVDRLEAFVKMVGH
HVAFLEADVLQAERDH GAFPQALRRWLGSAGL PSFRNVECSGTIPARC
NLRLPGSSDSPASASQ VAGITEVTCTGARDVR AAHTV
g8923691 115 MSVYSGKVLLQTTPPH VIGQLDKLIREVSTLD GVLEVRNEHFWTLGFG
SLAGSVHVRIRRDANE QMVLAHVTNRLYTLVS TLTVQIFKDDWIRPAL
LSGPVAANVLNFSDHH VIPMPLLKGTDGLNPY VHFLWKINFFLFFDME
SLSVAQAGVQWHDLGS LQPHLPGSSNSACLSL PSSWDYRHAPPHLPNF
CIISKDGVLPCWPCWS
g8924071 116 MESRSVAQTGVHWHNL SSLQPLPPRFKQFSCL SLRSSWDYTHLPPCLA
NFFVFLVETAFRHVGQ AGLKLLTSGDQPTSAS QSAGITGISHRTQPVG
RFLITDSIFLFVTDLL KFSISS
g8924204 117 MSKVLGGPFSKGHTAS DKYFQIFHNISFFETE SCSVAQAGVQWCNLGS
LQALPPRFTPFSCLSL PSSWDYRHPPPCPDNV FVFSVETGFHCVSQDG
LNLLTL
g8980667 118 MAQGTLIRVTPEQPTH AVCVLGTLTQLDICSS APEDCTSFSINASPGV
VVDIAHSPPAKKKSTG SSTWPLDPGVEVTLTM KAASGSTGDQKVQISY
YGPKTPPVKALLYLTA VDGVSPCHPGWSAMHD LAHCNLRLQVQAILCF
SVPSSWTTGACHHAWL IFVFLVEMEFHHVGQA GLELLTSGDLPASGSQ
SARITGMNHCARPSIF LILKYL
g9716913 119 MSQSPAFGPRRGSSPR GAAGAAARRNESQDYL LMDSELGEDGCPQAPL
PCYGYYPCFRGSDNRL AHRRQTVLREKGRRLA NRGPAYMFSDRSTSLS
IEEERFLDAAEYGNIP VVRKMLEECHSLNVNC VDYMGQNALQLAVANE
HLEITELLLKKENLSR VGDALLLAISKGYVRI VEAILSHPAFAEGKRL
ATSPSQSELQQDDFYA YDEDGTRFSHDVTPII LAAHCQEYEIVHTLLR
KGARIERPHDYFCKCN DCNQKQKHDSFSHSRS RINAYKGLASPAYLSL
SSEDPVMTALELSNEL AVLANIEKEFKNDYKK LSMQCKDFVVGLLDLR
RNTEEVEAILNGDVET LQSGDHGRPNLSRLKL AIKYEVKKMGKIMRGP
FMKFVAHAASFTIFLG LLVMNAADRFEGTKLL PNETSTDNAKQLFRMK
TSCFSWMEMLIISWVI GMIWAECKEIWTQGPK EYLFELWNMLDFGMLA
IFAASFIARFMAFWHA SKAQSIIDANDTLKDL TKVTLGDNVKYYNLAR
IKWDPSDPQIISEGLY AIAVVLSFSRIAYTLP ANESFGPLQISLGRTV
KDIFKFMVIFIMVFVA FMIGMFNLYSYYIGAK QNEAFTTVEESFKTLF
WAIFGLSEVKSVVINY NHKFIENIGYVLYGVY NVTMVIVLLNMLIAMI
NSSFQEIEDDADVEWK FARAKLWFSYFEEGRT LPVPFNLVPSPKSLFY
LLLKLKKWISELFQGH KKGFQEDAEMNKINEE KKLGILGSHEDLSKLS
LDKKQVGHNKQPSIRS SEDFHLNSFNNPPRQY QKIMKRLIKRYVLQAQ
IDKESDEVNEGELKEI KQDISSLRYELLEEKS QNTEDLAELIRELGEK
LSMEPNQEETNR
g9966865 120 MLRNSTFKNMQRRHTT LREKGRRQAIRGPAYM FNEKGTSLTPEEERFL
DSAEYGNIPVVRKMLE ESKTLNFNCVDYMGQN ALQLAVGNEHLEVTEL
LLKKENLARVGDALLL AISKGYVRIVEAILNH PAFAQGQRLTLSPLEQ
ELRDDDFYAYDEDGTR FSHDITPIILAAHCQE YEIVHILLLKGARIER
PHDYFCKCNECTEKQR KDSFSHSRSRMNAYKG LASAAYLSLSSEDPVL
TALELSNELARLANIE TEFKNDYRKLSMQCKD FVVGVLDLCRDTEEVE
AILNGDVNFQVWSDHH RPSLSRIKLAIKYEVK KFVAHPNCQQQLLTMW
YENLSGLR(QQSIAVKF LAVFGVSI)GLPFLAIA YWIAPCSKLGRTLRSP
FMKFVAHAVSFTIFLG LLVVNASDRFEGVKTL PNETFTDYPKQIFRVK
TTQFSWTEMLIMKWVL GMIWSECKEIWEEGPR EYVLHLWNLLDFGMLS
IFVASFTARFMAFLKA TEAQLYVDQHVQDDTL HNVSLPPEVAYFTYAR
DKWWPSDPQIISEGLY AIAVVLSFSRIAYILP ANESFGPLQISLGRTV
KDIFKFMVIFIMVFVA FMIGMFNLYSYYRGAK YNPAFTTVEESFKTLF
WSIFGLSEVISVVLKY DHKFIENIGYVLYGVY NVTMVVVLLNMLIAMI
NNSYQEIEEDADVEWK FARAKLWLSYFDEGRT LPAPFNLVPSPKSFYY
LIMRIKMCLIKLCKSK AKSCENDLEMGMLNSK FKKTRYQAGMRNSENL
TANNTLSKPTRYQKIM KRLIKRYVLKAQVDRE NDEVNEGELKEIKQDI
SSLRYELLEEKSQATG ELADLIQQLSEKFGKN LNKDHLRVNKGKDI
g9967846 121 MDDGCPQLPLPPHGYY PSLRGTDNRLTHRRQT VLREKGRRLANRGPAY
MFNDHSTTLSIEEERF LDAAEYGNIPVVRKML EECLSLNVNCVDYMGQ
NALQLAVANEHLEITE LLLKKENLSRVGDALL LAISKGYVRIVEAILS
HPAFAEGKRLATSPSQ SELQQDDFYAYDEDGT RFSHDVTPIILAAHCQ
EYEIVHTLLRKGARIE RPHDYFCKCSECNQKQ KHDSFSHSRSRINAYK
GLASPAYLSLSSEDPV MTALELSNELAVLANI EKEFKNDYKKLSMQCK
DFVVGLLDLCRNTEEV EAILNGDVETCQSGDQ GRPNLSRLKLAIKYEV
KKFVAHPNCQQQLLSI WYENLSGLRQQTMAVK FLVVLGVAIGLPFLAL
IYWCAPCSKMGKIMRG PFMKFVAHAASFTIFL GLLVMNAADRFEGTKL
RPNETSTDNAKQLFRM KTSCFSWMEMLIISWV IGMIWAECKEIWAQGP
KEYLFELWNMLDFGML AIFAASFIARFMAFWH ASKAQSIIDANDTLKD
LTKVTLGEDVKYYNLA RIKWDPSDPQIISEGL YAIAVVLSFSRIAYIL
PANESFGPLQISLGRT VKDIFKFMVIFIMVFV AFMIGMFNLYSYYIGA
KQNEAFTTVEESFKTL FWAIFGLSEVKSVVIN YNHKFIENIGYVLYGV
YNVTMVIVLLNMLIAM INSSFQEIEDDADVEW KFARAKLWFSYFEEGR
TLPVPFNLVPSPKSLL YLLLKFKKWGFELFQG HKKAFQEDAEMNKRNE
EKKFGILGSHEDLSKL SVDKKQLGQNKQSSIR SSEDFHLNSFNNPPRQ
YQKIMKRLIKRYVLQA QIDKESDEVNEGELKE IKQDISSLRYELLEEK
SQNTEDLAELIRKLGE KLSSEPKQEEINR
g9967886 122 MFNDHSTTLSIEEERF LDAAEYGNIPVVRKML EECLSLNVNCVDYMGQ
NALQLAVANEHLEITE LLLKKENLSRVGDALL LAISKGYVRIVEAILS
HPAFAEGKRLATSLSQ SELQQDDFYAYDEDGT RFSHDVTPIILAAHCQ
EYEIVHTLLRKGARIE RPHDYFCKCSECNQKQ KHDSFSHSRSRINAYK
GLASPAYLSLSSEDPV MTALELSNELAVLANI EKEFKNDYKKLSMQCK
DFVVGLLDLCRNTEEV EAILNGDIETCQPGDQ GRPNLSRLKLAIKYEV
KKFVAHPNCQQQLLSI WYENLSGLRQQTMAVK FLVVLGVAIGLPFLAL
IYWCAPCSKMGKIMRG PFMKFVAHAASFTIFL GLLVMNAADRFEGTKL
RPNETSTDNAKQLFRM KTSCFSWMEMLIISWV IGMVWAECKEIWAQGP
KEYLFELWNMLDFGML AIFAASFIARFMAFWH ASKAQSIIDANDTLKD
LTKVTLGEDVKYYNLA RIKWDPSDPQIISEGL YAIAVVLSFSRIAYIL
PANESFGPLQISLGRT VKDIFKFMVIFIMVFV AFMIGMFNLYSHYIGA
KQNEAFTTYVISDVLT MEIAD
g9967888 123 MDDGCPQLPLPPHGYY PSLRGTDNRLTHRRQT VLREKGRRLANRGPAY
MFNDHSTTLSIEEERF LDAAEYGNIPVVRKML EECLSLNVNCVDYMGQ
NALQLAVANEHLEITE LLLKKENLSRVGDALL LAISKGYVRIVEAILS
HPAFAEGKRLATSPSQ SELQQDDFYAYDEDGT RFSHDVTPIILAAHCQ
EYEIVHTLLRKGARIE RPHDYFCECSECNQKQ KHDSFSHSRSRINAYK
GLASPAYLSLSSEDPV MTALELSNELAVLANI EKEFKNDYKKLSMQCK
DFVVGLLDLCRNTEEV EAILNGDVETCQPGDQ GRPNLSRLKLAIKYEV
KKFVAHPNCQQQLLSI WYENLSGLRQQTMAVK FLVVLGVAIGLPFLAL
IYWCAPCSKMGKIMRG PFMKFVAHAASFTIFL GLLVMNAADRFEGTKL
RPNETSTDNAKQLFRM KTSCFSWMEMLIISWV IARIKWDPSDPQIISE
GLYAIAVVLSFSRIAY ILPANESFGPLQISLG RTVKDIFKFMVIFIMV
FVAFMIGMFHLYSYYI GAKQNEAFTTVEESFK TLFWAIFGLSEVKSVV
INYNHKFIENIGYVLY GVYNVTMVIVLLNMLI AMINSSFQEIEDDADV
EWKFARAKLWFSYFEE GRTLPVPFNLVPSPKS LLYLLLKFKKWGFELF
QGHKKAFQEDAEMNKR NEEKKFGILGSHEDLS KLSVDKKQLGQNKQSS
IRSSEDFHLNSFNNPP RQYQKIMKRLIKRYVL QAQIDKESDEVNEGEL
KEIKQDISSLRYELLE EKSQNTEDLAELIRKL GEKLSSEPKQEEINR
g9716913 124 MSQSPAFGPRRGSSPR GAAGAAARRNESQDYL LMDSELGEDGCPQAPL
PCYGYYPCFRGSDNRL AHRRQTVLREKGRRLA NRGPAYMFSDRSTSLS
IEEERFLDAAEYGNIP VVRKMLEECHSLNVNC VDYMGQNALQLAVANE
HLEITELLLKKENLSR VGDALLLAISKGYVRI VEAILSHPAFAEGKRL
ATSPSQSELQQDDFYA YDEDGTRFSHDVTPII LAAHCQEYEIVHTLLR
KGARIERPHDYFCKCN DCNQKQKHDSFSHSRS RINAYKGLASPAYLSL
SSEDPVMTALELSNEL AVLANIEKEFKNDYKK LSMQCKDFVVGLLDLR
RNTEEVEAILNGDVET LQSGDHGRPNLSRLKL AIKYEVKKMGKIMRGP
FMKFVAHAASFTIFLG LLVMNAADRFEGTKLL PNETSTDNAKQLFRMK
TSCFSWMEMLIISWVI GMIWAECKEIWTQGPK EYLFELWNMLDFGMLA
IFAASFIARFMAFWHA SKAQSIIDANDTLKDL TKVTLGDNVKYYNLAR
IKWDPSDPQIISEGLY AIAVVLSFSRIAYTLP ANESFGPLQISLGRTV
KDIFKFMVIFIMVFVA FMIGMFNLYSYYIGAK QNEAFTTVEESFKTLF
WAIFGLSEVKSVVINY NHKFIENIGYVLYGVY NVTMVIVLLNMLIAMI
NSSFQEIEDDADVEWK FARAKLWFSYFEEGRT LPVPFNLVPSPKSLFY
LLLKLKKWISELFQGH KKGFQEDAEMNKINEE KKLGILGSHEDLSKLS
LDKKQVGHNKQPSIRS SEDFHLNSFNNPPRQY QKIMKRLIKRYVLQAQ
IDKESDEVNEGELKEI KQDISSLRYELLEEKS QNTEDLAELIRELGEK
LSMEPNQEETNR
本发明的NTP肽、相关蛋白、相关肽及其片段、变体、衍生物、同源物和模拟物可用此领域技术人员已知的方法制备,如重组DNA技术、蛋白质合成和分离天然产生的NTP肽、相关蛋白、相关肽及其片段、变体、衍生物和同源物。
NTP肽、相关蛋白或相关肽可用熟知的重组DNA技术方法制备,如列于Sambrook等,(《分子克隆:实验室手册》(Molecular Cloning:A Laboratory Manual),Cold Spring Harbor Laboratory Press,Cold Spring Harbor,N.Y.[1989])和/或Ausubel等编,《新编分子生物学实验指南》(Current Protocols in Molecular Biology),GreenPublishers Inc.及Wiley和Sons,N.Y.[1994]的方法。
可获得编码NTP肽、相关蛋白或相关肽的基因或cDNA,例如通过筛选基因组或cDNA文库或通过PCR扩增。用于筛选文库的探针或引物可在其它已知基因或基因片段序列信息的基础上产生,这些基因或基因片段来自相同或相关基因家族,如在其它相关蛋白中发现的保守基序。此外,已鉴定了一种生物编码NTP肽、相关蛋白或相关肽的基因,该基因的所有或一部分可用作探针来鉴定其它生物的同源基因。此种探针或引物可用于筛选认为能表达NTP肽、相关蛋白或相关肽基因的多种组织来源的cDNA文库.通常,可采用高严谨性条件来尽可能减少筛选获得的假阳性数量。
另一种制备编码NTP肽、相关蛋白或相关肽的基因的方法采用化学合成,使用此领域技术人员熟知的方法,如Engels等(Angew.Chem.Intl.Ed.,28:716-734[1989])描述的方法。这些方法尤其包括磷酸三酯、亚磷酰胺、H-膦酸酯方法用于核酸合成。这种化学合成的优选方法是用标准亚磷酰胺化学的聚合物-支持的合成。一般,编码NTP肽、相关蛋白或相关肽的DNA长度为几百个核苷酸。可用这些方法将大于约100个核苷酸的核酸合成为几个片段。然后可将这些片段连接在一起形成全长NTP肽、相关蛋白或相关肽。通常,编码此蛋白质氨基末端的DNA片段具有编码甲硫氨酸的ATG。此甲硫氨酸可以或可不存在于相关蛋白、相关肽或NTP肽的成熟形式中,这取决于宿主细胞中产生的蛋白质是否设计成该细胞分泌的蛋白质。
可将编码相关蛋白、相关肽或NTP肽的基因、cDNA或其片段用标准连接技术插入合适的表达或扩增载体中。通常选择在所用具体宿主细胞中具有功能的载体(即载体与宿主细胞机制相容,从而其中的基因可扩增和/或表达)。编码相关蛋白、相关肽或NTP肽的基因、cDNA或其片段可在原核、酵母、昆虫(杆状病毒系统)和/或真核宿主细胞中扩增/表达。宿主细胞的选择部分取决于相关蛋白,相关肽或NTP肽是否糖基化和/或磷酸化。如果这样,优选酵母、昆虫或哺乳动物宿主细胞。
通常,用于任何宿主细胞的载体包含5’侧翼序列(也称为“启动子”)和其它调节元件如增强子、复制元件的起点、转录终止元件、含供体和受体剪接位点的完整内含子序列、信号肽序列、核糖体结合位点元件、聚腺苷酸化序列、用于插入编码待表达多肽的核酸的多接头区域、及可选择的标记元件。各个这些元件在下面讨论。任选的,载体可包含一尾序列,即位于相关蛋白、相关肽或NTP肽编码序列的5’或3’末端的寡核苷酸分子;该寡核苷酸分子编码聚组氨酸(如6个组氨酸)或其它标志如FLAG、HA(流感病毒血凝索)或存在可商业购买抗体的myc。此尾常在表达多肽时融合于该多肽,可作为从宿主细胞亲和纯化相关蛋白、相关肽或NTP肽的工具。例如可通过柱层析完成亲和纯化,此柱层析采用抗该尾巴的抗体抗作为亲和基质。任选地,随后可通过多种方法某些肽酶从纯化的相关蛋白、相关肽或NTP肽中去除该尾巴。
本领域技术人员可将人免疫球蛋白铰链区和Fc区融合于该相关蛋白、相关肽或NTP肽的N-或C-末端。随后Fc融合蛋白可用A蛋白亲和柱纯化。已知Fc体内可表现出长的药物动力学半衰期且发现融合Fc的蛋白质体内表现出的半衰期显著大于未融合蛋白质。同样,融合的Fc区使得一些分子可二聚化/多聚化而利用其生物活性。
5’侧翼序列可以是同源(即来自与宿主细胞相同的物种和/或品系)、异源(即来自与宿主细胞不同的物种或品质)、杂交的(即一个以上来源的5’侧翼序列的组合)、合成的,或可以是天然的相关蛋白、相关肽或NTP肽基因5’侧翼序列。同样,5’侧翼序列的来源可以是单细胞原核或真核生物、任何脊椎动物或无脊椎动物、或任何植物,只要此5’侧翼序列有功能且可被宿主细胞机制活化。
本发明载体中所用的5’侧翼序列可通过本领域熟知的一些方法来获得。通常,除了相关蛋白、相关肽或NTP肽基因侧翼序列外本文所用的5’侧翼序列前面已通过作图和/或限制性内切酶消化得到鉴定,因此可用合适的限制性内切酶从适当组织来源中分离得到。在一些情况中,此5′侧翼序列的全核苷酸序列可以是已知的。这里可用上述核酸合成或克隆的方法合成此5’侧翼序列。
当5’侧翼所有或仅部分序列已知时,它可用PCR和/或通过筛选基因组文库来获得,筛选所用的合适寡核苷酸和/或5’侧翼序列片段来自相同或另一物种。
当不知道5’侧翼序列时,含5’侧翼序列的DNA片段可从DNA的较大片断中分离,此DNA可包含例如编码序列或甚至另外的基因。分离可通过限制性内切酶消化完成,用一种或多种仔细选择的酶分离适当DNA片段。消化后,所需片段可通过琼脂糖凝胶纯化、柱或其它本领域技术人员已知的方法来分离。选择适当酶以达到此目的对此领域的一般技术人员是不难懂得的。
复制元件的起点通常是商业购买的原核表达载体的一部分,可协助宿主细胞中载体的扩增。在一些情况中,载体扩增到一定拷贝数对最佳表达相关蛋白、相关肽或NTP肽很重要。如果所选载体不含有复制起始位点,可在已知序列基础上化学合成此起点并连接入载体。转录终止元件一般位于NTP蛋白或NTP/肽编码序列的3’末端,作用是终止相关蛋白、相关肽或NTP肽的转录。通常,原核细胞中的转录终止元件是后面有一聚T序列的富含G-c的片段。虽然可从文库克隆或商业购买此元件作为载体部分,也可用上述核酸合成方法容易地合成。
可选择性标记基因元件编码宿主细胞在选择性培养基中存活和生长所必需的蛋白质。典型的选择标记基因元件编码的蛋白质(a)赋予原核宿主细胞对抗生素或其它毒素的抗性,如氨苄青霉素、四环素或卡那霉素的抗性,(b)弥补细胞的营养缺陷;或(c)提供复合培养基没有的关键营养素。优选的可选择标记是卡那霉素抗性基因、氨苄青霉素抗性基因和四环素抗性基因。
一般称为SD序列(原核生物)或Kozak序列(真核核生物)的核糖体结合元件,是mRNA翻译起始通常必需的。此元件通常位于启动子3’端和待合成的相关蛋白、相关肽或NTP肽编码序列的5’端。各SD序列不同但一般是聚嘌呤(即有高A-G含量)。已鉴定到许多SD序列,本领域普通技术人员可不难用上述方法合成各种SD序列并用于原核载体中。
在需要相关蛋白、相关肽或NTP肽从宿主细胞分泌时,可利用信号序列引导相关蛋白,相关肽或NTP肽分泌到宿主细胞外,可缺失此蛋白质的羧基末端部分以防止膜锚定。通常,信号序列位于相关蛋白/相关肽/NTP肽基因或cDNA的编码区域中,或连接在相关蛋白/相关肽/NTP肽基因编码区的5’末端。已鉴定到许多信号序列,任何一种在所选宿主细胞中有功能的信号序列可与相关蛋白/相关肽/NTP肽基因或cDNA结合使用。因此,该信号序列可与相关蛋白/相关肽/NTP肽基因或cDNA同源或异源,可与相关蛋自/相关肽/NTP肽基因或cDNA同源或异源。另外,此信号序列可用上述方法化学合成。在大部分情况中,通过信号肽的存在宿主细胞分泌多肽时会导致从此多肽中去除氨基末端的甲硫氨酸。
在许多情况中,相关蛋白/相关肽/NTP肽基因或cDNA的转录,可通过载体中存在一个或多个内含子而增加;当相关蛋白、相关肽或NTP肽在真核宿主细胞中产具体是哺乳动物宿主细胞生时尤其如此。所用内含子可以是相关蛋白/相关肽/NTP肽基因中天然存在的,特别是当所用基因是全长基因组序列或其片段时。当基因中无天然产生的此内含子时(对于大部分cDNAs如此),该内含子可获自另外的来源。由于此内含子必须转录有效,关于其侧翼序列和相关蛋白/相关肽/NTP肽基因的相对位置通常很重要。同样,当插入表达载体中的相关蛋白/相关肽/NTP肽基因是cDNA分子时,该内含子的优选位置是转录起始位点的3’端和聚A转录终止序列的5’端。对于相关蛋白/相关肽/NTP肽cDNA,此内含子或这些内含子优选位于cDNA一侧或另一侧(即5’或3’),从而不会打断此编码序列。只要此内含子与其插入的宿主细胞相容,任何来源的任何内含子均可用于实施本发明,包括病毒、原核和真核(植物或动物)生物的内含子。还包括在本文中的合成内含子。任选地,在载体中可使用一个以上的内含子。
当上述一个或多个元件不存在于待使用的载体中时,它们可单独获得并连接入载体。用于获得各元件的方法是本领域技术人员熟知的,且可与上述方法相比较(即合成DNA、文库筛选等)。
用于实施本发明的最终载体可从起始载体构建,如商业购买的载体。这种载体可以或可不包含一些完整载体中所含的元件。如果起始载体中没有所需元件,各元件可单独连接入载体,通过用合适的限制性内切酶切割载体,使此元件待连接末端和载体末端适合于连接。在一些情况中,可能必须使待连接在一起的末端成为“平端”,以获得满意的连接。通过先用Klenow DNA聚合酶或T4DNA聚合酶在所有四种核苷酸存在时填补“粘端”来获得平端。此过程是本领域熟知,其描述见例如Sambrook等,同上。另外,待插入此载体的两个或多个元件可先连接一起(如果它们的位置彼此相邻),随后连接入载体。
另一种构建此载体的方法是在一种反应混合物中同时进行多种元件的所有连接。这里,由于不适当的连接或插入元件将含产生许多无意义和无功能的载体。然而可通过限制性内切酶消化来鉴定和选择功能性载体。
实施本发明的优选载体是与细菌、昆虫和哺乳动物宿主细胞相容的那些载体。这种载体包括pCRII、pCR3和pcDNA3.1(Invitrogen Company,San Diego,Calif.)、pBSII(Stratagene Company,La Jolla,Calif.)、pET15b(Novagen,Madison,Wis.)、PGEX(Pharmacia Biotech,Piscataway,N.J.)、pEGFP-N2(Clontech,Palo Alto,Calif.)、pETL(BlueBacII;Invitrogen)和pFastBacDual(Gibco/BRL,Grand Island,N.Y.)。
在载体构建和编码全长或截短的相关蛋白、相关肽或NTP肽的核酸分子插入此载体的适当位点后,可将此完整的载体插入合适的宿主细胞用于扩增和/或多肽表达。宿主细胞可以是原核宿主细胞(如大肠杆菌)或真核宿主细胞(如酵母细胞、昆虫细胞或脊椎动物细胞)。当宿主细胞在合适条件下培养时,可合成相关蛋白、相关肽或NTP肽,随后从培养基收集(如果宿主细胞分泌它们到培养基中)或直接从产生它们的宿主细胞(如果它不被分泌)收集。
收集后,相关蛋白、相关肽或NTP肽可用分子筛层析、亲和层析等方法纯化。产生相关蛋白、相关肽或NTP肽的宿主细胞的选择部分取决于相关蛋白、相关肽或NTP肽是否糖基化或磷酸化(其中真核宿主细胞优选)、宿主细胞是否能折叠此蛋白质成其天然三级结构(如二硫桥的正确取向等)方式,从而通过具有生物活性的相关蛋白、相关肽或NTP肽而制备生物活性蛋白质。合成后可用下面讨论的合适化学条件折叠相关蛋白、相关肽或NTP肽。用于本发明的合适细胞或细胞系包括哺乳动物细胞,如中国仓鼠卵巢细胞(CHO)、人胚胎肾(HEK)293或293T细胞,或3T3细胞。选择合适的哺乳动物宿主细胞和转化、培养、扩增、筛选和产物生成及纯化的方法是本领域技术人员已知的。其它合适的哺乳动物细胞系包括猴COS-1和COS-7细胞系及CV-1细胞系。更具示范性的哺乳动物宿主细胞包括灵长类细胞系和啮齿动物细胞系,含转化的细胞系。正常二倍体细胞、衍生自原代组织体外培养的细胞株以及原代外植体也是合适的。候选细胞可以是在选择基因中有遗传型缺陷或可含有优势作用的选择基因。其它合适的哺乳动物细胞系包括但不限于小鼠成神经细胞瘤N2A细胞、海拉细胞、小鼠L-929细胞、衍生自Swiss、Balb-c或NIH小鼠的3T3系、BHK或HaK仓鼠细胞系。
与适合于本发明的宿主细胞同样有用的是细菌细胞。例如,多种大肠杆菌菌株(如HB101、DH5α、DH10和MC1061)是生物技术领域中熟知的宿主细胞。枯草芽孢杆菌(B.subtilis)、假单胞菌属(Pseudomonas spp.)、其它芽孢杆菌属(Bacillusspp.)、链霉菌属(Streptomyces spp.)等多种菌株可用于此方法。本领域技术人员已知的许多酵母细胞菌株也可作为表达本发明多肽的宿主细胞。
另外,需要时昆虫细胞系统可用于本发明的方法。这种系统已有描述,例如Kitts等(Biotechniques,14:810-817[1993])、Lucklow(Curr.Opin.Biotechnol.,4:564-572[1993])和Lucklow等(J.Virol.,67:4566-4579[1993])。优选的昆虫细胞是Sf-9和Hi5(Invitrogen,Carlsbad,Calif.)。
插入(也称为转化或转染)载体到所选宿主细胞中可用方法如氯化钙、电穿孔、显微注射、脂转染或DEAE-葡聚糖方法来完成。选择的方法部分利用所用类型宿主细胞的功能。这些方法和其它合适方法是本领域技术人员熟知的并被列出,例如见Sambrook等,同上。
含此载体(即转化的或转染的)的宿主细胞可用本领域技术人员熟知的标准培养基培养。此培养基通常含有细胞生长和存活必需的所有营养物。培养大肠杆菌细胞的合适培养基是例如Luria Broth(LB)和/或Terrific Broth(TB)。培养真核细胞的合适培养基是RPMI1640、MEM、DMEM,它们都添加有血清和/或培养特定细胞系所需的生长因子。培养昆虫的合适培养基是Grace培养基,添加有必需的yeastolate、乳白蛋白水解产物和/或胎牛血清。通常,培养基中加入抗生素或其它仅用于选择性生长转化细胞的化合物作为添加物。所用化合物将通过由转化宿主细胞的质粒上存在的可选择标记元件决定。例如,当可选择标记元件是卡那霉素抗性时,加入培养基的化合物是卡那霉素。
宿主细胞中产生的相关蛋白、相关肽或NTP肽的量可用本领域已知的标准方法评估。这种方法包括但不限于蛋白质印迹分析、SDS-聚丙烯酰胺凝胶电泳、非变性凝胶电泳、HPLC分离、质谱、免疫沉淀和/或活性试验如DNA结合凝胶移位试验。
如果相关蛋白、相关肽或NTP肽设计为从宿主细胞中分泌,大部分相关蛋白、相关肽或NTP肽可发现于细胞培养基中。以此方法制备的蛋白质通常不具有氨基末端甲硫氨酸,因为它在细胞分泌时被去除。然而如果相关蛋白、相关肽或NTP肽不从宿主细胞中分泌,它将存在于细胞质和/或核中(真核宿主细胞)或细胞溶质中(革兰阴性菌宿主细胞),且可具有氨基末端甲硫氨酸。
对位于宿主细胞细胞质和/或核中的相关蛋白、相关肽或NTP肽,通常先机械破碎宿主细胞或用洗涤剂释放胞内成分到缓冲溶液中。然后可从溶液中分离相关蛋白、相关肽或NTP肽。
从溶液中纯化相关蛋白、相关肽或NTP肽可采用多种技术完成。如果合成的蛋白质含有如6个组氨酸的钯(NTP蛋白/hexa His)或其它小肽如FLAG(Sigma-Aldritch,St.Louis,MI)或在其羧基或氨基末端含有钙调蛋白-结合肽(Stratagene,LaJolla,CA),它可采用一步法使溶液通过亲和柱来纯化,柱中的柱基质对该尾巴或直接对该蛋白质有高亲和性(即特异性识别相关蛋白或相关肽的单克隆抗体)。例如,聚组氨酸能以高亲和力特异性结合镍、锌及钴;因而使用以镍为基础的亲和树脂(如Qiagen的QIAexpress system或Invitrogen的Xpress System中所用的)或以钴为基础的亲和树脂(如BD Biosciences-CLONTECH的Talon system中所用的)的固定金属离子亲和层析可用于纯化NTP相关蛋白/聚组氨酸。(参见例如,Ausubel等编,《新编分子生物学实验指南》,10.11.8章节,John Wiley&Sons,纽约[1993])。
当制备的相关蛋白、相关肽或NTP肽没有附着尾巴又不能得到其抗体时,可使用其它熟知的纯化方法。这种方法包括但不限于离子交换层析、羟基磷灰石层析、疏水作用层析、分子筛层析、HPLC、结合凝胶洗提的天然凝胶电泳以及制备型等电聚焦(Isoprime机器/技术,Hoefer Scientific)。在一些情况下可联合一种或多种技术以提高纯度。
如果预期相关蛋白、相关肽或NTP肽主要发现于胞内,可用本领域技术人员已知的标准技术提取宿主细胞中的胞内物质(包括革兰阴性菌的包含体)。例如可离心后通过弗氏压碎器、匀浆和/或超声裂解宿主细胞以释放周质/细胞质成分。如果相关蛋白、相关肽或NTP肽在细胞溶质中形成包含体,该包含体常结合于内和/或外细胞膜,因此离心后主要见于沉淀物中。然后在存在还原剂如碱性pH的二硫苏糖醇或酸性pH的三羧乙基膦时用极端pH或用离液剂如去污剂、胍、胍衍生物、尿素或尿素衍生物处理此沉淀物以释放、破裂和溶解此包含体。然后可对已是可溶形式的相关蛋白、相关肽或NTP肽用凝胶电泳、免疫沉淀等分析。如果需要分离相关蛋白、相关肽或NTP肽,可用标准方法完成分离,如下面和Marston等(Meth.Enz.,182:264-275[1990])列出的方法。
在一些情况中,相关蛋白、相关肽或NTP肽分离时可能没有生物活性。可采用重折叠或转变此多肽成其三级结构并产生二硫键的多种方法恢复其生物活性。这些方法包括使溶解的多肽暴露于通常高于7的pH和存在的特定浓度离液剂。离液剂的选择非常类似于用于包含体溶解的选择,但通常浓度较低且不一定是溶解所用的同一离液剂。在大部分情况中,重折叠/氧化溶液也包含还原剂或特定比例的还原剂加其氧化形式,以产生特定氧化还原电势使二硫化物改组形成蛋白质的半胱氨酸桥。一些常用的氧化还原对包括半胱氨酸/胱胺、谷胱甘肽(GSH)/二硫双GSH(dithiobis GSH)、氯化铜、二硫苏糖醇(DTT)/二噻烷DTT、2-巯基乙醇(bME)/二硫-b(ME)。在许多情况中,需要共溶剂以提高重折叠的效率,用于此目的较常用试剂包括甘油、不同分子量的聚乙二醇和精氨酸。
如果宿主细胞中不形成显著程度的相关蛋白、相关肽或NTP肽包含体,细胞匀浆离心后相关蛋白、相关肽或NTP肽主要见于上清液中,相关蛋白、相关肽或NTP肽可用如下方法从上清液中分离获得。
当优选部分或完全分离相关蛋白、相关肽或NTP肽的情况中,可用本领域技术人员熟知的标准方法完成纯化。这种方法包括但不限于电泳分离,接着电洗脱、多种类型的层析(免疫亲和、分子筛和/或离子交换)、和/或高压液相层析。在一些情况中,优选使用一种以上的这些方法来完全纯化。
除了用重组DNA技术制备和纯化相关蛋白、相关肽或NTP肽外,相关蛋白、相关肽或NTP肽和它们的片段、变体、同源物和衍生物可用化学合成方法制备(如固相肽合成),使用本领域已知技术如描述于Merrifield等,(J.Am.Chem.Soc.,85:2149[1963])、Houghten等(Proc.Natl.Acad.Sci.USA,85:5132[1985])、Stewart和Young(《固相肽合成》(Solid Phase Peptide Synthesis),Pierce Chemical Co.,Rockford,III.[1984])。可合成氨基末端有或没有甲硫氨酸的这些多肽。化学合成的相关蛋白、相关肽或NTP肽可用参考文献所列方法氧化以形成二硫桥。预期相关蛋白、相关肽或NTP肽具有相当于重组产生或纯化自天然来源的相关蛋白、相关肽或NTP肽相的生物活性,因此可与重组或天然的相关蛋白、相关肽或NTP肽交换使用。
化学修饰的相关蛋白、相关肽或NTP肽组合物中包含连接于一聚合物的相关蛋白、相关肽或NTP肽属于本发明范围内。所选聚合物通常可溶于水从而其结合的蛋白质在水环境,如生理环境中不会沉淀。所选聚合物通常经修饰而具有一个反应基团如用于酰化的活性酯或用于烷化的醛,这样可如本方法所提供的那样,控制聚合程度。聚合物可以是任何分子量,可以分支或不分支。相关蛋白/相关肽/NTP肽聚合物范围包括聚合物的混合物。
在一些情况中,需要制备天然产生的相关蛋白、相关肽或NTP肽的核酸和/或氨基酸变体。核酸变体可用定点诱变、PCR扩增或其它合适方法产生,其中引物具有所需的点突变(诱变技术的描述参见Sambrook等,同上,Ausubel等,同上)。采用Engels等(同上),所述的化学合成方法也可制备这种变体。其它本领域技术人员已知的方法也可使用。
优选的核酸变体是用于产生相关蛋白、相关肽或NTP肽的宿主细胞中含有密码子优先的核苷酸取代的那些变体。这种“密码子最优化”可通过计算机算法确定,此算法结合密码子频率表如“Ecohigh.Cod”作为高表达细菌基因的密码子优先,由University of Wisconsin包版本9.0,遗传学计算机组,Madison,Wis提供。其它有用的密码子频率表包括“Celegans_high.cod”、“Celegans_low.cod”、“Drosophila_high.cod”、“Human_high.cod”、“Maize_high.cod”和“Yeast_high.cod”。其它优选变体是编码上述与野生型相比保守性氨基酸变化(如其中天然产生的氨基酸侧链的电荷或极性没有因被不同氨基酸取代而显著改变)的变体、和/或设计为产生新的糖基化和/或磷酸化位点的变体、或设计为缺失现有糖基化和/或磷酸化位点的变体。
相关蛋白、相关肽、NTP肽、其片断、同源物、变体、衍生物及其盐类可用此领域的普通技术人员已知的常规肽合成技术产生。这些技术包括化学偶联方法(参见Wunch,E:“有机化学方法”,第15卷,Band 1+2,Synthese von Peptiden,thimeVerlag,Stuttgart(1974)和Barrany,G.;Marrifield,R.B.:“肽”(The Peptides),E.Gross,J.Meienhofer编,第2卷,第1章,1-284页,Academic Press(1980))、酶偶联方法(参见Widmer,F.Johansen,J.T.,Carlsverg Res.Commun.,第44卷,37-46页(1979)和Kullmann,W.:“酶促性肽合成”(Enzymatic Peptide Synthesis),CRC Press Inc.BocaRaton,Fla.(1987)和Widmer,F.,Johansen,J.T.,“生物和医学中的合成肽”(SyntheticPeptides in Biology and Medicines),Alitalo,K.,Partanen,P.,Vatieri,A.编,79-86页,Elsevier,Amsterdam(1985))、或化学和酶方法的组合,如果这具有加工设计和经济的优点。使用本文提供的指南,本领域技术人员能改变相关蛋白、相关肽或NTP肽的肽序列以产生具有与原始或天然相关蛋白、相关肽或NTP肽相同或类似生物活性的同源物。
采用给定的相关蛋白、相关肽或NTP肽的模拟物而不是此蛋白质本身有其优点。通常,与该蛋白质和肽相比,肽模拟物的生物利用度更高,具有较长的作用时间且生产成本较低。
因此,上述相关蛋白、相关肽和NTP肽可用于开发具有类似生物活性从而具有类似治疗作用的小化学化合物。可采用组合化学技术和本领域已知的其它技术开发相关蛋白、相关肽和NTP肽的肽模拟物(参见例如《第20届欧洲肽专题讨论会论文集》(Proceedings of the 20th European Peptide Symposium),G.Jung,E.Bayer编,289-336页,和其中的参考文献)。
结构上修饰本领域已知的肽以产生肽模拟物的方法的例子包括倒置主链手性中心产生D-氨基酸残基结构,具体是在N-末端,导致对蛋白酶降解的稳定性提高而对活性没有不利影响。在论文“含氚D-丙氨酸1-肽T结合”,Smith C.S.等,DrugDevelopment Res.,15,371-379页(1988)中给出了一个例子。
第二种方法是改变稳定性所需的环状结构,如N到C链间的二酰亚胺和内酰胺(Ede等,Smith和Rivier编,《肽:化学和生物学》,Escom,Leiden,1991,268-270页)。例子见构型限制的胸腺五肽样化合物,如美国专利号4,457,489(1985),Goldstein,G.等所公开的那样,其内容全部纳入本文供参考。
第三种方法是用能赋予蛋白水解抗性的假肽键替换相关蛋白、相关肽或NTP肽中的肽键。已报道了一些假肽键一般不影响肽的结构和生物活性。此方法的一个例子是取代逆一反假肽键(“胸腺五肽的生物活性逆反转同源物”,Sisto A等,Rivier,J.E.和Marshall,G.R.编,“肽、化学、结构和生物学”,Escom,Leiden,1990,722-773页)和Dalpozzo等(1993),Int.J.Peptide Protein Res.,41:561-566,纳入本文供参考)。根据此修饰,此肽的氨基酸序列可能与上述相关蛋白、相关肽和NTP肽的序列相同,除了一个或多个肽键被逆反转假肽键所取代外。优选大部分N-末端肽键被取代,由于这种取代将赋予对外肽酶作用于N-末端水解蛋白的抗性。
合成具有一个或多个还原的逆反转假肽键的肽是本领域已知的(Sisto(1990)和Dalpozzo等,(1993),见上)。因此肽键可用非肽键替代使肽模拟物获得与原始肽相似的结构,从而生物活性相似。也可用其它类似结构的化学基团替代氨基酸的化学基团作进一步修饰。另一种已知可提高对酶裂解的稳定性而生物活性没有或很少损失的合适假肽键,是还原型电子等排物假肽键(Couder等(1993),Int.J.PeptideProtein Res.,41:181-184,全部纳入本文供参考)。因此,这些肽的氨基酸序列可能与相关蛋白、相关肽或NTP肽序列相同,除了一个或多个肽键被电子等排物假肽键替代外。优选大部分N-末端肽键被取代,由于这种取代将赋予对外肽酶作用于N-末端水解蛋白的抗性。合成具有一个或多个还原型电子等排假肽键的肽是本领域已知的(Couder等1993,见上)。其他例子包括导入酮亚甲基键或甲硫键来替代肽键。
相关蛋白、相关肽和NTP肽的拟肽衍生物代表了另一类肽模拟物,拟肽保留了生物活性的重要结构决定簇,但去除了肽键,可赋予对蛋白水解的抗性(Simon等,1992,Proc.Natl.Acad.Sci.USA,89:9367-9371,全部纳入本文供参考)。拟肽是N-取代的甘氨酸的寡聚物。已报道了一些N-烷基基团,各对应于天然氨基酸的侧链(Simon等,1992,见上)。相关蛋白、相关肽或NTP肽的一些或所有氨基酸用对应于所替代氨基酸的N-取代甘氨酸替代。
可通过NMR谱、晶体图和/或计算机-辅助分子模型确定原始相关蛋白、相关肽或NTP肽的三级结构来协助开发肽模拟物。这些技术可帮助开发具有比原始肽更高效力和/或更高生物利用率和/或更高稳定性的新组合物(Dean(1994),BioEssays,16:683-687;Cohen和Shatzmiller(1993),J.Mol.Graph.,11:166-173;Wiley和Rich(1993),Med.Res.Rev.,13:327-384;Moore(1994),Trends Pharmacol.Sci.,15:124-129;Hruby(1993),Biopolymers.,33:1073-1082;Bugg等(1993)Sci.Am.,269:92-98,全部纳入本文供参考)。
一旦一种潜在的肽模拟物化合物被鉴定,它可以用下面例子中列出的方法合成和分析以评估其活性。用上述方法获得的肽模拟化合物包括在本发明范围内,该化合物具有相关蛋白、相关肽或NTP肽的生物活性和类似的三维结构。本领域技术人员不难明白,此肽模拟物可从任何携带上述一种或多种修饰的相关蛋白、相关肽或NTP肽中产生。还将明白,本发明的肽模拟物除了其作为治疗化合物的用途外,可进一步用于开发甚至更强的非肽化合物。
今天许多机构都能够合成本文所述的相关蛋白、相关肽和NTP肽。例如,有了一种NTP肽的序列,这些机构就能合成肽并为合成的肽提供相应的文件并证明肽的相同性。
本发明还包括使用相关蛋白、相关肽和NTP肽和它们相应的核酸分子进行试验,以定性或定量测定哺乳动物组织或体液样品中相关蛋白、相关肽、NTP肽、相关蛋白/相关肽/NTP肽的DNA或相应RNA的存在。相关蛋白、相关肽、NTP肽和它们相应的核酸分子可用于这些试验的准备,无论相关蛋白、相关肽或NTP肽或者编码的相关蛋白、相关肽或NTP肽是否显示生物活性。相关蛋白、相关肽或NTP肽的核酸序列可能是杂交探针有用的来源以定性或定量测定哺乳动物组织或体液样品中相关蛋白、相关肽或NTP肽DNA或相应RNA的存在。
本身不具生物活性的相关蛋白、相关肽或NTP肽可用于制备识别和/或结合相关蛋白、相关肽或NTP肽的抗体。这种抗体可用标准方法制备。因此,与相关蛋白、相关肽或NTP肽反应的抗体以及短链抗体片段和这种抗体的其它反应片段也在本发明范围内。抗体可以是多克隆、单克隆、重组、嵌合、单链和/或双特异性。通常,抗体或其片段是人来源或“人源化”,即制备后给予病人时可防止对抗体的免疫反应或减少到最低程度。优选的抗体是人抗体,多克隆或单克隆。抗体片段可以是能与本发明相关蛋白、相关肽或NTP肽反应的任何片断,如Fab、Fab’等。本发明还提供了杂交瘤,方法是通过呈递作为抗源的相关蛋白、相关肽或NTP肽给所选哺乳动物,接着用已知技术使该哺乳动物的细胞(如脾细胞)与一些癌细胞融合以产生无限增殖的细胞系。本发明还包括产生这种细胞系和产生抗所有或部分相关蛋白、相关肽或NTP肽的抗体的方法。
此种抗体可进一步用于体内和体外诊断或研究目的,如以标记形式来检测体液或细胞样品中相关蛋白、相关肽或NTP肽的存在。
本发明还包括使用一种或多种相关蛋白、相关肽或NTP肽作为试验中的校准标准品,以定性或定量测定哺乳动物组织或体液样品中相关蛋白、相关肽、NTP肽、相关蛋白/相关肽/NTP肽的DNA或相应RNA的存在。
本发明涉及治疗需要除去细胞的疾病的新方法,如良性或恶性肿瘤、腺体(如前列腺)增生、不想要的面部汗毛、疣和不想要的脂肪组织。这种方法包括将治疗有效量的相关蛋白、相关肽或NTP肽给予需要的哺乳动物。
这类疾病可以是例如肺、乳房、胃、胰、前列腺、膀胱、骨、卵巢、皮肤、肾、窦、结肠、肠、胃、直肠、食道、血液、大脑和其覆盖物、脊髓和其覆盖物、肌肉、结缔组织、肾上腺、副甲状腺、甲状腺、子宫、睾丸、垂体、生殖器、肝脏、胆囊、眼、耳、鼻、喉、扁桃腺、口、淋巴结和淋巴系统及其它器官的肿瘤。
如本文所用,术语“恶性肿瘤”包括人类癌、肉瘤和黑素瘤的所有形式,它们以低度分化、适度分化、高度分化的形式出现。
本发明满足本领域治疗的需要,可以除去良性肿瘤而风险较小、不良的手术副作用较少。特别需要在手术危险区如体内深处位(例如脑、心脏、肺和其它)去除良性肿瘤的方法。
治疗必须除去细胞的疾病的方法可与治疗这些疾病的常规方法如手术切除、化疗和放射治疗结合使用。相关蛋白、相关肽或NTP肽可在这些常规治疗之前、期间或之后施用。
待治疗的疾病也可以是选自肺、乳房、胃、胰、前列腺、膀胱、骨、卵巢、皮肤、肾、窦、结肠、肠、胃、直肠、食道、血液、大脑和其覆盖物、脊髓和其覆盖物、肌肉、结缔组织、肾上腺、副甲状腺、甲状腺、子宫、睾丸、垂体、生殖器、肝脏、胆囊、眼、耳、鼻、喉、扁桃腺、口、淋巴结和淋巴系统的组织增生,肥大或过度生长。
可用本发明方法治疗的其它疾病是选自肺、乳房、胃、胰、前列腺、膀胱、骨、卵巢、皮肤、肾、窦、结肠、肠、胃、直肠、食道、血液、大脑和其覆盖物、脊髓和其覆盖物、肌肉、结缔组织、肾上腺、副甲状腺、甲状腺、子宫、睾丸、垂体、生殖器、肝脏、胆囊、眼、耳、鼻、喉、扁桃腺、口、淋巴结和淋巴系统的病毒,细菌或寄生虫改变的组织。
待治疗的疾病也可以是选自肺、乳房、胃、胰、前列腺、膀胱、骨、卵巢、皮肤、肾、窦、结肠、肠、胃、直肠、食道、血液、大脑和其覆盖物、脊髓和其覆盖物、肌肉、结缔组织、肾上腺、副甲状腺、甲状腺、子宫、睾丸、垂体、生殖器、肝脏、胆囊、眼、耳、鼻、喉、扁桃腺、口、淋巴结和淋巴系统的组织畸形或乱。
具体说,待治疗的疾病可以是扁桃体肥大、前列腺增生银屑病、湿疹、皮肤病或痔。待治疗的疾病可以是血管病如动脉粥样硬化或动脉硬化,或者是血管病如静脉曲张。待治疗的疾病也可以是以下组织的整容修饰,如皮肤、眼、耳、鼻、喉、口、肌肉、结缔组织、毛发或乳房组织。
相关蛋白、相关肽和/或NTP肽的治疗性组合物属于本发明范围内。这种组合物可包括治疗有效量的相关蛋白、相关肽或NTP肽与药学上可接受载体的混合物。载体物质可以是注射用水,优选在溶液中添加哺乳动物给药常用的其它物质。通常,用于治疗的相关蛋白、相关肽或NTP肽以组合物形式给药,该组合物包括纯化的相关蛋白、相关肽或NTP肽,加上一种或多种生理上可接受的载体、赋形剂或稀释剂。中性缓冲盐水或与血清白蛋白混合的盐水是适当载体的范例。优选此产物用合适的赋形剂(如蔗糖)制成冻干物。如果需要可包括其它标准载体、稀释剂和赋形剂。组合物包括此领域普通技术人员已知的pH值范围合适的缓冲液,包括pH7.0-8.5的Tris缓冲液、或pH 4.0-5.5的乙酸缓冲液,此缓冲液还可包括山梨醇或其合适的替代物。
对于靶向不想要的细胞成分的相关蛋白、相关肽或NTP肽偶联的或连接或结合的抗体、抗体片段、抗体样分子或对特异性肿瘤标记如细胞受体、信号肽或过度表达的酶有高亲和性的分子,也在发明范围内。这些抗体、抗体片段、抗体样分子或对特异性肿瘤标记有高亲和性的分子,可用于将所述相关蛋白、相关肽或NTP肽偶联物到特定细胞或靶组织。例如,具有特殊表面抗原或表达抗原的肿瘤可被这些抗体、抗体片段、抗体样结合分子靶向,因而肿瘤细胞可被相关蛋白、相关肽或NTP肽所杀死。这种采用抗体靶向的方法优点是降低剂量、增加结合和被靶细胞摄取的可能性、提高靶向和治疗转移性肿瘤和微小肿瘤的效率。
本发明还包括采用偶联于或连接或结合于蛋白质或其它分子的所述相关蛋白、相关肽和NTP肽以形成组合物,通过肿瘤-特异性或位点-特异性酶或蛋白酶或者通过靶向肿瘤或其它不想要的细胞的抗体偶联物,在肿瘤或其它不想要的细胞部位或附近裂解时,在肿瘤或其它不想要的细胞的部位或附近释放相关蛋白、相关肽或NTP肽。
本发明还包括采用偶联于或连接或结合于蛋白质或其它分子的所述相关蛋白、相关肽和NTP肽以形成组合物,在待治疗组织暴露于光(如激光疗法或其它光动力学或光活化疗法)、其它形式电磁辐射时,该组合物可释放相关蛋白、相关肽或NTP肽或相关蛋白、相关肽或NTP肽的一些生物活性片段,电磁辐射的其它形式有例如红外线辐射、紫外线辐射、x射线或γ射线辐射、局部加热、α或β辐射、超声波发射或其它局部能量源。
相关蛋白、相关肽或NTP肽可单独、一起或联合其它药物组合物使用,如对待治疗指征合适的细胞因子、生长因子、抗生素、细胞凋亡诱导剂、抗炎药物和/或化疗剂。
本发明还包括所述蛋白、相关肽或NTP肽的组合物,此组合物采用树状聚体、富勒烯和其它合成分子、聚合物及大分子,组合物中相关蛋白、相关肽或NTP肽和/或其相应DNA分子本身或与其它种类分子如肿瘤特异性标记偶联、结合于或包裹在上述分子、聚合物或大分子中。例如,美国专利号5,714,166《生物活性和/或靶树状聚体结合物》(Bioactive and/or Targeted Dendrimer Conjugates)提供了制备和利用靶树状聚合偶联物的方法,此种偶联物包括至少一种树状聚体和靶指示物以及至少一种与之偶联的生物活性剂剂。
本发明还包括所述相关蛋白、相关肽或NTP肽和/或基因及药物递送载体的治疗性组合物,递送载体有例如脂质乳剂、胶束聚合物、聚合物微球、电活化聚合物、水凝胶和脂质体。
采用可转运到不想要细胞的相关蛋白、相关肽或NTP肽或相关基因或基因同等物也在本发明范围内。肿瘤内过度表达所述相关蛋白、相关肽或NTP肽可用于诱导肿瘤中的细胞死亡并因而减少肿瘤细胞群。采用能转运所述相关蛋白、相关肽或NTP肽以治疗不想要的细胞成分的基因或基因同等物,其优点是所需剂量更少、可通过靶细胞分子的细胞后代传代,治疗次数必然减少、总体治疗减少。本发明还包括将编码含相关蛋白、相关肽或NTP肽的融合蛋白的基因转运给不想要的细胞或其邻近细胞,表达该基因及产生和/或分泌此融合蛋白后,此融合蛋白受到天然酶或蛋白酶或者前体药物的切割可释放出所述相关蛋白、相关肽或NTP肽到不想要的细胞或附近。
应用克隆的重组相关蛋白-、相关肽-或NTP肽-抗体偶联物;克隆的重组相关蛋白、、相关肽、或NTP肽-抗体片段偶联物;克隆的重组相关蛋白-、相关肽-或NTP肽-抗体样蛋白偶联物也包括在本发明范围内。与寻靶偶联物(如抗体、抗体片段、抗体样分子或者对癌特异性受体或其它肿瘤标记有高亲和性的分子)结合的克隆的所述相关蛋白、相关肽或NTP肽的优点,是这种分子兼有上述寻靶优点,及可制造和标准化生产克隆的偶联分子的优点。
口服给药的固体剂量形式包括但不限于胶囊、片剂、药丸、粉末和颗粒。在这种固体剂量形式中,优选将活性化合物与至少一种下列物质混合:(a)一种或多种惰性赋形剂(或载体),如柠檬酸钠或磷酸二钙;(b)填充剂或膨胀剂,如淀粉、乳糖、蔗糖、葡萄糖、甘露醇和硅酸;(c)粘合剂,如羧甲基纤维素、藻酸盐、明胶、聚乙烯吡咯烷酮、蔗糖和阿拉伯树胶;(d)保湿剂,如甘油;(e)崩解剂,如琼脂-琼脂、碳酸钙、马铃薯或木薯淀粉、褐藻酸、一些复合硅酸盐和碳酸钠;(f)溶液缓聚剂,如石蜡;(g)吸收加速剂,如季铵化合物;(h)润湿剂,如乙酰醇和甘油单硬脂酸盐;(i)吸收剂,如瓷土和斑脱土;(j)滑润剂,如滑石、硬脂酸钙、硬脂酸镁、固体聚乙二醇、月桂酰硫酸钠和它们的混合物。就胶囊、片剂、药丸而言,其剂量形式也可包括缓冲剂。
口服给药的液体剂量形式包括药学上可接受的乳剂、溶液、悬浮液、糖浆和酏剂。除了活性化合物外,液体剂量形式可包括本领域常用的惰性稀释剂如水或其它溶剂、增溶剂和乳化剂。乳化剂的范例是乙醇、异丙醇、碳酸乙酯、乙酸乙酯、苄醇、苯甲酸苄酯、丙二醇、1,3-丁二醇、二甲基甲酰胺,油如棉子油、花生油、玉米胚芽油、橄榄油、蓖麻油和芝麻油,甘油、四氢糠醇、聚乙二醇、山梨聚糖的脂肪酸酯或这些物质的混合物等。
除了这种惰性稀释剂,该组合物也可包括辅佐剂,如润湿剂、乳化剂和悬浮剂、甜味剂、调味剂和香味剂。
本发明组合物中活性成分的实际剂量水平可以改变以得到治疗有效量的相关蛋白、相关肽或NTP肽从而获得对具体组合物和给药方法的理想治疗反应。因此选择剂量水平取决于所需的治疗效果、给药途径、所需治疗的持续时间以及其它因素。
哺乳动物包括人的有效量可根据体表面积给药。用于不同大小、种类的动物和人的剂量间的相互关系(以体表的mg/M2为基础)的描述见E.J.Freireich等,Cancer Chemother.Rep.,50(4):219(1966)。体表面积可从个体身高体重大约确定(参见例如《科学表》(Scientific Tables),Geigy Pharmaceuticals,Ardsley,N.Y.537-538页(1970))。
给予宿主的所述相关蛋白、相关肽或NTP肽的每日总剂量可以是单剂或分开的剂量。剂量单位组合物包含几分之一的量可用于构成每天剂量。然而要理解的是,任何具体病人的特定剂量水平取决于多种因素,包括体重、整体健康、性别、饮食、给药时间和途径、所给药物的效力、吸收和排泄的比例、联用的其它药物以及所治疗具体疾病的严重性。
给予本发明的相关蛋白、相关肽或NTP肽组合物的方法,包括但不限于肌肉内、口服、静脉内、腹膜内、大脑内(实质内)、脑心室内、肿瘤内、病灶内、皮内、鞘内、鼻内、眼内、动脉内、局部、透皮、通过气雾剂、输注、推射、植入装置、缓释系统等。
另一种给予本发明的相关蛋白、相关肽或NTP肽组合物的方法,是经皮或透皮途径。这种实施方案的一个例子是使用贴片。具体是,贴片可用相关蛋白、相关肽或NTP肽的精细悬浮液制备,例如二甲亚砜(DMSO)或DMSO与棉子油的混合物,使其接触携带肿瘤的哺乳动物皮肤,离开皮肤囊(pouch)内肿瘤定位部位。含有其它溶剂和固体支持物的其它介质或其混合物也可同样起作用。此贴片可包含溶液或悬浮液形式的所述相关蛋白、相关肽或NTP肽化合物。然后可将贴片应用于病人皮肤,例如将它插入病人的皮肤囊,此种皮肤囊可通过用缝针、夹子或其它夹持装置折叠皮肤并夹持在一起来形成。应确保囊与皮肤连续接触而不干扰哺乳动物。除了使用皮肤囊,可使用任何能保证牢固放置的贴片与皮肤接触的装置。例如,粘附绷带可用来保持贴片在皮肤上。
所述相关蛋白、相关肽或NTP肽可以缓释制剂或制品给药。缓释制剂的合适例子包括成形物质形式的半透性聚合物基质,如薄膜或微胶囊。缓释基质包括聚酯、水凝胶、聚交酯(美国3,773,919、EP58,481)、L-谷氨酸和γ乙基-L-谷氨酰胺的共聚物(Sidman等,Biopolymers,22:547-556[1983])、聚(2-羟乙基-甲基丙烯酸盐)(Langer等,J.Biomed.Mater.Res.,15:167-277[1981]和Langer等,Chem.Tech.,12:98-105[1982])、乙烯乙酸聚乙烯(Langer等,同上)或聚-D(-)-3-羟基丁酸(EP133,988)。缓释组合物也包括脂质体,可用本领域已知的一些方法之一来制备(如Eppstein等,Proc.Natl.Acad.Sci.USA,82:3688-3692[1985];EP 36,676;EP 88,046和EP 143,949)。
另一种给予本发明相关蛋白、相关肽或NTP肽的方法,是将相关蛋白、相关肽或NTP肽直接或间接输入到待治疗的肿瘤或其它组织中。这种实施方案的一个例子是直接注射相关蛋白、相关肽或NTP肽到待治疗的肿瘤或其它组织中。此种治疗可以是单次注射、一段时间多次注射或几小时、几天或几个月内一系列注射,待治疗肿瘤或其它组织的消退或破坏可通过活组织检查、摄像或其它监测组织生长的方法来监控。可通过插入孔中如鼻、口、耳、阴道、直肠或尿道中的装置注射到待治疗的肿瘤或其它组织中或穿过切口以到达体内的肿瘤或组织,此种注射可与摄像或光学系统如超声波或纤维光镜结合进行,以确定注射部位是不合适。这种实施方案的另一个例子是采用可使相关蛋白、相关肽或NTP肽恒定输入到该种组织的装置。
又一种给予本发明相关蛋白、相关肽或NTP肽的方法是,与手术或类似的用于物理切除、消融或者杀死或破坏需要去除或破坏的肿瘤或其它组织或细胞成分的方法相结合,其中将本发明的相关蛋白、相关肽或NTP肽给予待去除的肿瘤或其它组织的周围接近区域,以破坏或阻止肿瘤细胞的生长,或此方法不会除去或破坏其它的细胞成分。
另一种给予本发明相关蛋白、相关肽或NTP肽的方法是将装置植入到待治疗的肿瘤或其它组织中。这种实施方案的一个例子是将含相关蛋白、相关肽或NTP肽的薄片植入到待治疗的肿瘤或其它组织中。薄片随时可释放治疗剂量的相关蛋白、相关肽或NTP肽到该组织中。另外,该组合物可局部应用,通过植入吸附了相关蛋白、相关肽或NTP肽的膜、海绵或其它合适物质到受影响的区域。使用植入装置时,此装置可植入到任何合适的组织或器官中,相关蛋白、相关肽或NTP肽的输送可直接通过该装置,经推注或经连续给药或经导管连续输注。
另外一种给药方法是将一个或多个拷贝的相关蛋白-、相关肽-或NTP肽-编码基因导入靶细胞,如果必要,诱导此基因复制开始胞内产生所述相关蛋白、相关肽或NTP肽。一种可用于基因治疗的方式是采用相关蛋白-、相关肽-或NTP肽-编码基因(编码相关蛋白、相关肽或NTP肽(或其片断、变体、同源物或衍生物)的基因组DNA、cDNA和/或合成的DNA),可特此基因操作性连接于一组成型或可诱导启动子以形成“基因治疗DNA构建物”。只要该启动子在构建物插入的细胞或组织类型中具有活性,它可与内源性相关蛋白-、相关肽-或NTP肽-编码基因同源或异源。如果需要,该基因治疗DNA构建物的其它成分可任选地包括设计用于位点特异性整合的DNA分子(如用于同源重组的内源性侧翼序列),组织特异性启动子、增强子或沉默子,能提供选择性优于亲代细胞的DNA分子、用作鉴定转化细胞标记的DNA分子、阴性选择系统、细胞特异结合剂(例如用于细胞靶向)、细胞特异性内化因子、提高载体表达的转录因子以及能使载体生产的因子。
体内或活体外输送基因到细胞或组织中的方法,包括(但不限于)直接注射裸露DNA、弹道方法、脂质体介导的转运、受体介导的转运(配体-DNA复合体)、电穿孔和磷酸钙沉淀,参见美国专利号4,970,154、WO 96/40958、美国专利号5,679,559、美国专利号5,676,954和美国专利号5,593,875,其公开的内容全部纳入本文供参考。
相关蛋白-、相关肽-或NTP肽-编码基因可通过植入患者的某些细胞中来输送,患者的这种细胞已用本文所述方法在活体外进行了遗传工程改造能表达和分泌所述相关蛋白、相关肽或NTP肽或其片段、变体、同源物或衍生物。这种细胞可以是动物或人细胞,可获自病人自身组织或另外的人或非人来源。任选地此种细胞可以是无限增殖的细胞或可以是干细胞。然而为减少免疫应答的机会,优选包裹这种细胞以防止向周围组织渗透。包裹物质一般是生物相容的半透性聚合性封闭物或膜,能使蛋白产物释放但可阻止病人免疫系统细胞或周围组织的其它有害因素的破坏。用于膜包裹细胞的方法是该领域技术人员所熟悉的,可制备包裹的细胞并植入到病人中而不需要过多的实验。参见例如美国专利号4,892,538;5,001,472和5,106,627,它们公布的内容全部纳入本文供参考。包裹活细胞的系统描述见PCTWO 91/10425。制备多种其它持续或受控制递送方式的技术是本领域技术人员已知的,如脂质体载体、生物可侵蚀的颗粒或珠,这些技术描述见例如美国专利号5,653,975,其公开的内容全部纳入本文供参考。可装包裹或不包裹的细胞植入到病人的适当机体组织或器官中。
* * * *
提供以下实施例以阐明本发明。然而应理解本发明不限于这些实施例中所述的具体条件和细节。在本说明书中,任何和所有公众可得到的文献纳入供参考,包括美国专利。
特别地,本发明特意包括了待审批美国专利申请序列号10/092,934:“用神经丝状蛋白治疗肿瘤和相关疾病的方法”中列出的实施例以供参考,此文显示完整的AD7c-NTP蛋白是在体外胶质瘤和成神经细胞瘤细胞培养物中以及体内正常啮齿动物肌肉组织、皮下结缔组织和真皮中,以及多种不同人和非人来源的肿瘤(包括乳腺癌、皮肤癌和乳头状瘤、结肠癌、脑胶质瘤和啮齿动物模型中的其它肿瘤)中造成细胞死亡的一种有效制剂。本发明还特意包括了待审批美国专利申请序列号10/153,334的实施例以供参考,该文显示NTP肽是在体内正常啮齿动物肌肉组织、皮下结缔组织、真皮和其它组织中造成细胞死亡的有效制剂。
实施例1
此实施例的目的是测定NTP肽#6对注射部位组织的作用。
用乙醚将雄性Sprague-Dawley大鼠(体重范围300克)麻醉,并在外科手术暴露前列腺后通过前列腺内灌输给予NTP肽#6。注射剂包括300μlNTP肽#6、1mg/mLPBS pH 7.4(1.0mg/kg)(n=8),对照仅注射PBS(n=6),并有未注射对照(n=2)。72小时后无痛处死动物。解剖前列腺,将其在10%的缓冲福尔马林中固定24小时,石蜡包埋,切片并用H&E染色。将每个动物的完整前列腺包埋并切片。所有染色切片进行组织学检测并进行测量。每个前列腺至少检测4张组织切片,测量每张组织切片相互垂直(90。)的两个截面的直径(每个前列腺总共测量8次或以上)。用每个前列腺这些测量值的平均直径,根据公式
结果:与对照(仅注射PBS的对照和未注射的对照没有可以觉察的变化)相比,注射了NTP肽#6的大鼠前列腺体积减小估计平均为45%。经过处理的大鼠前列腺显示腺上皮广泛丧失、扁平和萎缩。溶于PBS(pH7.4)的NTP肽#6通常以1.0mg/kg灌输到大鼠前列腺,在72小时时,与未处理或PBS处理的对照相比,估计前列腺体积减小40%以上。
实施例2
此实施例的目的是测定NTP肽#7对注射部位组织的作用。
给4只正常大鼠作皮内和皮下注射,各注射四个不同的点,四肢骨骼肌注射时,各注射两个不同的点,通过不锈钢26号针头从塑料注射器输注0.1-1mg/ml浓度的100-400ml盐水配的NTP肽#7。
观察动物24小时且在24小时后无痛处死动物。切取各渗透灶,固定在10%福尔马林中,石蜡包埋,染色并用标准组织病理学方法检测。
对照仅接受盐水注射。
结果:注射NTP肽#7后注射部位产生急性组织坏死。坏死在NTP肽#7注射部位的肌肉组织、皮下结缔组织和真皮中明显。坏死与注射区域相关连,似乎不扩散到离注射部分很远。
远离炎症的轻度区域,对照没有显示出坏死或细胞损失。对照显示出极少或没有肌肉变化。对照注射在注射部位有轻度至极小的急性炎症及针头引起的灶性微出血。
实施例3
此实施例的目的是测定相关肽#1对注射部位组织的作用。
如上述实施例2那样给大鼠作皮肤和皮下注射相关肽#1。
观察动物24小时且在24小时无痛处死动物。切取组织,固定在10%福尔马林中,石蜡包埋,染色并用标准组织病理学方法检测。
对照与实施例2相同。
结果:注射相关肽#1在注射部位产生细胞死亡和组织坏死。与上述实施例2类似,细胞死亡出现在注射了相关肽#1的肌肉组织、皮下结缔组织和真皮中。
远离炎症的轻度区域,对照显示出很轻微的坏死或细胞损失。对照注射在注射部位有轻度至很小的急性炎症偶有针头引起的灶性微出血。
实施例4
此实施例的目的是测定相关肽#2对注射部位组织的作用。
用乙醚将雄性Sprague-Dawley大鼠(体重范围300克)麻醉,并外科手术暴露前列腺后通过前列腺内灌输给予相关肽#2。注射剂包括300μl相关肽#2、1mg/mLPBS pH 7.4(1.0mg/kg)(n=8),对照仅注射PBS(n=6),并有未注射的对照(n=2)。72小时后无痛处死动物。解剖前列腺,将其在10%的缓冲福尔马林中固定24小时,石蜡包埋,切片并用H&E染色。将每个动物的完整前列腺包埋并切片。所有染色切片进行组织学检测并进行测量。每个前列腺至少检测4张组织切片,测量每张组织切片相互垂直(90°)的两个截面的直径(每个前列腺总共测量8次或以上)。用每个前列腺这些测量值的平均直径,根据公式
对照与实施例1相同。
结果:如上述实施例1所示,注射相关肽#2第72小时造成了前列腺中显著的细胞损失和萎缩。对照显示出最轻微的变化或没有变化,包括针头引起的轻度灶性炎症。
实施例5
此实施例的目的是测定相关肽#3对注射部位组织的作用。
如实施例1和4在正常大鼠的前列腺中注射相关肽#3。72小时后无痛处死动物并如上述实施例1和4检测前列腺。
结果:与对照相比,在72小时时发现显著的细胞损失和萎缩,而对照只有最轻微的变化。
* * * *
已经参考特别优选的实施方案和例子描述了本发明。然而,此领域的技术人员应理解,可对本发明作出多种改变但不背离本发明的思路和或范围。
序列表
<110>尼莫克斯股份有限公司(NYMOX CORPORATION)
<120>有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽
<130>10107-44
<140>PCT/CA02/01106
<141>2002-07-19
<150>US 60/306,161
<151>2001-07-19
<150>US 60/306,150
<151>2001-07-19
<150>US 60/331,477
<151>2001-11-16
<160>125
<170>PatentIn Ver.2.1
<210>1
<211>375
<212>PRT
<213>智人(Homo sapiens)
<400>1
Met Glu Phe Ser Leu Leu Leu Pro Arg Leu Glu Cys Asn Gly Ala Ile
1 5 10 15
Ser Ala His Arg Asn Leu Arg Leu Pro Gly Ser Ser Asp Ser Pro Ala
20 25 30
Ser Ala Ser Pro Val Ala Gly Ile Thr Gly Met Cys Thr His Ala Arg
35 40 45
Leu Ile Leu Tyr Phe Phe Leu Val Glu Met Glu Phe Leu His Val Gly
50 55 60
Gln Ala Gly Leu Glu Leu Pro Thr Ser Asp Asp Pro Ser Val Ser Ala
65 70 75 80
Ser Gln Ser Ala Arg Tyr Arg Thr Gly His His Ala Arg Leu Cys Leu
85 90 95
Ala Asn Phe Cys Gly Arg Asn Arg Val Ser Leu Met Cys Pro Ser Trp
100 105 110
Ser Pro Glu Leu Lys Gln Ser Thr Cys Leu Ser Leu Pro Lys Cys Trp
115 120 125
Asp Tyr Arg Arg Ala Ala Val Pro Gly Leu Phe Ile Leu Phe Phe Leu
130 135 140
Arg His Arg Cys Pro Thr Leu Thr Gln Asp Glu Val Gln Trp Cys Asp
145 150 155 160
His Ser Ser Leu Gln Pro Ser Thr Pro Glu Ile Lys His Pro Pro Ala
165 170 175
Ser Ala Ser Gln Val Ala Gly Thr Lys Asp Met His His Tyr Thr Trp
180 185 190
Leu Ile Phe Ile Phe Ile Phe Asn Phe Leu Arg Gln Ser Leu Asn Ser
195 200 205
Val Thr Gln Ala Gly Val Gln Trp Arg Asn Leu Gly Ser Leu Gln Pro
210 215 220
Leu Pro Pro Gly Phe Lys Leu Phe Ser Cys Pro Ser Leu Leu Ser Ser
225 230 235 240
Trp Asp Tyr Arg Arg Pro Pro Arg Leu Ala Asn Phe Phe Val Phe Leu
245 250 255
Val Glu Met Gly Phe Thr Met Phe Ala Arg Leu Ile Leu Ile Ser Gly
260 265 270
Pro Cys Asp Leu Pro Ala Ser Ala Ser Gln Ser Ala Gly Ile Thr Gly
275 280 285
Val Ser His His Ala Arg Leu Ile Phe Asn Phe Cys Leu Phe Glu Met
290 295 300
Glu Ser His Ser Val Thr Gln Ala Gly Val Gln Trp Pro Asn Leu Gly
305 310 315 320
Ser Leu Gln Pro Leu Pro Pro Gly Leu Lys Arg Phe Ser Cys Leu Ser
325 330 335
Leu Pro Ser Ser Trp Asp Tyr Gly His Leu Pro Pro His Pro Ala Asn
340 345 350
Phe Cys Ile Phe Ile Arg Gly Gly Val Ser Pro Tyr Leu Ser Gly Trp
355 360 365
Ser Gln Thr Pro Asp Leu Arg
370 375
<210>2
<211>122
<212>PRT
<213>未知生物
<220>
<223>未知生物的描述:未知NTP肽
<400>2
Met Met Val Cys Trp Asn Arg Phe Gly Lys Trp Val Tyr Phe Ile Ser
1 5 10 15
Ala Ile Phe Asn Phe Gly Pro Arg Tyr Leu Tyr His Gly Val Pro Phe
20 25 30
Tyr Phe Leu Ile Leu Val Arg Ile Ile Ser Phe Leu Ile Gly Asp Met
35 40 45
Glu Asp Val Leu Leu Asn Cys Thr Leu Leu Lys Arg Ser Ser Arg Phe
50 55 60
Arg Phe Trp Gly Ala Leu Val Cys Ser Met Asp Ser Cys Arg Phe Ser
65 70 75 80
Arg Val Ala Val Thr Tyr Arg Phe Ile Thr Leu Leu Asn Ile Pro Ser
85 90 95
Pro Ala Val Trp Met Ala Arg Asn Thr Ile Asp Gln Gln Val Leu Ser
100 105 110
Arg Ile Lys Leu Glu Ile Lys Arg Cys Leu
115 120
<210>3
<211>112
<212>PRT
<213>智人(Homo sapiens)
<400>3
Met Ala Gln Ser Arg Leu Thr Ala Thr Ser Ala Ser Arg Val Gln Ala
1 5 10 15
Ile Leu Leu Ser Gln Pro Pro Lys Gln Leu Gly Leu Arg Ala Pro Ala
20 25 30
Asn Thr Pro Leu Ile Phe Val Phe Ser Leu Glu Ala Gly Phe His His
35 40 45
Ile Cys Gln Ala Gly Leu Lys Leu Leu Thr Ser Gly Asp Pro Pro Ala
50 55 60
Ser Ala Phe Gln Ser Ala Gly Ile Thr Gly Val Ser His Leu Thr Gln
65 70 75 80
Pro Ala Asn Leu Asp Lys Lys Ile Cys Ser Asn Gly Gly Ser Cys Tyr
85 90 95
Val Ala Gln Ala Gly Leu Lys Leu Leu Ala Ser Cys Asn Pro Ser Lys
100 105 110
<210>4
<211>106
<212>PRT
<213>智人(Homo sapiens)
<400>4
Met Trp Thr Leu Lys Ser Ser Leu Val Leu Leu Leu Cys Leu Thr Cys
1 5 10 15
Ser Tyr Ala Phe Met Phe Ser Ser Leu Arg Gln Lys Thr Ser Glu Pro
20 25 30
Gln Gly Lys Val Pro Cys Gly Glu His Phe Arg Ile Arg Gln Asn Leu
35 40 45
Pro Glu His Thr Gln Gly Trp Leu Gly Ser Lys Trp Leu Trp Leu Leu
50 55 60
Phe Ala Val Val Pro Phe Val Ile Leu Lys Cys Gln Arg Asp Ser Glu
65 70 75 80
Lys Asn Lys Val Arg Met Ala Pro Phe Phe Leu His His Ile Asp Ser
85 90 95
Ile Ser Gly Val Ser Gly Lys Arg Met Phe
100 105
<210>5
<211>106
<212>PRT
<213>智人(Homo sapiens)
<400>5
Met Phe Phe Val Leu Tyr Arg Phe Cys Phe Cys Phe Phe Glu Thr Glu
1 5 10 15
Ser His Ser Leu Thr Gln Ala Gly Val Gln Trp Cys Glu Leu Gly Ser
20 25 30
Pro Gln Pro Leu Pro Ser Gly Phe Lys Arg Phe Ser Cys Leu Ser Leu
35 40 45
Leu Ser Ser Trp Asp Tyr Ser His Glu Pro Pro His Pro Val Ile Cys
50 55 60
Ser Phe Leu Met Glu Lys Cys Leu Ile Leu Tyr Lys Pro Asn Gly Asp
65 70 75 80
Thr Ile Gly Pro Ile Leu Val Gln Gln Gly Lys Arg Gln Lys Leu Tyr
85 90 95
Ile Ser Ala Asp Leu Val His Leu Ile Ala
100 105
<210>6
<211>98
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:未知NTP肽
<400>6
Glu Ala Tyr Tyr Thr Met Leu His Leu Pro Thr Thr Asn Arg Pro Lys
1 5 10 15
Ile Ala His Cys Ile Leu Phe Asn Gln Pro His Ser Pro Arg Ser Asn
20 25 30
Ser His Ser His Pro Asn Pro Leu Lys Leu His Arg Arg Ser His Ser
35 40 45
His Asn Arg Pro Arg Ala Tyr Ile Leu Ile Thr Ile Leu Pro Ser Lys
50 55 60
Leu Lys Leu Arg Thr His Ser Gln Ser His His Asn Pro Leu Ser Arg
65 70 75 80
Thr Ser Asn Ser Thr Pro Thr Asn Ser Phe Leu Met Thr Ser Ser Lys
85 90 95
Pro Arg
<210>7
<211>75
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:未知NTP肽
<400>7
Ser Ser Ser Leu Gly Leu Pro Lys Cys Trp Asp Tyr Arg His Glu Leu
1 5 10 15
Leu Ser Leu Ala Leu Met Ile Asn Phe Arg Val Met Ala Cys Thr Phe
20 25 30
Lys Gln His Ile Glu Leu Arg Gln Lys Ile Ser Ile Val Pro Arg Lys
35 40 45
Leu Cys Cys Met Gly Pro Val Cys Pro Val Lys Ile Ala Leu Leu Thr
50 55 60
Ile Asn Gly His Cys Thr Trp Leu Pro Ala Ser
65 70 75
<210>8
<211>68
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:未知NTP肽
<400>8
Met Phe Val Phe Cys Leu Ile Leu Asn Arg Glu Lys Ile Lys Gly Gly
1 5 10 15
Asn Ser Ser Phe Phe Leu Leu Ser Phe Phe Phe Ser Phe Gln Asn Cys
20 25 30
Cys Gln Cys Phe Gln Cys Arg Thr Thr Glu Gly Tyr Ala Val Glu Cys
35 40 45
Phe Tyr Cys Leu Val Asp Lys Ala Ala Phe Glu Cys Trp Trp Phe Tyr
50 55 60
Ser Phe Asp Thr
65
<210>9
<211>61
<212>PRT
<213>智人(Homo sapiens)
<400>9
Met Glu Pro His Thr Val Ala Gln Ala Gly Val Pro Gln His Asp Leu
1 5 10 15
Gly Ser Leu Gln Ser Leu Leu Pro Arg Phe Lys Arg Phe Ser Cys Leu
20 25 30
Ile Leu Pro Lys Ile Trp Asp Tyr Arg Asn Met Asn Thr Ala Leu Ile
35 40 45
Lys Arg Asn Arg Tyr Thr Pro Glu Thr Gly Arg Lys Ser
50 55 60
<210>10
<211>5
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:合成肽
<400>10
Ser Ser Trp Asp Tyr
1 5
<210>11
<211>9
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:合成肽
<400>11
Pro Ala Ser Ala Ser Pro Val Ala Gly
1 5
<210>12
<211>11
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:合成肽
<400>12
Gly Ala Ile Ser Ala His Arg Asn Leu Arg Leu
1 5 10
<210>13
<211>6
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:合成肽
<400>13
Phe Phe Leu Val Glu Met
1 5
<210>14
<211>9
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:合成肽
<400>14
Ser Val Thr Gln Ala Gly Val Gln Trp
1 5
<210>15
<211>17
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:合成肽
<400>15
Ile Asp Gln Gln Val Leu Ser Arg Ile Lys Leu Glu Ile Lys Arg Cys
1 5 10 15
Leu
<210>16
<211>9
<212>PRT
<213>人工序列
<220>
<223>人工序列的描述:合成肽
<400>16
Leu Ser Arg Ile Lys Leu Glu Ile Lys
1 5
<210>17
<211>22
<212>PRT
<213>智人(Homo sapiens)
<400>17
Gly Asp His Gly Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala Ile Lys
1 5 10 15
Tyr Glu Val Lys Lys Met
20
<210>18
<211>16
<212>PRT
<213>智人(Homo sapiens)
<400>18
Gln Gln Ser Ile Ala Val Lys Phe Leu Ala Val Phe Gly Val Ser Ile
1 5 10 15
<210>19
<211>21
<212>PRT
<213>智人(Homo sapiens)
<400>19
Gly Leu Leu Phe Pro Val Phe Ser Val Cys Tyr Leu Ile Ala Pro Lys
1 5 10 15
Ser Pro Leu Gly Leu
20
<210>20
<211>581
<212>PRT
<213>智人(Homo sapiens)
<400>20
Met Glu Val Ser Pro Leu Gln Pro Val Asn Glu Asn Met Gln Val Asn
1 5 10 15
Lys Ile Lys Lys Asn Glu Asp Ala Lys Lys Arg Leu Ser Val Glu Arg
20 25 30
I1e Tyr Gln Lys Lys Thr Gln Leu Glu His Ile Leu Leu Arg Pro Asp
35 40 45
Thr Tyr Ile Gly Ser Val Glu Leu Val Thr Gln Gln Met Trp Val Tyr
50 55 60
Asp Glu Asp Val Gly Ile Asn Tyr Arg Glu Val Thr Phe Val Pro Gly
65 70 75 80
Leu Tyr Lys Ile Phe Asp Glu Ile Leu Val Asn Ala Ala Asp Asn Lys
85 90 95
Gln Arg Asp Pro Lys Met Ser Cys Ile Arg Val Thr Ile Asp Pro Glu
100 105 110
Asn Asn Leu Ile Ser Ile Trp Asn Asn Gly Lys Gly Ile Pro Val Val
115 120 125
Glu His Lys Val Glu Lys Met Tyr Val Pro Ala Leu Ile Phe Gly Gln
130 135 140
Leu Leu Thr Ser Ser Asn Tyr Asp Asp Asp Glu Lys Lys Val Thr Gly
145 150 155 160
Gly Arg Asn Gly Tyr Gly Ala Lys Leu Cys Asn Ile Phe Ser Thr Lys
165 170 175
Phe Thr Val Glu Thr Ala Ser Arg Glu Tyr Lys Lys Met Phe Lys Gln
180 185 190
Thr Trp Met Asp Asn Met Gly Arg Ala Gly Glu Met Glu Leu Lys Pro
195 200 205
Phe Asn Gly Glu Asp Tyr Thr Cys Ile Thr Phe Gln Pro Asp Leu Ser
210 215 220
Lys Phe Lys Met Gln Ser Leu Asp Lys Asp Ile Val Ala Leu Met Val
225 230 235 240
Arg Arg Ala Tyr Asp Ile Ala Gly Ser Thr Lys Asp Val Lys Val Phe
245 250 255
Leu Asn Gly Asn Lys Leu Pro Val Lys Gly Phe Arg Ser Tyr Val Asp
260 265 270
Met Tyr Leu Lys Asp Lys Leu Asp Glu Thr Gly Asn Ser Leu Lys Val
275 280 285
Ile His Glu Gln Val Asn His Arg Trp Glu Val Cys Leu Thr Met Ser
290 295 300
Glu Lys Gly Phe Gln Gln Ile Ser Phe Val Asn Ser Ile Ala Thr Ser
305 310 315 320
Lys Gly Gly Arg His Val Asp Tyr Val Ala Asp Gln Ile Val Thr Lys
325 330 335
Leu Val Asp Val Val Lys Lys Lys Asn Lys Gly Gly Val Ala Val Lys
340 345 350
Ala His Gln Arg Glu Leu Cys Asn Gly Ala Ile Leu Ala His Cys Asn
355 360 365
Leu Arg Leu Met Gly Ser Ser Asp Ser Pro Ala Ser Ala Ser Arg Val
370 375 380
Ala Gly Ile Ala Gly Gly Cys His His Thr Gln Leu Ile Phe Val Phe
385 390 395 400
Leu Val Glu Thr Gly Phe His His Val Gly Gln Ala Gly Leu Glu Arg
405 410 415
Leu Thr Ser Gly Asp Pro Pro Ala Ser Ala Ser Gln Ser Ser Gly Ile
420 425 430
Thr Asp Val Lys Val Lys Asn His Met Trp Ile Phe Val Asn Ala Leu
435 440 445
Ile Glu Asn Pro Thr Phe Asp Ser Gln Thr Lys Glu Asn Met Thr Leu
450 455 460
Gln Pro Lys Ser Phe Gly Ser Thr Cys Gln Leu Ser Glu Lys Phe Ile
465 470 475 480
Lys Ala Ala Ile Gly Cys Gly Ile Val Glu Ser Ile Leu Asn Trp Val
485 490 495
Lys Phe Lys Ala Gln Val Gln Leu Asn Lys Lys Cys Ser Ala Val Lys
500 505 510
His Asn Arg Ile Lys Gly Ile Pro Lys Leu Asp Asp Ala Asn Asp Ala
515 520 525
Gly Gly Arg Asn Ser Thr Glu Cys Thr Leu Ile Leu Thr Glu Gly Asp
530 535 540
Ser Ala Lys Thr Leu Ala Val Ser Gly Leu Gly Val Val Gly Arg Asp
545 550 555 560
Lys Tyr Gly Val Phe Pro Leu Arg Gly Lys Ile Leu Asn Val Arg Glu
565 570 575
Ala Ser His Lys Gln
580
<210>21
<211>163
<212>PRT
<213>智人(Homo sapiens)
<400>21
Met Thr Gly Asp Lys Gly Pro Gln Arg Leu Ser Gly Ser Ser Tyr Gly
1 5 10 15
Ser Ile Ser Ser Pro Thr Ser Pro Thr Ser Pro Gly Pro Gln Gln Ala
20 25 30
Pro Pro Arg Glu Thr Tyr Leu Ser Glu Lys Ile Pro Ile Pro Asp Thr
35 40 45
Lys Pro Gly Thr Phe Ser Leu Arg Lys Leu Trp Ala Phe Thr Gly Pro
50 55 60
Gly Phe Leu Met Ser Ile Ala Phe Leu Asp Pro Gly Asn Ile Glu Ser
65 70 75 80
Asp Leu Gln Ala Gly Ala Val Ala Gly Phe Lys Leu Leu Trp Val Leu
85 90 95
Leu Trp Ala Thr Val Leu Gly Leu Leu Cys Gln Arg Leu Ala Ala Arg
100 105 110
Leu Gly Val Val Thr Gly Lys Asp Leu Gly Glu Val Cys His Leu Tyr
115 120 125
Tyr Pro Lys Ser Glu Ser Arg Ser Val Ala Gln Ser Gly Val Gln Trp
130 135 140
Cys Asp Val Ser Ser Leu Gln Pro Leu Pro Pro Arg Cys Pro Ala Pro
145 150 155 160
Ser Ser Gly
<210>22
<211>151
<212>PRT
<213>智人(Homo sapiens)
<400>22
Met Met Leu Ser Val Gln Glu Asn Val His Arg Cys Ile Cys Lys His
1 5 10 15
Tyr Ala Pro Pro Thr Ala Pro His Leu Phe Phe Glu Thr Glu Ser His
20 25 30
Ser Val Thr Gln Ala Gly Val Gln Trp Cys Asp Leu Gly Ser Leu Gln
35 40 45
Pro Ser Pro Pro Gly Phe Lys Gln Phe Ser Cys Leu Ser Leu Ser Arg
50 55 60
Ser Trp Asp Tyr Arg Arg Val Pro Leu Cys Leu Ala Asn Phe Ile Val
65 70 75 80
Phe Leu Val Glu Thr Gly Phe Cys Arg Val Gly Gln Ala Gly Leu Lys
85 90 95
Leu Leu Thr Ser Ser Asp Leu Pro Ala Ser Ala Cys Gln Ser Ala Gly
100 105 110
Asp Tyr Arg His Glu Pro Leu Arg Leu Ala Leu Thr Leu Cys His Phe
115 120 125
Ile Ser Arg Thr Cys Thr Ser Val Asp Phe Tyr Ile Cys Arg Asp Leu
130 135 140
Glu Arg Ile Pro His Gly His
145 150
<210>23
<211>129
<212>PRT
<213>智人(Homo sapiens)
<400>23
Met Ile Ser Ala His Arg Asn Leu His Leu Pro Gly Ser Ser Asn Ser
1 5 10 15
Pro Ala Ser Ala Phe Leu Ser Ser Trp Asp Tyr Arg His Val Pro Pro
20 25 30
Cys Pro Ala Asn Val Val Phe Leu Val Glu Met Gly Phe Leu His Val
35 40 45
Gly Gln Ala Gly Leu Glu Leu Pro Thr Ser Asp Asp Pro Pro Thr Leu
50 55 60
Ala Ser Gln Ser Ala Gly Ile Thr Gly Val Ser His Arg Thr Trp Gln
65 70 75 80
Glu Phe Ala Ser Leu Thr Val Ser Gln Ala Val Leu Arg Met Leu Val
85 90 95
Trp Gly Pro Gln Phe Glu Asn His Cys Ser Lys Leu Leu Met Ala Ser
100 105 110
Glu Gly Asp Ser Ser Leu Val Phe Phe Leu Tyr Pro Leu Ser Asn Leu
115 120 125
Asn
<210>24
<211>155
<212>PRT
<213>智人(Homo sapiens)
<400>24
Met Gln Gly Ser His Ser Ala Val Gln Ala Gly Val Trp Trp Cys His
1 5 10 15
His Asp Ser Leu Gln Pro Trp Pro Pro Gly Leu Arg Arg Ser Ser Cys
20 25 30
Leu Ser Leu Gln Ser Leu Trp Asp Tyr Arg Ser Leu Ala Leu Ser Leu
35 40 45
Arg Leu Ala Cys Asn Gly Thr Thr Ser Ala His Cys Asp Leu Cys Leu
50 55 60
Leu Ser Ser Ser Asp Ser Pro Ala Ser Ala Ser Gln Val Ala Gly Ile
65 70 75 80
Thr Gly Glu Lys Thr Ala Glu Pro His Lys Ala His Ala Ala Gln Gly
85 90 95
Glu Arg His Leu Ser Ser His Met Ser Pro Asp Glu Asn Met Thr Glu
100 105 110
Lys Phe Cys Pro Gly Pro Arg Ala Ser Phe His Leu Arg Ile Leu Ala
115 120 125
Ala Ser Arg His Leu Val Lys Arg Leu Leu Asn Glu Tyr Thr Val Thr
130 135 140
Val Leu Arg Asp Lys Ser Tyr Leu Arg Asn Asn
145 150 155
<210>25
<211>127
<212>PRT
<213>智人(Homo sapiens)
<400>25
Met Lys Asn Tyr Tyr Tyr Phe Leu Gly Gln Gly Leu Thr Leu Ser Pro
1 5 10 15
Arg Leu Glu Cys Ser Ser Thr Ile Ser Ala His Cys Asn Leu His Leu
20 25 30
Leu Gly Ser Ser Asn Ser Pro Val Ala Ala Ser Pro Val Ala Gly Thr
35 40 45
Thr Gly Thr Cys His His Asp Trp Leu Ile Phe Val Phe Leu Val Glu
50 55 60
Thr Gly Phe His His Ile Gly Gln Thr Gly Leu Glu Phe Leu Thr Ser
65 70 75 80
Gly Asp Pro Pro Thr Leu Ala Ser Lys Ser Ala Gly Ile Thr Gly Val
85 90 95
Ser His Cys Ala Trp Pro Thr Phe Leu Leu Asn Asp Met Arg His Ser
100 105 110
Phe Asn Lys Asn Leu Val Ile Ile Phe Tyr Val Pro Ala Ile Ser
115 120 125
<210>26
<211>137
<212>PRT
<213>智人(Homo sapiens)
<400>26
Met Arg Arg Glu Leu Leu Ala Gly Ile Leu Leu Arg Ile Thr Phe Asn
1 5 10 15
Phe Phe Leu Phe Phe Phe Leu Pro Phe Pro Leu Val Val Phe Phe Ile
20 25 30
Tyr Phe Tyr Phe Tyr Phe Phe Leu Glu Met Glu Ser His Tyr Val Ala
35 40 45
Gln Ala Gly Leu Glu Leu Leu Gly Ser Ser Asn Pro Pro Ala Ser Ala
50 55 60
Ser Leu Val Ala Gly Thr Leu Ser Val His His Cys Ala Cys Phe Glu
65 70 75 80
Ser Phe Thr Lys Arg Lys Lys Lys Leu Lys Lys Ala Phe Arg Phe Ile
85 90 95
Gln Cys Leu Leu Leu Gly Leu Leu Lys Val Arg Pro Leu Gln His Gln
100 105 110
Gly Val Asn Ser Cys Asp Cys Glu Arg Gly Tyr Phe Gln Gly Ile Phe
115 120 125
Met Gln Ala Ala Pro Trp Glu Gly Thr
130 135
<210>27
<211>1150
<212>PRT
<213>智人(Homo sapiens)
<400>27
Met Ser Lys Thr Leu Lys Lys Lys Lys His Trp Leu Ser Lys Val Gln
1 5 10 15
Glu Cys Ala Val Ser Trp Ala Gly Pro Pro Gly Asp Phe Gly Ala Glu
20 25 30
Ile Arg Gly Gly Ala Glu Arg Gly Glu Phe Pro Tyr Leu Gly Arg Leu
35 40 45
Arg Glu Glu Pro Gly Gly Gly Thr Cys Cys Ile Val Ser Gly Lys Ala
50 55 60
Pro Asn Pro Ser Asp Val Leu Leu Glu Val Asn Gly Thr Pro Val Ser
65 70 75 80
Gly Leu Thr Asn Arg Asp Thr Leu Ala Val Ile Arg His Phe Arg Glu
85 90 95
Pro Ile Arg Leu Lys Thr Val Lys Pro Gly Lys Val Ile Asn Lys Asp
100 105 110
Leu Arg His Tyr Leu Ser Leu Gln Phe Gln Lys Gly Ser Ile Asp His
115 120 125
Lys Leu Gln Gln Val Ile Arg Asp Asn Leu Tyr Leu Arg Thr Ile Pro
130 135 140
Cys Thr Thr Arg Ala Pro Arg Asp Gly Glu Val Pro Gly Val Asp Tyr
145 150 155 160
Asn Phe Ile Ser Val Glu Gln Phe Lys Ala Leu Glu Glu Ser Gly Ala
165 170 175
Leu Leu Glu Ser Gly Thr Tyr Asp Gly Asn Phe Tyr Gly Thr Pro Lys
180 185 190
Pro Pro Ala Glu Pro Ser Pro Phe Gln Pro Asp Pro Val Asp Gln Val
195 200 205
Leu Phe Asp Asn Glu Phe Asp Ala Glu Ser Gln Arg Lys Arg Thr Thr
210 215 220
Ser Val Ser Lys Met Glu Arg Met Asp Ser Ser Leu Pro Glu Glu Glu
225 230 235 240
Glu Asp Glu Asp Lys Gly Ala Ile Asn Gly Ser Gly Asn Ala Glu Asn
245 250 255
Arg Glu Arg His Ser Glu Ser Ser Asp Trp Met Lys Thr Val Pro Ser
260 265 270
Tyr Asn Gln Thr Asn Ser Ser Met Asp Phe Arg Asn Tyr Met Met Arg
275 280 285
Asp Glu Thr Leu Glu Pro Leu Pro Lys Asn Trp Glu Met Ala Tyr Thr
290 295 300
Asp Thr Gly Met Ile Tyr Phe Ile Asp His Asn Thr Lys Thr Thr Thr
305 310 315 320
Trp Leu Asp Pro Arg Leu Cys Lys Lys Ala Lys Ala Pro Glu Asp Cys
325 330 335
Glu Asp Gly Glu Leu Pro Tyr Gly Trp Glu Lys Ile Glu Asp Pro Gln
340 345 350
Tyr Gly Thr Tyr Tyr Val Asp Phe Thr Leu Val Ala Gln Ala Gly Val
355 360 365
Gln Trp His Asp Leu Gly Ser Leu Gln Pro Pro Pro Pro Gly Phe Asn
370 375 380
His Leu Asn Gln Lys Thr Gln Phe Glu Asn Pro Val Glu Glu Ala Lys
385 390 395 400
Arg Lys Lys Gln Leu Gly Gln Val Glu Ile Gly Ser Ser Lys Pro Asp
405 410 415
Met Glu Lys Ser His Phe Thr Arg Asp Pro Ser Gln Leu Lys Gly Val
420 425 430
Leu Val Arg Ala Ser Leu Lys Lys Ser Thr Met Gly Phe Gly Phe Thr
435 440 445
Ile Ile Gly Gly Asp Arg Pro Asp Glu Phe Leu Gln Val Lys Asn Val
450 455 460
Leu Lys Asp Gly Pro Ala Ala Gln Asp Gly Lys Ile Ala Pro Gly Asp
465 470 475 480
Val Ile Val Asp Ile Asn Gly Asn Cys Val Phe Gly His Thr His Ala
485 490 495
Asp Val Val Gln Met Phe Gln Leu Val Pro Val Asn Gln Tyr Val Asn
500 505 510
Leu Thr Leu Cys Arg Gly Tyr Pro Leu Pro Asp Asp Ser Glu Asp Pro
515 520 525
Val Val Asp Ile Val Ala Ala Thr Pro Val Ile Asn Gly Gln Ser Leu
530 535 540
Thr Lys Gly Glu Thr Cys Met Asn Pro Gln Asp Phe Lys Pro Gly Ala
545 550 555 560
Met Val Leu Glu Gln Asn Gly Lys Ser Gly His Thr Ser Thr Gly Asp
565 570 575
Gly Leu Asn Gly Pro Ser Asp Ala Ser Glu Gln Arg Val Ser Met Ala
580 585 590
Ser Ser Gly Ser Ser Gln Pro Glu Leu Val Thr Ile Pro Leu Ile Lys
595 600 605
Gly Pro Lys Gly Phe Gly Phe Ala Ile Ala Asp Ser Pro Thr Gly Gln
610 615 620
Lys Val Lys Met Ile Leu Asp Ser Gln Trp Cys Gln Gly Leu Gln Lys
625 630 635 640
Glu Asp Ile Ile Lys Glu Ile Tyr His Gln Asn Val Gln Asn Leu Thr
645 650 655
His Leu Gln Val Val Glu Val Leu Lys Gln Phe Pro Val Gly Ala Asp
660 665 670
Val Pro Leu Leu Ile Leu Arg Gly Gly Pro Pro Ser Thr Thr Lys Thr
675 680 685
Ala Lys Met Lys Thr Asp Lys Lys Glu Asn Ala Gly Ser Leu Glu Ala
690 695 700
Ile Asn Glu Pro Ile Pro Gln Pro Met Pro Phe Pro Pro Ser Ile Ile
705 710 715 720
Arg Ser Gly Ser Pro Lys Leu Asp Pro Ser Glu Val Tyr Leu Lys Ser
725 730 735
Lys Thr Leu Tyr Glu Asp Lys Pro Pro Asn Thr Lys Asp Leu Asp Val
740 745 750
Phe Leu Arg Lys Gln Glu Ser Gly Phe Gly Phe Arg Val Leu Gly Gly
755 760 765
Asp Gly Pro Asp Gln Ser Ile Tyr Ile Gly Ala Ile Ile Pro Leu Gly
770 775 780
Ala Ala Glu Lys Asp Gly Arg Leu Arg Ala Ala Asp Glu Leu Met Cys
785 790 795 800
Ile Asp Gly Ile Pro Val Lys Gly Lys Ser His Lys Gln Val Leu Asp
805 810 815
Leu Met Thr Thr Ala Ala Arg Asn Gly His Val Leu Leu Thr Val Arg
820 825 830
Arg Lys Ile Phe Tyr Gly Glu Lys Gln Pro Glu Asp Asp Ser Ser Gln
835 840 845
Ala Phe Ile Ser Thr Gln Asn Gly Ser Pro Arg Leu Asn Arg Ala Glu
850 855 860
Val Pro Ala Arg Pro Ala Pro Gln Glu Pro Tyr Asp Val Val Leu Gln
865 870 875 880
Arg Lys Glu Asn Glu Gly Phe Gly Phe Val Ile Leu Thr Ser Lys Asn
885 890 895
Lys Pro Pro Pro Gly Val Ile Pro His Lys Ile Gly Arg Val Ile Glu
900 905 910
Gly Ser Pro Ala Asp Arg Cys Gly Lys Leu Lys Val Gly Asp His Ile
915 920 925
Ser Ala Val Asn Gly Gln Ser Ile Val Glu Leu Ser His Ala Asn Ile
930 935 940
Val Gln Leu Ile Lys Asp Ala Gly Val Thr Val Thr Leu Thr Val Ile
945 950 955 960
Ala Glu Glu Glu His His Gly Pro Pro Ser Gly Thr Asn Ser Ala Arg
965 970 975
Gln Ser Pro Ala Leu Gln His Arg Pro Met Gly Gln Ser Gln Ala Asn
980 985 990
His Ile Pro Gly Asp Arg Ser Ala Leu Glu Gly Glu Ile Gly Lys Asp
995 1000 1005
Val Ser Thr Ser Tyr Arg His Ser Trp Ser Asp His Lys His Leu Ala
1010 1015 1020
Gln Pro Asp Thr Ala Val Ile Ser Val Val Gly Ser Arg His Asn Gln
1025 1030 1035 1040
Asn Leu Gly Cys Tyr Pro Val Glu Leu Glu Arg Gly Pro Arg Gly Phe
1045 1050 1055
Gly Phe Ser Leu Arg Gly Gly Lys Glu Tyr Asn Met Gly Leu Phe Ile
1060 1065 1070
Leu Arg Leu Ala Glu Asp Gly Pro Ala Ile Lys Asp Gly Arg Ile His
1075 1080 1085
Val Gly Asp Gln Ile Val Glu Ile Asn Gly Glu Pro Thr Gln Gly Ile
1090 1095 1100
Thr His Thr Arg Ala Ile Glu Leu Ile Gln Ala Gly Gly Asn Lys Val
1105 1110 1115 1120
Leu Leu Leu Leu Arg Pro Gly Thr Gly Leu Ile Pro Asp His Gly Leu
1125 1130 1135
Ala Pro Ser Gly Leu Cys Ser Tyr Val Lys Pro Glu Gln His
1140 1145 1150
<210>28
<211>253
<212>PRT
<213>智人(Homo sapiens)
<400>28
Met Ala Asp Asp Gln Gly Cys Ile Glu Glu Gln Gly Val Glu Asp Ser
1 5 10 15
Ala Asn Glu Asp Ser Val Asp Ala Lys Pro Asp Arg Ser Ser Phe Val
20 25 30
Pro Ser Leu Phe Ser Lys Lys Lys Lys Asn Val Thr Met Arg Ser Ile
35 40 45
Lys Thr Thr Arg Asp Arg Val Pro Thr Tyr Gln Tyr Asn Met Asn Phe
50 55 60
Glu Lys Leu Gly Lys Cys Ile Ile Ile Asn Asn Lys Asn Phe Asp Lys
65 70 75 80
Val Thr Gly Met Gly Val Arg Asn Gly Thr Asp Lys Asp Ala Glu Ala
85 90 95
Leu Phe Lys Cys Phe Arg Ser Leu Gly Phe Asp Val Ile Val Tyr Asn
100 105 110
Asp Cys Ser Cys Ala Lys Met Gln Asp Leu Leu Lys Lys Ala Ser Glu
115 120 125
Glu Asp His Thr Asn Ala Ala Cys Phe Ala Cys Ile Leu Leu Ser His
130 135 140
Gly Glu Glu Asn Met Glu Ser Cys Ser Val Thr Gln Ala Gly Val Gln
145 150 155 160
Arg Arg Asp Leu Gly Arg Leu Gln Pro Pro Pro Pro Arg Leu Ala Glu
165 170 175
Gly Pro Ser Leu Met Met Ala Ser Arg Pro Thr Arg Gly Pro Ser Met
180 185 190
Thr Gln Met Leu Ile Leu Asp Thr Arg Ser Gln Trp Lys Leu Thr Ser
195 200 205
Ser Ser Pro Ile Pro Arg Phe Gln Ala Ile Thr Arg Gly Gly Ala Gln
210 215 220
Glu Glu Ala Pro Gly Leu Cys Lys Pro Ser Ala Pro Ser Trp Arg Ser
225 230 235 240
Thr Glu Lys Thr Trp Lys Ser Cys Arg Ser Ser Pro Gly
245 250
<210>29
<211>111
<212>PRT
<213>智人(Homo sapiens)
<400>29
Met Gly Leu Ser Ile Ala Ser His Phe Gly Leu Leu Ile Lys Lys Val
1 5 10 15
Glu Arg Asn Ile Leu Phe Phe Phe Arg Arg Ser Leu Ala Leu Cys Gln
20 25 30
Ala Gly Val Gln Trp Arg Tyr Leu Ser Gln Leu Thr Ala Ala Ser Ala
35 40 45
Ser Trp Val Gln Ala Ile Leu Cys Leu Ser Leu Pro Ser Ser Trp Asp
50 55 60
Tyr Arg His Met Pro Pro Arg Pro Ala Asn Phe Cys Ile Leu Ser Arg
65 70 75 80
Asp Gly Ile Ser Pro Cys Trp Pro Gly Trp Ser Arg Ser Leu Asp Leu
85 90 95
Val Ile Arg Pro Pro Arg Pro Pro Lys Val Leu Arg Leu Gln Ala
100 105 110
<210>30
<211>118
<212>PRT
<213>智人(Homo sapiens)
<400>30
Met Gln Ile Ile Phe Phe Phe Leu Phe Leu Arg Trp Ser Phe Thr Leu
1 5 10 15
Val Ala Gln Ala Gly Val Gln Trp Arg Asp Leu Ser Ser Pro Gln Pro
20 25 30
Pro Pro Pro Arg Phe Lys Arg Phe Ser Cys Leu Ser Pro Pro Ser Ser
35 40 45
Trp Asp Tyr Arg His Ala Pro Pro His Pro Ala Asn Phe Val Phe Leu
50 55 60
Val Glu Thr Gly Phe Leu Arg Val Gly Gln Ala Gly Leu Glu Leu Leu
65 70 75 80
Thr Ser Gly Asp Pro Pro Ala Ser Ala Ser Gln Ser Ala Gly Ile Thr
85 90 95
Gly Val Ser His His Thr Gln Pro Asp Ala Asn Asn Phe Leu Arg Lys
100 105 110
Leu Phe Gln Lys Leu Phe
115
<210>31
<211>139
<212>PRT
<213>智人(Homo sapiens)
<400>31
Met Gly His Pro Arg Ala Ile Gln Pro Ser Val Phe Phe Ser Pro Tyr
1 5 10 15
Asp Val His Phe Leu Leu Tyr Pro Ile Arg Cys Pro Tyr Leu Lys Ile
20 25 30
Gly Arg Phe His Ile Lys Leu Lys Gly Leu His Phe Leu Phe Ser Phe
35 40 45
Leu Phe Phe Phe Phe Glu Thr Gln Ser His Ser Val Thr Arg Leu Glu
50 55 60
Cys Ser Gly Thr Ile Ser Ala His Cys Asn Leu Cys Leu Pro Gly Ser
65 70 75 80
Ser Asn Ser Pro Ala Ser Ala Ser Gln Val Ala Gly Thr Thr Gly Thr
85 90 95
Cys His His Ala Gln Leu Ile Phe Val Phe Leu Ala Glu Met Gly Phe
100 105 110
His His Ile Gly Gln Asp Gly Leu Asp Leu Asn Leu Val Ile His Pro
115 120 125
Pro Arg Ser Pro Lys Ala Leu Gly Leu Gln Ala
130 135
<210>32
<211>69
<212>PRT
<213>智人(Homo sapiens)
<400>32
Met Pro Asn His Tyr Ser Phe Cys Phe Cys Phe Cys Phe Cys Phe Arg
1 5 10 15
Arg Ser Leu Ala Leu Ser Pro Arg Leu Glu Cys Ser Gly Ala Ile Leu
20 25 30
Ala His Gly Lys Leu His Leu Pro Gly Ser Arg His Ser Pro Ala Ser
35 40 45
Ala Ser Pro Val Ala Gly Thr Lys Gly Ala Arg His His Ala Arg Leu
50 55 60
Ile Phe Leu Tyr Phe
65
<210>33
<211>162
<212>PRT
<213>智人(Homo sapiens)
<400>33
Leu Phe Thr Asn Ser Pro Phe Ser Leu Leu Ser Pro Ala Gln Trp Leu
1 5 10 15
Cys Phe Gly Thr His Leu Gly His Val Gln Ser Val Ser His Leu Gln
20 25 30
Trp Glu Gly Ser Val Gln Glu Ser Leu Arg Ser Val Arg Asn Ser Arg
35 40 45
Cys Ala Leu Pro Met Leu Ser Ala Pro Cys Ser Leu Ser Leu His Phe
50 55 60
Leu Leu Phe Ser Leu Ser Pro Phe Phe Phe Phe Glu Ile Arg Val Leu
65 70 75 80
Leu Tyr Arg Gln Ala Gly Val Gln Trp Cys Tyr Leu Gly Ser Leu Gln
85 90 95
Pro Leu Pro Pro Gly Phe Lys Gln Phe Ser Cys Leu Ser Tyr Pro Ser
100 105 110
Ser Trp Asp Tyr Arg Arg Pro Pro Pro Arg Gln Ala Asn Phe Cys Ile
115 120 125
Phe Ser Thr Asp Gly Val Ser Pro Cys Trp Pro Arg Trp Ser Leu Ser
130 135 140
Leu Asp Leu Met Ile Arg Pro Pro Gln Pro Pro Glu Val Leu Gly Leu
145 150 155 160
Gln Val
<210>34
<211>232
<212>PRT
<213>智人(Homo sapiens)
<400>34
Met Gly Arg Leu Val Leu Leu Trp Gly Ala Ala Val Phe Leu Leu Gly
1 5 10 15
Gly Trp Met Ala Leu Gly Gln Gly Gly Ala Glu Gly Val Gln Ile Gln
20 25 30
Ile Ile Tyr Phe Asn Leu Glu Thr Val Gln Val Thr Trp Asn Ala Ser
35 40 45
Lys Tyr Ser Arg Thr Asn Leu Thr Phe His Tyr Arg Phe Asn Gly Asp
50 55 60
Glu Ala Tyr Asp Gln Cys Thr Asn Tyr Leu Leu Gln Glu Gly His Thr
65 70 75 80
Ser Gly Cys Leu Leu Asp Ala Glu Gln Arg Asp Asp Ile Leu Tyr Phe
85 90 95
Ser Ile Arg Asn Gly Thr His Pro Val Phe Thr Ala Ser Arg Trp Met
100 105 110
Val Tyr Tyr Leu Lys Pro Ser Ser Pro Lys His Val Arg Phe Ser Trp
115 120 125
His Gln Asp Ala Val Thr Val Thr Cys Ser Asp Leu Ser Tyr Gly Asp
130 135 140
Leu Leu Tyr Glu Val Gln Tyr Arg Ser Pro Phe Asp Thr Glu Trp Gln
145 150 155 160
Thr Gln Ser Arg Ser Val Thr Gln Ala Gly Val Gln Trp Cys Asp Leu
165 170 175
Cys Leu Leu Gln Pro Ser Pro Pro Arg Phe Lys Arg Phe Ser Cys Leu
180 185 190
Ser Leu Pro Ser Ser Trp Asp Tyr Arg His Pro Pro Pro Arg Leu Ala
195 200 205
Asn Phe Cys Ile Ile Ser Arg Asp Gly Val Ser Pro Cys Trp Pro Gly
210 215 220
Trp Ser Arg Thr Cys Asp Leu Arg
225 230
<210>35
<211>506
<212>PRT
<213>智人(Homo sapiens)
<400>35
Met Glu Phe Leu Lys Val Ala Arg Arg Asn Lys Arg Glu Gln Leu Glu
1 5 10 15
Gln Ile Gln Lys Glu Leu Ser Val Leu Glu Glu Asp Ile Lys Arg Val
20 25 30
Glu Glu Met Ser Gly Leu Tyr Ser Pro Val Ser Glu Asp Ser Thr Val
35 40 45
Pro Gln Phe Glu Ala Pro Ser Pro Ser His Ser Ser Ile Ile Asp Ser
50 55 60
Thr Glu Tyr Ser Gln Pro Pro Gly Phe Ser Gly Ser Ser Gln Ala Gly
65 70 75 80
Val Gln Trp Arg Tyr Leu Gly Ser Leu Gln Pro Pro Pro Pro Arg Tyr
85 90 95
Lys Arg Phe Ser Cys Leu Thr Leu Pro Ser Ser Trp Asp Tyr Arg Arg
100 105 110
Leu Pro Pro His Leu Thr Lys Lys Gln Pro Trp Tyr Asn Ser Thr Leu
115 120 125
Ala Ser Arg Arg Lys Arg Leu Thr Ala His Phe Glu Asp Leu Glu Gln
130 135 140
Cys Tyr Phe Ser Thr Arg Met Ser Arg Ile Ser Asp Asp Ser Arg Thr
145 150 155 160
Ala Ser Gln Leu Asp Glu Phe Gln Glu Cys Leu Ser Lys Phe Thr Arg
165 170 175
Tyr Asn Ser Val Arg Pro Leu Ala Thr Leu Ser Tyr Ala Ser Asp Leu
180 185 190
Tyr Asn Gly Ser Ser Ile Val Ser Ser Ile Glu Phe Asp Arg Asp Cys
195 200 205
Asp Tyr Phe Ala Ile Ala Gly Val Thr Lys Lys Ile Lys Val Tyr Glu
210 215 220
Tyr Asp Thr Val Ile Gln Asp Ala Val Asp Ile His Tyr Pro Glu Asn
225 230 235 240
Glu Met Thr Cys Asn Ser Lys Ile Ser Cys Ile Ser Trp Ser Ser Tyr
245 250 255
His Lys Asn Leu Leu Ala Ser Ser Asp Tyr Glu Gly Thr Val Ile Leu
260 265 270
Trp Asp Gly Phe Thr Gly Gln Arg Ser Lys Val Tyr Gln Glu His Glu
275 280 285
Lys Arg Cys Trp Ser Val Asp Phe Asn Leu Met Asp Pro Lys Leu Leu
290 295 300
Ala Ser Gly Ser Asp Asp Ala Lys Val Lys Leu Trp Ser Thr Asn Leu
305 310 315 320
Asp Asn Ser Val Ala Ser Ile Glu Ala Lys Ala Asn Val Cys Cys Val
325 330 335
Lys Phe Ser Pro Ser Ser Arg Tyr His Leu Ala Phe Gly Cys Ala Asp
340 345 350
His Cys Val His Tyr Tyr Asp Leu Arg Asn Thr Lys Gln Pro Ile Met
355 360 365
Val Phe Lys Gly His Arg Lys Ala Val Ser Tyr Ala Lys Phe Val Ser
370 375 380
Gly Glu Glu Ile Val Ser Ala Ser Thr Asp Ser Gln Leu Lys Leu Trp
385 390 395 400
Asn Val Gly Lys Pro Tyr Cys Leu Arg Ser Phe Lys Gly His Ile Asn
405 410 415
Glu Lys Asn Phe Val Gly Leu Ala Ser Asn Gly Asp Tyr Ile Ala Cys
420 425 430
Gly Ser Glu Asn Asn Ser Leu Tyr Leu Tyr Tyr Lys Gly Leu Ser Lys
435 440 445
Thr Leu Leu Thr Phe Lys Phe Asp Thr Val Lys Ser Val Leu Asp Lys
450 455 460
Asp Arg Lys Glu Asp Asp Thr Asn Glu Phe Val Ser Ala Val Cys Trp
465 470 475 480
Arg Ala Leu Pro Asp Gly Glu Ser Asn Val Leu Ile Ala Ala Asn Ser
485 490 495
Gln Gly Thr Ile Lys Val Leu Glu Leu Val
500 505
<210>36
<211>120
<212>PRT
<213>智人(Homo sapiens)
<400>36
Met Gly Ser Tyr Phe Val Ala Arg Ala Gly Cys Lys Leu Leu Gly Leu
1 5 10 15
Lys Gly Thr Ser His Phe Ser Leu Pro Lys Cys Arg Asn Cys Arg Arg
20 25 30
Glu Pro Leu Pro Gly Leu Phe Phe Leu Phe Phe Val Phe Phe Phe Leu
35 40 45
Arg Arg Ser Leu Ala Leu Ser Pro Arg Leu Glu Cys Ser Gly Ala Ile
50 55 60
Val Ala His Cys Lys Leu Gly Leu Pro Gly Ser Leu His Ser Pro Ala
65 70 75 80
Ser Ala Ser Gln Val Ala Gly Thr Ile Gly Thr Cys His Asn Thr Arg
85 90 95
Ile Ile Phe Cys Ile Leu Val Glu Thr Gly Phe His Arg Val Ser Gln
100 105 110
Asp Gly Val Asp Leu Leu Thr Leu
115 120
<210>37
<211>257
<212>PRT
<213>智人(Homo sapiens)
<400>37
Met Asp Cys Gly Ser Val Gly Gly Gln Arg Thr Gln Arg Leu Pro Gly
1 5 10 15
Arg Gln Arg Leu Leu Phe Leu Pro Val Gly Leu Ser Gly Arg Pro Gly
20 25 30
Gly Ser Glu Thr Ser Ala Arg Arg Cys Pro Ser Ala Leu Ser Asp Gly
35 40 45
Leu Gly Ala Leu Arg Pro Arg Ala Pro Ala Ala Arg Gly Gly Val Ser
50 55 60
Arg Ala Ser Pro Leu Leu Leu Leu Leu Leu Val Pro Ser Pro Arg Leu
65 70 75 80
Ala Ala Ala Ala Pro Arg Arg Gln Leu Gly Asp Trp Glu Arg Ser Arg
85 90 95
Leu Gly Tyr Ala Ala Pro Pro Ala Gly Arg Ser Gly Ala Trp Arg Cys
100 105 110
Ser Pro Gly Val Ala Ala Ala Ala Gly Ala Leu Pro Gln Tyr His Gly
115 120 125
Pro Ala Pro Ala Leu Val Ser Cys Arg Arg Glu Leu Ser Leu Ser Ala
130 135 140
Gly Ser Leu Gln Leu Glu Arg Lys Arg Arg Asp Phe Thr Ser Ser Gly
145 150 155 160
Ser Arg Lys Leu Tyr Phe Asp Thr His Ala Leu Val Cys Leu Leu Glu
165 170 175
Asp Asn Glu Ser His Ser Phe Ile Gln Ala Gly Val Gln Trp His Ser
180 185 190
Leu Gly Leu Leu Gln Pro Pro Pro Pro Gly Phe Lys Arg Ser Ser His
195 200 205
Leu Ile Leu Leu Ser Ser Trp Asp Tyr Arg His Ala Pro Pro His Leu
210 215 220
Asp Asn Phe Ser Val Phe Leu Leu Glu Thr Gly Phe His His Val Gly
225 230 235 240
Gln Ala Gly Leu Lys Leu Leu Thr Ser Ser Asp Pro Pro Thr Leu Ala
245 250 255
Ser
<210>38
<211>438
<212>PRT
<213>智人(Homo sapiens)
<400>38
Met Ser Pro Ala Thr Thr Gly Thr Phe Leu Leu Thr Val Tyr Ser Ile
1 5 10 15
Phe Ser Lys Val His Ser Asp Arg Asn Val Tyr Pro Ser Ala Gly Val
20 25 30
Leu Phe Val His Val Leu Glu Arg Glu Tyr Phe Lys Gly Glu Phe Pro
35 40 45
Pro Tyr Pro Lys Pro Gly Glu Ile Ser Asn Asp Pro Ile Thr Phe Asn
50 55 60
Thr Asn Leu Met Gly Tyr Pro Asp Arg Pro Gly Trp Leu Arg Tyr Ile
65 70 75 80
Gln Arg Thr Pro Tyr Ser Asp Gly Val Leu Tyr Gly Ser Pro Thr Ala
85 90 95
Glu Asn Val Gly Lys Pro Thr Ile Ile Glu Ile Thr Ala Tyr Asn Arg
100 105 110
Arg Thr Phe Glu Thr Ala Arg His Asn Leu Ile Ile Asn Ile Met Ser
115 120 125
Ala Glu Asp Phe Pro Leu Pro Tyr Gln Ala Glu Phe Phe Ile Lys Asn
130 135 140
Met Asn Val Glu Glu Met Leu Ala Ser Glu Val Leu Gly Asp Phe Leu
145 150 155 160
Gly Ala Val Lys Asn Val Trp Gln Pro Glu Arg Leu Asn Ala Ile Asn
165 170 175
Ile Thr Ser Ala Leu Asp Arg Gly Gly Arg Val Pro Leu Pro Ile Asn
180 185 190
Asp Leu Lys Glu Gly Val Tyr Val Met Val Gly Ala Asp Val Pro Phe
195 200 205
Ser Ser Cys Leu Arg Glu Val Glu Asn Pro Gln Asn Gln Leu Arg Cys
210 215 220
Ser Gln Glu Met Glu Pro Val Ile Thr Cys Asp Lys Lys Phe Arg Thr
225 230 235 240
Gln Phe Tyr Ile Asp Trp Cys Lys Ile Ser Leu Val Asp Lys Thr Lys
245 250 255
Gln Val Ser Thr Tyr Gln Glu Val Ile Arg Gly Glu Gly Ile Leu Pro
260 265 270
Asp Gly Gly Glu Tyr Lys Pro Pro Ser Asp Ser Leu Lys Ser Arg Asp
275 280 285
Tyr Tyr Thr Asp Phe Leu Ile Thr Leu Ala Val Pro Ser Ala Val Ala
290 295 300
Leu Val Leu Phe Leu Ile Leu Ala Tyr Ile Met Cys Cys Arg Arg Glu
305 310 315 320
Gly Val Glu Lys Arg Asn Met Gln Thr Pro Asp Ile Gln Leu Val His
325 330 335
His Ser Ala Ile Gln Lys Ser Thr Lys Glu Leu Arg Asp Met Ser Lys
340 345 350
Asn Arg Glu Ile Ala Trp Pro Leu Ser Thr Leu Pro Val Phe His Pro
355 360 365
Val Thr Gly Glu Ile Ile Pro Pro Leu His Thr Asp Asn Tyr Asp Ser
370 375 380
Thr Asn Met Pro Leu Met Gln Thr Gln Gln Trp Ser Phe Ala Pro Val
385 390 395 400
Ala Gln Ala Gly Val Gln Trp Arg Asp Leu Gly Ser Leu Gln Pro Pro
405 410 415
Pro Pro Arg Asn Leu Pro His Gln Thr Gln Ile Pro Gln Gln Gln Thr
420 425 430
Thr Gly Lys Trp Tyr Pro
435
<210>39
<211>171
<212>PRT
<213>智人(Homo sapiens)
<400>39
Met Leu Gly Leu Arg Lys Ala Ala Ala Ile Ser Leu Leu Leu Arg Asn
1 5 10 15
Val Gly Leu Gln Leu Ala Thr Leu Leu Met Ser Gln Lys Lys Leu Gly
20 25 30
Phe Cys Gly Asn Phe Leu Phe Leu Asn Leu Ala Ile Ile Gln Thr Lys
35 40 45
Ile Ser Ser Ser Phe Phe Phe Phe Leu Arg Gln Ser Leu Thr Leu Ser
50 55 60
Pro Arg Leu Glu Cys Asn Gly Ala Ile Ser Ala His Cys His Leu Arg
65 70 75 80
Leu Pro Asp Ser Ser Asn Ser Pro Ala Ser Ala Ser Gln Val Thr Gly
85 90 95
Ile Thr Gly Ser His His His Ala Trp Leu Ile Phe Val Phe Leu Val
100 105 110
Glu Thr Gly Phe Cys His Val Gly Gln Asp Gly Leu Glu Leu Leu Thr
115 120 125
Ser Gly Asp Pro Pro Ala Ser Ala Ser Gln Ser Ala Gly Ile Thr Gly
130 135 140
Met Ser His His Thr Trp Pro Thr Asp Leu Phe Phe Lys Thr Val Leu
145 150 155 160
Pro Ala Arg Leu Gly Leu Trp Asp Ser Ser Val
165 170
<210>40
<211>365
<212>PRT
<213>智人(Homo sapiens)
<400>40
Met His Ala Val Pro Arg Gly Phe Gly Lys Lys Val Arg Val Gly Val
1 5 10 15
Gln Ser Cys Pro Ser Pro Phe Ser Gly Gln Ala Cys Pro Gln Pro Ser
20 25 30
Ser Val Phe Trp Ser Leu Leu Lys Asn Leu Pro Phe Leu Glu His Leu
35 40 45
Glu Leu Ile Gly Ser Asn Phe Ser Ser Ala Met Pro Arg Asn Glu Pro
50 55 60
Ala Ile Arg Asn Ser Leu Pro Pro Cys Ser Arg Ala Gln Ser Val Gly
65 70 75 80
Asp Ser Glu Val Ala Ala Ile Gly Gln Leu Ala Phe Leu Arg His Leu
85 90 95
Thr Leu Ala Gln Leu Pro Ser Val Leu Thr Gly Ser Gly Leu Val Asn
100 105 110
Ile Gly Pro Gln Cys Gln Gln Leu Arg Ser Leu Ser Leu Ala Asn Leu
115 120 125
Gly Met Met Gly Lys Val Val Tyr Met Pro Ala Leu Ser Asp Met Leu
130 135 140
Lys His Cys Lys Arg Leu Arg Asp Leu Arg Leu Glu Gln Pro Tyr Phe
145 150 155 160
Ser Ala Asn Ala Gln Phe Phe Gln Ala Leu Ser Gln Cys Pro Ser Leu
165 170 175
Gln Arg Leu Cys Leu Val Ser Arg Ser Gly Thr Leu Gln Pro Asp Ala
180 185 190
Val Leu Ala Phe Met Ala Arg Cys Leu Gln Val Val Met Cys His Leu
195 200 205
Phe Thr Gly Glu Ser Leu Ala Thr Cys Lys Ser Leu Gln Gln Ser Leu
210 215 220
Leu Arg Arg Trp Gly Glu Val Thr Gly Arg Arg Pro Gln Leu Phe Thr
225 230 235 240
Glu Leu Arg Glu Glu Pro Ser Ala Arg Thr Ser Arg Ala Thr Gly Arg
245 250 255
Arg Gln Pro Cys Leu Pro Asp Ser Gly Val Val Cys Cys Pro Cys Gly
260 265 270
Arg Pro Leu Ala Val Ser Gly Ile Ile Leu Val Gly Val Ser Pro Ser
275 280 285
Leu Val Val Lys Thr Thr Cys Val Tyr Arg Val Leu Phe Lys Asn Leu
290 295 300
Asp Tyr Ala Ser Ile Phe Phe Leu Val Cys Leu Phe Glu Thr Glu Ser
305 310 315 320
His Ser Val Val Gln Ala Gly Val Gln Trp Arg Asp Leu Ser Ser Leu
325 330 335
Gln Pro Leu Leu Ser Gly Leu Gln Pro Gln Pro Pro Glu Gln Leu Glu
340 345 350
Asn Glu Leu Glu Ile Gly Phe Ser Tyr Cys Phe Val Ile
355 360 365
<210>41
<211>125
<212>PRT
<213>智人(Homo sapiens)
<400>41
Met Glu Glu Asp Glu Phe Ile Gly Glu Lys Thr Phe Gln Arg Tyr Cys
1 5 10 15
Ala Glu Phe Ile Lys His Ser Gln Gln Ile Gly Asp Ser Trp Glu Trp
20 25 30
Arg Pro Ser Lys Asp Cys Ser Asp Gly Tyr Met Cys Lys Ile His Phe
35 40 45
Gln Ile Lys Asn Gly Ser Val Met Ser His Leu Gly Ala Ser Thr His
50 55 60
Gly Gln Thr Cys Leu Pro Met Glu Val Lys Ser Cys Ser Val Thr Gln
65 70 75 80
Ala Gly Val Gln Leu Arg Asp Leu Ser Ser Leu Gln Pro Pro Pro Ser
85 90 95
Gly Phe Lys Gln Phe Ser Cys Leu Ser Leu Pro Ser Asn Trp Asp Tyr
100 105 110
Arg Gly Ser Pro Leu His Leu Ala Asn Phe Leu Tyr Phe
115 120 125
<210>42
<211>120
<212>PRT
<213>智人(Homo sapiens)
<400>42
Met Thr Thr Cys Glu Phe Glu Phe Ile Phe Leu Lys Glu Gln Val Thr
1 5 10 15
Arg Ile Cys Asn Ile Ala Pro Leu Lys Ala Tyr Phe Ser Val His Lys
20 25 30
Met Gly Lys Ile Leu Lys Lys Leu Ser Asn Phe Ser Phe Leu Thr His
35 40 45
Arg Gln Ser Leu Thr Leu Ser Pro Arg Leu Glu Cys Ser Gly Ala Ile
50 55 60
Ser Ala His Cys Asn Leu His Leu Leu Gly Ser Ser Asn Ser Ala Ala
65 70 75 80
Ser Ala Ser Arg Val Ala Gly Thr Thr Gly Ala Cys His His Ala Gln
85 90 95
Leu Ile Phe Val Phe Leu Val Glu Thr Gly Phe His His Val Gly Gln
100 105 110
Asp Gly Leu Gly Leu Leu Thr Ser
115 120
<210>43
<211>643
<212>PRT
<213>智人(Homo sapiens)
<400>43
Met Ser Cys Asn Pro Ser Phe Gly Gly Ile Gly Lys Gly His Leu Met
1 5 10 15
Arg Glu Val Asp Ala Leu Asp Gly Leu Cys Ser Arg Ile Cys Asp Gln
20 25 30
Ser Gly Val His Tyr Lys Val Leu Asn Arg Arg Lys Gly Pro Ala Val
35 40 45
Trp Gly Leu Arg Ala Gln Ile Asp Arg Lys Leu Tyr Lys Gln Asn Met
50 55 60
Gln Lys Glu Ile Leu Asn Thr Pro Leu Leu Thr Val Gln Glu Gly Ala
65 70 75 80
Val Glu Asp Leu Ile Leu Thr Glu Pro Glu Pro Glu His Thr Gly Lys
85 90 95
Cys Arg Val Ser Gly Val Val Leu Val Asp Gly Ser Thr Val Tyr Ala
100 105 110
Glu Ser Val Ile Leu Thr Thr Gly Thr Phe Leu Arg Gly Met Ile Val
115 120 125
Ile Gly Leu Glu Thr His Pro Ala Gly Arg Leu Gly Asp Gln Pro Ser
130 135 140
Ile Gly Leu Ala Gln Thr Leu Glu Lys Leu Gly Phe Val Val Gly Arg
145 150 155 160
Leu Lys Thr Gly Thr Pro Pro Arg Ile Ala Lys Glu Ser Ile Asn Phe
165 170 175
Ser Ile Leu Asn Lys His Ile Pro Asp Asn Pro Ser Ile Pro Phe Ser
180 185 190
Phe Thr Asn Glu Thr Val Trp Ile Lys Pro Glu Asp Gln Leu Pro Cys
195 200 205
Tyr Leu Thr His Thr Asn Pro Arg Val Asp Glu Ile Val Leu Lys Asn
210 215 220
Leu His Leu Asn Ser His Val Lys Glu Thr Thr Arg Gly Pro Arg Tyr
225 230 235 240
Cys Pro Ser Ile Glu Ser Lys Val Leu Arg Phe Pro Asn Arg Leu His
245 250 255
Gln Val Trp Leu Glu Pro Glu Gly Met Asp Ser Asp Leu Ile Tyr Pro
260 265 270
Gln Gly Leu Ser Met Thr Leu Pro Ala Glu Leu Gln Glu Lys Met Ile
275 280 285
Thr Cys Ile Arg Gly Leu Glu Lys Ala Lys Val Ile Gln Pro Asp Gly
290 295 300
Val Leu Leu Leu Leu Pro Arg Met Glu Cys Asn Gly Ala Ile Ser Ala
305 310 315 320
His His Asn Leu Pro Leu Pro Gly Tyr Gly Val Gln Tyr Asp Tyr Leu
325 330 335
Asp Pro Arg Gln Ile Thr Pro Ser Leu Glu Thr His Leu Val Gln Arg
340 345 350
Leu Phe Phe Ala Gly Gln Ile Asn Gly Thr Thr Gly Tyr Glu Glu Ala
355 360 365
Ala Ala Gln Gly Val Ile Ala Gly Ile Asn Ala Ser Leu Arg Val Ser
370 375 380
Arg Lys Pro Pro Phe Val Val Ser Arg Thr Glu Gly Tyr Ile Gly Val
385 390 395 400
Leu Ile Asp Asp Leu Thr Thr Leu Gly Thr Ser Glu Pro Tyr Arg Met
405 410 415
Phe Thr Ser Arg Val Glu Phe Arg Leu Ser Leu Arg Pro Asp Asn Ala
420 425 430
Asp Ser Arg Leu Thr Leu Arg Gly Tyr Lys Asp Ala Gly Cys Val Ser
435 440 445
Gln Gln Arg Tyr Glu Arg Ala Cys Trp Met Lys Ser Ser Leu Glu Glu
450 455 460
Gly Ile Ser Val Leu Lys Ser Ile Glu Phe Leu Ser Ser Lys Trp Lys
465 470 475 480
Lys Leu Ile Pro Glu Ala Ser Ile Ser Thr Ser Arg Ser Leu Pro Val
485 490 495
Arg Ala Leu Asp Val Leu Lys Tyr Glu Glu Val Asp Met Asp Ser Leu
500 505 510
Ala Lys Ala Val Pro Glu Pro Leu Lys Lys Tyr Thr Lys Cys Arg Glu
515 520 525
Leu Ala Glu Arg Leu Lys Ile Glu Ala Thr Tyr Glu Ser Val Leu Phe
530 535 540
His Gln Leu Gln Glu Ile Lys Gly Val Gln Gln Asp Glu Ala Leu Gln
545 550 555 560
Leu Pro Lys Asp Leu Asp Tyr Leu Thr Ile Arg Asp Val Ser Leu Ser
565 570 575
His Glu Val Arg Glu Lys Leu His Phe Ser Arg Pro Gln Thr Ile Gly
580 585 590
Ala Ala Ser Arg Ile Pro Gly Val Thr Pro Ala Ala Ile Ile Asn Leu
595 600 605
Leu Arg Phe Val Lys Thr Thr Gln Arg Arg Gln Ser Ala Met Asn Glu
610 615 620
Ser Ser Lys Thr Asp Gln Tyr Leu Cys Asp Ala Asp Arg Leu Gln Glu
625 630 635 640
Arg Glu Leu
<210>44
<211>123
<212>PRT
<213>智人(Homo sapiens)
<400>44
Met Pro Phe Leu Tyr Asp Ile Ser Ser Cys Trp Thr Ser Phe Cys Phe
1 5 10 15
Leu Phe Phe Ser Pro Leu Asp Gly Val Leu Leu Cys Phe Pro Gly Trp
20 25 30
Asn Ala Val Ala Arg Ser Gln Leu Thr Ala Thr Ser Ala Ser Gln Val
35 40 45
Gln Ala Ile Leu Leu Val Ser Ala Ser Gly Val Ala Gly Ile Ile Gly
50 55 60
Thr Cys His His Ala Gln Pro Ile Phe Val Phe Leu Val Glu Met Gly
65 70 75 80
Phe His His Val Gly Gln Ala Cys Leu Lys Leu Leu Asn Ser Gly Asp
85 90 95
Pro Pro Ala Ser Ala Ser Gln Ser Ala Gly Ile Thr Gly Met Ser His
100 105 110
His Ala Arg Pro Phe Phe Phe Phe Phe Ser Phe
115 120
<210>45
<211>133
<212>PRT
<213>智人(Homo sapiens)
<400>45
Met Ser Glu Ala Glu Asn Glu Phe Ile Asn Trp Val Ala Thr Ala Ala
1 5 10 15
Ile Glu Ala Asn Cys Ser Gln Cys Trp Leu Cys Val Glu Leu Pro Glu
20 25 30
Ala Ala Gly Asn Gly Leu Pro Trp Arg Ile Val Pro Ala Asn Ile Ser
35 40 45
Glu Trp Ile Cys Gln Tyr Gln Trp Glu Trp Asp Asn Thr Trp Phe Cys
50 55 60
Phe Asp Phe Leu Ser Gln Ser Val Ser Leu Ser Pro Arg Leu Glu Cys
65 70 75 80
Ser Gly Thr Ile Leu Ala Gln Cys Asn Leu Cys Leu Leu Gly Ser Ser
85 90 95
Asp Ser Pro Ala Ser Ala Ser Gln Val Ala Gly Ile Ile Gly Ala Cys
100 105 110
Arg His Ala Trp Leu Ile Phe Cys Ile Phe Ser Arg Asp Gly Val Ser
115 120 125
Pro Tyr Cys Pro Gly
130
<210>46
<211>244
<212>PRT
<213>智人(Homo sapiens)
<400>46
Met Ala Leu Phe Leu Asp Lys Met Gly Ser Leu Gln Lys Gly Asn Tyr
1 5 10 15
Ser Ser Gln Ser Gly Met Ile Pro Gly Ser Trp Gln His Lys Met Lys
20 25 30
Leu Gln Leu Ile Leu Lys Ser Ser Lys Ala Tyr Tyr Val Leu Ser Asp
35 40 45
Ala Ala Met Ser Leu Gln Lys Tyr Gly Arg Ala Leu Arg Tyr Ile Lys
50 55 60
Leu Ala Leu Gln Ser His Asp Thr Tyr Cys Cys Leu Cys Thr Asn Met
65 70 75 80
Leu Ser Glu Val Leu Leu Phe Leu Ser Gln Tyr Leu Thr Leu Cys Gly
85 90 95
Asp Ile Gln Leu Met Leu Ala Gln Asn Ala Asn Asn Arg Ala Ala His
100 105 110
Leu Glu Glu Phe His Tyr Gln Thr Lys Glu Asp Gln Glu Ile Leu His
115 120 125
Ser Leu His Arg Glu Ser Ser Cys Gln Gly Val Pro Gln Ala Trp Thr
130 135 140
Thr Trp Phe Thr Val Gly Leu Cys Ser Leu Ala His Ala Tyr Leu Ser
145 150 155 160
Ile Gln Lys Arg Gly Arg Asn Ile Arg Val Leu Ile Phe Ala Leu Tyr
165 170 175
Leu Phe Ile Tyr Phe Leu Arg Arg Ser Phe Ala Leu Val Ala Gln Ala
180 185 190
Gly Val Gln Trp Cys Asn Leu Gly Ser Leu Lys Pro Pro Pro Pro Gly
195 200 205
Phe Lys Gln Phe Ser Cys Leu Ser Leu Pro Ser Ser Trp Asn Tyr Arg
210 215 220
His Ala Pro Pro Cys Pro Ala Ser Pro Pro Trp Pro Pro Lys Val Leu
225 230 235 240
Gly Leu Gln Val
<210>47
<211>79
<212>PRT
<213>智人(Homo sapiens)
<400>47
Arg Ser Leu Thr Leu Trp Pro Ser Leu Glu Tyr Ser Gly Thr Ile Ser
1 5 10 15
Ala His Cys Asn Leu Arg Leu Pro Gly Ser Ser Asp Ser Arg Ala Ser
20 25 30
Ala Ser Arg Ala Ala Gly Ile Thr Gly Val Ser His Cys Ala Arg Pro
35 40 45
Cys Met Leu Phe Asp Pro Glu Phe Asp Leu Leu Ala Gly Val Gln Leu
50 55 60
Leu Pro Phe Glu Pro Pro Thr Gly Lys Ala Leu Ser Arg Lys Asp
65 70 75
<210>48
<211>495
<212>PRT
<213>智人(Homo sapiens)
<400>48
Met Glu Phe Arg Lys Leu Arg Gly Met Glu Thr Arg Pro Pro Ala Asn
1 5 10 15
Thr Ala Arg Leu Gln Pro Pro Arg Asp Leu Arg Ser Ser Ser Pro Arg
20 25 30
Lys Gln Leu Ser Glu Ser Ser Asp Asp Asp Tyr Asp Asp Val Asp Ile
35 40 45
Pro Thr Pro Ala Glu Asp Thr Pro Pro Pro Leu Pro Pro Lys Pro Lys
50 55 60
Phe Arg Ser Pro Ser Asp Glu Gly Pro Gly Ser Met Gly Asp Asp Gly
65 70 75 80
Gln Leu Ser Pro Gly Val Leu Val Arg Cys Ala Ser Gly Pro Pro Pro
85 90 95
Asn Ser Pro Arg Pro Gly Pro Pro Pro Ser Thr Ser Ser Pro His Leu
100 105 110
Thr Ala His Ser Glu Pro Ser Leu Trp Asn Pro Pro Ser Arg Glu Leu
115 120 125
Asp Lys Pro Pro Leu Leu Pro Pro Lys Lys Glu Lys Met Lys Arg Lys
130 135 140
Gly Cys Ala Leu Leu Val Lys Leu Phe Asn Gly Cys Pro Leu Arg Ile
145 150 155 160
His Ser Thr Ala Ala Trp Thr His Pro Ser Thr Lys Asp Gln His Leu
165 170 175
Leu Leu Gly Ala Glu Glu Gly Ile Phe Ile Leu Asn Arg Asn Asp Gln
180 185 190
Glu Ala Thr Leu Glu Met Leu Phe Pro Ser Arg Thr Thr Trp Val Tyr
195 200 205
Ser Ile Asn Asn Val Leu Met Ser Leu Ser Gly Lys Thr Pro His Leu
210 215 220
Tyr Ser His Ser Ile Leu Gly Leu Leu Glu Arg Lys Glu Thr Arg Ala
225 230 235 240
Gly Asn Pro Ile Ala His Ile Ser Pro His Arg Leu Leu Ala Arg Lys
245 250 255
Asn Met Val Ser Thr Lys Ile Gln Asp Thr Lys Gly Cys Arg Ala Cys
260 265 270
Cys Val Ala Glu Gly Ala Ser Ser Gly Gly Pro Phe Leu Cys Gly Ala
275 280 285
Leu Glu Thr Ser Val Val Leu Leu Gln Trp Tyr Gln Pro Met Asn Lys
290 295 300
Phe Leu Leu Val Arg Gln Val Leu Phe Pro Leu Pro Thr Pro Leu Ser
305 310 315 320
Val Phe Ala Leu Leu Thr Gly Pro Gly Ser Glu Leu Pro Ala Val Cys
325 330 335
Ile Gly Val Ser Pro Gly Arg Pro Gly Lys Ser Val Leu Phe His Thr
340 345 350
Val Arg Phe Gly Ala Leu Ser Cys Trp Leu Gly Glu Met Ser Thr Glu
355 360 365
His Arg Gly Pro Val Gln Val Thr Gln Val Glu Glu Asp Met Val Met
370 375 380
Val Leu Met Asp Gly Ser Val Lys Leu Val Thr Pro Glu Gly Ser Pro
385 390 395 400
Val Arg Gly Leu Arg Thr Pro Glu Ile Pro Met Thr Glu Ala Val Glu
405 410 415
Ala Val Ala Met Val Gly Gly Gln Leu Gln Ala Phe Trp Lys His Gly
420 425 430
Val Gln Val Trp Ala Leu Gly Ser Asp Gln Leu Leu Gln Glu Leu Arg
435 440 445
Asp Pro Thr Leu Thr Phe Arg Leu Leu Gly Ser Pro Arg Leu Glu Cys
450 455 460
Ser Gly Thr Ile Ser Pro His Cys Asn Leu Leu Leu Pro Gly Ser Ser
465 470 475 480
Asn Ser Pro Ala Ser Ala Ser Arg Val Ala Gly Ile Thr Gly Leu
485 490 495
<210>49
<211>102
<212>PRT
<213>智人(Homo sapiens)
<400>49
Met Ser Met Val Leu Gly Gly Pro Phe Ser Lys Gly His Thr Ala Ser
1 5 10 15
Asp Glu Tyr Phe Gln Ile Phe His Asn Ile Ser Phe Phe Glu Thr Glu
20 25 30
Ser Cys Ser Val Ala Gln Ala Gly Val Gln Trp Cys Asn Leu Gly Ser
35 40 45
Leu Gln Ala Leu Pro Pro Arg Phe Thr Pro Phe Ser Cys Leu Ser Leu
50 55 60
Pro Ser Ser Trp Asp Tyr Arg His Pro Pro Pro Cys Pro Asp Asn Val
65 70 75 80
Phe Val Phe Ser Val Glu Thr Gly Leu His Cys Val Ser Gln Asp Gly
85 90 95
Leu Asn Leu Leu Thr Leu
100
<210>50
<211>257
<212>PRT
<213>智人(Homo sapiens)
<400>50
Met Asp Cys Gly Ser Val Gly Gly Gln Arg Thr Gln Arg Leu Pro Gly
1 5 101 5
Arg Gln Arg Leu Leu Phe Leu Pro Val Gly Leu Ser Gly Arg Pro Gly
20 25 30
Gly Ser Glu Thr Ser Ala Arg Arg Cys Leu Ser Ala Leu Ser Asp Gly
35 40 45
Leu Gly Ala Leu Arg Pro Arg Ala Pro Ala Ala Arg Gly Gly Val Ser
50 55 60
Arg Ala Ser Pro Leu Leu Leu Leu Leu Leu Val Pro Ser Pro Arg Leu
65 70 75 80
Ala Ala Ala Ala Pro Arg Arg Gln Leu Gly Asp Trp Glu Arg Ser Arg
85 90 95
Leu Gly Tyr Ala Ala Pro Pro Ala Gly Arg Ser Ser Ala Trp Arg Cys
100 105 110
Ser Pro Gly Val Ala Ala Ala Ala Gly Ala Leu Pro Gln Tyr His Gly
115 120 125
Pro Ala Pro Ala Leu Val Ser Cys Arg Arg Glu Leu Ser Leu Ser Ala
130 135 140
Gly Ser Leu Gln Leu Glu Arg Lys Arg Arg Asp Phe Thr Ser Ser Gly
145 150 155 160
Ser Arg Lys Leu Tyr Phe Asp Thr His Ala Leu Val Cys Leu Leu Glu
165 170 175
Asp Asn Glu Ser His Ser Phe Ile Gln Ala Gly Val Gln Trp His Ser
180 185 190
Leu Gly Leu Leu Gln Pro Pro Pro Pro Gly Phe Lys Arg Ser Ser His
195 200 205
Leu Ile Leu Leu Ser Ser Trp Asp Tyr Arg His Ala Pro Pro His Leu
210 215 220
Asp Asn Phe Ser Val Phe Leu Leu Glu Thr Gly Phe His His Val Gly
225 230 235 240
Gln Ala Gly Leu Lys Leu Leu Thr Ser Ser Asp Pro Pro Thr Leu Ala
245 250 255
Ser
<210>51
<211>92
<212>PRT
<213>智人(Homo sapiens)
<400>51
Met Asn Phe Phe Phe Lys Thr Glu Phe Leu Ser Val Thr Gln Ala Gly
1 5 10 15
Met Gln Trp His Asn Phe Ser Ser Leu Gln Pro Leu Pro Pro Gly Phe
20 25 30
Lys Gln Phe Ser Cys Leu Ser Leu Leu Ser Ser Trp Asp Tyr Arg His
35 40 45
Thr Pro Pro Cys Pro Ala Asn Phe Cys Ile Phe Ser Arg Gly Gly Val
50 55 60
Ser Pro Cys Trp Ser Gly Trp Ser Arg Thr Pro Asp Phe Met Ile His
65 70 75 80
Pro Pro Arg Pro Pro Lys Val Leu Arg Leu Gln Lys
85 90
<210>52
<211>841
<212>PRT
<213>智人(Homo sapiens)
<400>52
Met Pro Leu Ala Ala Tyr Cys Tyr Leu Arg Val Val Gly Lys Gly Ser
1 5 10 15
Tyr Gly Glu Val Thr Leu Val Lys His Arg Arg Asp Gly Lys Gln Tyr
20 25 30
Val Ile Lys Lys Leu Asn Leu Arg Asn Ala Ser Ser Arg Glu Arg Arg
35 40 45
Ala Ala Glu Gln Glu Ala Gln Leu Leu Ser Gln Leu Lys His Pro Asn
50 55 60
Ile Val Thr Tyr Lys Glu Ser Trp Glu Gly Gly Asp Gly Leu Leu Tyr
65 70 75 80
Ile Val Met Gly Phe Cys Glu Gly Gly Asp Leu Tyr Arg Lys Leu Lys
85 90 95
Glu Gln Lys Gly Gln Leu Leu Pro Glu Asn Gln Val Val Glu Trp Phe
100 105 110
Val Gln Ile Ala Met Ala Leu Gln Tyr Leu His Glu Lys His Ile Leu
115 120 125
His Arg Asp Leu Lys Thr Gln Asn Val Phe Leu Thr Arg Thr Asn Ile
130 135 140
Ile Lys Val Gly Asp Leu Gly Ile Ala Arg Val Leu Glu Asn His Cys
145 150 155 160
Asp Met Ala Ser Thr Leu Ile Gly Thr Pro Tyr Tyr Met Ser Pro Glu
165 170 175
Leu Phe Ser Asn Lys Pro Tyr Asn Tyr Lys Ser Asp Val Trp Ala Leu
180 185 190
Gly Cys Cys Val Tyr Glu Met Ala Thr Leu Lys His Ala Phe Asn Ala
195 200 205
Lys Asp Met Asn Ser Leu Val Tyr Arg Ile Ile Glu Gly Lys Leu Pro
210 215 220
Pro Met Pro Arg Asp Tyr Ser Pro Glu Leu Ala Glu Leu Ile Arg Thr
225 230 235 240
Met Leu Ser Lys Arg Pro Glu Glu Arg Pro Ser Val Arg Ser Ile Leu
245 250 255
Arg Gln Pro Tyr Ile Lys Arg Gln Ile Ser Phe Phe Leu Glu Ala Thr
260 265 270
Lys Ile Lys Thr Ser Lys Asn Asn Ile Lys Asn Gly Asp Ser Gln Ser
275 280 285
Lys Pro Phe Ala Thr Val Val Ser Gly Glu Ala Glu Ser Asn His Glu
290 295 300
Val Ile His Pro Gln Pro Leu Ser Ser Glu Gly Ser Gln Thr Tyr Ile
305 310 315 320
Met Gly Glu Gly Lys Cys Leu Ser Gln Glu Lys Pro Arg Ala Ser Gly
325 330 335
Leu Leu Lys Ser Pro Ala Ser Leu Lys Ala His Thr Cys Lys Gln Asp
340 345 350
Leu Ser Asn Thr Thr Glu Leu Ala Thr Ile Ser Ser Val Asn Ile Asp
355 360 365
Ile Leu Pro Ala Lys Gly Arg Asp Ser Val Ser Asp Gly Phe Val Gln
370 375 380
Glu Asn Gln Pro Arg Tyr Leu Asp Ala Ser Asn Glu Leu Gly Gly Ile
385 390 395 400
Cys Ser Ile Ser Gln Val Glu Glu Glu Met Leu Gln Asp Asn Thr Lys
405 410 415
Ser Ser Ala Gln Pro Glu Asn Leu Ile Pro Met Trp Ser Ser Asp Ile
420 425 430
Val Thr Gly Glu Lys Asn Glu Pro Val Lys Pro Leu Gln Pro Leu Ile
435 440 445
Lys Glu Gln Lys Pro Lys Asp Gln Ser Leu Ala Leu Ser Pro Lys Leu
450 455 460
Glu Cys Ser Gly Thr Ile Leu Ala His Ser Asn Leu Arg Leu Leu Gly
465 470 475 480
Ser Ser Asp Ser Pro Ala Ser Ala Ser Arg Val Ala Gly Ile Thr Gly
485 490 495
Val Cys His His Ala Gln Asp Gln Val Ala Gly Glu Cys Ile Ile Glu
500 505 510
Lys Gln Gly Arg Ile His Pro Asp Leu Gln Pro His Asn Ser Gly Ser
515 520 525
Glu Pro Ser Leu Ser Arg Gln Arg Arg Gln Lys Arg Arg Glu Gln Thr
530 535 540
Glu His Arg Gly Glu Lys Arg Gln Val Arg Arg Asp Leu Phe Ala Phe
545 550 555 560
Gln Glu Ser Pro Pro Arg Phe Leu Pro Ser His Pro Ile Val Gly Lys
565 570 575
Val Asp Val Thr Ser Thr Gln Lys Glu Ala Glu Asn Gln Arg Arg Val
580 585 590
Val Thr Gly Ser Val Ser Ser Ser Arg Ser Ser Glu Met Ser Ser Ser
595 600 605
Lys Asp Arg Pro Leu Ser Ala Arg Glu Arg Arg Arg Leu Lys Gln Ser
610 615 620
Gln Glu Glu Met Ser Ser Ser Gly Pro Ser Val Arg Lys Ala Ser Leu
625 630 635 640
Ser Val Ala Gly Pro Gly Lys Pro Gln Glu Glu Asp Gln Pro Leu Pro
645 650 655
Ala Arg Arg Leu Ser Ser Asp Cys Ser Val Thr Gln Glu Arg Lys Gln
660 665 670
Ile His Cys Leu Ser Glu Asp Glu Leu Ser Ser Ser Thr Ser Ser Thr
675 680 685
Asp Lys Ser Asp Gly Asp Tyr Gly Glu Gly Lys Gly Gln Thr Asn Glu
690 695 700
Ile Asn Ala Leu Val Gln Leu Met Thr Gln Thr Leu Lys Leu Asp Ser
705 710 715 720
Lys Glu Ser Cys Glu Asp Val Pro Val Ala Asn Pro Val Ser Glu Phe
725 730 735
Lys Leu His Arg Lys Tyr Arg Asp Thr Leu Ile Leu His Gly Lys Val
740 745 750
Ala Glu Glu Ala Glu Glu Ile His Phe Lys Glu Leu Pro Ser Ala Ile
755 760 765
Met Pro Gly Ser Glu Lys Ile Arg Arg Leu Val Glu Val Leu Arg Thr
770 775 780
Asp Val Ile Arg Gly Leu Gly Val Gln Leu Leu Glu Gln Val Tyr Asp
785 790 795 800
Leu Leu Glu Glu Glu Asp Glu Phe Asp Arg Glu Val Arg Leu Arg Glu
805 810 815
His Met Gly Glu Lys Tyr Thr Thr Tyr Ser Val Lys Ala Arg Gln Leu
820 825 830
Lys Phe Phe Glu Glu Asn Met Asn Phe
835 840
<210>53
<211>85
<212>PRT
<213>智人(Homo sapiens)
<400>53
Met Phe Ile Ser Phe Gly Arg Leu Ile Phe Ser Phe Phe Leu Thr Trp
1 5 10 15
Ser Leu Ser Leu Ser Pro Arg Leu Glu Cys Ser Gly Thr Ile Leu Ala
20 25 30
His Cys Asn Pro Thr Ser Gln Val Gln Ala Ile Leu Pro Ala Ser Ala
35 40 45
Ser Arg Val Ala Gly Ile Thr Gly Met His His His Thr Cys Leu Ile
50 55 60
Phe Val Leu Leu Val Lys Met Gly Phe Cys His Val Gly His Ala Gly
65 70 75 80
Leu Glu Leu Val Thr
85
<210>54
<211>73
<212>PRT
<213>智人(Homo sapiens)
<400>54
Met Glu Ser Gly Gln Pro Ser Leu Ser Phe Tyr Phe Leu Phe Ile Tyr
1 5 10 15
Phe Phe Glu Ile Gly Ser His Phe Val Thr Gln Ala Gly Val Gln Trp
20 25 30
His Asn Leu Asp Ser Leu Gln Leu Ser Leu Ala Ser Ala Pro Gln Val
35 40 45
Ala Gly Thr Thr Gly Ala Cys His His Ala Arg Leu Ile Phe Gly Val
50 55 60
Phe Cys Arg Asp Trp Val Leu Pro Cys
65 70
<210>55
<211>181
<212>PRT
<213>智人(Homo sapiens)
<400>55
Met Leu Leu Val Asp Ala Asp Gln Pro Glu Pro Met Arg Ser Gly Ala
1 5 10 15
Arg Glu Leu Ala Leu Phe Leu Thr Pro Glu Pro Gly Ala Glu Ala Lys
20 25 30
Glu Val Glu Glu Thr Ile Glu Gly Met Leu Leu Arg Leu Glu Glu Phe
35 40 45
Cys Ser Leu Ala Asp Leu Ile Arg Ser Asp Thr Ser Gln Ile Leu Glu
50 55 60
Glu Asn Ile Pro Val Leu Lys Ala Lys Leu Thr Glu Met Arg Gly Ile
65 70 75 80
Tyr Ala Lys Val Asp Arg Leu Glu Ala Phe Val Lys Met Val Gly His
85 90 95
His Val Ala Phe Leu Glu Ala Asp Val Leu Gln Ala Glu Arg Asp His
100 105 110
Gly Ala Phe Pro Gln Ala Leu Arg Arg Trp Leu Gly Ser Ala Gly Leu
115 120 125
Pro Ser Phe Arg Asn Val Glu Cys Ser Gly Thr Ile Pro Ala Arg Cys
130 135 140
Asn Leu Arg Leu Pro Gly Ser Ser Asp Ser Pro Ala Ser Ala Ser Gln
145 150 155 160
Val Ala Gly Ile Pro Glu Val Thr Cys Thr Gly Ala Arg Asp Val Arg
165 170 175
Ala Ala His Thr Val
180
<210>56
<211>876
<212>PRT
<213>大鼠(Rattus norvegicus)
<400>56
Met Ser Arg Gly Asn Glu Asn Arg Leu Thr His Arg Arg Gln Thr Val
1 5 10 15
Leu Arg Glu Lys Gly Arg Arg Leu Ala Asn Arg Gly Pro Ala Tyr Met
20 25 30
Phe Asn Asp His Ser Thr Ser Leu Ser Ile Glu Glu Glu Arg Phe Leu
35 40 45
Asp Ala Ala Glu Tyr Gly Asn Ile Pro Val Val Arg Lys Met Leu Glu
50 55 60
Glu Cys Leu Ser Leu Asn Val Asn Cys Val Asp Tyr Met Gly Gln Asn
65 70 75 80
Ala Leu Gln Leu Ala Val Ala Asn Glu His Leu Glu Ile Thr Glu Leu
85 90 95
Leu Leu Lys Lys Glu Asn Leu Ser Arg Val Gly Asp Ala Leu Leu Leu
100 105 110
Ala Ile Ser Lys Gly Tyr Val Arg Ile Val Glu Ala Ile Leu Asn His
115 120 125
Pro Ala Phe Ala Glu Gly Lys Arg Leu Ala Thr Ser Pro Ser Gln Ser
130 135 140
Glu Leu Gln Gln Asp Asp Phe Tyr Ala Tyr Asp Glu Asp Gly Thr Arg
145 150 155 160
Phe Ser His Asp Val Thr Pro Ile Ile Leu Ala Ala His Cys Gln Glu
165 170 175
Tyr Glu Ile Val His Thr Leu Leu Arg Lys Gly Ala Arg Ile Glu Arg
180 185 190
Pro His Asp Tyr Phe Cys Lys Cys Thr Glu Cys Ser Gln Lys Gln Lys
195 200 205
His Asp Ser Phe Ser His Ser Arg Ser Arg Ile Asn Ala Tyr Lys Gly
210 215 220
Leu Ala Ser Pro Ala Tyr Leu Ser Leu Ser Ser Glu Asp Pro Val Met
225 230 235 240
Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala Val Leu Ala Asn Ile Glu
245 250 255
Lys Glu Phe Lys Asn Asp Tyr Arg Lys Leu Ser Met Gln Cys Lys Asp
260 265 270
Phe Val Val Gly Leu Leu Asp Leu Cys Arg Asn Thr Glu Glu Val Glu
275 280 285
Ala Ile Leu Asn Gly Asp Ala Glu Thr Arg Gln Pro Gly Asp Leu Ala
290 295 300
Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala Ile Lys Tyr Glu Val Lys
305 310 315 320
Lys Phe Val Ala His Pro Asn Cys Gln Gln Gln Leu Leu Ser Ile Trp
325 330 335
Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln Thr Met Ala Val Lys Phe
340 345 350
Leu Val Val Leu Ala Val Ala Ile Gly Leu Pro Phe Leu Ala Leu Ile
355 360 365
Tyr Trp Cys Ala Pro Cys Ser Lys Met Gly Lys Ile Leu Arg Gly Pro
370 375 380
Phe Met Lys Phe Val Ala His Ala Ala Ser Phe Thr Ile Phe Leu Gly
385 390 395 400
Leu Leu Val Met Asn Ala Ala Asp Arg Phe Glu Gly Thr Lys Leu Leu
405 410 415
Pro Asn Glu Thr Ser Thr Asp Asn Ala Arg Gln Leu Phe Arg Met Lys
420 425 430
Thr Ser Cys Phe Ser Trp Met Glu Met Leu Ile Ile Ser Trp Val Ile
435 440 445
Gly Met Ile Trp Ala Glu Cys Lys Glu Ile Trp Thr Gln Gly Pro Lys
450 455 460
Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu Asp Phe Gly Met Leu Ala
465 470 475 480
Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe Met Ala Phe Trp His Ala
485 490 495
Ser Lys Ala Gln Ser Ile Ile Asp Ala Asn Asp Thr Leu Lys Asp Leu
500 505 510
Thr Lys Val Thr Leu Gly Asp Asn Val Lys Tyr Tyr Asn Leu Ala Arg
515 520 525
Ile Lys Trp Asp Pro Thr Asp Pro Gln Ile Ile Ser Glu Gly Leu Tyr
530 535 540
Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Ile Leu Pro
545 550 555 560
Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr Val
565 570 575
Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val Phe Val Ala
580 585 590
Phe Met Ile Gly Met Phe Asn Leu Tyr Ser Tyr Tyr Ile Gly Ala Lys
595 600 605
Gln Asn Glu Ala Phe Thr Thr Val Glu Glu Ser Phe Lys Thr Leu Phe
610 615 620
Trp Ala Ile Phe Gly Leu Ser Glu Val Lys Ser Val Val Ile Asn Tyr
625 630 635 640
Asn His Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr Gly Val Tyr
645 650 655
Asn Val Thr Met Val Ile Val Leu Leu Asn Met Leu Ile Ala Met Ile
660 665 670
Asn Ser Ser Phe Gln Glu Ile Glu Asp Asp Ala Asp Val Glu Trp Lys
675 680 685
Phe Ala Arg Ala Lys Leu Trp Phe Ser Tyr Phe Glu Glu Gly Arg Thr
690 695 700
Leu Pro Val Pro Phe Asn Leu Val Pro Ser Pro Lys Ser Leu Leu Tyr
705 710 715 720
Leu Leu Leu Lys Phe Lys Lys Trp Met Ser Glu Leu Ile Gln Gly His
725 730 735
Lys Lys Gly Phe Gln Glu Asp Ala Glu Met Asn Lys Arg Asn Glu Glu
740 745 750
Lys Lys Phe Gly Ile Leu Gly Ser His Glu Asp Leu Ser Lys Phe Ser
755 760 765
Leu Asp Arg Asn Gln Leu Ala His Asn Lys Gln Ser Ser Thr Arg Ser
770 775 780
Ser Glu Asp Phe His Leu Asn Ser Phe Ser Asn Pro Pro Arg Gln Tyr
785 790 795 800
Gln Lys Ile Met Lys Arg Leu Ile Lys Arg Tyr Val Leu Gln Ala Gln
805 810 815
Ile Asp Lys Glu Ser Asp Glu Val Asn Glu Gly Glu Leu Lys Glu Ile
820 825 830
Lys Gln Asp Ile Ser Ser Leu Arg Tyr Glu Leu Leu Glu Glu Lys Ser
835 840 845
Gln Asn Thr Glu Asp Leu Ala Glu Leu Ile Arg Lys Leu Gly Glu Arg
850 855 860
Leu Ser Leu Glu Ser Lys Gln Glu Glu Ser Arg Arg
865 870 875
<210>57
<211>808
<212>PRT
<213>大鼠(Rattus norvegicus)
<400>57
Met Ser Arg Gly Asn Glu Asn Arg Leu Thr His Arg Arg Gln Thr Val
1 5 10 15
Leu Arg Glu Lys Gly Arg Arg Leu Ala Asn Arg Gly Pro Ala Tyr Met
20 25 30
Phe Asn Asp His Ser Thr Ser Leu Ser Ile Glu Glu Glu Arg Phe Leu
35 40 45
Asp Ala Ala Glu Tyr Gly Asn Ile Pro Val Val Arg Lys Met Leu Glu
50 55 60
Glu Cys Leu Ser Leu Asn Val Asn Cys Val Asp Tyr Met Gly Gln Asn
65 70 75 80
Ala Leu Gln Leu Ala Val Ala Asn Glu His Leu Glu Ile Thr Glu Leu
85 90 95
Leu Leu Lys Lys Glu Asn Leu Ser Arg Val Gly Asp Ala Leu Leu Leu
100 105 110
Ala Ile Ser Lys Gly Tyr Val Arg Ile Val Glu Ala Ile Leu Asn His
115 120 125
Pro Ala Phe Ala Glu Gly Lys Arg Leu Ala Thr Ser Pro Ser Gln Ser
130 135 140
Glu Leu Gln Gln Asp Asp Phe Tyr Ala Tyr Asp Glu Asp Gly Thr Arg
145 150 155 160
Phe Ser His Asp Val Thr Pro Ile Ile Leu Ala Ala His Cys Gln Glu
165 170 175
Tyr Glu Ile Val His Thr Leu Leu Arg Lys Gly Ala Arg Ile Glu Arg
180 185 190
Pro His Asp Tyr Phe Cys Lys Cys Thr Glu Cys Ser Gln Lys Gln Lys
195 200 205
His Asp Ser Phe Ser His Ser Arg Ser Arg Ile Asn Ala Tyr Lys Gly
210 215 220
Leu Ala Ser Pro Ala Tyr Leu Ser Leu Ser Ser Glu Asp Pro Val Met
225 230 235 240
Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala Val Leu Ala Asn Ile Glu
245 250 255
Lys Glu Phe Lys Asn Asp Tyr Arg Lys Leu Ser Met Gln Cys Lys Asp
260 265 270
Phe Val Val Gly Leu Leu Asp Leu Cys Arg Asn Thr Glu Glu Val Glu
275 280 285
Ala Ile Leu Asn Gly Asp Ala Glu Thr Arg Gln Pro Gly Asp Leu Ala
290 295 300
Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala Ile Lys Tyr Glu Val Lys
305 310 315 320
Lys Phe Val Ala His Pro Asn Cys Gln Gln Gln Leu Leu Ser Ile Trp
325 330 335
Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln Thr Met Ala Val Lys Phe
340 345 350
Leu Val Val Leu Ala Val Ala Ile Gly Leu Pro Phe Leu Ala Leu Ile
355 360 365
Tyr Trp Cys Ala Pro Cys Ser Lys Met Gly Lys Ile Leu Arg Gly Pro
370 375 380
Phe Met Lys Phe Val Ala His Ala Ala Ser Phe Thr Ile Phe Leu Gly
385 390 395 400
Leu Leu Val Met Asn Ala Ala Asp Arg Phe Glu Gly Thr Lys Leu Leu
405 410 415
Pro Asn Glu Thr Ser Thr Asp Asn Ala Arg Gln Leu Phe Arg Met Lys
420 425 430
Thr Ser Cys Phe Ser Trp Met Glu Met Leu Ile Ile Ser Trp Val Ile
435 440 445
Gly Met Ile Trp Ala Glu Cys Lys Glu Ile Trp Thr Gln Gly Pro Lys
450 455 460
Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu Asp Phe Gly Met Leu Ala
465 470 475 480
Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe Met Ala Phe Trp His Ala
485 490 495
Ser Lys Ala Gln Ser Ile Ile Asp Ala Asn Asp Thr Leu Lys Asp Leu
500 505 510
Thr Lys Val Thr Leu Gly Asp Asn Val Lys Tyr Tyr Asn Leu Ala Arg
515 520 525
Ile Lys Trp Asp Pro Thr Asp Pro Gln Ile Ile Ser Glu Gly Leu Tyr
530 535 540
Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Ile Leu Pro
545 550 555 560
Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr Val
565 570 575
Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val Phe Val Ala
580 585 590
Phe Met Ile Gly Met Phe Asn Leu Tyr Ser Tyr Tyr Ile Gly Ala Lys
595 600 605
Gln Asn Glu Ala Phe Thr Thr Val Glu Glu Ser Phe Lys Thr Leu Phe
6l0 615 620
Trp Ala Ile Phe Gly Leu Ser Glu Val Arg Ser Val Val Ile Asn Tyr
625 630 635 640
Asn His Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr Gly Val Tyr
645 650 655
Asn Val Thr Met Val Ile Val Leu Leu Asn Met Leu Ile Ala Met Ile
660 665 670
Asn Ser Ser Phe Gln Glu Ile Glu Arg Asn Glu Glu Lys Lys Phe Gly
675 680 685
Ile Leu Gly Ser His Glu Asp Leu Ser Lys Phe Ser Leu Asp Arg Asn
690 695 700
Gln Leu Ala His Asn Lys Gln Ser Ser Thr Arg Ser Ser Glu Asp Phe
705 710 715 720
His Leu Asn Ser Phe Ser Asn Pro Pro Arg Gln Tyr Gln Lys Ile Met
725 730 735
Lys Arg Leu Ile Lys Arg Tyr Val Leu Gln Ala Gln Ile Asp Lys Glu
740 745 750
Ser Asp Glu Val Asn Glu Gly Glu Leu Lys Glu Ile Lys Gln Asp Ile
755 760 765
Ser Ser Leu Arg Tyr Glu Leu Leu Glu Glu Lys Ser Gln Asn Thr Glu
770 775 780
Asp Leu Ala Glu Leu Ile Arg Arg Leu Gly Glu Arg Leu Ser Leu Glu
785 790 795 800
Ser Lys Gln Glu Glu Ser Arg Arg
805
<210>58
<211>83
<212>PRT
<213>智人(Homo sapiens)
<400>58
Met Glu Ser Arg Ser Val Ala Gln Ala Gly Val Gln Trp Pro Asp Leu
1 5 10 15
Gly Ser Leu Gln Pro Leu Pro Pro Arg Phe Lys Arg Phe Phe Cys Leu
20 25 30
Ser Leu Gln Ser Ser Trp Asp Tyr Arg His Ala Pro Pro Arg Pro Ala
35 40 45
Asn Phe Val Phe Leu Val Glu Thr Gly Phe Cys His Val Ser Gln Ala
50 55 60
Gly Leu Glu Leu Leu Thr Ser Ser Asp Pro Pro Pro Arg Pro Pro Lys
65 70 75 80
Val Leu Arg
<210>59
<211>141
<212>PRT
<213>智人(Homo sapiens)
<400>59
Met Ile Ser Val His Cys Asn Leu Cys Leu Pro Gly Ser Ser Asp Pro
1 5 10 15
Pro Ala Ser Ala Ser Gln Val Ala Gly Ile Thr Gly Val Arg His Cys
20 25 30
Met Ala Ser Gly Ala Val Leu Asn Lys Val Arg Arg His Gln Cys Ser
35 40 45
Gly Asp Leu Glu Val Arg Gly Ser His Gly Ser Leu Gly Glu Ala Pro
50 55 60
Trp Gly Lys Ser Val Pro Gly Arg Gly Thr Ala Ser Arg Lys Gly Pro
65 70 75 80
Gly Ala Gly Val Ile Gly Asn Ser Lys Glu Ala Ser Thr Gly Arg Ala
85 90 95
Gln Trp Ser Ala Pro Val Ile Pro Ala Thr Gln Glu Ala Lys Ala Gly
100 105 110
Gly Leu Leu Glu Pro Arg Ser Leu Ile Ser Ala Trp Ala Thr Tyr Gln
115 120 125
Asp Leu Ile Ser Ile Asn Lys Leu Lys Glu Lys Arg Gly
130 135 140
<210>60
<211>177
<212>PRT
<213>智人(Homo sapiens)
<400>60
Met Thr Arg Ser Leu Phe Lys Gly Asn Phe Trp Ser Ala Asp Ile Leu
1 5 10 15
Ser Thr Ile Gly Tyr Asp Asn Ile Ile Gln His Leu Asn Asn Gly Arg
20 25 30
Lys Asn Cys Lys Glu Phe Glu Asp Phe Leu Lys Glu Arg Ala Ala Ile
35 40 45
Glu Glu Arg Tyr Gly Lys Asp Leu Leu Asn Leu Ser Arg Lys Lys Pro
50 55 60
Cys Gly Gln Ser Glu Ile Asn Thr Leu Lys Arg Ala Leu Glu Val Phe
65 70 75 80
Lys Gln Gln Val Asp Asn Val Ala Gln Cys His Ile Gln Leu Ala Gln
85 90 95
Ser Leu Arg Glu Glu Ala Arg Lys Met Glu Glu Phe Arg Glu Lys Gln
100 105 110
Lys Leu Gln Arg Lys Lys Met Glu Ser His Ser Val Thr Gln Ala Gly
115 120 125
Ala Gln Trp His Asp Leu Gly Ser Leu Gln Ala Leu Pro Pro Gly Phe
130 135 140
Met Pro Phe Ser Cys Leu Ser Leu Pro Ser Ser Trp Asn Tyr Arg Leu
145 150 155 160
Pro Pro Pro Pro Arg Leu Ala Glu Pro Arg Asn Gln Asp His Gly Val
165 170 175
Ala
<210>61
<211>66
<212>PRT
<213>智人(Homo sapiens)
<400>61
Met Glu Ser His Ser Val Thr Gln Ala Gly Val Gln Trp Arg Asp Leu
1 5 10 15
Gly Ser Leu Gln Pro Leu Pro Pro Gly Phe Lys Gln Phe Ser His Leu
20 25 30
Ser Leu Pro Ser Ser Trp Asp Tyr Arg Arg Val Pro Pro Tyr Leu Gly
35 40 45
Asn Phe Cys Ile Phe Ser Gly Glu Gly Val Ser Pro Cys Trp Pro Gly
50 55 60
Trp Ser
65
<210>62
<211>392
<212>PRT
<213>智人(Homo sapiens)
<400>62
Met Gly Ser Leu Ser Thr Ala Asn Val Glu Phe Cys Leu Asp Val Phe
1 5 10 15
Lys Glu Leu Asn Ser Asn Asn Ile Gly Asp Asn Ile Phe Phe Ser Ser
20 25 30
Leu Ser Leu Leu Tyr Ala Leu Ser Met Val Leu Leu Gly Ala Arg Gly
35 40 45
Glu Thr Ala Glu Gln Leu Glu Lys Val Leu His Phe Ser His Thr Val
50 55 60
Asp Ser Leu Lys Pro Gly Phe Lys Asp Ser Pro Lys Cys Ser Gln Ala
65 70 75 80
Gly Arg Ile His Ser Glu Phe Gly Val Glu Phe Ser Gln Ile Asn Gln
85 90 95
Pro Asp Ser Asn Cys Thr Leu Ser Ile Ala Asn Arg Leu Tyr Gly Thr
100 105 110
Lys Thr Met Ala Phe His Gln Gln Tyr Leu Ser Cys Ser Glu Lys Trp
115 120 125
Tyr Gln Ala Arg Leu Gln Thr Val Asp Phe Glu Gln Ser Thr Glu Glu
130 135 140
Thr Arg Lys Thr Ile Asn Ala Trp Val Glu Asn Lys Thr Asn Gly Lys
145 150 155 160
Val Ala Asn Leu Phe Gly Lys Ser Thr Ile Asp Pro Ser Ser Val Met
165 170 175
Val Leu Val Asn Thr Ile Tyr Phe Lys Gly Gln Arg Gln Asn Lys Phe
180 185 190
Gln Val Arg Glu Thr Val Lys Ser Pro Phe Gln Leu Ser Glu Gly Lys
195 200 205
Asn Val Thr Val Glu Met Met Tyr Gln Ile Gly Thr Phe Lys Leu Ala
210 215 220
Phe Val Lys Glu Pro Gln Met Gln Val Leu Glu Leu Pro Tyr Val Asn
225 230 235 240
Asn Lys Leu Ser Met Ile Ile Leu Leu Pro Val Gly Ile Ala Asn Leu
245 250 255
Lys Gln Ile Glu Lys Gln Leu Asn Ser Gly Thr Phe His Glu Trp Thr
260 265 270
Ser Ser Ser Asn Met Met Glu Arg Glu Val Glu Val His Leu Pro Arg
275 280 285
Phe Lys Leu Glu Ile Lys Tyr Glu Leu Asn Ser Leu Leu Lys Pro Leu
290 295 300
Gly Val Thr Asp Leu Phe Asn Gln Val Lys Ala Asp Leu Ser Gly Met
305 310 315 320
Ser Pro Thr Lys Gly Leu Tyr Leu Ser Lys Ala Ile His Lys Ser Tyr
325 330 335
Leu Asp Val Ser Glu Glu Gly Thr Glu Ala Ala Ala Ala Thr Gly Asp
340 345 350
Ser Ile Ala Val Lys Ser Leu Pro Met Arg Ala Gln Phe Lys Ala Asn
355 360 365
His Pro Phe Leu Phe Phe Ile Arg His Thr His Thr Asn Thr Ile Leu
370 375 380
Phe Cys Gly Lys Leu Ala Ser Pro
385 390
<210>63
<211>982
<212>PRT
<213>智人(Homo sapiens)
<400>63
Met Ala Gln Phe Tyr Tyr Lys Arg Asn Val Asn Ala Pro Tyr Arg Asp
1 5 10 15
Arg Ile Pro Leu Arg Ile Val Arg Ala Glu Ser Glu Leu Ser Pro Ser
20 25 30
Glu Lys Ala Tyr Leu Asn Ala Val Glu Lys Gly Asp Tyr Ala Ser Val
35 40 45
Lys Lys Ser Leu Glu Glu Ala Glu Ile Tyr Phe Lys Ile Asn Ile Asn
50 55 60
Cys Ile Asp Pro Leu Gly Arg Thr Ala Leu Leu Ile Ala Ile Glu Asn
65 70 75 80
Glu Asn Leu Glu Leu Ile Glu Leu Leu Leu Ser Phe Asn Val Tyr Val
85 90 95
Gly Asp Ala Leu Leu His Ala Ile Arg Lys Glu Val Val Gly Ala Val
100 105 110
Glu Leu Leu Leu Asn His Lys Lys Pro Ser Gly Glu Lys Gln Val Pro
115 120 125
Pro Ile Leu Leu Asp Lys Gln Phe Ser Glu Phe Thr Pro Asp Ile Thr
130 135 140
Pro Ile Ile Leu Ala Ala His Thr Asn Asn Tyr Glu Ile Ile Lys Leu
145 150 155 160
Leu Val Gln Lys Gly Val Ser Val Pro Arg Pro His Glu Val Arg Cys
165 170 175
Asn Cys Val Glu Cys Val Ser Ser Ser Asp Val Asp Ser Leu Arg His
180 185 190
Ser Arg Ser Arg Leu Asn Ile Tyr Lys Ala Leu Ala Ser Pro Ser Leu
195 200 205
Ile Ala Leu Ser Ser Glu Asp Pro Phe Leu Thr Ala Phe Gln Leu Ser
210 215 220
Trp Glu Leu Gln Glu Leu Ser Lys Val Glu Asn Glu Phe Lys Ser Glu
225 230 235 240
Tyr Glu Glu Leu Ser Arg Gln Cys Lys Gln Phe Ala Lys Asp Leu Leu
245 250 255
Asp Gln Thr Arg Ser Ser Arg Glu Leu Glu Ile Ile Leu Asn Tyr Arg
260 265 270
Asp Asp Asn Ser Leu Ile Glu Glu Gln Ser Gly Asn Asp Leu Ala Arg
275 280 285
Leu Lys Leu Ala Ile Lys Tyr Arg Gln Lys Glu Phe Val Ala Gln Pro
290 295 300
Asn Cys Gln Gln Leu Leu Ala Ser Arg Trp Tyr Asp Glu Phe Pro Gly
305 310 315 320
Trp Arg Arg Arg His Trp Ala Val Lys Met Val Thr Cys Phe Ile Ile
325 330 335
Gly Leu Leu Phe Pro Val Phe Ser Val Cys Tyr Leu Ile Ala Pro Lys
340 345 350
Ser Pro Leu Gly Leu Phe Ile Arg Lys Pro Phe Ile Lys Phe Ile Cys
355 360 365
His Thr Ala Ser Tyr Leu Thr Phe Leu Phe Leu Leu Leu Leu Ala Ser
370 375 380
Gln His Ile Asp Arg Ser Asp Leu Asn Arg Gln Gly Pro Pro Pro Thr
385 390 395 400
Ile Val Glu Trp Met Ile Leu Pro Trp Val Leu Gly Phe Ile Trp Gly
405 410 415
Glu Ile Lys Gln Met Trp Asp Gly Gly Leu Gln Asp Tyr Ile His Asp
420 425 430
Trp Trp Asn Leu Met Asp Phe Val Met Asn Ser Leu Tyr Leu Ala Thr
435 440 445
Ile Ser Leu Lys Ile Val Ala Phe Val Lys Tyr Ser Ala Leu Asn Pro
450 455 460
Arg Glu Ser Trp Asp Met Trp His Pro Thr Leu Val Ala Glu Ala Leu
465 470 475 480
Phe Ala Ile Ala Asn Ile Phe Ser Ser Leu Arg Leu Ile Ser Leu Phe
485 490 495
Thr Ala Asn Ser His Leu Gly Pro Leu Gln Ile Ser Leu Gly Arg Met
500 505 510
Leu Leu Asp Ile Leu Lys Phe Leu Phe Ile Tyr Cys Leu Val Leu Leu
515 520 525
Ala Phe Ala Asn Gly Leu Asn Gln Leu Tyr Phe Tyr Tyr Glu Glu Thr
530 535 540
Lys Gly Leu Thr Cys Lys Gly Ile Arg Cys Glu Lys Gln Asn Asn Ala
545 550 555 560
Phe Ser Thr Leu Phe Glu Thr Leu Gln Ser Leu Phe Trp Ser Ile Phe
565 570 575
Gly Leu Ile Asn Leu Tyr Val Thr Asn Val Lys Ala Gln His Glu Phe
580 585 590
Thr Glu Phe Val Gly Ala Thr Met Phe Gly Thr Tyr Asn Val Ile Ser
595 600 605
Leu Val Val Leu Leu Asn Met Leu Ile Ala Met Met Asn Asn Ser Tyr
610 615 620
Gln Leu Ile Ala Asp His Ala Asp Ile Glu Trp Lys Phe Ala Arg Thr
625 630 635 640
Lys Leu Trp Met Ser Tyr Phe Glu Glu Gly Gly Thr Leu Pro Thr Pro
645 650 655
Phe Asn Val Ile Pro Ser Pro Lys Ser Leu Trp Tyr Leu Ile Lys Trp
660 665 670
Ile Trp Thr His Leu Cys Lys Lys Lys Met Arg Arg Lys Pro Glu Ser
675 680 685
Phe Gly Thr Ile Gly Val Arg Thr Gln His Arg Arg Ala Ala Asp Asn
690 695 700
Leu Arg Arg His His Gln Tyr Gln Glu Val Met Arg Asn Leu Val Lys
705 710 715 720
Arg Tyr Val Ala Ala Met Ile Arg Asp Ala Lys Thr Glu Glu Gly Leu
725 730 735
Thr Glu Glu Asn Phe Lys Glu Leu Lys Gln Asp Ile Ser Ser Phe Arg
740 745 750
Phe Glu Val Leu Gly Leu Leu Arg Gly Ser Lys Leu Ser Thr Ile Gln
755 760 765
Ser Ala Asn Ala Ser Lys Glu Ser Ser Asn Ser Ala Asp Ser Asp Glu
770 775 780
Lys Ser Asp Ser Glu Gly Asn Ser Lys Asp Lys Lys Lys Asn Phe Ser
785 790 795 800
Leu Phe Asp Leu Thr Thr Leu Ile His Pro Arg Ser Ala Ala Ile Ala
805 810 815
Ser Glu Arg His Asn Ile Ser Asn Gly Ser Ala Leu Val Val Gln Glu
820 825 830
Pro Pro Arg Glu Lys Gln Arg Lys Val Asn Phe Val Thr Asp Ile Lys
835 840 845
Asn Phe Gly Leu Phe His Arg Arg Ser Lys Gln Asn Ala Ala Glu Gln
850 855 860
Asn Ala Asn Gln Ile Phe Ser Val Ser Glu Glu Val Ala Arg Gln Gln
865 870 875 880
Ala Ala Gly Pro Leu Glu Arg Asn Ile Gln Leu Glu Ser Arg Gly Leu
885 890 895
Ala Ser Arg Gly Asp Leu Ser Ile Pro Gly Leu Ser Glu Gln Cys Val
900 905 910
Leu Val Asp His Arg Glu Arg Asn Thr Asp Thr Leu Gly Leu Gln Val
915 920 925
Gly Lys Arg Val Cys Pro Phe Lys Ser Glu Lys Val Val Val Glu Asp
930 935 940
Thr Val Pro Ile Ile Pro Lys Glu Lys His Ala Lys Glu Glu Asp Ser
945 950 955 960
Ser Ile Asp Tyr Asp Leu Asn Leu Pro Asp Thr Val Thr His Glu Asp
965 970 975
Tyr Val Thr Thr Arg Leu
980
<210>64
<211>323
<212>PRT
<213>智人(Homo sapiens)
<400>64
Met Ala Gln Phe Tyr Tyr Lys Arg Asn Val Asn Ala Pro Tyr Arg Asp
1 5 10 15
Arg Ile Pro Leu Arg Ile Val Arg Ala Glu Ser Glu Leu Ser Pro Ser
20 25 30
Glu Lys Ala Tyr Leu Asn Ala Val Glu Lys Gly Asp Tyr Ala Ser Val
35 40 45
Lys Lys Ser Leu Glu Glu Ala Glu Ile Tyr Phe Lys Ile Asn Ile Asn
50 55 60
Cys Ile Asp Pro Leu Gly Arg Thr Ala Leu Leu Ile Ala Ile Glu Asn
65 70 75 80
Glu Asn Leu Glu Leu Ile Glu Leu Leu Leu Ser Phe Asn Val Tyr Val
85 90 95
Gly Asp Ala Leu Leu His Ala Ile Arg Lys Glu Val Val Gly Ala Val
100 105 110
Glu Leu Leu Leu Asn His Lys Lys Pro Ser Gly Glu Lys Gln Val Pro
115 120 125
Pro Ile Leu Leu Asp Lys Gln Phe Ser Glu Phe Thr Pro Asp Ile Thr
130 135 140
Pro Ile Ile Leu Ala Ala His Thr Asn Asn Tyr Glu Ile Ile Lys Leu
145 150 155 160
Leu Val Gln Lys Gly Val Ser Val Pro Arg Pro His Glu Mal Arg Cys
165 170 175
Asn Cys Val Glu Cys Val Ser Ser Ser Asp Val Asp Ser Leu Arg His
180 185 190
Ser Arg Ser Arg Leu Asn Ile Tyr Lys Ala Leu Ala Ser Pro Ser Leu
195 200 205
Ile Ala Leu Ser Ser Glu Asp Pro Phe Leu Thr Ala Phe Gln Leu Ser
210 215 220
Trp Glu Leu Gln Glu Leu Ser Lys Val Glu Asn Glu Phe Lys Ser Glu
225 230 235 240
Tyr Glu Glu Leu Ser Arg Gln Cys Lys Gln Phe Ala Lys Asp Leu Leu
245 250 255
Asp Gln Thr Arg Ser Ser Arg Glu Leu Glu Ile Ile Leu Asn Tyr Arg
260 265 270
Asp Asp Asn Ser Leu Ile Glu Glu Gln Ser Gly Asn Asp Leu Ala Arg
275 280 285
Leu Lys Leu Ala Ile Lys Tyr Arg Gln Lys Glu Ala Ser Tyr Gly Glu
290 295 300
Lys Leu Asn Arg Cys Gly Met Ala Asp Phe Arg Thr Thr Ser Met Ile
305 310 315 320
Gly Gly Ile
<210>65
<211>930
<212>PRT
<213>大鼠(Rattus norvegicus)
<400>65
Met Ser Gln Ser Pro Gly Phe Val Thr Arg Arg Gly Gly Ser Pro Lys
1 5 10 15
Ala Ala Pro Gly Ala Gly Ala Arg Arg Asn Glu Ser Gln Asp Tyr Leu
20 25 30
Leu Met Asp Glu Leu Gly Asp Asp Gly Tyr Pro Gln Leu Gln Gln Pro
35 40 45
Pro Tyr Gly Tyr Tyr Pro Ser Phe Arg Gly Asn Glu Asn Arg Leu Thr
50 55 60
His Arg Arg Gln Thr Val Leu Arg Glu Lys Gly Arg Arg Leu Ala Asn
65 70 75 80
Arg Gly Pro Ala Tyr Met Phe Asn Asp His Ser Thr Ser Leu Ser Ile
85 90 95
Glu Glu Glu Arg Phe Leu Asp Ala Ala Glu Tyr Gly Asn Ile Pro Val
100 105 110
Val Arg Lys Met Leu Glu Glu Cys Leu Ser Leu Asn Val Asn Cys Val
115 120 125
Asp Tyr Met Gly Gln Asn Ala Leu Gln Leu Ala Val Ala Asn Glu His
130 135 140
Leu Glu Ile Thr Glu Leu Leu Leu Lys Lys Glu Asn Leu Ser Arg Val
145 150 155 160
Gly Asp Ala Leu Leu Leu Ala Ile Ser Lys Gly Tyr Val Arg Ile Val
165 170 175
Glu Ala Ile Leu Asn His Pro Ala Phe Ala Glu Gly Lys Arg Leu Ala
180 185 190
Thr Ser Pro Ser Gln Ser Glu Leu Gln Gln Asp Asp Phe Tyr Ala Tyr
195 200 205
Asp Glu Asp Gly Thr Arg Phe Ser His Asp Val Thr Pro Ile Ile Leu
210 215 220
Ala Ala His Cys Gln Glu Tyr Glu Ile Val His Thr Leu Leu Arg Lys
225 230 235 240
Gly Ala Arg Ile Glu Arg Pro His Asp Tyr Phe Cys Lys Cys Thr Glu
245 250 255
Cys Ser Gln Lys Gln Lys His Asp Ser Phe Ser His Ser Arg Ser Arg
260 265 270
Ile Asn Ala Tyr Lys Gly Leu Ala Ser Pro Ala Tyr Leu Ser Leu Ser
275 280 285
Ser Glu Asp Pro Val Met Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala
290 295 300
Val Leu Ala Asn Ile Glu Lys Glu Phe Lys Asn Asp Tyr Arg Lys Leu
305 310 315 320
Ser Met Gln Cys Lys Asp Phe Val Val Gly Leu Leu Asp Leu Cys Arg
325 330 335
Asn Thr Glu Glu Val Glu Ala Ile Leu Asn Gly Asp Ala Glu Thr Arg
340 345 350
Gln Pro Gly Asp Leu Ala Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala
355 360 365
Ile Lys Tyr Glu Val Lys Lys Phe Val Ala His Pro Asn Cys Gln Gln
370 375 380
Gln Leu Leu Ser Ile Trp Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln
385 390 395 400
Thr Met Ala Val Lys Phe Leu Val Val Leu Ala Val Ala Ile Gly Leu
405 410 415
Pro Phe Leu Ala Leu Ile Tyr Trp Cys Ala Pro Cys Ser Lys Met Gly
420 425 430
Lys Ile Leu Arg Gly Pro Phe Met Lys Phe Val Ala His Ala Ala Ser
435 440 445
Phe Thr Ile Phe Leu Gly Leu Leu Val Met Asn Ala Ala Asp Arg Phe
450 455 450
Glu Gly Thr Lys Leu Leu Pro Asn Glu Thr Ser Thr Asp Asn Ala Arg
465 470 475 480
Gln Leu Phe Arg Met Lys Thr Ser Cys Phe Ser Trp Met Glu Met Leu
485 490 495
Ile Ile Ser Trp Val Ile Gly Met Ile Trp Ala Glu Cys Lys Glu Ile
500 505 510
Trp Thr Gln Gly Pro Lys Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu
515 520 525
Asp Phe Gly Met Leu Ala Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe
530 535 540
Met Ala Phe Trp His Ala Ser Lys Ala Gln Ser Ile Ile Asp Ala Asn
545 550 555 560
Asp Thr Leu Lys Asp Leu Thr Lys Val Thr Leu Gly Asp Asn Val Lys
565 570 575
Tyr Tyr Asn Leu Ala Arg Ile Lys Trp Asp Pro Thr Asp Pro Gln Ile
580 585 590
Ile Ser Glu Gly Leu Tyr Ala Ile Ala Val Val Leu Ser Phe Ser Arg
595 600 605
Ile Ala Tyr Ile Leu Pro Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile
610 615 620
Ser Leu Gly Arg Thr Val Lys Asp Ile Phe Lys Phe Met Val Ile Phe
625 630 635 640
Ile Met Val Phe Val Ala Phe Met Ile Gly Met Phe Asn Leu Tyr Ser
645 650 655
Tyr Tyr Ile Gly Ala Lys Gln Asn Glu Ala Phe Thr Thr Val Glu Glu
660 665 670
Ser Phe Lys Thr Leu Phe Trp Ala Ile Phe Gly Leu Ser Glu Val Lys
675 680 685
Ser Val Val Ile Asn Tyr Asn His Lys Phe Ile Glu Asn Ile Gly Tyr
690 695 700
Val Leu Tyr Gly Val Tyr Asn Val Thr Met Val Ile Val Leu Leu Asn
705 710 715 720
Met Leu Ile Ala Met Ile Asn Ser Ser Phe Gln Glu Ile Glu Asp Asp
725 730 735
Ala Asp Val Glu Trp Lys Phe Ala Arg Ala Lys Leu Trp Phe Ser Tyr
740 745 750
Phe Glu Glu Gly Arg Thr Leu Pro Val Pro Phe Asn Leu Val Pro Ser
755 760 765
Pro Lys Ser Leu Leu Tyr Leu Leu Leu Lys Phe Lys Lys Trp Met Ser
770 775 780
Glu Leu Ile Gln Gly His Lys Lys Gly Phe Gln Glu Asp Ala Glu Met
785 790 795 800
Asn Lys Arg Asn Glu Glu Lys Lys Phe Gly Ile Leu Gly Ser His Glu
805 810 815
Asp Leu Ser Lys Phe Ser Leu Asp Arg Asn Gln Leu Ala His Asn Lys
820 825 830
Gln Ser Ser Thr Arg Ser Ser Glu Asp Phe His Leu Asn Ser Phe Ser
835 840 845
Asn Pro Pro Arg Gln Tyr Gln Lys Ile Met Lys Arg Leu Ile Lys Arg
850 855 860
Tyr Val Leu Gln Ala Gln Ile Asp Lys Glu Ser Asp Glu Val Asn Glu
865 870 875 880
Gly Glu Leu Lys Glu Ile Lys Gln Asp Ile Ser Ser Leu Arg Tyr Glu
885 890 895
Leu Leu Glu Glu Lys Ser Gln Asn Thr Glu Asp Leu Ala Glu Leu Ile
900 905 910
Arg Lys Leu Gly Glu Arg Leu Ser Leu Glu Ser Lys Gln Glu Glu Ser
915 920 925
Arg Arg
930
<210>66
<211>139
<212>PRT
<213>智人(Homo sapiens)
<400>66
Met Gly His Pro Arg Ala Ile Gln Pro Ser Val Phe Phe Ser Pro Tyr
1 5 10 15
Asp Val His Phe Leu Leu Tyr Pro Ile Arg Cys Pro Tyr Leu Lys Ile
20 25 30
Gly Arg Phe His Ile Lys Leu Lys Gly Leu His Phe Leu Phe Ser Phe
35 40 45
Leu Phe Phe Phe Phe Glu Thr Gln Ser His Ser Val Thr Arg Leu Glu
50 55 60
Cys Ser Gly Thr Ile Ser Ala His Cys Asn Leu Cys Leu Pro Gly Ser
65 70 75 80
Ser Asn Ser Pro Ala Ser Ala Ser Arg Val Ala Gly Thr Ala Gly Thr
85 90 95
Cys Arg Arg Ala Gln Leu Ile Phe Val Phe Leu Ala Glu Met Gly Phe
100 105 110
His His Val Gly Arg Asp Gly Leu Asp Leu Asn Leu Val Ile His Pro
115 120 125
Pro Arg Ser Pro Lys Ala Leu Gly Leu Gln Ala
130 135
<210>67
<21l>392
<212>PRT
<213>智人(Homo sapiens)
<400>67
Met Gly Ser Leu Ser Thr Ala Asn Val Glu Phe Cys Leu Asp Val Phe
1 5 10 15
Lys Glu Leu Asn Ser Asn Asn Ils Gly Asp Asn Ile Phe Phe Ser Ser
20 25 30
Leu Ser Leu Leu Tyr Ala Leu Ser Met Val Leu Leu Gly Ala Arg Gly
35 40 45
Glu Thr Ala Glu Gln Leu Glu Lys Val Leu His Phe Ser His Thr Val
50 55 60
Asp Ser Leu Lys Pro Gly Phe Lys Asp Ser Pro Lys Cys Ser Gln Ala
65 70 75 80
Gly Arg Ile His Ser Glu Phe Gly Val Glu Phe Ser Gln Ile Asn Gln
85 90 95
Pro Asp Ser Asn Cys Thr Leu Ser Ile Ala Asn Arg Leu Tyr Gly Thr
100 105 110
Lys Thr Met Ala Phe His Gln Gln Tyr Leu Ser Cys Ser Glu Lys Trp
115 120 125
Tyr Gln Ala Arg Leu Gln Thr Val Asp Phe Glu Gln Ser Thr Glu Glu
130 135 140
Thr Arg Lys Met Ile Asn Ala Trp Val Glu Asn Lys Thr Asn Gly Lys
145 150 155 160
Val Ala Asn Leu Phe Gly Lys Ser Thr Ile Asp Pro Ser Ser Val Met
165 170 175
Val Leu Val Asn Thr Ile Tyr Phe Lys Gly Gln Arg Gln Asn Lys Phe
180 185 190
Gln Val Arg Glu Thr Val Lys Ser Pro Phe Gln Leu Ser Glu Gly Lys
195 200 205
Asn Val Thr Val Glu Met Met Tyr Gln Ile Gly Thr Phe Lys Leu Ala
210 215 220
Phe Val Lys Glu Pro Gln Met Gln Val Leu Glu Leu Pro Tyr Val Asn
225 230 235 240
Asn Lys Leu Ser Met Ile Ile Leu Leu Pro Val Gly Ile Ala Asn Leu
245 250 255
Lys Gln Ile Glu Lys Gln Leu Asn Ser Gly Thr Phe His Glu Trp Thr
260 265 270
Ser Ser Ser Asn Met Met Glu Arg Glu Val Glu Val His Leu Pro Arg
275 280 285
Phe Lys Leu Glu Ile Lys Tyr Glu Leu Asn Ser Leu Leu Lys Pro Leu
290 295 300
Gly Val Thr Asp Leu Phe Asn Gln Val Lys Ala Asp Leu Ser Gly Met
305 310 315 320
Ser Pro Thr Lys Gly Leu Tyr Leu Ser Lys Ala Ile His Lys Ser Tyr
325 330 335
Leu Asp Val Ser Glu Glu Gly Thr Glu Ala Ala Ala Ala Thr Gly Asp
340 345 350
Ser Ile Ala Val Lys Ser Leu Pro Met Arg Ala Gln Phe Lys Ala Asn
355 360 365
His Pro Phe Leu Phe Phe Ile Arg His Thr His Thr Asn Thr Ile Leu
370 375 380
Phe Cys Gly Lys Leu Ala Ser Pro
385 390
<210>68
<211>862
<212>PRT
<213>智人(Homo sapiens)
<400>68
Met Leu Arg Asn Ser Thr Phe Lys Asn Met Gln Arg Arg His Thr Thr
1 5 10 15
Leu Arg Glu Lys Gly Arg Arg Gln Ala Ile Arg Gly Pro Ala Tyr Met
20 25 30
Phe Asn Glu Lys Gly Thr Ser Leu Thr Pro Glu Glu Glu Arg Phe Leu
35 40 45
Asp Ser Ala Glu Tyr Gly Asn Ile Pro Val Val Arg Lys Met Leu Glu
50 55 60
Glu Ser Lys Thr Leu Asn Phe Asn Cys Val Asp Tyr Met Gly Gln Asn
65 70 75 80
Ala Leu Gln Leu Ala Val Gly Asn Glu His Leu Glu Val Thr Glu Leu
85 90 95
Leu Leu Lys Lys Glu Asn Leu Ala Arg Val Gly Asp Ala Leu Pro Leu
100 105 110
Ala Ile Ser Lys Gly Tyr Val Arg Ile Val Glu Ala Ile Leu Asn His
115 120 125
Pro Ala Phe Ala Gln Gly Gln Arg Leu Thr Leu Ser Pro Leu Glu Gln
130 135 140
Glu Leu Arg Asp Asp Asp Phe Tyr Ala Tyr Asp Glu Asp Gly Thr Arg
145 150 155 160
Phe Ser His Asp Ile Thr Pro Ile Ile Leu Ala Ala His Cys Gln Glu
165 170 175
Tyr Glu Ile Val His Ile Leu Leu Leu Lys Gly Ala Arg Ile Glu Arg
180 185 190
Pro His Asp Tyr Phe Cys Lys Cys Asn Glu Cys Thr Glu Lys Gln Arg
195 200 205
Lys Asp Ser Phe Ser His Ser Arg Ser Arg Met Asn Ala Tyr Lys Gly
2l0 215 220
Leu Ala Ser Ala Ala Tyr Leu Ser Leu Ser Ser Glu Asp Pro Val Leu
225 230 235 240
Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala Arg Leu Ala Asn Ile Glu
245 250 255
Thr Glu Phe Lys Asn Asp Tyr Arg Lys Leu Ser Met Gln Cys Lys Asp
260 265 270
Phe Val Val Gly Val Leu Asp Leu Cys Arg Asp Thr Glu Glu Val Glu
275 280 285
Ala Ile Leu Asn Gly Asp Val Asn Phe Gln Val Trp Ser Asp His His
290 295 300
Arg Pro Ser Leu Ser Arg Ile Lys Leu Ala Ile Lys Tyr Glu Val Lys
305 310 315 320
Lys Phe Val Ala His Pro Asn Cys Gln Gln Gln Leu Leu Thr Met Trp
325 330 335
Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln Ser Ile Ala Val Lys Phe
340 345 350
Leu Ala Val Phe Gly Val Ser Ile Gly Leu Pro Phe Leu Ala Ile Ala
355 360 365
Tyr Trp Ile Ala Pro Cys Ser Lys Leu Gly Arg Thr Leu Arg Ser Pro
370 375 380
Phe Met Lys Phe Val Ala His Ala Val Ser Phe Thr Ile Phe Leu Gly
385 390 395 400
Leu Leu Val Val Asn Ala Ser Asp Arg Phe Glu Gly Val Lys Thr Leu
405 410 415
Pro Asn Glu Thr Phe Thr Asp Tyr Pro Lys Gln Ile Phe Arg Val Lys
420 425 430
Thr Thr Gln Phe Ser Trp Thr Glu Met Leu Ile Met Lys Trp Val Leu
435 440 445
Gly Met Ile Trp Ser Glu Cys Lys Glu Ile Trp Glu Glu Gly Pro Arg
450 455 460
Glu Tyr Val Leu His Leu Trp Asn Leu Leu Asp Phe Gly Met Leu Ser
465 470 475 480
Ile Phe Val Ala Ser Phe Thr Ala Arg Phe Met Ala Phe Leu Lys Ala
485 490 495
Thr Glu Ala Gln Leu Tyr Val Asp Gln His Val Gln Asp Asp Thr Leu
500 505 510
His Asn Val Ser Leu Pro Pro Glu Val Ala Tyr Phe Thr Tyr Ala Arg
515 520 525
Asp Lys Trp Trp Pro Ser Asp Pro Gln Ile Ile Ser Glu Gly Leu Tyr
530 535 540
Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Ile Leu Pro
545 550 555 560
Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr Val
565 570 575
Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val Phe Val Ala
580 585 590
Phe Met Ile Gly Met Phe Asn Leu Tyr Ser Tyr Tyr Arg Gly Ala Lys
595 600 605
Tyr Asn Pro Ala Phe Thr Thr Val Glu Glu Ser Phe Lys Thr Leu Phe
610 615 620
Trp Ser Ile Phe Gly Leu Ser Glu Val Ile Ser Val Val Leu Lys Tyr
625 630 635 640
Asp His Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr Gly Val Tyr
645 650 655
Asn Val Thr Met Val Val Val Leu Leu Asn Met Leu Ile Ala Met Ile
660 665 670
Asn Asn Ser Tyr Gln Glu Ile Glu Glu Asp Ala Asp Val Glu Trp Lys
675 680 685
Phe Ala Arg Ala Lys Leu Trp Leu Ser Tyr Phe Asp Glu Gly Arg Thr
690 695 700
Leu Pro Ala Pro Phe Asn Leu Val Pro Ser Pro Lys Ser Phe Tyr Tyr
705 710 715 720
Leu Ile Met Arg Ile Lys Met Cys Leu Ile Lys Leu Cys Lys Ser Lys
725 730 735
Ala Lys Ser Cys Glu Asn Asp Leu Glu Met Gly Met Leu Asn Ser Lys
740 745 750
Phe Lys Lys Thr Arg Tyr Gln Ala Gly Met Arg Asn Ser Glu Asn Leu
755 760 765
Thr Ala Asn Asn Thr Leu Ser Lys Pro Thr Arg Tyr Gln Lys Ile Met
770 775 780
Lys Arg Leu Ile Lys Arg Tyr Val Leu Lys Ala Gln Val Asp Arg Glu
785 790 795 800
Asn Asp Glu Val Asn Glu Gly Glu Leu Lys Glu Ile Lys Gln Asp Ile
805 810 815
Ser Ser Leu Arg Tyr Glu Leu Leu Glu Glu Lys Ser Gln Ala Thr Gly
820 825 830
Glu Leu Ala Asp Leu Ile Gln Gln Leu Ser Glu Lys Phe Gly Lys Asn
835 840 845
Leu Asn Lys Asp His Leu Arg Val Asn Lys Gly Lys Asp Ile
850 855 860
<210>69
<211>1265
<212>PRT
<213>智人(Homo sapiens)
<400>69
Met Lys Val Arg Leu Leu Arg Gln Leu Ser Ala Ala Ala Lys Val Lys
1 5 10 15
Ala Pro Ser Gly Leu Gln Gly Pro Pro Gln Ala His Gln Phe Ile Ser
20 25 30
Leu Leu Leu Glu Glu Tyr Gly Ala Leu Cys Gln Ala Ala Arg Ser Ile
35 40 45
Ser Thr Phe Leu Gly Thr Leu Glu Asn Glu His Leu Lys Lys Phe Gln
50 55 60
Val Thr Trp Glu Leu His Asn Lys His Leu Phe Glu Asn Leu Val Phe
65 70 75 80
Ser Glu Pro Leu Leu Gln Ser Asn Leu Pro Ala Leu Val Ser Gln Ile
85 90 95
Arg Leu Gly Thr Thr Thr His Asp Thr Cys Ser Glu Asp Thr Tyr Ser
100 105 110
Thr Leu Leu Gln Arg Tyr Gln Arg Ser Glu Glu Glu Leu Arg Arg Val
115 120 125
Ala Glu Glu Trp Leu Glu Cys Gln Lys Arg Ile Asp Ala Tyr Val Asp
130 135 140
Glu Gln Met Thr Met Lys Thr Lys Gln Arg Met Leu Thr Glu Asp Trp
145 150 155 160
Glu Leu Phe Lys Gln Arg Arg Phe Ile Glu Glu Gln Leu Thr Asn Lys
165 170 175
Lys Ala Val Thr Gly Glu Asn Asn Phe Thr Asp Thr Met Arg His Val
180 185 190
Leu Ser Ser Arg Leu Ser Met Pro Asp Cys Pro Asn Cys Asn Tyr Arg
195 200 205
Arg Arg Cys Ala Cys Asp Asp Cys Ser Leu Ser His Ile Leu Thr Cys
210 215 220
Gly Ile Met Asp Pro Pro Val Thr Asp Asp Ile His Ile His Gln Leu
225 230 235 240
Pro Leu Gln Val Asp Pro Ala Pro Asp Tyr Leu Ala Glu Arg Ser Pro
245 250 255
Pro Ser Val Ser Ser Ala Ser Ser Gly Ser Gly Ser Ser Ser Pro Ile
260 265 270
Thr Ile Gln Gln His Pro Arg Leu Ile Leu Thr Asp Ser Gly Ser Ala
275 280 285
Pro Thr Phe Cys Ser Asp Asp Glu Asp Val Ala Pro Leu Ser Ala Lys
290 295 300
Phe Ala Asp Ile Tyr Pro Leu Ser Asn Tyr Asp Asp Thr Glu Val Val
305 310 315 320
Ala Asn Met Asn Gly Ile His Ser Glu Leu Asn Gly Gly Gly Glu Asn
325 330 335
Met Ala Leu Lys Asp Glu Ser Pro Gln Ile Ser Ser Thr Ser Ser Ser
340 345 350
Ser Ser Glu Ala Asp Asp Glu Glu Ala Asp Gly Glu Ser Ser Gly Glu
355 360 365
Pro Pro Gly Ala Pro Lys Glu Asp Gly Val Leu Gly Ser Arg Ser Pro
370 375 380
Arg Thr Glu Glu Ser Lys Ala Asp Ser Pro Pro Pro Ser Tyr Pro Thr
385 390 395 400
Gln Gln Ala Glu Gln Ala Pro Asn Thr Cys Glu Cys His Val Cys Lys
405 410 415
Gln Glu Ala Ser Gly Leu Thr Pro Ser Ala Met Thr Ala Gly Ala Leu
420 425 430
Pro Pro Gly His Gln Phe Leu Ser Pro Glu Lys Pro Thr His Pro Ala
435 440 445
Leu His Leu Tyr Pro His Ile His Gly His Val Pro Leu His Thr Val
450 455 460
Pro His Leu Pro Arg Pro Leu Ile His Pro Thr Leu Tyr Ala Thr Pro
465 470 475 480
Pro Phe Thr His Ser Lys Ala Leu Pro Pro Ala Pro Val Gln Asn His
485 490 495
Thr Asn Lys His Gln Val Phe Asn Ala Ser Leu Gln Asp His Ile Tyr
500 505 510
Pro Ser Cys Phe Gly Asn Thr Pro Glu Trp Asn Ser Ser Lys Phe Ile
515 520 525
Ser Leu Trp Gly Ser Glu Val Met Asn Asp Lys Asn Trp Asn Pro Gly
530 535 540
Thr Phe Leu Pro Asp Thr Ile Ser Gly Ser Glu Ile Leu Gly Pro Thr
545 550 555 560
Leu Ser Glu Thr Arg Pro Glu Ala Leu Pro Pro Pro Ser Ser Asn Glu
565 570 575
Thr Pro Ala Val Ser Asp Ser Lys Glu Lys Lys Asn Ala Ala Lys Lys
580 585 590
Lys Cys Leu Tyr Asn Phe Gln Asp Ala Phe Met Glu Ala Asn Lys Val
595 600 605
Val Met Ala Thr Ser Ser Ala Thr Ser Ser Val Ser Cys Thr Ala Thr
6l0 615 620
Thr Val Gln Ser Ser Asn Ser Gln Phe Arg Val Ser Ser Lys Arg Pro
625 630 635 640
Pro Ser Val Gly Asp Val Phe His Gly Ile Ser Lys Glu Asp His Arg
645 650 655
His Ser Ala Pro Ala Ala Pro Arg Asn Ser Pro Thr Gly Leu Ala Pro
660 665 670
Leu Pro Ala Leu Ser Pro Ala Ala Leu Ser Pro Ala Ala Leu Ser Pro
675 680 685
Ala Ser Thr Pro His Leu Ala Ash Leu Ala Ala Pro Ser Phe Pro Lys
690 695 700
Thr Ala Thr Thr Thr Pro Gly Phe Val Asp Thr Arg Lys Ser Phe Cys
705 710 715 720
Pro Ala Pro Leu Pro Pro Ala Thr Asp Gly Ser Ile Ser Ala Pro Pro
725 730 735
Ser Val Cys Ser Asp Pro Asp Cys Glu Gly His Arg Cys Glu Asn Gly
740 745 750
Val Tyr Asp Pro Gln Gln Asp Asp Gly Asp Glu Ser Ala Asp Glu Asp
755 760 765
Ser Cys Ser Glu His Ser Ser Ser Thr Ser Thr Ser Thr Asn Gln Lys
770 775 780
Glu Gly Lys Tyr Cys Asp Cys Cys Tyr Cys Glu Phe Phe Gly His Gly
785 790 795 800
Gly Pro Pro Ala Ala Pro Thr Ser Arg Asn Tyr Ala Glu Met Arg Glu
805 810 815
Lys Leu Arg Leu Arg Leu Thr Lys Arg Lys Glu Glu Gln Pro Lys Lys
820 825 830
Met Asp Gln Ile Ser Glu Arg Glu Ser Val Val Asp His Arg Arg Val
835 840 845
Glu Asp Leu Leu Gln Phe Ile Asn Ser Ser Glu Thr Lys Pro Val Ser
850 855 860
Ser Thr Arg Ala Ala Lys Arg Ala Arg His Lys Gln Arg Lys Leu Glu
865 870 875 880
Glu Lys Ala Arg Leu Glu Ala Glu Ala Arg Ala Arg Glu His Leu His
885 890 895
Leu Gln Glu Glu Gln Arg Arg Arg Glu Glu Glu Glu Asp Glu Glu Glu
900 905 910
Glu Glu Asp Arg Phe Lys Glu Glu Phe Gln Arg Leu Gln Glu Leu Gln
915 920 925
Lys Leu Arg Ala Val Lys Lys Lys Lys Lys Glu Arg Pro Ser Lys Asp
930 935 940
Cys Pro Lys Leu Asp Met Leu Thr Arg Asn Phe Gln Ala Ala Thr Glu
945 950 955 960
Ser Val Pro Asn Ser Gly Asn Ile His Asn Gly Ser Leu Glu Gln Thr
965 970 975
Glu Glu Pro Glu Thr Ser Ser His Ser Pro Ser Arg His Met Asn His
980 985 990
Ser Glu Pro Arg Pro Gly Leu Gly Ala Asp Gly Asp Ala Ala Asp Pro
995 1000 1005
Val Asp Thr Arg Asp Ser Lys Phe Leu Leu Pro Lys Glu Val Asn Gly
1010 1015 1020
Lys Gln His Glu Pro Leu Ser Phe Phe Phe Asp Ile Met Gln His His
1025 1030 1035 1040
Lys Glu Gly Asn Gly Lys Gln Lys Leu Arg Gln Thr Ser Lys Ala Ser
1045 1050 1055
Ser Glu Pro Ala Arg Arg Pro Thr Glu Pro Pro Lys Ala Thr Glu Gly
1060 1065 1070
Gln Ser Lys Pro Arg Ala Gln Thr Glu Ser Lys Ala Lys Val Val Asp
1075 1080 1085
Leu Met Ser Ile Thr Glu Gln Lys Arg Glu Glu Arg Lys Val Asn Ser
1090 1095 1100
Asn Asn Asn Asn Lys Lys Gln Leu Asn His Ile Lys Asp Glu Lys Ser
1105 1110 1115 1120
Asn Pro Thr Pro Met Glu Pro Thr Ser Pro Gly Glu His Gln Gln Asn
1125 1130 1135
Ser Lys Leu Val Leu Ala Glu Ser Pro Gln Pro Lys Gly Lys Asn Lys
1140 1145 1150
Lys Asn Lys Lys Lys Lys Gly Asp Arg Val Asn Asn Ser Ile Asp Gly
1155 1160 1165
Val Ser Leu Leu Leu Pro Ser Leu Gly Tyr Asn Gly Ala Ile Leu Ala
1170 1175 1180
His Cys Asn Leu Arg Leu Pro Gly Ser Ser Asp Cys Ala Ala Ser Ala
1185 1190 1195 1200
Ser Gln Val Val Gly Ile Thr Asp Asp Val Phe Leu Pro Lys Asp Ile
1205 1210 1215
Asp Leu Asp Ser Val Asp Met Asp Glu Thr Glu Arg Glu Val Glu Tyr
1220 1225 1230
Phe Lys Arg Phe Cys Leu Asp Ser Ala Arg Gln Thr Arg Gln Arg Leu
1235 1240 1245
Ser Ile Asn Trp Ser Asn Phe Ser Leu Lys Lys Ala Thr Phe Ala Ala
1250 1255 1260
His
1265
<210>70
<211>392
<212>PRT
<213>智人(Homo sapiens)
<400>70
Met Gly Ser Leu Ser Thr Ala Asn Val Glu Phe Cys Leu Asp Val Phe
1 5 10 15
Lys Glu Leu Asn Ser Asn Asn Ile Gly Asp Asn Ile Phe Phe Ser Ser
20 25 30
Leu Ser Leu Leu Tyr Ala Leu Ser Met Val Leu Leu Gly Ala Arg Gly
35 40 45
Glu Thr Ala Glu Gln Leu Glu Lys Val Leu His Phe Ser His Thr Val
50 55 60
Asp Ser Leu Lys Pro Gly Phe Lys Asp Ser Pro Lys Cys Ser Gln Ala
65 70 75 80
Gly Arg Ile His Ser Glu Phe Gly Val Glu Phe Ser Gln Ile Asn Gln
85 90 95
Pro Asp Ser Asn Cys Thr Leu Ser Ile Ala Asn Arg Leu Tyr Gly Thr
100 105 110
Lys Thr Met Ala Phe His Gln Gln Tyr Leu Ser Cys Ser Glu Lys Trp
115 120 125
Tyr Gln Ala Arg Leu Gln Thr Val Asp Phe Glu Gln Ser Thr Glu Glu
130 135 140
Thr Arg Lys Met Ile Asn Ala Trp Val Glu Asn Lys Thr Asn Gly Lys
145 150 155 160
Val Ala Asn Leu Phe Gly Lys Ser Thr Ile Asp Pro Ser Ser Val Met
165 170 175
Val Leu Val Asn Ile Ile Tyr Phe Lys Gly Gln Arg Gln Asn Lys Phe
180 185 190
Gln Val Arg Glu Thr Val Lys Ser Pro Phe Gln Leu Ser Glu Gly Lys
195 200 205
Asn Val Thr Val Glu Met Met Tyr Gln Ile Gly Thr Phe Lys Leu Ala
210 215 220
Phe Val Lys Glu Pro Gln Met Gln Val Leu Glu Leu Pro Tyr Val Asn
225 230 235 240
Asn Lys Leu Ser Met Ile Ile Leu Leu Pro Val Gly Ile Ala Asn Leu
245 250 255
Lys Gln Ile Glu Lys Gln Leu Asn Ser Gly Thr Phe His Glu Trp Thr
260 265 270
Ser Ser Ser Asn Met Met Glu Arg Glu Val Glu Val His Leu Pro Arg
275 280 285
Phe Lys Leu Glu Ile Lys Tyr Glu Leu Asn Ser Leu Leu Lys Pro Leu
290 295 300
Gly Val Thr Asp Leu Phe Asn Gln Val Lys Ala Asp Leu Ser Gly Met
305 310 315 320
Ser Pro Thr Lys Gly Leu Tyr Leu Ser Lys Ala Ile His Lys Ser Tyr
325 330 335
Leu Asp Val Ser Glu Glu Gly Thr Glu Ala Ala Ala Ala Thr Gly Asp
340 345 350
Ser Ile Ala Val Lys Ser Leu Pro Met Arg Ala Gln Phe Lys Ala Asn
355 360 365
His Pro Phe Leu Phe Phe Ile Arg His Thr His Thr Asn Thr Ile Leu
370 375 380
Phe Cys Gly Lys Leu Ala Ser Pro
385 390
<210>71
<211>793
<212>PRT
<213>智人(Homo sapiens)
<400>71
Met Met Ala Ala Leu Tyr Pro Ser Thr Asp Leu Ser Gly Ala Ser Ser
1 5 10 15
Ser Ser Leu Pro Ser Ser Pro Ser Ser Ser Ser Pro Asn Glu Val Met
20 25 30
Ala Leu Lys Asp Val Arg Glu Val Lys Glu Glu Asn Thr Leu Asn Glu
35 40 45
Lys Leu Phe Leu Leu Ala Cys Asp Lys Gly Asp Tyr Tyr Met Val Lys
50 55 60
Lys Ile Leu Glu Glu Asn Ser Ser Gly Asp Leu Asn Ile Asn Cys Val
65 70 75 80
Asp Val Leu Gly Arg Asn Ala Val Thr Ile Thr Ile Glu Asn Glu Asn
85 90 95
Leu Asp Ile Leu Gln Leu Leu Leu Asp Tyr Gly Cys Gln Ser Ala Asp
100 105 110
Ala Leu Leu Val Ala Ile Asp Ser Glu Val Val Gly Ala Val Asp Ile
115 120 125
Leu Leu Asn His Arg Pro Lys Arg Ser Ser Arg Pro Thr Ile Val Lys
130 135 140
Leu Met Glu Arg Ile Gln Asn Pro Glu Tyr Ser Thr Thr Met Asp Val
145 150 155 160
Ala Pro Val Ile Leu Ala Ala His Arg Asn Asn Tyr Glu Ile Leu Thr
165 170 175
Met Leu Leu Lys Gln Asp Val Ser Leu Pro Lys Pro His Ala Val Gly
180 185 190
Cys Glu Cys Thr Leu Cys Ser Ala Lys Asn Lys Lys Asp Ser Leu Arg
195 200 205
His Ser Arg Phe Arg Leu Asp Ile Tyr Arg Cys Leu Ala Ser Pro Ala
2l0 215 220
Leu Ile Met Leu Thr Glu Glu Asp Pro Ile Leu Arg Ala Phe Glu Leu
225 230 235 240
Ser Ala Asp Leu Lys Glu Leu Ser Leu Val Glu Val Glu Phe Arg Asn
245 250 255
Asp Tyr Glu Glu Leu Ala Arg Gln Cys Lys Met Phe Ala Lys Asp Leu
260 265 270
Leu Ala Gln Ala Arg Asn Ser Arg Glu Leu Glu Val Ile Leu Asn His
275 280 285
Thr Ser Ser Asp Glu Pro Leu Asp Lys Arg Gly Leu Leu Glu Glu Arg
290 295 300
Met Asn Leu Ser Arg Leu Lys Leu Ala Ile Lys Tyr Asn Gln Lys Glu
305 310 315 320
Phe Val Ser Gln Ser Asn Cys Gln Gln Phe Leu Asn Thr Val Trp Phe
325 330 335
Gly Gln Met Ser Gly Tyr Arg Arg Lys Pro Thr Cys Lys Lys Ile Met
340 345 350
Thr Val Leu Thr Val Gly Ile Phe Trp Pro Val Leu Ser Leu Cys Tyr
355 360 365
Leu Ile Ala Pro Lys Ser Gln Phe Gly Arg Ile Ile His Thr Pro Phe
370 375 380
Met Lys Phe Ile Ile His Gly Ala Ser Tyr Phe Thr Phe Leu Leu Leu
385 390 395 400
Leu Asn Leu Tyr Ser Leu Val Tyr Asn Glu Asp Lys Lys Asn Thr Met
405 410 415
Gly Pro Ala Leu Glu Arg Ile Asp Tyr Leu Leu Ile Leu Trp Ile Ile
420 425 430
Gly Met Ile Trp Ser Asp Ile Lys Arg Leu Trp Tyr Glu Gly Leu Glu
435 440 445
Asp Phe Leu Glu Glu Ser Arg Asn Gln Leu Ser Phe Val Met Asn Ser
450 455 460
Leu Tyr Leu Ala Thr Phe Ala Leu Lys Val Val Ala His Asn Lys Phe
465 470 475 480
His Asp Phe Ala Asp Arg Lys Asp Trp Asp Ala Phe His Pro Thr Leu
485 490 495
Val Ala Glu Gly Leu Phe Ala Phe Ala Asn Val Leu Ser Tyr Leu Arg
500 505 510
Leu Phe Phe Met Tyr Thr Thr Ser Ser Ile Leu Gly Pro Leu Gln Ile
515 520 525
Ser Met Gly Gln Met Leu Gln Asp Phe Gly Lys Phe Leu Gly Met Phe
530 535 540
Leu Leu Val Leu Phe Ser Phe Thr Ile Gly Leu Thr Gln Leu Tyr Asp
545 550 555 560
Lys Gly Tyr Thr Ser Lys Glu Gln Lys Asp Cys Val Gly Ile Phe Cys
565 570 575
Glu Gln Gln Ser Asn Asp Thr Phe His Ser Phe Ile Gly Thr Cys Phe
580 585 590
Ala Leu Phe Trp Tyr Ile Phe Ser Leu Ala His Val Ala Ile Phe Val
595 600 605
Thr Arg Phe Ser Tyr Gly Glu Glu Leu Gln Ser Phe Val Gly Ala Val
610 615 620
Ile Val Gly Thr Tyr Asn Val Val Val Val Ile Val Leu Thr Lys Leu
625 630 635 640
Leu Val Ala Met Leu His Lys Ser Phe Gln Leu Ile Ala Asn His Glu
645 650 655
Asp Lys Glu Trp Lys Phe Ala Arg Ala Lys Leu Trp Leu Ser Tyr Phe
660 665 670
Asp Asp Lys Cys Thr Leu Pro Pro Pro Phe Asn Ile Ile Pro Ser Pro
675 680 685
Lys Thr Ile Cys Tyr Met Ile Ser Ser Leu Ser Lys Trp Ile Cys Ser
690 695 700
His Thr Ser Lys Gly Lys Val Lys Arg Gln Asn Ser Leu Lys Glu Trp
705 710 715 720
Arg Asn Leu Lys Gln Lys Arg Asp Glu Asn Tyr Gln Lys Val Met Cys
725 730 735
Cys Leu Val His Arg Tyr Leu Thr Ser Met Arg Gln Lys Met Gln Ser
740 745 750
Thr Asp Gln Ala Thr Val Glu Asn Leu Asn Glu Leu Arg Gln Asp Leu
755 760 765
Ser Lys Phe Arg Asn Glu Ile Arg Asp Leu Leu Gly Phe Arg Thr Ser
770 775 780
Lys Tyr Ala Met Phe Tyr Pro Arg Asn
785 790
<210>72
<211>982
<212>PRT
<213>智人(Homo sapiens)
<400>72
Met Ala Gln Phe Tyr Tyr Lys Arg Asn Val Asn Ala Pro Tyr Arg Asp
1 5 10 15
Arg Ile Pro Leu Arg Ile Val Arg Ala Glu Ser Glu Leu Ser Pro Ser
20 25 30
Glu Lys Ala Tyr Leu Asn Ala Val Glu Lys Gly Asp Tyr Ala Ser Val
35 40 45
Lys Lys Ser Leu Glu Glu Ala Glu Ile Tyr Phe Lys Ile Asn Ile Asn
50 55 60
Cys Ile Asp Pro Leu Gly Arg Thr Ala Leu Leu Ile Ala Ile Glu Asn
65 70 75 80
Glu Asn Leu Glu Leu Ile Glu Leu Leu Leu Ser Phe Asn Val Tyr Val
85 90 95
Gly Asp Ala Leu Leu His Ala Ile Arg Lys Glu Val Val Gly Ala Val
100 105 110
Glu Leu Leu Leu Asn His Lys Lys Pro Ser Gly Glu Lys Gln Val Pro
115 120 125
Pro Ile Leu Leu Asp Lys Gln Phe Ser Glu Phe Thr Pro Asp Ile Thr
130 135 140
Pro Ile Ile Leu Ala Ala His Thr Asn Asn Tyr Glu Ile Ile Lys Leu
145 150 155 160
Leu Val Gln Lys Gly Val Ser Val Pro Arg Pro His Glu Val Arg Cys
165 170 175
Asn Cys Val Glu Cys Val Ser Ser Ser Asp Val Asp Ser Leu Arg His
180 185 190
Ser Arg Ser Arg Leu Asn Ile Tyr Lys Ala Leu Ala Ser Pro Ser Leu
195 200 205
Ile Ala Leu Ser Ser Glu Asp Pro Phe Leu Thr Ala Phe Gln Leu Ser
210 215 220
Trp Glu Leu Gln Glu Leu Ser Lys Val Glu Asn Glu Phe Lys Ser Glu
225 230 235 240
Tyr Glu Glu Leu Ser Arg Gln Cys Lys Gln Phe Ala Lys Asp Leu Leu
245 250 255
Asp Gln Thr Arg Ser Ser Arg Glu Leu Glu Ile Ile Leu Asn Tyr Arg
260 265 270
Asp Asp Asn Ser Leu Ile Glu Glu Gln Ser Gly Asn Asp Leu Ala Arg
275 280 285
Leu Lys Leu Ala Ile Lys Tyr Arg Gln Lys Glu Phe Val Ala Gln Pro
290 295 300
Asn Cys Gln Gln Leu Leu Ala Ser Arg Trp Tyr Asp Glu Phe Pro Gly
305 310 315 320
Trp Arg Arg Arg His Trp Ala Val Lys Met Val Thr Cys Phe Ile Ile
325 330 335
Gly Leu Leu Phe Pro Val Phe Ser Val Cys Tyr Leu Ile Ala Pro Lys
340 345 350
Ser Pro Leu Gly Leu Phe Ile Arg Lys Pro Phe Ile Lys Phe Ile Cys
355 360 365
His Thr Ala Ser Tyr Leu Thr Phe Leu Phe Leu Leu Leu Leu Ala Ser
370 375 380
Gln His Ile Asp Arg Ser Asp Leu Asn Arg Gln Gly Pro Pro Pro Thr
385 390 395 400
Ile Val Glu Trp Met Ile Leu Pro Trp Val Leu Gly Phe Ile Trp Gly
405 410 415
Glu Ile Lys Gln Met Trp Asp Gly Gly Leu Gln Asp Tyr Ile His Asp
420 425 430
Trp Trp Asn Leu Met Asp Phe Val Met Asn Ser Leu Tyr Leu Ala Thr
435 440 445
Ile Ser Leu Lys Ile Val Ala Phe Val Lys Tyr Ser Ala Leu Asn Pro
450 455 460
Arg Glu Ser Trp Asp Met Trp His Pro Thr Leu Val Ala Glu Ala Leu
465 470 475 480
Phe Ala Ile Ala Asn Ile Phe Ser Ser Leu Arg Leu Ile Ser Leu Phe
485 490 495
Thr Ala Asn Ser His Leu Gly Pro Leu Gln Ile Ser Leu Gly Arg Met
500 505 510
Leu Leu Asp Ile Leu Lys Phe Leu Phe Ile Tyr Cys Leu Val Leu Leu
515 520 525
Ala Phe Ala Asn Gly Leu Asn Gln Leu Tyr Phe Tyr Tyr Glu Glu Thr
530 535 540
Lys Gly Leu Thr Cys Lys Gly Ile Arg Cys Glu Lys Gln Asn Asn Ala
545 550 555 560
Phe Ser Thr Leu Phe Glu Thr Leu Gln Ser Leu Phe Trp Ser Ile Phe
565 570 575
Gly Leu Ile Asn Leu Tyr Val Thr Asn Val Lys Ala Gln His Glu Phe
580 585 590
Thr Glu Phe Val Gly Ala Thr Met Phe Gly Thr Tyr Asn Val Ile Ser
595 600 605
Leu Val Val Leu Leu Asn Met Leu Ile Ala Met Met Asn Asn Ser Tyr
610 615 620
Gln Leu Ile Ala Asp His Ala Asp Ile Glu Trp Lys Phe Ala Arg Thr
625 630 635 640
Lys Leu Trp Met Ser Tyr Phe Glu Glu Gly Gly Thr Leu Pro Thr Pro
645 650 655
Phe Asn Val Ile Pro Ser Pro Lys Ser Leu Trp Tyr Leu Ile Lys Trp
660 665 670
Ile Trp Thr His Leu Cys Lys Lys Lys Met Arg Arg Lys Pro Glu Ser
675 680 685
Phe Gly Thr Ile Gly Val Arg Thr Gln His Arg Arg Ala Ala Asp Asn
690 695 700
Leu Arg Arg His His Gln Tyr Gln Val Ile Met Arg Asn Leu Val Lys
705 710 715 720
Arg Tyr Val Ala Ala Met Ile Arg Asp Ala Lys Thr Glu Glu Gly Leu
725 730 735
Thr Glu Glu Asn Phe Lys Glu Leu Lys Gln Asp Ile Ser Ser Phe Arg
740 745 750
Phe Glu Val Leu Gly Leu Leu Arg Gly Ser Lys Leu Ser Thr Ile Gln
755 760 755
Ser Ala Asn Ala Ser Lys Glu Ser Ser Asn Ser Ala Asp Ser Asp Glu
770 775 780
Lys Ser Asp Ser Glu Gly Asn Ser Lys Asp Lys Lys Lys Asn Phe Ser
785 790 795 800
Leu Phe Asp Leu Thr Thr Leu Ile His Pro Arg Ser Ala Ala Ile Ala
805 810 815
Ser Glu Arg His Asn Ile Ser Asn Gly Ser Ala Leu Mal Val Gln Glu
820 825 830
Pro Pro Arg Glu Lys Gln Arg Lys Val Asn Phe Val Thr Asp Ile Lys
835 840 845
Asn Phe Gly Leu Phe His Arg Arg Ser Lys Gln Asn Ala Ala Glu Gln
850 855 860
Asn Ala Asn Gln Ile Phe Ser Val Ser Glu Glu Val Ala Arg Gln Gln
865 870 875 880
Ala Ala Gly Pro Leu Glu Arg Asn Ile Gln Leu Glu Ser Arg Gly Leu
885 890 895
Ala Ser Arg Gly Asp Leu Ser Ile Pro Gly Leu Ser Glu Gln Cys Val
900 905 910
Leu Val Asp His Arg Glu Arg Asn Thr Asp Thr Leu Gly Leu Gln Val
915 920 925
Gly Lys Arg Val Cys Pro Phe Lys Ser Glu Lys Val Val Val Glu Asp
930 935 940
Thr Val Pro Ile Ile Pro Lys Glu Lys His Ala Lys Glu Glu Asp Ser
945 950 955 960
Ser Ile Asp Tyr Asp Leu Asn Leu Pro Asp Thr Val Thr His Glu Asp
965 970 975
Tyr Val Thr Thr Arg Leu
980
<210>73
<211>930
<212>PRT
<213>小家鼠(Mus musculus)
<400>73
Met Ser Gln Ser Pro Arg Phe Val Thr Arg Arg Gly Gly Ser Leu Lys
1 5 10 15
Ala Ala Pro Gly Ala Gly Thr Arg Arg Asn Glu Ser Gln Asp Tyr Leu
20 25 30
Leu Met Asp Glu Leu Gly Asp Asp Gly Tyr Pro Gln Leu Pro Leu Pro
35 40 45
Pro Tyr Gly Tyr Tyr Pro Ser Phe Arg Gly Asn Glu Asn Arg Leu Thr
50 55 60
His Arg Arg Gln Thr Ile Leu Arg Glu Lys Gly Arg Arg Leu Ala Asn
65 70 75 80
Arg Gly Pro Ala Tyr Met Phe Asn Asp His Ser Thr Ser Leu Ser Ile
85 90 95
Glu Glu Glu Arg Phe Leu Asp Ala Ala Glu Tyr Gly Asn Ile Pro Val
100 105 110
Val Arg Lys Met Leu Glu Glu Cys His Ser Leu Asn Val Asn Cys Val
115 120 125
Asp Tyr Met Gly Gln Asn Ala Leu Gln Leu Ala Val Ala Asn Glu His
130 135 140
Leu Glu Ile Thr Glu Leu Leu Leu Lys Lys Glu Asn Leu Ser Arg Val
145 150 155 160
Gly Asp Ala Leu Leu Leu Ala Ile Ser Lys Gly Tyr Val Arg Ile Val
165 170 175
Glu Ala Ile Leu Asn His Pro Ala Phe Ala Glu Gly Lys Arg Leu Ala
180 185 190
Thr Ser Pro Ser Gln Ser Glu Leu Gln Gln Asp Asp Phe Tyr Ala Tyr
195 200 205
Asp Glu Asp Gly Thr Arg Phe Ser His Asp Val Thr Pro Ile Ile Leu
210 215 220
Ala Ala His Cys Gln Glu Tyr Glu Ile Val His Thr Leu Leu Arg Lys
225 230 235 240
Gly Ala Arg Ile Glu Arg Pro His Asp Tyr Phe Cys Lys Cys Thr Glu
245 250 255
Cys Ser Gln Lys Gln Lys His Asp Ser Phe Ser His Ser Arg Ser Arg
260 265 270
Ile Asn Ala Tyr Lys Gly Leu Ala Ser Pro Ala Tyr Leu Ser Leu Ser
275 280 285
Ser Glu Asp Pro Val Met Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala
290 295 300
Val Leu Ala Asn Ile Glu Lys Glu Phe Lys Asn Asp Tyr Arg Lys Leu
305 310 315 320
Ser Met Gln Cys Lys Asp Phe Val Val Gly Leu Leu Asp Leu Cys Arg
325 330 335
Asn Thr Glu Glu Val Glu Ala Ile Leu Asn Gly Asp Ala Glu Thr Arg
340 345 350
Gln Pro Gly Asp Phe Gly Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala
355 360 365
Ile Lys Tyr Glu Val Lys Lys Phe Val Ala His Pro Asn Cys Gln Gln
370 375 380
Gln Leu Leu Ser Ile Trp Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln
385 390 395 400
Thr Met Ala Val Lys Phe Leu Val Val Leu Ala Val Ala Ile Gly Leu
405 410 415
Pro Phe Leu Ala Leu Ile Tyr Trp Cys Ala Pro Cys Ser Lys Met Gly
420 425 430
Lys Ile Leu Arg Gly Pro Phe Met Lys Phe Val Ala His Ala Ala Ser
435 440 445
Phe Thr Ile Phe Leu Gly Leu Leu Val Met Asn Ala Ala Asp Arg Phe
450 455 460
Glu Gly Thr Lys Leu Leu Pro Asn Glu Thr Ser Thr Asp Asn Ala Arg
465 470 475 480
Gln Leu Phe Arg Met Lys Thr Ser Cys Phe Ser Trp Met Glu Met Leu
485 490 495
Ile Ile Ser Trp Val Ile Gly Met Ile Trp Ala Glu Cys Lys Glu Ile
500 505 510
Trp Thr Gln Gly Pro Lys Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu
515 520 525
Asp Phe Gly Met Leu Ala Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe
530 535 540
Met Ala Phe Trp His Ala Ser Lys Ala Gln Ser Ile Ile Asp Ala Asn
545 550 555 560
Asp Thr Leu Lys Asp Leu Thr Lys Val Thr Leu Gly Asp Asn Val Lys
565 570 575
Tyr Tyr Asn Leu Ala Arg Ile Lys Trp Asp Pro Thr Asp Pro Gln Ile
580 585 590
Ile Ser Glu Gly Leu Tyr Ala Ile Ala Val Val Leu Ser Phe Ser Arg
595 600 605
Ile Ala Tyr Ile Leu Pro Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile
610 615 620
Ser Leu Gly Arg Thr Val Lys Asp Ile Phe Lys Phe Met Val Ile Phe
625 630 635 640
Ile Met Val Phe Val Ala Phe Met Ile Gly Met Phe Asn Leu Tyr Ser
645 650 655
Tyr Tyr Ile Gly Ala Lys Gln Asn Glu Ala Phe Thr Thr Val Glu Glu
660 665 670
Ser Phe Lys Thr Leu Phe Trp Ala Ile Phe Gly Leu Ser Glu Val Lys
675 680 685
Ser Val Val Ile Asn Tyr Asn His Lys Phe Ile Glu Asn Ile Gly Tyr
690 695 700
Val Leu Tyr Gly Val Tyr Asn Val Thr Met Val Ile Val Leu Leu Asn
705 710 715 720
Met Leu Ile Ala Met Ile Asn Ser Ser Phe Gln Glu Ile Glu Asp Asp
725 730 735
Ala Asp Val Glu Trp Lys Phe Ala Arg Ala Lys Leu Trp Phe Ser Tyr
740 745 750
Phe Glu Glu Gly Arg Thr Leu Pro Val Pro Phe Asn Leu Val Pro Ser
755 760 765
Pro Lys Ser Leu Leu Tyr Leu Leu Leu Lys Phe Lys Lys Trp Met Cys
770 775 780
Glu Leu Ile Gln Gly Gln Lys Gln Gly Phe Gln Glu Asp Ala Glu Met
785 790 795 800
Asn Lys Arg Asn Glu Glu Lys Lys Phe Gly Ile Ser Gly Ser His Glu
805 810 815
Asp Leu Ser Lys Phe Ser Leu Asp Lys Asn Gln Leu Ala His Asn Lys
820 825 830
Gln Ser Ser Thr Arg Ser Ser Glu Asp Tyr His Leu Asn Ser Phe Ser
835 840 845
Asn Pro Pro Arg Gln Tyr Gln Lys Ile Met Lys Arg Leu Ile Lys Arg
850 855 860
Tyr Val Leu Gln Ala Gln Ile Asp Lys Glu Ser Asp Glu Val Asn Glu
865 870 875 880
Gly Glu Leu Lys Glu Ile Lys Gln Asp Ile Ser Ser Leu Arg Tyr Glu
885 890 895
Leu Leu Glu Glu Lys Ser Gln Asn Thr Glu Asp Leu Ala Glu Leu Ile
900 905 910
Arg Lys Leu Gly Glu Arg Leu Ser Leu Glu Pro Lys Leu Glu Glu Ser
915 920 925
Arg Arg
930
<210>74
<211>826
<212>PRT
<213>智人(Homo sapiens)
<400>74
Pro Ser Gly Leu Pro Leu Leu Pro Val Leu Phe Ala Leu Gly Gly Leu
1 5 10 15
Leu Leu Leu Ser Asn Ala Ser Cys Val Gly Gly Val Leu Trp Gln Arg
20 25 30
Arg Leu Arg Arg Leu Ala Glu Ala Leu Asn Phe Pro Pro His Leu His
35 40 45
Pro Gly Arg Ser Glu Glu Asp Arg Val Arg Asn Glu Tyr Glu Glu Ser
50 55 60
Gln Trp Thr Gly Glu Arg Asp Thr Gln Ser Ser Thr Val Ser Thr Thr
65 70 75 80
Glu Ala Glu Pro Tyr Tyr Arg Ser Leu Arg Asp Phe Ser Pro Gln Leu
85 90 95
Pro Pro Thr Gln Glu Glu Val Ser Tyr Ser Arg Gly Phe Thr Gly Glu
100 105 110
Asp Glu Asp Met Ala Phe Pro Gly His Leu Tyr Asp Glu Val Glu Arg
115 120 125
Thr Tyr Pro Pro Ser Gly Ala Trp Gly Pro Leu Tyr Asp Glu Val Gln
130 135 140
Met Gly Pro Trp Asp Leu His Trp Pro Glu Asp Thr Tyr Gln Asp Pro
145 150 155 160
Arg Gly Ile Tyr Asp Gln Val Ala Gly Asp Leu Asp Thr Leu Glu Pro
165 170 175
Asp Ser Leu Pro Phe Glu Leu Arg Gly His Leu Val Trp Gly Phe Asn
180 185 190
His Val Ser Gln Ala Gly Leu Lys Leu Leu Ala Ser Ser Asp Pro Pro
195 200 205
Ala Ser Ala Ser Gln Ser Ala Glu Ile Thr Glu Ser His Ser Val Val
210 215 220
Gln Val Gly Val Gln Trp Arg Tyr Phe Gly Ser Leu His Pro Leu Pro
225 230 235 240
Pro Gly Ser Arg Asp Ser Leu Ala Ser Ala Ser Arg Ile Ala Gly Ile
245 250 255
Thr Ala Pro Trp Glu Ala Glu Val Ser Arg Ser Pro Gln Gly Thr Gln
260 265 270
Asp Ser Pro Val Thr Arg Ser Gly Pro Pro Ser Arg Gly Trp Gln Ser
275 280 285
Leu Ser Phe Asp Gly Gly Ala Phe His Leu Lys Gly Thr Gly Glu Leu
290 295 300
Thr Arg Ala Leu Leu Val Leu Arg Leu Cys Ala Trp Pro Pro Leu Val
305 310 315 320
Thr His Gly Leu Leu Leu Gln Ala Trp Ser Arg Arg Leu Leu Gly Ser
325 330 335
Arg Leu Ser Gly Ala Phe Leu Arg Ala Ser Val Tyr Gly Gln Phe Val
340 345 350
Ala Gly Glu Thr Ala Glu Glu Val Lys Gly Cys Val Gln Gln Leu Arg
355 360 365
Thr Leu Ser Leu Arg Pro Leu Leu Ala Val Pro Thr Glu Glu Glu Pro
370 375 380
Asp Ser Ala Ala Lys Arg Met Arg Leu His His Val Gly Gln Ala Gly
385 390 395 400
Leu Glu Leu Leu Thr Pro Ala Ala Ser Gly Ser Val Ala Gln Ala Gly
405 410 415
Val Gln Trp Arg Gln Ser Ser Asp Arg Gly Gly Gly Asn Gln Ala Ala
420 425 430
Ala Ser Arg Ser Ser Leu Leu Gln Glu Ala Ala Phe Ser Pro Pro Cys
435 440 445
Gly Arg Leu Gln Leu Pro Ala Gln Pro Ala Ser Arg His Gly Ala Arg
450 455 460
Gly Arg Gly Ser Met Lys Ala Lys Ser Leu Thr Ser Arg His Leu Leu
465 470 475 480
Ala Ser Gln Gly Gln Glu Thr Ile Ile Lys Thr Lys Val Arg Ile Pro
485 490 495
Ala Leu Trp Lys Ala Glu Pro Gly Gln His Ser Lys Thr Pro Ser Gln
500 505 510
Gln Asn Lys Ser Gln Tyr Val Thr Thr Leu Trp Glu Ala Asp Val Gly
515 520 525
Arg Ser Leu Glu Asn Leu Gln Val Ser Cys Leu Asn Ala Glu Gln Asn
530 535 540
Gln His Leu Arg Ala Ser Leu Ser Arg Leu His Arg Val Thr Pro Pro
545 550 555 560
Ala Gly Thr Ser Thr Ser Gly Pro Pro Ser Ala Ala Cys Ile Gly Trp
565 570 575
His Ser Arg Leu His Arg Val Ala Gln Tyr Ala Arg Ala Gln His Val
580 585 590
Arg Leu Leu Val Asp Ala Glu Tyr Thr Ser Leu Asn Pro Ala Leu Ser
595 600 605
Leu Leu Val Ala Ala Leu Ala Val Arg Trp Asn Ser Pro Gly Glu Gly
610 615 620
Gly Pro Trp Val Trp Asn Thr Tyr Gln Ala Cys Leu Lys Asp Thr Phe
625 630 635 640
Glu Arg Leu Gly Arg Asp Ala Glu Ala Ala His Arg Ala Gly Leu Ala
645 650 655
Phe Gly Val Lys Leu Val Arg Gly Ala Tyr Leu Asp Lys Glu Arg Ala
660 665 670
Val Ala Gln Leu His Gly Met Glu Asp Pro Thr Gln Pro Asp Tyr Glu
675 680 685
Ala Thr Ser Glu Leu Asn Arg Ala Ser Pro Phe Ser Tyr Ser Arg Cys
690 695 700
Leu Glu Leu Met Leu Thr His Val Ala Arg His Gly Pro Met Cys His
705 710 715 720
Leu Met Val Ala Ser His Asn Glu Glu Ser Val Arg Gln Ala Thr Lys
725 730 735
Arg Met Trp Glu Leu Gly Ile Pro Leu Asp Gly Thr Val Cys Phe Gly
740 745 750
Gln Leu Leu Gly Met Cys Asp His Val Ser Leu Ala Leu Gly Gln Ala
755 760 765
Gly Tyr Val Val Tyr Lys Ser Ile Pro Tyr Gly Ser Leu Glu Glu Val
770 775 780
Ile Pro Tyr Leu Ile Arg Arg Ala Gln Glu Asn Arg Ser Val Leu Gln
785 790 795 800
Gly Ala Arg Arg Glu Gln Glu Leu Leu Ser Gln Glu Leu Trp Arg Arg
805 810 815
Leu Leu Pro Gly Cys Arg Arg Ile Pro His
820 825
<210>75
<211>39
<212>PRT
<213>智人(Homo sapiens)
<400>75
Ser Cys Ser Val Thr Leu Ala Gly Val Gln Trp Arg Asp Leu Gly Leu
1 5 10 15
Leu Gln Pro Leu Pro Pro Lys Phe Lys Arg Phe Ser Cys Leu Ser Phe
20 25 30
Pro Ser Ser Trp Asp Tyr Arg
35
<210>76
<211>46
<212>PRT
<213>智人(Homo sapiens)
<400>76
Glu Met Glu Phe Asn Cys Glu Ser Cys Ser Val Thr Leu Ala Gly Val
1 5 10 15
Gln Trp Arg Asp Leu Gly Leu Leu Gln Pro Leu Pro Pro Lys Phe Lys
20 25 30
Arg Phe Ser Cys Leu Ser Phe Pro Ser Ser Trp Asp Tyr Arg
35 40 45
<210>77
<211>810
<212>PRT
<213>智人(Homo sapiens)
<400>77
Met Cys Pro Gly Ile Pro Gly Pro Arg Ala Glu Ala Ala Val Gly Thr
1 5 10 15
Thr His Pro Phe Ser Ser Pro Gly Ala Trp Leu Gly Ser Gly Ser Gly
20 25 30
Ser Gly Pro Val Gly Ala Pro Pro Pro Ser Pro Gly Leu Pro Pro Ser
35 40 45
Trp Ala Ala Met Met Ala Ala Leu Tyr Pro Ser Thr Asp Leu Ser Gly
50 55 60
Ala Ser Ser Ser Ser Leu Pro Ser Ser Pro Ser Ser Ser Ser Pro Asn
65 70 75 80
Glu Val Met Ala Leu Lys Asp Val Arg Glu Val Lys Glu Glu Asn Thr
85 90 95
Leu Asn Glu Lys Leu Phe Leu Leu Ala Cys Asp Lys Gly Asp Tyr Tyr
100 105 110
Met Val Lys Lys Ile Leu Glu Glu Asn Ser Ser Gly Asp Leu Asn Ile
115 120 125
Asn Cys Val Asp Val Leu Gly Arg Asn Ala Val Thr Ile Thr Ile Glu
130 135 140
Asn Glu Asn Leu Asp Ile Leu Gln Leu Leu Leu Asp Tyr Gly Cys Gln
145 150 155 160
Lys Leu Met Glu Arg Ile Gln Asn Pro Glu Tyr Ser Thr Thr Met Asp
165 170 175
Val Ala Pro Val Ile Leu Ala Ala His Arg Asn Asn Tyr Glu Ile Leu
180 185 190
Thr Met Leu Leu Lys Gln Asp Val Ser Leu Pro Lys Pro His Ala Val
195 200 205
Gly Cys Glu Cys Thr Leu Cys Ser Ala Lys Asn Lys Lys Asp Ser Leu
210 215 220
Arg His Ser Arg Phe Arg Leu Asp Ile Tyr Arg Cys Leu Ala Ser Pro
225 230 235 240
Ala Leu Ile Met Leu Thr Glu Glu Asp Pro Ile Leu Arg Ala Phe Glu
245 250 255
Leu Ser Ala Asp Leu Lys Glu Leu Ser Leu Val Glu Val Glu Phe Arg
260 265 270
Asn Asp Tyr Glu Glu Leu Ala Arg Gln Cys Lys Met Phe Ala Lys Asp
275 280 285
Leu Leu Ala Gln Ala Arg Asn Ser Arg Glu Leu Glu Val Ile Leu Asn
290 295 300
His Thr Ser Ser Asp Glu Pro Leu Asp Lys Arg Gly Leu Leu Glu Glu
305 310 315 320
Arg Met Asn Leu Ser Arg Leu Lys Leu Ala Ile Lys Tyr Asn Gln Lys
325 330 335
Glu Phe Val Ser Gln Ser Asn Cys Gln Gln Phe Leu Asn Thr Val Trp
340 345 350
Phe Gly Gln Met Ser Gly Tyr Arg Arg Lys Pro Thr Cys Lys Lys Ile
355 360 365
Met Thr Val Leu Thr Val Gly Ile Phe Trp Pro Val Leu Ser Leu Cys
370 375 380
Tyr Leu Ile Ala Pro Lys Ser Gln Phe Gly Arg Ile Ile His Thr Pro
385 390 395 400
Phe Met Lys Phe Ile Ile His Gly Ala Ser Tyr Phe Thr Phe Leu Leu
405 410 415
Leu Leu Asn Leu Tyr Ser Leu Val Tyr Asn Glu Asp Lys Lys Asn Thr
420 425 430
Met Gly Pro Ala Leu Glu Arg Ile Asp Tyr Leu Leu Ile Leu Trp Ile
435 440 445
Ile Gly Met Ile Trp Ser Asp Ile Lys Arg Leu Trp Tyr Glu Gly Leu
450 455 460
Glu Asp Phe Leu Glu Glu Ser Arg Asn Gln Leu Ser Phe Val Met Asn
465 470 475 480
Ser Leu Tyr Leu Ala Thr Phe Ala Leu Lys Val Val Ala His Asn Lys
485 490 495
Phe His Asp Phe Ala Asp Arg Lys Asp Trp Asp Ala Phe His Pro Thr
500 505 510
Leu Val Ala Glu Gly Leu Phe Ala Phe Ala Asn Val Leu Ser Tyr Leu
515 520 525
Arg Leu Phe Phe Met Tyr Thr Thr Ser Ser Ile Leu Gly Pro Leu Gln
530 535 540
Ile Ser Met Gly Gln Met Leu Gln Asp Phe Gly Lys Phe Leu Gly Met
545 550 555 560
Phe Leu Leu Val Leu Phe Ser Phe Thr Ile Gly Leu Thr Gln Leu Tyr
565 570 575
Asp Lys Gly Tyr Thr Ser Lys Glu Gln Lys Asp Cys Val Gly Ile Phe
580 585 590
Cys Glu Gln Gln Ser Asn Asp Thr Phe His Ser Phe Ile Gly Thr Cys
595 600 605
Phe Ala Leu Phe Trp Tyr Ile Phe Ser Leu Ala His Val Ala Ile Phe
610 615 620
Val Thr Arg Phe Ser Tyr Gly Glu Glu Leu Gln Ser Phe Val Gly Ala
625 630 635 640
Val Ile Val Gly Thr Tyr Asn Val Val Val Val Ile Val Leu Thr Lys
645 650 655
Leu Leu Val Ala Met Leu His Lys Ser Phe Gln Leu Ile Ala Asn His
660 665 670
Glu Asp Lys Glu Trp Lys Phe Ala Arg Ala Lys Leu Trp Leu Ser Tyr
675 680 685
Phe Asp Asp Lys Cys Thr Leu Pro Pro Pro Phe Asn Ile Ile Pro Ser
690 695 700
Pro Lys Thr Ile Cys Tyr Met Ile Ser Ser Leu Ser Lys Trp Ile Cys
705 710 715 720
Ser His Thr Ser Lys Gly Lys Val Lys Arg Gln Asn Ser Leu Lys Glu
725 730 735
Trp Arg Asn Leu Lys Gln Lys Arg Asp Glu Asn Tyr Gln Lys Val Met
740 745 750
Cys Cys Leu Val His Arg Tyr Leu Thr Ser Met Arg Gln Lys Met Gln
755 760 765
Ser Thr Asp Gln Ala Thr Val Glu Asn Leu Asn Glu Leu Arg Gln Asp
770 775 780
Leu Ser Lys Phe Arg Asn Glu Ile Arg Asp Leu Leu Gly Phe Arg Thr
785 790 795 800
Ser Lys Tyr Ala Met Phe Tyr Pro Arg Asn
805 810
<210>78
<211>876
<212>PRT
<213>小家鼠(Mus musculus)
<400>78
Met Ser Arg Gly Asn Glu Asn Arg Leu Thr His Arg Arg Gln Thr Ile
1 5 10 15
Leu Arg Glu Lys Gly Arg Arg Leu Ala Asn Arg Gly Pro Ala Tyr Met
20 25 30
Phe Asn Asp His Ser Thr Ser Leu Ser Ile Glu Glu Glu Arg Phe Leu
35 40 45
Asp Ala Ala Glu Tyr Gly Asn Ile Pro Val Val Arg Lys Met Leu Glu
50 55 60
Glu Cys His Ser Leu Asn Val Asn Cys Val Asp Tyr Met Gly Gln Asp
65 70 75 80
Ala Leu Gln Leu Ala Val Ala Asn Glu His Leu Glu Ile Thr Glu Leu
85 90 95
Leu Leu Lys Lys Glu Asn Leu Ser Arg Val Gly Asp Ala Leu Leu Leu
100 105 110
Ala Ile Ser Lys Gly Tyr Val Arg Ile Val Glu Ala Ile Leu Asn His
115 120 125
Pro Ala Phe Ala Glu Gly Lys Arg Leu Ala Thr Ser Pro Ser Gln Ser
130 135 140
Glu Leu Gln Gln Asp Asp Phe Tyr Ala Tyr Asp Glu Asp Gly Thr Arg
145 150 155 160
Phe Ser His Asp Val Thr Pro Ile Ile Leu Ala Ala His Cys Gln Glu
165 170 175
Tyr Glu Ile Val His Thr Leu Leu Arg Lys Gly Ala Arg Ile Glu Arg
180 185 190
Pro His Asp Tyr Phe Cys Lys Cys Thr Glu Cys Ser Gln Lys Gln Lys
195 200 205
His Asp Ser Phe Ser His Ser Arg Ser Arg Ile Asn Ala Tyr Lys Gly
210 215 220
Leu Ala Ser Pro Ala Tyr Leu Ser Leu Ser Ser Glu Asp Pro Val Met
225 230 235 240
Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala Val Leu Ala Asn Ile Glu
245 250 255
Lys Glu Phe Lys Asn Asp Tyr Arg Lys Leu Ser Met Gln Cys Lys Asp
260 265 270
Phe Val Val Gly Leu Leu Asp Leu Cys Arg Asn Thr Glu Glu Val Glu
275 280 285
Ala Ile Leu Asn Gly Asp Ala Glu Thr Arg Gln Pro Gly Asp Phe Gly
290 295 300
Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala Ile Lys Tyr Glu Val Lys
305 310 315 320
Lys Phe Val Ala His Pro Asn Cys Gln Gln Gln Leu Leu Ser Ile Trp
325 330 335
Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln Thr Met Ala Val Lys Phe
340 345 350
Leu Val Val Leu Ala Val Ala Ile Gly Leu Pro Phe Leu Ala Leu Ile
355 360 365
Tyr Trp Cys Ala Pro Cys Ser Lys Met Gly Lys Ile Leu Arg Gly Pro
370 375 380
Phe Met Lys Phe Val Ala His Ala Ala Ser Phe Thr Ile Phe Leu Gly
385 390 395 400
Leu Leu Val Met Asn Ala Ala Asp Arg Phe Glu Gly Thr Lys Leu Leu
405 410 415
Pro Asn Glu Thr Ser Thr Asp Asn Ala Arg Gln Leu Phe Arg Met Lys
420 425 430
Thr Ser Cys Phe Ser Trp Met Glu Met Leu Ile Ile Ser Trp Val Ile
435 440 445
Gly Met Ile Trp Ala Glu Cys Lys Glu Ile Trp Thr Gln Gly Pro Lys
450 455 460
Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu Asp Phe Gly Met Leu Ala
465 470 475 480
Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe Met Ala Phe Trp His Ala
485 490 495
Ser Lys Ala Gln Ser Ile Ile Asp Ala Asn Asp Thr Leu Lys Asp Leu
500 505 510
Thr Lys Val Thr Leu Gly Asp Asn Val Lys Tyr Tyr Asn Leu Ala Arg
515 520 525
Ile Lys Trp Asp Pro Thr Asp Pro Gln Ile Ile Ser Glu Gly Leu Tyr
530 535 540
Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Ile Leu Pro
545 550 555 560
Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr Val
565 570 575
Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val Phe Val Ala
580 585 590
Phe Met Ile Gly Met Phe Asn Leu Tyr Ser Tyr Tyr Ile Gly Ala Lys
595 600 605
Gln Asn Glu Ala Phe Thr Thr Val Glu Glu Ser Phe Lys Thr Leu Phe
610 615 620
Trp Ala Ile Phe Gly Leu Ser Glu Val Lys Ser Val Val Ile Asn Tyr
625 630 635 640
Asn His Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr Gly Val Tyr
645 650 655
Asn Val Thr Met Val Ile Val Leu Leu Asn Met Leu Ile Ala Met Ile
660 665 670
Asn Ser Ser Phe Gln Glu Ile Glu Asp Asp Ala Asp Val Glu Trp Lys
675 680 685
Phe Ala Arg Ala Lys Leu Trp Phe Ser Tyr Phe Glu Glu Gly Arg Thr
690 695 700
Leu Pro Val Pro Phe Asn Leu Val Pro Ser Pro Lys Ser Leu Leu Tyr
705 710 715 720
Leu Leu Leu Lys Phe Lys Lys Trp Met Cys Glu Leu Ile Gln Gly Gln
725 730 735
Lys Gln Gly Phe Gln Glu Asp Ala Glu Met Asn Lys Arg Asn Glu Glu
740 745 750
Lys Lys Phe Gly Ile Ser Gly Ser His Glu Asp Leu Ser Lys Phe Ser
755 760 765
Leu Asp Lys Asn Gln Leu Ala His Asn Lys Gln Ser Ser Thr Arg Ser
770 775 780
Ser Glu Asp Tyr His Leu Asn Ser Phe Ser Asn Pro Pro Arg Gln Tyr
785 790 795 800
Gln Lys Ile Met Lys Arg Leu Ile Lys Arg Tyr Val Leu Gln Ala Gln
805 810 815
Ile Asp Lys Glu Ser Asp Glu Val Asn Glu Gly Glu Leu Lys Glu Ile
820 825 830
Lys Gln Asp Ile Ser Ser Leu Arg Tyr Glu Leu Leu Glu Glu Lys Ser
835 840 845
Gln Asn Thr Glu Asp Leu Ala Glu Leu Ile Arg Lys Leu Gly Glu Arg
850 855 860
Leu Ser Leu Glu Pro Lys Leu Glu Glu Ser Arg Arg
865 870 875
<210>79
<211>368
<212>PRT
<213>智人(Homo sapiens)
<400>79
Asp Arg Leu Ser Leu Leu Ser Pro Arg Leu Glu Cys Asn Gly Met Ile
1 5 10 15
Leu Ala His Cys Lys Leu Arg Leu Pro Gly Phe Lys Arg Phe Ser Cys
20 25 30
Leu Ser Leu Pro Ser Ser Trp Asp Tyr Arg His Val Pro Pro Arg Gln
35 40 45
Val His Phe Val Phe Ser Val Glu Thr Gly Phe His Arg Ala Gly Gln
50 55 60
Ala Gly Leu Glu Leu Leu Thr Ser Ser Val Pro Pro Thr Ser Ala Phe
65 70 75 80
Pro Lys Cys Trp Asp Tyr Arg Arg Asp Asp Gln Ala Trp Pro Thr Leu
85 90 95
Ser Ser Phe Arg Gly Leu Asn Lys Phe Ala Phe Leu Pro Lys Phe Phe
100 105 110
Ala His Pro Ile Ser Gln Phe Gln Arg Val Glu Cys Asn Val Gly Cys
115 120 125
Pro Ile Leu Leu Ala Met Lys Tyr Leu Ala Tyr Ser Ser Leu Pro Gly
130 135 140
Ala Asp Thr Met Leu Tyr Phe Tyr Phe Tyr Glu Gln Glu Ala Ser Leu
145 150 155 160
Ala Val Cys Asn Ile Cys Arg Gln Lys Phe His Trp Val Leu Tyr Gln
165 170 175
Ile Ser His Leu Tyr Arg Gly Val Ile Val Asp Asn Phe Leu Leu His
180 185 190
Pro Asp Gly Arg Phe Thr Trp Thr Ile Phe Phe Leu Ser Trp Val Lys
195 200 205
Gln Asn Ser Leu Val Asp Phe Phe Phe Gly Thr Glu Ser Arg Ser Val
210 215 220
Ala Leu Leu Pro Arg Leu Glu Cys Ser Gly Ala Met Ser Thr Leu His
225 230 235 240
Thr Val Leu Arg Pro Ala Tyr Ser His Ile Tyr His Pro Asp Val Lys
245 250 255
Glu Lys Thr His Phe Leu Gly Asn Val Phe Asn Lys Arg Lys Leu Gln
260 265 270
Lys Lys Ile Leu Lys Thr Pro Asn Pro Leu Cys Ala Leu His Ser Ala
275 280 285
Pro Ser Pro Ser Leu Pro Pro Phe Leu Arg Cys Thr Gly Arg Leu Pro
290 295 300
Phe Tyr Leu Gly Leu Asp Asp Phe Leu Phe Val Ala Gly Ala Leu Met
305 310 315 320
Phe Leu Pro Val Ser Phe Leu Asn Pro His Thr Leu Thr Trp Pro Pro
325 330 335
Gln Cys Cys Thr Arg Ser Asp Cys Asn Pro Leu Arg Gly Gln Arg Glu
340 345 350
Ile Ser Ala Leu Ser His Ser Leu Pro Thr Gly Leu Ser Met Pro Leu
355 360 365
<210>80
<211>341
<212>PRT
<213>智人(Homo sapiens)
<400>80
Met Ala Ala Leu Tyr Ala Cys Thr Lys Cys His Gln Arg Phe Pro Phe
1 5 10 15
Glu Ala Leu Ser Gln Gly Gln Gln Leu Cys Lys Glu Cys Arg Ile Ala
20 25 30
His Pro Val Val Lys Cys Thr Tyr Cys Arg Thr Glu Tyr Gln Gln Glu
35 40 45
Arg Leu Glu Cys Asn Gly Thr Ile Ser Ala His Cys Asn Leu His Leu
50 55 60
Pro Gly Ser Ser Asp Ser Pro Ala Ser Ser Ser Arg Val Ala Gly Ile
65 70 75 80
Thr Gly Ile Lys Thr Asn Thr Ile Cys Lys Lys Cys Ala Gln Asn Val
85 90 95
Gln Leu Tyr Gly Thr Pro Lys Pro Cys Gln Tyr Cys Asn Ile Ile Ala
100 105 110
Ala Phe Ile Gly Asn Lys Cys Gln Arg Cys Thr Asn Ser Glu Lys Lys
115 120 125
Tyr Gly Pro Pro Tyr Ser Cys Glu Gln Cys Lys Gln Gln Cys Ala Phe
130 135 140
Asp Arg Lys Asp Asp Arg Lys Lys Val Asp Gly Lys Leu Leu Cys Trp
145 150 155 160
Leu Cys Thr Leu Ser Tyr Lys Arg Val Leu Gln Lys Thr Lys Glu Gln
165 170 175
Arg Lys His Leu Ser Ser Ser Ser Arg Ala Gly His Gln Glu Lys Glu
180 185 190
Gln Tyr Ser Arg Leu Ser Gly Gly Gly His Tyr Asn Ser Gln Lys Thr
195 200 205
Leu Ser Thr Ser Ser Ile Gln Asn Glu Ile Pro Lys Lys Lys Ser Lys
210 215 220
Phe Glu Ser Ile Thr Thr Asn Gly Asp Ser Phe Ser Pro Asp Leu Ala
225 230 235 240
Leu Asp Ser Pro Gly Thr Asp His Phe Val Ile Ile Ala Gln Leu Lys
245 250 255
Glu Glu Val Ala Thr Leu Lys Lys Met Leu His Gln Lys Asp Gln Met
260 265 270
Ile Leu Glu Lys Glu Lys Lys Ile Thr Glu Leu Lys Ala Asp Phe Gln
275 280 285
Tyr Gln Glu Ser Gln Met Arg Ala Lys Met Asn Gln Met Glu Lys Thr
290 295 300
His Lys Glu Val Thr Glu Gln Leu Gln Ala Lys Asn Arg Glu Leu Leu
305 310 315 320
Lys Gln Ala Ala Ala Leu Ser Lys Ser Lys Lys Ser Glu Lys Ser Gly
325 330 335
Ala Ile Thr Ser Pro
340
<210>81
<211>312
<212>PRT
<213>智人(Homo sapiens)
<400>81
Met Ala Ala Leu Tyr Ala Cys Thr Lys Cys His Gln Arg Phe Pro Phe
1 5 10 15
Glu Ala Leu Ser Gln Gly Gln Gln Leu Cys Lys Glu Cys Arg Ile Ala
20 25 30
His Pro Val Val Lys Cys Thr Tyr Cys Arg Thr Glu Tyr Gln Gln Glu
35 40 45
Arg Leu Glu Cys Asn Gly Thr Ile Ser Ala His Cys Asn Leu His Leu
50 55 60
Pro Gly Ser Ser Asp Ser Pro Ala Ser Ser Ser Arg Val Ala Gly Ile
65 70 75 80
Thr Gly Ile Lys Thr Asn Thr Ile Cys Lys Lys Cys Ala Gln Asn Val
85 90 95
Gln Leu Tyr Gly Thr Pro Lys Pro Cys Gln Tyr Cys Asn Ile Ile Ala
100 105 110
Ala Phe Ile Gly Asn Lys Cys Gln Arg Cys Thr Asn Ser Glu Lys Lys
115 120 125
Tyr Gly Pro Pro Tyr Ser Cys Glu Gln Cys Lys Gln Gln Cys Ala Phe
130 135 140
Asp Arg Lys Asp Asp Arg Lys Lys Val Asp Gly Lys Leu Leu Cys Trp
145 150 155 160
Leu Cys Thr Leu Ser Tyr Lys Arg Val Leu Gln Lys Thr Lys Glu Gln
165 170 175
Arg Lys His Leu Ser Ser Ser Ser Arg Ala Gly His Gln Glu Lys Glu
180 185 190
Gln Tyr Ser Arg Leu Ser Gly Gly Gly His Tyr Asn Ser Phe Ser Pro
195 200 205
Asp Leu Ala Leu Asp Ser Pro Gly Thr Asp His Phe Val Ile Ile Ala
210 215 220
Gln Leu Lys Glu Glu Val Ala Thr Leu Lys Lys Met Leu His Gln Lys
225 230 235 240
Asp Gln Met Ile Leu Glu Lys Glu Lys Lys Ile Thr Glu Leu Lys Ala
245 250 255
Asp Phe Gln Tyr Gln Glu Ser Gln Met Arg Ala Lys Met Asn Gln Met
260 265 270
Glu Lys Thr His Lys Glu Val Thr Glu Gln Leu Gln Ala Lys Asn Arg
275 280 285
Glu Leu Leu Lys Gln Ala Ala Ala Leu Ser Lys Ser Lys Lys Ser Glu
290 295 300
Lys Ser Gly Ala Ile Thr Ser Pro
305 310
<210>82
<211>100
<212>PRT
<213>智人(Homo sapiens)
<400>82
Phe Phe Phe Phe Phe Phe Glu Thr Glu Ser Cys Ser Val Ala Glu Ala
1 5 10 15
Gly Val Gln Trp Cys Asp Leu Gly Ser Leu Lys Ser Pro Pro Pro Gly
20 25 30
Ser Ser Asp Ser Pro Ala Ser Ala Ser Arg Val Ala Gly Ile Thr Gly
35 40 45
Met His His His Thr Gln Leu Ile Phe Val Phe Leu Val Glu Thr Gly
50 55 60
Ser His Met Gln Leu Ser Asp Ser Thr Leu Val Ile Thr Thr Ala Gln
65 70 75 80
Asn Ala Lys Ile Thr Ala Arg Ala Pro Arg Asp Leu Phe Phe Phe Phe
85 90 95
Phe Phe Phe Phe
100
<210>83
<211>56
<212>PRT
<213>智人(Homo sapiens)
<400>83
Leu Pro Leu Leu Pro Arg Met Glu Cys Arg Gly Met Ile Ser Ala His
1 5 10 15
Cys Asn Leu Cys Arg Ser Gly Ser Ser Asp Ser Pro Ala Ser Ala Ser
20 25 30
Arg Val Ala Gly Ile Thr Gly Thr Cys His His Ala Gln Leu Ser Phe
35 40 45
Pro Phe Phe Leu Phe Met Arg Trp
50 55
<210>84
<211>46
<212>PRT
<213>智人(Homo sapiens)
<400>84
Leu Pro Leu Leu Pro Arg Met Glu Cys Arg Gly Met Ile Ser Ala His
1 5 10 15
Cys Asn Leu Cys Arg Ser Gly Ser Ser Asp Ser Pro Ala Ser Ala Ser
20 25 30
Arg Val Ala Gly Ile Thr Gly Thr Cys His His Ala Gln Leu
35 40 45
<210>85
<211>699
<212>PRT
<213>智人(Homo sapiens)
<220>
<221>MOD_RES
<222>(677)
<223>可变氨基酸
<400>85
Met Asp Ile Glu Asp Glu Glu Asn Met Ser Ser Ser Ser Thr Asp Val
1 5 10 15
Lys Glu Asn Arg Asn Leu Asp Asn Val Ser Pro Lys Asp Gly Ser Thr
20 25 30
Pro Gly Pro Gly Glu Gly Ser Gln Leu Ser Asn Gly Gly Gly Gly Gly
35 40 45
Pro Gly Arg Lys Arg Pro Leu Glu Glu Gly Ser Asn Gly His Ser Lys
50 55 60
Tyr Arg Leu Lys Lys Arg Arg Lys Thr Pro Gly Pro Val Leu Pro Lys
65 70 75 80
Asn Ala Leu Met Gln Leu Asn Glu Ile Lys Pro Gly Leu Gln Tyr Thr
85 90 95
Leu Leu Ser Gln Thr Gly Pro Val His Ala Pro Leu Phe Val Met Ser
100 105 110
Val Glu Val Asn Gly Gln Val Phe Glu Gly Ser Gly Pro Thr Lys Lys
115 120 125
Lys Ala Lys Leu His Ala Ala Glu Lys Ala Leu Arg Ser Phe Val Gln
130 135 140
Phe Pro Asn Ala Ser Glu Ala His Leu Ala Met Gly Arg Thr Leu Ser
145 150 155 160
Val Asn Thr Asp Phe Thr Ser Asp Gln Ala Asp Phe Pro Asp Thr Leu
165 170 175
Phe Asn Gly Phe Glu Thr Pro Asp Lys Ala Glu Pro Pro Phe Tyr Val
180 185 190
Gly Ser Asn Gly Asp Asp Ser Phe Ser Ser Ser Gly Asp Leu Ser Leu
195 200 205
Ser Ala Ser Pro Val Pro Ala Ser Leu Ala Gln Pro Pro Leu Pro Val
210 215 220
Leu Pro Pro Phe Pro Pro Pro Ser Gly Lys Asn Pro Val Met Ile Leu
225 230 235 240
Asn Glu Leu Arg Pro Gly Leu Lys Tyr Asp Phe Leu Ser Glu Ser Gly
245 250 255
Glu Ser His Ala Lys Ser Phe Val Met Ser Val Val Val Asp Gly Gln
260 265 270
Phe Phe Glu Gly Ser Gly Arg Asn Lys Lys Leu Ala Lys Ala Arg Ala
275 280 285
Ala Gln Ser Ala Leu Ala Ala Ile Phe Asn Leu His Leu Asp Gln Thr
290 295 300
Pro Ser Arg Gln Pro Ile Pro Ser Glu Gly Leu Gln Leu His Leu Pro
305 310 315 320
Gln Val Leu Ala Asp Ala Val Ser Arg Leu Val Leu Gly Lys Phe Gly
325 330 335
Asp Leu Thr Asp Asn Phe Ser Ser Pro His Ala Arg Arg Lys Val Leu
340 345 350
Ala Gly Val Val Met Thr Thr Gly Thr Asp Val Lys Asp Ala Lys Val
355 360 365
Ile Ser Val Ser Thr Gly Thr Lys Cys Ile Asn Gly Glu Tyr Met Ser
370 375 380
Asp Arg Gly Leu Ala Leu Asn Asp Cys His Ala Glu Ile Ile Ser Arg
385 390 395 400
Arg Ser Leu Leu Arg Phe Leu Tyr Thr Gln Leu Glu Leu Tyr Leu Asn
405 410 415
Asn Lys Asp Asp Gln Lys Arg Ser Ile Phe Gln Lys Ser Glu Arg Gly
420 425 430
Gly Phe Arg Leu Lys Glu Asn Val Gln Phe His Leu Tyr Ile Ser Thr
435 440 445
Ser Pro Cys Gly Asp Ala Arg Ile Phe Ser Pro His Glu Pro Ile Leu
450 455 460
Glu Gly Ser Arg Ser Tyr Thr Gln Ala Gly Val Gln Trp Cys Asn His
465 470 475 480
Gly Ser Leu Gln Pro Arg Pro Pro Gly Leu Leu Ser Asp Pro Ser Thr
485 490 495
Ser Thr Phe Gln Gly Ala Gly Thr Thr Glu Pro Ala Asp Arg His Pro
500 505 510
Asn Arg Lys Ala Arg Gly Gln Leu Arg Thr Lys Ile Glu Ser Gly Glu
515 520 525
Gly Thr Ile Pro Val Arg Ser Asn Ala Ser Ile Gln Thr Trp Asp Gly
530 535 540
Val Leu Gln Gly Glu Arg Leu Leu Thr Met Ser Cys Ser Asp Lys Ile
545 550 555 560
Ala Arg Trp Asn Val Val Gly Ile Gln Gly Ser Leu Leu Ser Ile Phe
565 570 575
Val Glu Pro Ile Tyr Phe Ser Ser Ile Ile Leu Gly Ser Leu Tyr His
580 585 590
Gly Asp His Leu Ser Arg Ala Met Tyr Gln Arg Ile Ser Asn Ile Glu
595 600 605
Asp Leu Pro Pro Leu Tyr Thr Leu Asn Lys Pro Leu Leu Ser Gly Ile
610 615 620
Ser Asn Ala Glu Ala Arg Gln Pro Gly Lys Ala Pro Asn Phe Ser Val
625 630 635 640
Asn Trp Thr Val Gly Asp Ser Ala Ile Glu Val Ile Asn Ala Thr Thr
645 650 655
Gly Lys Asp Glu Leu Gly Arg Ala Ser Arg Leu Cys Lys His Ala Leu
660 665 670
Tyr Cys Arg Trp Xaa Ala Cys Ala Arg Gln Gly Ser Leu Pro Leu Thr
675 680 685
Thr Leu Gln Asp Tyr Gln Ala Gln Arg Val Pro
690 695
<210>86
<21l>331
<212>PRT
<213>智人(Homo sapiens)
<400>86
Met Leu Leu Ser Gln Asn Ala Phe Ile Val Arg Ser Leu Asn Leu Val
1 5 10 15
Leu Met Val Tyr Ile Ser Leu Val Phe Gly Ile Ser Tyr Asp Ser Pro
20 25 30
Asp Tyr Thr Asp Glu Ser Cys Thr Phe Lys Ile Ser Leu Arg Asn Phe
35 40 45
Arg Ser Ile Leu Ser Trp Glu Leu Lys Asn His Ser Ile Val Pro Thr
50 55 60
His Tyr Thr Leu Leu Tyr Thr Ile Met Ser Lys Pro Glu Asp Leu Lys
65 70 75 80
Val Val Lys Asn Cys Ala Asn Thr Thr Arg Ser Phe Cys Asp Leu Thr
85 90 95
Asp Glu Trp Arg Ser Thr His Glu Ala Tyr Val Thr Val Leu Glu Gly
100 105 110
Phe Ser Gly Asn Thr Thr Leu Phe Ser Cys Ser His Asn Phe Trp Leu
115 120 125
Ala Ile Asp Met Ser Phe Glu Pro Pro Glu Phe Glu Ile Val Gly Phe
130 135 140
Thr Asn His Ile Asn Val Met Val Lys Phe Pro Ser Ile Val Glu Glu
145 150 155 160
Glu Leu Gln Phe Asp Leu Ser Leu Val Ile Glu Glu Gln Ser Glu Gly
165 170 175
Ile Val Lys Lys His Lys Pro Glu Ile Lys Gly Asn Met Ser Gly Asn
180 185 190
Phe Thr Tyr Ile Ile Asp Lys Leu Ile Pro Asn Thr Asn Tyr Cys Val
195 200 205
Ser Val Tyr Leu Glu His Ser Asp Glu Gln Ala Val Ile Lys Ser Pro
210 215 220
Leu Lys Cys Thr Leu Leu Pro Pro Gly Gln Glu Ser Glu Ser Ala Glu
225 230 235 240
Ser Ala Lys Ile Gly Gly Ile Ile Thr Val Phe Leu Ile Ala Leu Val
245 250 255
Leu Thr Ser Thr Ile Val Thr Leu Lys Trp Ile Gly Tyr Ile Cys Leu
260 265 270
Arg Asn Ser Leu Pro Lys Val Leu Arg Gln Gly Leu Thr Lys Gly Trp
275 280 285
Asn Ala Val Ala Ile His Arg Cys Ser His Asn Ala Leu Gln Ser Glu
290 295 300
Thr Pro Glu Leu Lys Gln Ser Ser Cys Leu Ser Phe Pro Ser Ser Trp
305 310 315 320
Asp Tyr Lys Arg Ala Ser Leu Cys Pro Ser Asp
325 330
<210>87
<211>841
<212>PRT
<213>智人(Homo sapiens)
<400>87
Met Pro Leu Ala Ala Tyr Cys Tyr Leu Arg Val Val Gly Lys Gly Ser
1 5 10 15
Tyr Gly Glu Val Thr Leu Val Lys His Arg Arg Asp Gly Lys Gln Tyr
20 25 30
Val Ile Lys Lys Leu Asn Leu Arg Asn Ala Ser Ser Arg Glu Arg Arg
35 40 45
Ala Ala Glu Gln Glu Ala Gln Leu Leu Ser Gln Leu Lys His Pro Asn
50 55 60
Ile Val Thr Tyr Lys Glu Ser Trp Glu Gly Gly Asp Gly Leu Leu Tyr
65 70 75 80
Ile Val Met Gly Phe Cys Glu Gly Gly Asp Leu Tyr Arg Lys Leu Lys
85 90 95
Glu Gln Lys Gly Gln Leu Leu Pro Glu Asn Gln Val Val Glu Trp Phe
100 105 110
Val Gln Ile Ala Met Ala Leu Gln Tyr Leu His Glu Lys His Ile Leu
115 120 125
His Arg Asp Leu Lys Thr Gln Asn Val Phe Leu Thr Arg Thr Asn Ile
130 135 140
Ile Lys Val Gly Asp Leu Gly Ile Ala Arg Val Leu Glu Asn His Cys
145 150 155 160
Asp Met Ala Ser Thr Leu Ile Gly Thr Pro Tyr Tyr Met Ser Pro Glu
165 170 175
Leu Phe Ser Asn Lys Pro Tyr Asn Tyr Lys Ser Asp Val Trp Ala Leu
180 185 190
Gly Cys Cys Val Tyr Glu Met Ala Thr Leu Lys His Ala Phe Asn Ala
195 200 205
Lys Asp Met Asn Ser Leu Val Tyr Arg Ile Ile Glu Gly Lys Leu Pro
210 215 220
Ala Met Pro Arg Asp Tyr Ser Pro Glu Leu Ala Glu Leu Ile Arg Thr
225 230 235 240
Met Leu Ser Lys Arg Pro Glu Glu Arg Pro Ser Val Arg Ser Ile Leu
245 250 255
Arg Gln Pro Tyr Ile Lys Arg Gln Ile Ser Phe Phe Leu Glu Ala Thr
260 265 270
Lys Ile Lys Thr Ser Lys Asn Asn Ile Lys Asn Gly Asp Ser Gln Ser
275 280 285
Lys Pro Phe Ala Thr Val Val Ser Gly Glu Ala Glu Ser Asn His Glu
290 295 300
Val Ile His Pro Gln Pro Leu Ser Ser Glu Gly Ser Gln Thr Tyr Ile
305 310 315 320
Met Gly Glu Gly Lys Cys Leu Ser Gln Glu Lys Pro Arg Ala Ser Gly
325 330 335
Leu Leu Lys Ser Pro Ala Ser Leu Lys Ala His Thr Cys Lys Gln Asp
340 345 350
Leu Ser Asn Thr Thr Glu Leu Ala Thr Ile Ser Ser Val Asn Ile Asp
355 360 365
Ile Leu Pro Ala Lys Gly Arg Asp Ser Val Ser Asp Gly Phe Val Gln
370 375 380
Glu Asn Gln Pro Arg Tyr Leu Asp Ala Ser Asn Glu Leu Gly Gly Ile
385 390 395 400
Cys Ser Ile Ser Gln Val Glu Glu Glu Met Leu Gln Asp Asn Thr Lys
405 410 415
Ser Ser Ala Gln Pro Glu Asn Leu Ile Pro Met Trp Ser Ser Asp Ile
420 425 430
Val Thr Gly Glu Lys Asn Glu Pro Val Lys Pro Leu Gln Pro Leu Ile
435 440 445
Lys Glu Gln Lys Pro Lys Asp Gln Ser Leu Ala Leu Ser Pro Lys Leu
450 455 460
Glu Cys Ser Gly Thr Ile Leu Ala His Ser Asn Leu Arg Leu Leu Gly
465 470 475 480
Ser Ser Asp Ser Pro Ala Ser Ala Ser Arg Val Ala Gly Ile Thr Gly
485 490 495
Val Cys His His Ala Gln Asp Gln Val Ala Gly Glu Cys Ile Ile Glu
500 505 510
Lys Gln Gly Arg Ile His Pro Asp Leu Gln Pro His Asn Ser Gly Ser
515 520 525
Glu Pro Ser Leu Ser Arg Gln Arg Arg Gln Lys Arg Arg Glu Gln Thr
530 535 540
Glu His Arg Gly Glu Lys Arg Gln Val Arg Arg Asp Leu Phe Ala Phe
545 550 555 560
Gln Glu Ser Pro Pro Arg Phe Leu Pro Ser His Pro Ile Val Gly Lys
565 570 575
Val Asp Val Thr Ser Thr Gln Lys Glu Ala Glu Asn Gln Arg Arg Val
580 585 590
Val Thr Gly Ser Val Ser Ser Ser Arg Ser Ser Glu Met Ser Ser Ser
595 600 605
Lys Asp Arg Pro Leu Ser Ala Arg Glu Arg Arg Arg Leu Lys Gln Ser
610 615 620
Gln Glu Glu Met Ser Ser Ser Gly Pro Ser Val Arg Lys Ala Ser Leu
625 630 635 640
Ser Val Ala Gly Pro Gly Lys Pro Gln Glu Glu Asp Gln Pro Leu Pro
645 650 655
Ala Arg Arg Leu Ser Ser Asp Cys Ser Val Thr Gln Glu Arg Lys Gln
660 665 670
Ile His Cys Leu Ser Glu Asp Glu Leu Ser Ser Ser Thr Ser Ser Thr
675 680 685
Asp Lys Ser Asp Gly Asp Tyr Gly Glu Gly Lys Gly Gln Thr Asn Glu
690 695 700
Ile Asn Ala Leu Val Gln Leu Met Thr Gln Thr Leu Lys Leu Asp Ser
705 710 715 720
Lys Glu Ser Cys Glu Asp Val Pro Val Ala Asn Pro Val Ser Glu Phe
725 730 735
Lys Leu His Arg Lys Tyr Arg Asp Thr Leu Ile Leu His Gly Lys Val
740 745 750
Ala Glu Glu Ala Glu Glu Ile His Phe Lys Glu Leu Pro Ser Ala Ile
755 760 765
Met Pro Gly Ser Glu Lys Ile Arg Arg Leu Val Glu Val Leu Arg Thr
770 775 780
Asp Val Ile Arg Gly Leu Gly Val Gln Leu Leu Glu Gln Val Tyr Asp
785 790 795 800
Leu Leu Glu Glu Glu Asp Glu Phe Asp Arg Glu Val Arg Leu Arg Glu
805 810 815
His Met Gly Glu Lys Tyr Thr Thr Tyr Ser Val Lys Ala Arg Gln Leu
820 825 830
Lys Phe Phe Glu Glu Asn Met Asn Phe
835 840
<210>88
<211>759
<212>PRT
<213>智人(Homo sapiens)
<400>88
Met Met Ala Ala Leu Tyr Pro Ser Thr Asp Leu Ser Gly Ala Ser Ser
1 5 10 15
Ser Ser Leu Pro Ser Ser Pro Ser Ser Ser Ser Pro Asn Glu Val Met
20 25 30
Ala Leu Lys Asp Val Arg Glu Val Lys Glu Glu Asn Thr Leu Asn Glu
35 40 45
Lys Leu Phe Leu Leu Ala Cys Asp Lys Gly Asp Tyr Tyr Met Val Lys
50 55 60
Lys Ile Leu Glu Glu Asn Ser Ser Gly Asp Leu Asn Ile Asn Cys Val
65 70 75 80
Asp Val Leu Gly Arg Asn Ala Val Thr Ile Thr Ile Glu Asn Glu Asn
85 90 95
Leu Asp Ile Leu Gln Leu Leu Leu Asp Tyr Gly Cys Gln Lys Leu Met
100 105 110
Glu Arg Ile Gln Asn Pro Glu Tyr Ser Thr Thr Met Asp Val Ala Pro
115 120 125
Val Ile Leu Ala Ala His Arg Asn Asn Tyr Glu Ile Leu Thr Met Leu
130 135 140
Leu Lys Gln Asp Val Ser Leu Pro Lys Pro His Ala Val Gly Cys Glu
145 150 155 160
Cys Thr Leu Cys Ser Ala Lys Asn Lys Lys Asp Ser Leu Arg His Ser
165 170 175
Arg Phe Arg Leu Asp Ile Tyr Arg Cys Leu Ala Ser Pro Ala Leu Ile
180 185 190
Met Leu Thr Glu Glu Asp Pro Ile Leu Arg Ala Phe Glu Leu Ser Ala
195 200 205
Asp Leu Lys Glu Leu Ser Leu Val Glu Val Glu Phe Arg Asn Asp Tyr
210 215 220
Glu Glu Leu Ala Arg Gln Cys Lys Met Phe Ala Lys Asp Leu Leu Ala
225 230 235 240
Gln Ala Arg Asn Ser Arg Glu Leu Glu Val Ile Leu Asn His Thr Ser
245 250 255
Ser Asp Glu Pro Leu Asp Lys Arg Gly Leu Leu Glu Glu Arg Met Asn
260 265 270
Leu Ser Arg Leu Lys Leu Ala Ile Lys Tyr Asn Gln Lys Glu Phe Val
275 280 285
Ser Gln Ser Asn Cys Gln Gln Phe Leu Asn Thr Val Trp Phe Gly Gln
290 295 300
Met Ser Gly Tyr Arg Arg Lys Pro Thr Cys Lys Lys Ile Met Thr Val
305 310 315 320
Leu Thr Val Gly Ile Phe Trp Pro Val Leu Ser Leu Cys Tyr Leu Ile
325 330 335
Ala Pro Lys Ser Gln Phe Gly Arg Ile Ile His Thr Pro Phe Met Lys
340 345 350
Phe Ile Ile His Gly Ala Ser Tyr Phe Thr Phe Leu Leu Leu Leu Asn
355 360 365
Leu Tyr Ser Leu Val Tyr Asn Glu Asp Lys Lys Asn Thr Met Gly Pro
370 375 380
Ala Leu Glu Arg Ile Asp Tyr Leu Leu Ile Leu Trp Ile Ile Gly Met
385 390 395 400
Ile Trp Ser Asp Ile Lys Arg Leu Trp Tyr Glu Gly Leu Glu Asp Phe
405 410 415
Leu Glu Glu Ser Arg Asn Gln Leu Ser Phe Val Met Asn Ser Leu Tyr
420 425 430
Leu Ala Thr Phe Ala Leu Lys Val Val Ala His Asn Lys Phe His Asp
435 440 445
Phe Ala Asp Arg Lys Asp Trp Asp Ala Phe His Pro Thr Leu Val Ala
450 455 460
Glu Gly Leu Phe Ala Phe Ala Asn Val Leu Ser Tyr Leu Arg Leu Phe
465 470 475 480
Phe Met Tyr Thr Thr Ser Ser Ile Leu Gly Pro Leu Gln Ile Ser Met
485 490 495
Gly Gln Met Leu Gln Asp Phe Gly Lys Phe Leu Gly Met Phe Leu Leu
500 505 510
Val Leu Phe Ser Phe Thr Ile Gly Leu Thr Gln Leu Tyr Asp Lys Gly
515 520 525
Tyr Thr Ser Lys Glu Gln Lys Asp Cys Val Gly Ile Phe Cys Glu Gln
530 535 540
Gln Ser Asn Asp Thr Phe His Ser Phe Ile Gly Thr Cys Phe Ala Leu
545 550 555 560
Phe Trp Tyr Ile Phe Ser Leu Ala His Val Ala Ile Phe Val Thr Arg
565 570 575
Phe Ser Tyr Gly Glu Glu Leu Gln Ser Phe Val Gly Ala Val Ile Val
580 585 590
Gly Thr Tyr Asn Val Val Val Val Ile Val Leu Thr Lys Leu Leu Val
595 600 605
Ala Met Leu His Lys Ser Phe Gln Leu Ile Ala Asn His Glu Asp Lys
610 615 620
Glu Trp Lys Phe Ala Arg Ala Lys Leu Trp Leu Ser Tyr Phe Asp Asp
625 630 635 640
Lys Cys Thr Leu Pro Pro Pro Phe Asn Ile Ile Pro Ser Pro Lys Thr
645 650 655
Ile Cys Tyr Met Ile Ser Ser Leu Ser Lys Trp Ile Cys Ser His Thr
660 665 670
Ser Lys Gly Lys Val Lys Arg Gln Asn Ser Leu Lys Glu Trp Arg Asn
675 680 685
Leu Lys Gln Lys Arg Asp Glu Asn Tyr Gln Lys Val Met Cys Cys Leu
690 695 700
Val His Arg Tyr Leu Thr Ser Met Arg Gln Lys Met Gln Ser Thr Asp
705 710 715 720
Gln Ala Thr Val Glu Asn Leu Asn Glu Leu Arg Gln Asp Leu Ser Lys
725 730 735
Phe Arg Asn Glu Ile Arg Asp Leu Leu Gly Phe Arg Thr Ser Lys Tyr
740 745 750
Ala Met Phe Tyr Pro Arg Asn
755
<210>89
<211>848
<212>PRT
<213>智人(Homo sapiens)
<400>89
Met Glu Gly Ser Pro Ser Leu Arg Arg Met Thr Val Met Arg Glu Lys
1 5 10 15
Gly Arg Arg Gln Ala Val Arg Gly Pro Ala Phe Met Phe Asn Asp Arg
20 25 30
Gly Thr Ser Leu Thr Ala Glu Glu Glu Arg Phe Leu Asp Ala Ala Glu
35 40 45
Tyr Gly Asn Ile Pro Val Val Arg Lys Met Leu Glu Glu Ser Lys Thr
50 55 60
Leu Asn Val Asn Cys Val Asp Tyr Met Gly Gln Asn Ala Leu Gln Leu
65 70 75 80
Ala Val Gly Asn Glu His Leu Glu Val Thr Glu Leu Leu Leu Lys Lys
85 90 95
Glu Asn Leu Ala Arg Ile Gly Asp Ala Leu Leu Leu Ala Ile Ser Lys
100 105 110
Gly Tyr Val Arg Ile Val Glu Ala Ile Leu Asn His Pro Gly Phe Ala
115 120 125
Ala Ser Lys Arg Leu Thr Leu Ser Pro Cys Glu Gln Glu Leu Gln Asp
130 135 140
Asp Asp Phe Tyr Ala Tyr Asp Glu Asp Gly Thr Arg Phe Ser Pro Asp
145 150 155 160
Ile Thr Pro Ile Ile Leu Ala Ala His Cys Gln Lys Tyr Glu Val Val
165 170 175
His Met Leu Leu Met Lys Gly Ala Arg Ile Glu Arg Pro His Asp Tyr
180 185 190
Phe Cys Lys Cys Gly Asp Cys Met Glu Lys Gln Arg His Asp Ser Phe
195 200 205
Ser His Ser Arg Ser Arg Ile Asn Ala Tyr Lys Gly Leu Ala Ser Pro
210 215 220
Ala Tyr Leu Ser Leu Ser Ser Glu Asp Pro Val Leu Thr Ala Leu Glu
225 230 235 240
Leu Ser Asn Glu Leu Ala Lys Leu Ala Asn Ile Glu Lys Glu Phe Lys
245 250 255
Asn Asp Tyr Arg Lys Leu Ser Met Gln Cys Lys Asp Phe Val Val Gly
260 265 270
Val Leu Asp Leu Cys Arg Asp Ser Glu Glu Val Glu Ala Ile Leu Asn
275 280 285
Gly Asp Leu Glu Ser Ala Glu Pro Leu Glu Val His Arg His Lys Ala
290 295 300
Ser Leu Ser Arg Val Lys Leu Ala Ile Lys Tyr Glu Val Lys Lys Phe
305 310 315 320
Val Ala His Pro Asn Cys Gln Gln Gln Leu Leu Thr Ile Trp Tyr Glu
325 330 335
Asn Leu Ser Gly Leu Arg Glu Gln Thr Ile Ala Ile Lys Cys Leu Val
340 345 350
Val Leu Val Val Ala Leu Gly Leu Pro Phe Leu Ala Ile Gly Tyr Trp
355 360 365
Ile Ala Pro Cys Ser Arg Leu Gly Lys Ile Leu Arg Ser Pro Phe Met
370 375 380
Lys Phe Val Ala His Ala Ala Ser Phe Ile Ile Phe Leu Gly Leu Leu
385 390 395 400
Val Phe Asn Ala Ser Asp Arg Phe Glu Gly Ile Thr Thr Leu Pro Asn
405 410 415
Ile Thr Val Thr Asp Tyr Pro Lys Gln Ile Phe Arg Val Lys Thr Thr
420 425 430
Gln Phe Thr Trp Thr Glu Met Leu Ile Met Val Trp Val Leu Gly Met
435 440 445
Met Trp Ser Glu Cys Lys Glu Leu Trp Leu Glu Gly Pro Arg Glu Tyr
450 455 460
Ile Leu Gln Leu Trp Asn Val Leu Asp Phe Gly Met Leu Ser Ile Phe
465 470 475 480
Ile Ala Ala Phe Thr Ala Arg Phe Leu Ala Phe Leu Gln Ala Thr Lys
485 490 495
Ala Gln Gln Tyr Val Asp Ser Tyr Val Gln Glu Ser Asp Leu Ser Glu
500 505 510
Val Thr Leu Pro Pro Glu Ile Gln Tyr Phe Thr Tyr Ala Arg Asp Lys
515 520 525
Trp Leu Pro Ser Asp Pro Gln Ile Ile Ser Glu Gly Leu Tyr Ala Ile
530 535 540
Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Ile Leu Pro Ala Asn
545 550 555 560
Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr Val Lys Asp
565 570 575
Ile Phe Lys Phe Met Val Leu Phe Ile Met Val Phe Phe Ala Phe Met
580 585 590
Ile Gly Met Phe Ile Leu Tyr Ser Tyr Tyr Leu Gly Ala Lys Val Asn
595 600 605
Ala Ala Phe Thr Thr Val Glu Glu Ser Phe Lys Thr Leu Phe Trp Ser
610 615 620
Ile Phe Gly Leu Ser Glu Val Thr Ser Val Val Leu Lys Tyr Asp His
625 630 635 640
Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr Gly Ile Tyr Asn Val
645 650 655
Thr Met Val Val Val Leu Leu Asn Met Leu Ile Ala Met Ile Asn Ser
660 665 670
Ser Tyr Gln Glu Ile Glu Asp Asp Ser Asp Val Glu Trp Lys Phe Ala
675 680 685
Arg Ser Lys Leu Trp Leu Ser Tyr Phe Asp Asp Gly Lys Thr Leu Pro
690 695 700
Pro Pro Phe Ser Leu Val Pro Ser Pro Lys Ser Phe Val Tyr Phe Ile
705 710 715 720
Met Arg Ile Val Asn Phe Pro Lys Cys Arg Arg Arg Arg Leu Gln Lys
725 730 735
Asp Ile Glu Met Gly Met Gly Asn Ser Lys Ser Arg Leu Asn Leu Phe
740 745 750
Thr Gln Ser Asn Ser Arg Val Phe Glu Ser His Ser Phe Asn Ser Ile
755 760 765
Leu Asn Gln Pro Thr Arg Tyr Gln Gln Ile Met Lys Arg Leu Ile Lys
770 775 780
Arg Tyr Val Leu Lys Ala Gln Val Asp Lys Glu Asn Asp Glu Val Asn
785 790 795 800
Glu Gly Glu Leu Lys Glu Ile Lys Gln Asp Ile Ser Ser Leu Arg Tyr
805 810 815
Glu Leu Leu Glu Asp Lys Ser Gln Ala Thr Glu Glu Leu Ala Ile Leu
820 825 830
Ile His Lys Leu Ser Glu Lys Leu Asn Pro Ser Met Leu Arg Cys Glu
835 840 845
<210>90
<211>215
<212>PRT
<213>智人(Homo sapiens)
<400>90
Met Ser Glu Thr Val Pro Pro Ala Pro Ala Ala Ser Ala Ala Pro Glu
1 5 10 15
Lys Pro Leu Ala Gly Lys Lys Ala Lys Lys Pro Ala Lys Ala Ala Ala
20 25 30
Ala Ser Lys Lys Lys Pro Ala Gly Pro Ser Val Ser Glu Leu Ile Val
35 40 45
Gln Ala Ala Ser Ser Ser Lys Glu Arg Gly Gly Val Ser Leu Ala Ala
50 55 60
Leu Lys Lys Ala Leu Ala Ala Ala Gly Tyr Asp Val Glu Lys Asn Asn
65 70 75 80
Ser Arg Ile Lys Leu Gly Ile Lys Ser Leu Val Ser Lys Gly Thr Leu
85 90 95
Val Gln Thr Lys Gly Thr Gly Ala Ser Gly Ser Phe Lys Leu Asn Lys
100 105 110
Lys Ala Ser Ser Val Glu Thr Lys Pro Gly Ala Ser Lys Val Ala Thr
115 120 125
Lys Thr Lys Ala Thr Gly Ala Ser Lys Lys Leu Lys Lys Ala Thr Gly
130 135 140
Ala Ser Lys Lys Ser Val Lys Thr Pro Lys Lys Ala Lys Lys Pro Ala
145 150 155 160
Ala Thr Arg Lys Ser Ser Lys Asn Pro Lys Lys Pro Lys Thr Val Lys
165 170 175
Pro Lys Lys Val Ala Lys Ser Pro Ala Lys Ala Lys Ala Val Lys Pro
180 185 190
Lys Ala Ala Lys Ala Arg Val Thr Lys Pro Lys Thr Ala Lys Pro Lys
195 200 205
Lys Ala Ala Pro Lys Lys Lys
210 215
<210>91
<211>931
<212>PRT
<213>智人(Homo sapiens)
<400>91
Met Ser Gln Ser Pro Ala Phe Gly Pro Arg Arg Gly Ser Ser Pro Arg
1 5 10 15
Gly Ala Ala Gly Ala Ala Ala Arg Arg Asn Glu Ser Gln Asp Tyr Leu
20 25 30
Leu Met Asp Ser Glu Leu Gly Glu Asp Gly Cys Pro Gln Ala Pro Leu
35 40 45
Pro Cys Tyr Gly Tyr Tyr Pro Cys Phe Arg Gly Ser Asp Asn Arg Leu
50 55 60
Ala His Arg Arg Gln Thr Val Leu Arg Glu Lys Gly Arg Arg Leu Ala
65 70 75 80
Asn Arg Gly Pro Ala Tyr Met Phe Ser Asp Arg Ser Thr Ser Leu Ser
85 90 95
Ile Glu Glu Glu Arg Phe Leu Asp Ala Ala Glu Tyr Gly Asn Ile Pro
100 105 110
Val Val Arg Lys Met Leu Glu Glu Cys His Ser Leu Asn Val Asn Cys
115 120 125
Val Asp Tyr Met Gly Gln Asn Ala Leu Gln Leu Ala Val Ala Asn Glu
130 135 140
His Leu Glu Ile Thr Glu Leu Leu Leu Lys Lys Glu Asn Leu Ser Arg
145 150 155 160
Val Gly Asp Ala Leu Leu Leu Ala Ile Ser Lys Gly Tyr Val Arg Ile
165 170 175
Val Glu Ala Ile Leu Ser His Pro Ala Phe A1a Glu Gly Lys Arg Leu
180 185 190
Ala Thr Ser Pro Ser Gln Ser Glu Leu Gln Gln Asp Asp Phe Tyr Ala
195 200 205
Tyr Asp Glu Asp Gly Thr Arg Phe Ser His Asp Val Thr Pro Ile Ile
210 215 220
Leu Ala Ala His Cys Gln Glu Tyr Glu Ile Val His Thr Leu Leu Arg
225 230 235 240
Lys Gly Ala Arg Ile Glu Arg Pro His Asp Tyr Phe Cys Lys Cys Asn
245 250 255
Asp Cys Asn Gln Lys Gln Lys His Asp Ser Phe Ser His Ser Arg Ser
260 265 270
Arg Ile Asn Ala Tyr Lys Gly Leu Ala Ser Pro Ala Tyr Leu Ser Leu
275 280 285
Ser Ser Glu Asp Pro Val Met Thr Ala Leu Glu Leu Ser Asn Glu Leu
290 295 300
Ala Val Leu Ala Asn Ile Glu Lys Glu Phe Lys Asn Asp Tyr Lys Lys
305 310 315 320
Leu Ser Met Gln Cys Lys Asp Phe Val Val Gly Leu Leu Asp Leu Cys
325 330 335
Arg Asn Thr Glu Glu Val Glu Ala Ile Leu Asn Gly Asp Val Glu Thr
340 345 350
Leu Gln Ser Gly Asp His Gly Arg Pro Asn Leu Ser Arg Leu Lys Leu
355 360 365
Ala Ile Lys Tyr Glu Val Lys Lys Phe Val Ala His Pro Asn Cys Gln
370 375 380
Gln Gln Leu Leu Ser Ile Trp Tyr Glu Asn Leu Ser Gly Leu Arg Gln
385 390 395 400
Gln Thr Met Ala Val Lys Phe Leu Val Val Leu Ala Val Ala Ile Gly
405 410 415
Leu Pro Phe Leu Ala Leu Ile Tyr Trp Phe Ala Pro Cys Ser Lys Met
420 425 430
Gly Lys Ile Met Arg Gly Pro Phe Met Lys Phe Val Ala His Ala Ala
435 440 445
Ser Phe Thr Ile Phe Leu Gly Leu Leu Val Met Asn Ala Ala Asp Arg
450 455 460
Phe Glu Gly Thr Lys Leu Leu Pro Asn Glu Thr Ser Thr Asp Asn Ala
465 470 475 480
Lys Gln Leu Phe Arg Met Lys Thr Ser Cys Phe Ser Trp Met Glu Met
485 490 495
Leu Ile Ile Ser Trp Val Ile Gly Met Ile Trp Ala Glu Cys Lys Glu
500 505 510
Ile Trp Thr Gln Gly Pro Lys Glu Tyr Leu Phe Glu Leu Trp Asn Met
515 520 525
Leu Asp Phe Gly Met Leu Ala Ile Phe Ala Ala Ser Phe Ile Ala Arg
530 535 540
Phe Met Ala Phe Trp His Ala Ser Lys Ala Gln Ser Ile Ile Asp Ala
545 550 555 560
Asn Asp Thr Leu Lys Asp Leu Thr Lys Val Thr Leu Gly Asp Asn Val
565 570 575
Lys Tyr Tyr Asn Leu Ala Arg Ile Lys Trp Asp Pro Ser Asp Pro Gln
580 585 590
Ile Ile Ser Glu Gly Leu Tyr Ala Ile Ala Val Val Leu Ser Phe Ser
595 600 605
Arg Ile Ala Tyr Ile Leu Pro Ala Asn Glu Ser Phe Gly Pro Leu Gln
610 615 620
Ile Ser Leu Gly Arg Thr Val Lys Asp Ile Phe Lys Phe Met Val Ile
625 630 635 640
Phe Ile Met Val Phe Val Ala Phe Met Ile Gly Met Phe Asn Leu Tyr
645 650 655
Ser Tyr Tyr Ile Gly Ala Lys Gln Asn Glu Ala Phe Thr Thr Val Glu
660 665 670
Glu Ser Phe Lys Thr Leu Phe Trp Ala Ile Phe Gly Leu Ser Glu Val
675 680 685
Lys Ser Val Val IIe Asn Tyr Asn His Lys Phe Ile Glu Asn Ile Gly
690 695 700
Tyr Val Leu Tyr Gly Val Tyr Asn Val Thr Met Val Ile Val Leu Leu
705 710 715 720
Asn Met Leu Ile Ala Met Ile Asn Ser Ser Phe Gln Glu Ile Glu Asp
725 730 735
Asp Ala Asp Val Glu Trp Lys Phe Ala Arg Ala Lys Leu Trp Phe Ser
740 745 750
Tyr Phe Glu Glu Gly Arg Thr Leu Pro Val Pro Phe Asn Leu Val Pro
755 760 765
Ser Pro Lys Ser Leu Phe Tyr Leu Leu Leu Lys Leu Lys Lys Trp Ile
770 775 780
Ser Glu Leu Phe Gln Gly His Lys Lys Gly Phe Gln Glu Asp Ala Glu
785 790 795 800
Met Asn Lys Ile Asn Glu Glu Lys Lys Leu Gly Ile Leu Gly Ser His
805 810 815
Glu Asp Leu Ser Lys Leu Ser Leu Asp Lys Lys Gln Val Gly His Asn
820 825 830
Lys Gln Pro Ser Ile Arg Ser Ser Glu Asp Phe His Leu Asn Ser Phe
835 840 845
Asn Asn Pro Pro Arg Gln Tyr Gln Lys Ile Met Lys Arg Leu Ile Lys
850 855 860
Arg Tyr Val Leu Gln Ala Gln Ile Asp Lys Glu Ser Asp Glu Val Asn
865 870 875 880
Glu Gly Glu Leu Lys Glu Ile Lys Gln Asp Ile Ser Ser Leu Arg Tyr
885 890 895
Glu Leu Leu Glu Glu Lys Ser Gln Asn Thr Glu Asp Leu Ala Glu Leu
900 905 910
Ile Arg Glu Leu Gly Glu Lys Leu Ser Met Glu Pro Asn Gln Glu Glu
915 920 925
Thr Asn Arg
930
<210>92
<400>92
000
<210>93
<211>15
<212>PRT
<213>智人(Homo sapiens)
<400>93
Ser Arg Asp Pro Pro Ala Ser Ala Ser Gln Val Thr Gly Ile Arg
1 5 10 15
<210>94
<211>396
<212>PRT
<213>智人(Homo sapiens)
<400>94
Met Ala Ser Leu Ser Arg Ala Leu Arg Val Ala Ala Ala His Pro Arg
1 5 10 15
Gln Ser Pro Thr Arg Gly Met Gly Pro Cys Asn Leu Ser Ser Ala Ala
20 25 30
Gly Pro Thr Ala Glu Lys Ser Val Pro Tyr Gln Arg Thr Leu Lys Glu
35 40 45
Gly Gln Gly Thr Ser Val Val Ala Gln Gly Pro Ser Arg Pro Leu Pro
50 55 60
Ser Thr Ala Asn Val Val Val Ile Gly Gly Gly Ser Leu Gly Cys Gln
65 70 75 80
Thr Leu Tyr His Leu Ala Lys Leu Gly Met Ser Gly Ala Val Leu Leu
85 90 95
Glu Arg Glu Arg Leu Thr Ser Gly Thr Thr Trp His Thr Ala Gly Leu
100 105 110
Leu Trp Gln Leu Arg Pro Ser Asp Val Glu Val Glu Leu Leu Ala His
115 120 125
Thr Arg Arg Val Val Ser Arg Glu Leu Glu Glu Glu Thr Gly Leu His
130 135 140
Thr Gly Trp Ile Gln Asn Gly Gly Leu Phe Ile Ala Ser Asn Arg Gln
145 150 155 160
Arg Leu Asp Glu Tyr Lys Arg Leu Met Ser Leu Gly Lys Ala Tyr Gly
165 170 175
Val Glu Ser His Val Leu Ser Pro Ala Glu Thr Lys Thr Leu Tyr Pro
180 185 190
Leu Met Asn Val Asp Asp Leu Tyr Gly Thr Leu Tyr Val Pro His Asp
195 200 205
Gly Thr Met Asp Pro Ala Gly Thr Cys Thr Thr Leu Ala Arg Ala Ala
210 215 220
Ser Ala Arg Gly Ala Gln Val Ile Glu Asn Cys Pro Val Thr Gly Ile
225 230 235 240
Arg Val Trp Thr Asp Asp Phe Gly Val Arg Arg Val Ala Gly Val Glu
245 250 255
Thr Gln His Gly Ser Ile Gln Thr Pro Cys Val Val Asn Cys Ala Gly
260 265 270
Val Trp Ala Ser Ala Val Gly Arg Met Ala Gly Val Lys Val Pro Leu
275 280 285
Val Ala Met His His Ala Tyr Val Val Thr Glu Arg Ile Glu Gly Ile
290 295 300
Gln Ser Phe Thr Leu Leu Pro Thr Leu Glu Tyr Ser Gly Thr Val Ser
305 310 315 320
Ala His Cys Asn Leu Arg Leu Pro Gly Ser Ser Asn Ser Arg Ala Ser
325 330 335
Ala Ser His Val Ala Gly Ile Lys Cys Ala Arg His His Thr Arg Leu
340 345 350
Ile Phe Phe Cys Ile Leu Val Glu Thr Glu Phe His His Val Ala Lys
355 360 365
Ala Gly Leu Glu Leu Leu Ser Ser Gly Asn Pro Pro Ile Ser Asp Phe
370 375 380
Gln Ser Ala Arg Ile Thr Gly Val Ser His His Ala
385 390 395
<210>95
<211>72
<212>PRT
<213>智人(Homo sapiens)
<400>95
Leu Leu Trp Val Leu Leu Trp Ala Thr Val Leu Gly Leu Leu Cys Gln
1 5 10 15
Arg Leu Ala Ala Arg Leu Gly Val Val Thr Gly Lys Asp Leu Gly Glu
20 25 30
Val Cys His Leu Tyr Tyr Pro Lys Ser Glu Ser Arg Ser Val Ala Gln
35 40 45
Ser Gly Val Gln Trp Cys Asp Val Ser Ser Leu Gln Pro Leu Pro Pro
50 55 60
Arg Cys Pro Ala Pro Ser Ser Gly
65 70
<210>96
<211>84
<212>PRT
<213>智人(Homo sapiens)
<400>96
Met Glu Thr Glu Ser Gly Ser Val Ala Gln Ala Gly Val Gln Trp His
1 5 10 15
Asn Leu Gly Ser Leu Gln Pro Pro Pro Ser Arg Leu Lys Gln Leu Ser
20 25 30
Tyr Leu Ser Leu Pro Ser Ser Trp Asp Tyr Arg Cys Thr Pro Pro His
35 40 45
Pro Ala Asn Phe Leu Tyr Phe Asn Arg Asp Gly Ile Ser Pro Cys Cys
50 55 60
Pro Gly Trp Ser Pro Thr Pro Lys Leu Thr Gln Ser Thr His Leu Gly
65 70 75 80
Leu Ser Lys Cys
<210>97
<211>836
<212>PRT
<213>智人(Homo sapiens)
<400>97
Met Ala Gln Phe Tyr Tyr Lys Arg Asn Val Asn Ala Pro Tyr Arg Asp
1 5 10 15
Arg Ile Pro Leu Arg Ile Val Arg Ala Glu Ser Glu Leu Ser Pro Ser
20 25 30
Glu Lys Ala Tyr Leu Asn Ala Val Glu Lys Gly Asp Tyr Ala Ser Val
35 40 45
Lys Lys Ser Leu Glu Glu Ala Glu Ile Tyr Phe Lys Ile Asn Ile Asn
50 55 60
Cys Ile Asp Pro Leu Gly Arg Thr Ala Leu Leu Ile Ala Ile Glu Asn
65 70 75 80
Glu Asn Leu Glu Leu Ile Glu Leu Leu Leu Ser Phe Asn Val Tyr Val
85 90 95
Gly Asp Ala Leu Leu His Ala Ile Arg Lys Glu Val Val Gly Ala Val
100 105 110
Glu Leu Leu Leu Asn His Lys Lys Pro Ser Gly Glu Lys Gln Val Pro
115 120 125
Pro Ile Leu Leu Asp Lys Gln Phe Ser Glu Phe Thr Pro Asp Ile Thr
130 135 140
Pro Ile Ile Leu Ala Ala His Thr Asn Asn Tyr Glu Ile Ile Lys Leu
145 150 155 160
Leu Val Gln Lys Gly Val Ser Val Pro Arg Pro His Glu Val Arg Cys
165 170 175
Asn Cys Val Glu Cys Val Ser Ser Ser Asp Val Asp Ser Leu Arg His
180 185 190
Ser Arg Ser Arg Leu Asn Ile Tyr Lys Ala Leu Ala Ser Pro Ser Leu
195 200 205
Ile Ala Leu Ser Ser Glu Asp Pro Phe Leu Thr Ala Phe Gln Leu Ser
210 215 220
Trp Glu Leu Gln Glu Leu Ser Lys Val Glu Asn Glu Phe Lys Ser Glu
225 230 235 240
Tyr Glu Glu Leu Ser Arg Gln Cys Lys Gln Phe Ala Lys Asp Leu Leu
245 250 255
Asp Gln Thr Arg Ser Ser Arg Glu Leu Glu Ile Ile Leu Asn Tyr Arg
260 265 270
Asp Asp Asn Ser Leu Ile Glu Glu Gln Ser Gly Asn Asp Leu Ala Arg
275 280 285
Leu Lys Leu Ala Ile Lys Tyr Arg Gln Lys Glu Phe Val Ala Gln Pro
290 295 300
Asn Cys Gln Gln Leu Leu Ala Ser Arg Trp Tyr Asp Glu Phe Pro Gly
305 310 315 320
Trp Arg Arg Arg His Trp Ala Val Lys Met Val Thr Cys Phe Ile Ile
325 330 335
Gly Leu Leu Phe Pro Val Phe Ser Val Cys Tyr Leu Ile Ala Pro Lys
340 345 350
Ser Pro Leu Gly Leu Phe Ile Arg Lys Pro Phe Ile Lys Phe Ile Cys
355 360 365
His Thr Ala Ser Tyr Leu Thr Phe Leu Phe Leu Leu Leu Leu Ala Ser
370 375 380
Gln His Ile Asp Arg Ser Asp Leu Asn Arg Gln Gly Pro Pro Pro Thr
385 390 395 400
Ile Val Glu Trp Met Ile Leu Pro Trp Val Leu Gly Phe Ile Trp Gly
405 410 415
Glu Ile Lys Gln Met Trp Asp Gly Gly Leu Gln Asp Tyr Ile His Asp
420 425 430
Trp Trp Asn Leu Met Asp Phe Val Met Asn Ser Leu Tyr Leu Ala Thr
435 440 445
Ile Ser Leu Lys Ile Val Ala Phe Val Lys Tyr Ser Ala Leu Asn Pro
450 455 460
Arg Glu Ser Trp Asp Met Trp His Pro Thr Leu Val Ala Glu Ala Leu
465 470 475 480
Phe Ala Ile Ala Asn Ile Phe Ser Ser Leu Arg Leu Ile Ser Leu Phe
485 490 495
Thr Ala Asn Ser His Leu Gly Pro Leu Gln Ile Ser Leu Gly Arg Met
500 505 510
Leu Leu Asp Ile Leu Lys Phe Leu Phe Ile Tyr Cys Leu Val Leu Leu
515 520 525
Ala Phe Ala Asn Gly Leu Asn Gln Leu Tyr Phe Tyr Tyr Glu Glu Thr
530 535 540
Lys Gly Leu Thr Cys Lys Gly Ile Arg Cys Glu Lys Gln Asn Asn Ala
545 550 555 560
Phe Ser Thr Leu Phe Glu Thr Leu Gln Ser Leu Phe Trp Ser Ile Phe
565 570 575
Gly Leu Ile Asn Leu Tyr Val Thr Asn Val Lys Ala Gln His Glu Phe
580 585 590
Thr Glu Phe Val Gly Ala Thr Met Phe Gly Thr Tyr Asn Val Ile Ser
595 600 605
Leu Val Val Leu Leu Asn Met Leu Ile Ala Met Met Asn Asn Ser Tyr
610 615 620
Gln Leu Ile Ala Asp His Ala Asp Ile Glu Trp Lys Phe Ala Arg Thr
625 630 635 640
Lys Leu Trp Met Ser Tyr Phe Glu Glu Gly Gly Thr Leu Pro Thr Pro
645 650 655
Phe Asn Val Ile Pro Ser Pro Lys Ser Leu Trp Tyr Leu Ile Lys Trp
660 665 670
Ile Trp Thr His Leu Cys Lys Lys Lys Met Arg Arg Lys Pro Glu Ser
675 680 685
Phe Gly Thr Ile Gly Arg Arg Ala Ala Asp Asn Leu Arg Arg His His
690 695 700
Gln Tyr Gln Glu Val Met Arg Asn Leu Val Lys Arg Tyr Val Ala Ala
705 710 715 720
Met Ile Arg Asp Ala Lys Thr Glu Glu Val Ala Arg Gln Gln Ala Ala
725 730 735
Gly Pro Leu Glu Arg Asn Ile Gln Leu Glu Ser Arg Gly Leu Ala Ser
740 745 750
Arg Gly Asp Leu Ser Ile Pro Gly Leu Ser Glu Gln Cys Val Leu Val
755 760 765
Asp His Arg Glu Arg Asn Thr Asp Thr Leu Gly Leu Gln Val Gly Lys
770 775 780
Arg Val Cys Pro Phe Lys Ser Glu Lys Val Val Val Glu Asp Thr Val
785 790 795 800
Pro Ile Ile Pro Lys Glu Lys His Ala Lys Glu Glu Asp Ser Ser Ile
805 810 815
Asp Tyr Asp Leu Asn Leu Pro Asp Thr Val Thr His Glu Asp Tyr Val
820 825 830
Thr Thr Arg Leu
835
<210>98
<211>828
<212>PRT
<213>智人(Homo sapiens)
<400>98
Met Ala Gln Phe Tyr Tyr Lys Arg Asn Val Asn Ala Pro Tyr Arg Asp
1 5 10 15
Arg Ile Pro Leu Arg Ile Val Arg Ala Glu Ser Glu Leu Ser Pro Ser
20 25 30
Glu Lys Ala Tyr Leu Asn Ala Val Glu Lys Gly Asp Tyr Ala Ser Val
35 40 45
Lys Lys Ser Leu Glu Glu Ala Glu Ile Tyr Phe Lys Ile Asn Ile Asn
50 55 60
Cys Ile Asp Pro Leu Gly Arg Thr Ala Leu Leu Ile Ala Ile Glu Asn
65 70 75 80
Glu Asn Leu Glu Leu Ile Glu Leu Leu Leu Ser Phe Asn Val Tyr Val
85 90 95
Gly Asp Ala Leu Leu His Ala Ile Arg Lys Glu Val Val Gly Ala Val
100 105 110
Glu Leu Leu Leu Asn His Lys Lys Pro Ser Gly Glu Lys Gln Val Pro
115 120 125
Pro Ile Leu Leu Asp Lys Gln Phe Ser Glu Phe Thr Pro Asp Ile Thr
130 135 140
Pro Ile Ile Leu Ala Ala His Thr Asn Asn Tyr Glu Ile Ile Lys Leu
145 150 155 160
Leu Val Gln Lys Gly Val Ser Val Pro Arg Pro His Glu Val Arg Cys
165 170 175
Asn Cys Val Glu Cys Val Ser Ser Ser Asp Val Asp Ser Leu Arg His
180 185 190
Ser Arg Ser Arg Leu Asn Ile Tyr Lys Ala Leu Ala Ser Pro Ser Leu
195 200 205
Ile Ala Leu Ser Ser Glu Asp Pro Phe Leu Thr Ala Phe Gln Leu Ser
210 215 220
Trp Glu Leu Gln Glu Leu Ser Lys Val Glu Asn Glu Phe Lys Ser Glu
225 230 235 240
Tyr Glu Glu Leu Ser Arg Gln Cys Lys Gln Phe Ala Lys Asp Leu Leu
245 250 255
Asp Gln Thr Arg Ser Ser Arg Glu Leu Glu Ile Ile Leu Asn Tyr Arg
260 265 270
Asp Asp Asn Ser Leu Ile Glu Glu Gln Ser Gly Asn Asp Leu Ala Arg
275 280 285
Leu Lys Leu Ala Ile Lys Tyr Arg Gln Lys Glu Phe Val Ala Gln Pro
290 295 300
Asn Cys Gln Gln Leu Leu Ala Ser Arg Trp Tyr Asp Glu Phe Pro Gly
305 310 315 320
Trp Arg Arg Arg His Trp Ala Val Lys Met Val Thr Cys Phe Ile Ile
325 330 335
Gly Leu Leu Phe Pro Val Phe Ser Val Cys Tyr Leu Ile Ala Pro Lys
340 345 350
Ser Pro Leu Gly Leu Phe Ile Arg Lys Pro Phe Ile Lys Phe Ile Cys
355 360 365
His Thr Ala Ser Tyr Leu Thr Phe Leu Phe Leu Leu Leu Leu Ala Ser
370 375 380
Gln His Ile Asp Arg Ser Asp Leu Asn Arg Gln Gly Pro Pro Pro Thr
385 390 395 400
Ile Val Glu Trp Met Ile Leu Pro Trp Val Leu Gly Phe Ile Trp Gly
405 410 415
Glu Ile Lys Gln Met Trp Asp Gly Gly Leu Gln Asp Tyr Ile His Asp
420 425 430
Trp Trp Asn Leu Met Asp Phe Val Met Asn Ser Leu Tyr Leu Ala Thr
435 440 445
Ile Ser Leu Lys Ile Val Ala Phe Val Lys Tyr Ser Ala Leu Asn Pro
450 455 460
Arg Glu Ser Trp Asp Met Trp His Pro Thr Leu Val Ala Glu Ala Leu
465 470 475 480
Phe Ala Ile Ala Asn Ile Phe Ser Ser Leu Arg Leu Ile Ser Leu Phe
485 490 495
Thr Ala Asn Ser His Leu Gly Pro Leu Gln Ile Ser Leu Gly Arg Met
500 505 510
Leu Leu Asp Ile Leu Lys Phe Leu Phe Ile Tyr Cys Leu Val Leu Leu
515 520 525
Ala Phe Ala Asn Gly Leu Asn Gln Leu Tyr Phe Tyr Tyr Glu Glu Thr
530 535 540
Lys Gly Leu Thr Cys Lys Gly Ile Arg Cys Glu Lys Gln Asn Asn Ala
545 550 555 560
Phe Ser Thr Leu Phe Glu Thr Leu Gln Ser Leu Phe Trp Ser Ile Phe
565 570 575
Gly Leu Ile Asn Leu Tyr Val Thr Asn Val Lys Ala Gln His Glu Phe
580 585 590
Thr Glu Phe Val Gly Ala Thr Met Phe Gly Thr Tyr Asn Val Ile Ser
595 600 605
Leu Val Val Leu Leu Asn Met Leu Ile Ala Met Met Asn Asn Ser Tyr
610 615 620
Gln Leu Ile Ala Arg Arg Ala Ala Asp Asn Leu Arg Arg His His Gln
625 630 635 640
Tyr Gln Glu Val Met Arg Asn Leu Val Lys Arg Tyr Val Ala Ala Met
645 650 655
Ile Arg Asp Ala Lys Thr Glu Glu Gly Leu Thr Glu Glu Asn Phe Lys
660 665 670
Glu Leu Lys Gln Asp Ile Ser Ser Phe Arg Phe Glu Val Leu Gly Leu
675 680 685
Leu Arg Gly Ser Lys Leu Ser Thr Ile Gln Ser Ala Asn Ala Ser Lys
690 695 700
Glu Ser Ser Asn Ser Ala Asp Ser Asp Glu Lys Ser Asp Ser Glu Glu
705 710 715 720
Glu Val Ala Arg Gln Gln Ala Ala Gly Pro Leu Gl uArg Asn Ile Gln
725 730 735
Leu Glu Ser Arg Gly Leu Ala Ser Arg Gly Asp Leu Ser Ile Pro Gly
740 745 750
Leu Ser Glu Gln Cys Val Leu Val Asp His Arg Glu Arg Asn Thr Asp
755 760 765
Thr Leu Gly Leu Gln Val Gly Lys Arg Val Cys Pro Phe Lys Ser Glu
770 775 780
Lys Val Val Val Glu Asp Thr Val Pro Ile Ile Pro Lys Glu Lys His
785 790 795 800
Ala Lys Glu Glu Asp Ser Ser Ile Asp Tyr Asp Leu Asn Leu Pro Asp
805 810 815
Thr Val Thr His Glu Asp Tyr Val Thr Thr Arg Leu
820 825
<210>99
<211>73
<212>PRT
<213>智人(Homo sapiens)
<220>
<221>MOD_RES
<222>(18)
<223>可变氨基酸
<400>99
Met Arg Thr Lys Ser Glu Arg Glu Ile His Leu Cys Val Leu Gly Phe
1 5 10 15
Phe Xaa Phe Phe Phe Glu Thr Gly Ser Arg Ser Val Ala Gln Ala Gly
20 25 30
Val Gln Arg His Ser His Gly Ser Leu Gln Pro Arg Pro Pro Gly Leu
35 40 45
Ile Gln Phe Ser His Leu Ser Leu Pro Ser Ser Trp Asp Tyr Arg His
50 55 60
Ala Pro Pro His Leu Val Asn Phe Leu
65 70
<210>100
<211>61
<212>PRT
<213>智人(Homo sapiens)
<400>100
Arg Phe Phe Phe Phe Phe Phe Phe Glu Glu Ser Arg Ser Phe Ala Gln
1 5 10 15
Ala Gly Val Gln Trp Arg Tyr Leu Gly Ser Leu Gln Pro Pro Pro Pro
20 25 30
Gly Phe Thr Arg Phe Ser Cys Leu Ser Leu Leu Ser Ser Trp Asp Tyr
35 40 45
Arg Arg Pro Pro Pro Arg Pro Ala Asn Phe Leu Tyr Phe
50 55 60
<210>101
<211>1258
<212>PRT
<213>智人(Homo sapiens)
<400>101
Glu Leu Ser Phe Pro Leu Leu Ser Leu Asp Phe Gly Ala His Gln Gly
1 5 10 15
Leu Gly Ser Ala Asp Met Gly Asp Met Lys Thr Pro Asp Phe Asp Asp
20 25 30
Leu Leu Ala Ala Phe Asp Ile Pro Asp Ile Asp Ala Asn Glu Ala Ile
35 40 45
His Ser Gly Pro Glu Glu Asn Glu Gly Pro Gly Gly Pro Gly Lys Pro
50 55 60
Glu Pro Gly Val Gly Ser Glu Ser Glu Asp Thr Ala Ala Ala Ser Ala
65 70 75 80
Gly Asp Gly Pro Gly Val Pro Ala Gln Ala Ser Asp His Gly Leu Pro
85 90 95
Pro Pro Asp Ile Ser Val Val Ser Val Ile Val Lys Asn Thr Val Cys
100 105 110
Pro Glu Gln Ser Glu Ala Leu Ala Gly Gly Ser Ala Gly Asp Gly Ala
115 120 125
Gln Ala Ala Gly Val Thr Lys Glu Gly Pro Val Gly Pro His Arg Met
130 135 140
Gln Asn Gly Phe Gly Ser Pro Glu Pro Ser Leu Pro Gly Thr Pro His
145 150 155 160
Ser Pro Ala Pro Pro Ser Gly Gly Thr Trp Lys Glu Lys Gly Met Glu
165 170 175
Gly Lys Thr Pro Leu Asp Leu Phe Ala His Phe Gly Pro Glu Pro Gly
180 185 190
Asp His Ser Asp Pro Leu Pro Pro Ser Ala Pro Ser Pro Thr Arg Glu
195 200 205
Gly Ala Leu Thr Pro Pro Pro Phe Pro Ser Ser Phe Glu Leu Ala Gln
210 215 220
Glu Asn Gly Pro Gly Met Gln Pro Pro Val Ser Ser Pro Pro Leu Gly
225 230 235 240
Ala Leu Lys Gln Glu Ser Cys Ser Pro His His Pro Gln Val Leu Ala
245 250 255
Gln Gln Gly Ser Gly Ser Ser Pro Lys Ala Thr Asp Ile Pro Ala Ser
260 265 270
Ala Ser Pro Pro Pro Val Ala Gly Val Pro Phe Phe Lys Gln Ser Pro
275 280 285
Gly His Gln Ser Pro Leu Ala Ser Pro Lys Val Pro Val Cys Gln Pro
290 295 300
Leu Lys Glu Glu Asp Asp Asp Glu Gly Pro Val Asp Lys Ser Ser Pro
305 310 315 320
Gly Ser Pro Gln Ser Pro Ser Ser Gly Ala Glu Ala Ala Asp Glu Asp
325 330 335
Ser Asn Asp Ser Pro Ala Ser Ser Ser Ser Arg Pro Leu Lys Val Arg
340 345 350
Ile Lys Thr Ile Lys Thr Ser Cys Gly Asn Ile Thr Arg Thr Val Thr
355 360 365
Gln Val Pro Ser Asp Pro Asp Pro Pro Ala Pro Leu Ala Glu Gly Ala
370 375 380
Phe Leu Ala Glu Ala Ser Leu Leu Lys Leu Ser Pro Ala Thr Pro Thr
385 390 395 400
Ser Glu Gly Pro Lys Val Val Ser Val Gln Leu Gly Asp Gly Thr Arg
405 410 415
Leu Lys Gly Thr Val Leu Pro Val Ala Thr Ile Gln Asn Ala Ser Thr
420 425 430
Ala Met Leu Met Ala Ala Ser Val Ala Arg Lys Ala Val Val Leu Pro
435 440 445
Gly Gly Thr Ala Thr Ser Pro Lys Met Ile Ala Lys Asn Val Leu Gly
450 455 460
Leu Val Pro Gln Ala Leu Pro Lys Ala Asp Gly Arg Ala Gly Leu Gly
465 470 475 480
Thr Gly Gly Gln Lys Val Asn Gly Ala Ser Val Val Met Val Gln Pro
485 490 495
Ser Lys Thr Ala Thr Gly Pro Ser Thr Gly Gly Gly Thr Val Ile Ser
500 505 510
Arg Thr Gln Ser Ser Leu Val Glu Ala Phe Asn Lys Ile Leu Asn Ser
515 520 525
Lys Asn Leu Leu Pro Ala Tyr Arg Pro Asn Leu Ser Pro Pro Ala Glu
530 535 540
Ala Gly Leu Ala Leu Pro Pro Thr Gly Tyr Arg Cys Leu Glu Cys Gly
545 550 555 560
Asp Ala Phe Ser Leu Glu Lys Ser Leu Ala Arg His Tyr Asp Arg Arg
565 570 575
Ser Met Arg Ile Glu Val Thr Cys Asn His Cys Ala Arg Arg Leu Val
580 585 590
Phe Phe Asn Lys Cys Ser Leu Leu Leu His Ala Arg Glu His Lys Asp
595 600 605
Lys Gly Leu Val Met Gln Cys Ser His Leu Val Met Arg Pro Val Ala
610 615 620
Leu Asp Gln Met Val Gly Gln Pro Asp Ile Thr Pro Leu Leu Pro Val
625 630 635 640
Ala Val Pro Pro Val Ser Gly Pro Leu Ala Leu Pro Ala Leu Gly Lys
645 650 655
Gly Glu Gly Ala Ile Thr Ser Ser Ala Ile Thr Thr Val Ala Ala Glu
660 665 670
Ala Pro Val Leu Pro Leu Ser Thr Glu Pro Pro Ala Ala Pro Ala Thr
675 680 685
Ser Ala Tyr Thr Cys Phe Arg Cys Leu Glu Cys Lys Glu Gln Cys Arg
690 695 700
Asp Lys Ala Gly Met Ala Ala His Phe Gln Gln Leu Gly Pro Pro Ala
705 710 715 720
Pro Gly Ala Thr Ser Asn Val Cys Pro Thr Cys Pro Met Met Leu Pro
725 730 735
Asn Arg Cys Ser Phe Ser Ala His Gln Arg Met His Lys Asn Arg Pro
740 745 750
Pro His Val Cys Pro Glu Cys Gly Gly Asn Phe Leu Gln Ala Asn Phe
755 760 765
Gln Thr His Leu Arg Glu Ala Cys Leu His Val Ser Arg Arg Val Gly
770 775 780
Tyr Arg Cys Pro Ser Cys Ser Val Val Phe Gly Gly Val Asn Ser Ile
785 790 795 800
Lys Ser His Ile Gln Thr Ser His Cys Glu Val Phe His Lys Cys Pro
805 810 815
Ile Cys Pro Met Ala Phe Lys Ser Gly Pro Ser Ala His Ala His Leu
820 825 830
Tyr Ser Gln His Pro Ser Phe Gln Thr Gln Gln Ala Lys Leu Ile Tyr
835 840 845
Lys Cys Ala Met Cys Asp Thr Val Phe Thr His Lys Pro Leu Leu Ser
850 855 860
Ser His Phe Asp Gln His Leu Leu Pro Gln Arg Val Ser Val Phe Lys
865 870 875 880
Cys Pro Ser Cys Pro Leu Leu Phe Ala Gln Lys Arg Thr Met Leu Glu
885 890 895
His Leu Lys Asn Thr His Gln Ser Gly Arg Leu Glu Glu Thr Ala Gly
900 905 910
Lys Gly Ala Gly Gly Ala Leu Leu Thr Pro Lys Thr Glu Pro Glu Glu
915 920 925
Leu Ala Val Ser Gln Gly Gly Ala Ala Pro Ala Thr Glu Glu Ser Ser
930 935 940
Ser Ser Ser Glu Glu Glu Glu Val Pro Ser Ser Pro Glu Pro Pro Arg
945 950 955 960
Pro Ala Lys Arg Pro Arg Arg Glu Leu Gly Ser Lys Gly Leu Lys Gly
965 970 975
Gly Gly Gly Gly Pro Gly Gly Trp Thr Cys Gly Leu Cys His Ser Trp
980 985 990
Phe Pro Glu Arg Asp Glu Tyr Val Ala His Met Lys Lys Glu His Gly
995 1000 1005
Lys Ser Val Lys Lys Phe Pro Cys Arg Leu Cys Glu Arg Ser Phe Cys
1010 1015 1020
Ser Ala Pro Ser Leu Arg Arg His Val Arg Val Asn His Glu Gly Ile
1025 1030 1035 1040
Lys Arg Val Tyr Pro Cys Arg Tyr Cys Thr Glu Gly Lys Arg Thr Phe
1045 1050 1055
Ser Ser Arg Leu Ile Leu Glu Lys His Val Gln Val Arg His Gly Leu
1060 1065 1070
Gln Leu Gly Ala Gln Ser Pro Gly Arg Gly Thr Thr Leu Ala Arg Gly
1075 1080 1085
Ser Ser Ala Arg Ala Gln Gly Pro Gly Arg Lys Arg Arg Gln Ser Ser
1090 1095 1100
Asp Ser Cys Ser Glu Glu Pro Asp Ser Thr Thr Pro Pro Ala Lys Ser
1105 1110 1115 1120
Pro Arg Gly Gly Pro Gly Ser Gly Gly His Gly Pro Leu Arg Tyr Arg
1125 1130 1135
Ser Ser Ser Ser Thr Glu Gln Ser Leu Met Met Gly Leu Arg Val Glu
1140 1145 1150
Asp Gly Ala Gln Gln Cys Leu Asp Cys Gly Leu Cys Phe Ala Ser Pro
1155 1160 1165
Gly Ser Leu Ser Arg His Arg Phe Ile Ser His Lys Lys Arg Arg Gly
1170 1175 1180
Val Gly Lys Ala Ser Ala Leu Gly Leu Gly Asp Gly Glu Glu Glu Ala
1185 1190 1195 1200
Pro Pro Ser Arg Ser Asp Pro Asp Gly Gly Asp Ser Pro Leu Pro Ala
1205 1210 1215
Ser Gly Gly Pro Leu Thr Cys Lys Val Cys Gly Lys Ser Cys Asp Ser
1220 1225 1230
Pro Leu Asn Leu Lys Thr His Phe Arg Thr His Gly Met Ala Phe Ile
1235 1240 1245
Arg Ala Arg Gln Gly Ala Val Gly Asp Asn
1250 1255
<210>102
<211>930
<212>PRT
<213>小家鼠(Mus musculus)
<400>102
Met Ser Gln Ser Pro Arg Phe Val Thr Arg Arg Gly Gly Ser Leu Lys
1 5 10 15
Ala Ala Pro Gly Ala Gly Thr Arg Arg Asn Glu Ser Gln Asp Tyr Leu
20 25 30
Leu Met Asp Glu Leu Gly Asp Asp Gly Tyr Pro Gln Leu Pro Leu Pro
35 40 45
Pro Tyr Gly Tyr Tyr Pro Ser Phe Arg Gly Asn Glu Asn Arg Leu Thr
50 55 60
His Arg Arg Gln Thr Ile Leu Arg Glu Lys Gly Arg Arg Leu Ala Asn
65 70 75 80
Arg Gly Pro Ala Tyr Met Phe Asn Asp His Ser Thr Ser Leu Ser Ile
85 90 95
Glu Glu Glu Arg Phe Leu Asp Ala Val Glu Tyr Gly Asn Ile Pro Val
100 105 110
Val Trp Lys Met Leu Glu Glu Cys His Ser Leu Asn Val Asn Cys Val
115 120 125
Asp Tyr Met Gly Gln Asn Ala Leu Gln Leu Ala Val Ala Asn Glu His
130 135 140
Leu Glu Ile Thr Glu Leu Leu Leu Lys Lys Glu Asn Leu Ser Arg Val
145 150 155 160
Gly Asp Ala Leu Leu Leu Ala Ile Ser Lys Gly Tyr Val Arg Ile Val
165 170 175
Glu Ala Ile Leu Asn His Pro Ser Phe Ala Glu Gly Lys Arg Leu Ala
180 185 190
Thr Ser Pro Ser Gln Ser Glu Leu Gln Gln Asp Asp Phe Tyr Ala Tyr
195 200 205
Asp Glu Asp Gly Thr Arg Phe Ser His Asp Val Thr Pro Ile Ile Leu
210 215 220
Ala Ala His Cys Gln Glu Tyr Glu Ile Val His Thr Leu Leu Arg Lys
225 230 235 240
Gly Ala Arg Ile Glu Arg Pro His Asp Tyr Phe Cys Lys Cys Thr Glu
245 250 255
Cys Ser Gln Lys Gln Lys His Asp Ser Phe Ser His Ser Arg Ser Arg
260 265 270
Ile Asn Ala Tyr Lys Gly Leu Ala Ser Pro Ala Tyr Leu Ser Leu Ser
275 280 285
Ser Glu Asp Pro Val Met Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala
290 295 300
Val Leu Ala Asn Ile Glu Lys Glu Phe Lys Asn Asp Tyr Arg Lys Leu
305 310 315 320
Ser Met Gln Cys Lys Asp Phe Val Val Gly Leu Leu Asp Leu Cys Arg
325 330 335
Asn Thr Glu Glu Val Glu Ala Ile Leu Asn Gly Asp Ala Glu Thr Arg
340 345 350
Gln Pro Gly Asp Phe Gly Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala
355 360 365
Ile Lys Asp Glu Val Lys Lys Phe Val Ala His Pro Asn Cys Gln Gln
370 375 380
Gln Leu Leu Ser Ile Trp Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln
385 390 395 400
Thr Met Ala Val Lys Phe Leu Val Val Leu Ala Val Ala Ile Gly Leu
405 410 415
Pro Phe Leu Ala Leu Ile Tyr Trp Cys Ala Pro Cys Ser Lys Met Gly
420 425 430
Lys Ile Leu Pro Arg Pro Phe Met Lys Phe Val Ala His Ala Ala Ser
435 440 445
Phe Thr Ile Phe Leu Gly Leu Leu Val Met Asn Ala Ala Asp Arg Phe
450 455 460
Glu Gly Thr Lys Leu Leu Pro Asn Glu Thr Ser Thr Asp Asn Ala Arg
465 470 475 480
Gln Leu Phe Arg Met Lys Thr Ser Cys Phe Ser Trp Met Glu Met Leu
485 490 495
Ile Ile Ser Trp Val Ile Gly Met Ile Trp Ala Glu Cys Lys Glu Ile
500 505 510
Trp Thr Gln Gly Pro Lys Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu
515 520 525
Asp Phe Gly Met Leu Ala Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe
530 535 540
Met Ala Phe Trp His Ala Ser Lys Ala Gln Ser Ile Ile Asp Ala Asn
545 550 555 560
Asp Thr Leu Lys Asp Leu Thr Lys Val Thr Leu Gly Asp Asn Val Lys
565 570 575
Tyr Tyr Asn Leu Ala Arg Ile Lys Trp Asp Pro Thr Asp Pro Gln Ile
580 585 590
Ile Ser Glu Gly Leu Tyr Ala Ile Ala Val Val Leu Ser Phe Ser Arg
595 600 605
Ile Ala Tyr Ile Leu Pro Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile
610 615 620
Ser Leu Gly Arg Thr Val Lys Asp Ile Phe Lys Phe Met Val Ile Phe
625 630 635 640
Ile Met Val Phe Val Ala Phe Met Ile Gly Met Phe Asn Leu Tyr Ser
645 650 655
Tyr Tyr Ile Gly Ala Lys Gln Asn Glu Ala Phe Thr Thr Val Glu Glu
660 665 670
Ser Phe Lys Thr Leu Phe Trp Ala Ile Phe Gly Leu Ser Glu Val Lys
675 680 685
Ser Val Val Ile Asn Tyr Asn His Lys Phe Ile Glu Asn Ile Gly Tyr
690 695 700
Val Leu Tyr Gly Val Tyr Asn Val Thr Met Val Ile Val Leu Leu Asn
705 710 715 720
Met Leu Ile Ala Met Ile Asn Ser Ser Phe Gln Glu Ile Glu Asp Asp
725 730 735
Ala Asp Val Glu Trp Lys Phe Ala Arg Ala Lys Leu Trp Phe Ser Tyr
740 745 750
Phe Glu Glu Gly Arg Thr Leu Pro Val Pro Phe Asn Leu Val Pro Ser
755 760 765
Pro Lys Ser Leu Leu Tyr Leu Leu Leu Lys Phe Lys Lys Trp Met Cys
770 775 780
Glu Leu Ile Gln Gly Gln Lys Gln Gly Phe Gln Glu Asp Ala Glu Met
785 790 795 800
Asn Lys Arg Asn Glu Glu Lys Lys Phe Gly Ile Ser Gly Ser His Glu
805 810 815
Asp Leu Ser Lys Phe Ser Leu Asp Lys Asn Gln Leu Ala His Asn Lys
820 825 830
Gln Ser Ser Thr Arg Ser Ser Glu Asp Tyr His Leu Asn Ser Phe Ser
835 840 845
Asn Pro Pro Arg Gln Tyr Gln Lys Ile Met Lys Arg Leu Ile Lys Arg
850 855 860
Tyr Val Leu Gln Ala Gln Ile Asp Lys Glu Ser Asp Glu Val Asn Glu
865 870 875 880
Gly Glu Leu Lys Glu Ile Lys Gln Asp Ile Ser Ser Leu Arg Tyr Glu
885 890 895
Leu Leu Glu Glu Lys Ser Gln Asn Ser Glu Asp Leu Ala Glu Leu Ile
900 905 910
Arg Lys Leu Gly Glu Arg Leu Ser Leu Glu Pro Lys Leu Glu Glu Ser
915 920 925
Arg Arg
930
<210>103
<211>522
<212>PRT
<213>智人(Homo sapiens)
<400>103
Gly Phe Leu Pro Ala Thr Lys Asn Leu Leu Asn Glu Lys Asn His Gly
1 5 10 15
Val Leu His Thr Ser Val Val Leu Leu Thr Glu Met Cys Glu Arg Ser
20 25 30
Pro Asp Met Leu Ala His Phe Arg Glu Asn Glu Lys Leu Val Pro Gln
35 40 45
Leu Val Arg Ile Leu Lys Asn Leu Ile Met Ser Gly Tyr Ser Pro Gly
50 55 60
His Asp Val Ser Gly Ile Ser Asp Pro Phe Leu Gln Val Arg Ile Leu
65 70 75 80
Arg Leu Leu Arg Ile Leu Gly Arg Asn Asp Asp Asp Ser Ser Glu Ala
85 90 95
Met Asn Asp Ile Leu Ala Gln Val Ala Thr Asn Thr Glu Thr Ser Lys
100 105 110
Asn Val Gly Asn Ala Ile Leu Tyr Glu Thr Val Leu Thr Ile Met Asp
115 120 125
Ile Lys Ser Glu Ser Gly Leu Arg Val Leu Ala Ile Asn Ile Leu Gly
130 135 140
Arg Phe Leu Leu Asn Asn Asp Lys Asn Ile Arg Tyr Val Ala Leu Thr
145 150 155 160
Ser Leu Leu Lys Thr Val Gln Thr Asp His Asn Ala Val Gln Arg His
165 170 175
Arg Ser Thr Ile Val Asp Cys Leu Lys Asp Leu Asp Val Ser Ile Lys
180 185 190
Arg Arg Ala Met Glu Leu Ser Phe Ala Leu Val Asn Gly Asn Asn Ile
195 200 205
Arg Gly Met Met Lys Glu Leu Leu Tyr Phe Leu Asp Ser Cys Glu Pro
210 215 220
Glu Phe Lys Ala Asp Cys Ala Ser Gly Ile Phe Leu Ala Ala Glu Lys
225 230 235 240
Tyr Ala Pro Ser Lys Arg Trp His Ile Asp Thr Ile Met Arg Val Leu
245 250 255
Thr Thr Ala Gly Ser Tyr Val Arg Asp Asp Ala Val Pro Asn Leu Ile
260 265 270
Gln Leu Ile Thr Asn Ser Val Glu Met His Ala Tyr Thr Val Gln Arg
275 280 285
Leu Tyr Lys Ala Ile Leu Gly Asp Tyr Ser Gln Gln Pro Leu Val Gln
290 295 300
Val Ala Ala Trp Cys Ile Gly Glu Tyr Gly Asp Leu Leu Val Ser Gly
305 310 315 320
Gln Cys Glu Glu Glu Glu Pro Ile Gln Val Thr Glu Asp Glu Val Leu
325 330 335
Asp Ile Leu Glu Ser Val Leu Ile Ser Asn Met Ser Thr Ser Val Thr
340 345 350
Arg Gly Tyr Ala Leu Thr Ala Ile Met Lys Leu Ser Thr Arg Phe Thr
355 360 365
Cys Thr Val Asn Arg Ile Lys Lys Val Val Ser Ile Tyr Gly Ser Ser
370 375 380
Ile Asp Val Glu Leu Gln Arg Arg Ala Val Glu Tyr Asn Ala Leu Phe
385 390 395 400
Lys Lys Tyr Asp His Met Arg Ser Ala Leu Leu Glu Arg Met Pro Val
405 410 415
Met Glu Lys Val Thr Thr Asn Gly Pro Thr Glu Ile Val Gln Thr Asn
420 425 430
Gly Glu Thr Glu Pro Ala Pro Leu Glu Thr Lys Pro Pro Pro Ser Gly
435 440 445
Pro Gln Pro Thr Ser Gln Ala Asn Asp Leu Leu Asp Leu Leu Gly Gly
450 455 460
Asn Asp Ile Thr Pro Val Ile Pro Thr Ala Pro Thr Ser Lys Pro Ser
465 470 475 480
Ser Ala Gly Gly Glu Leu Leu Asp Leu Leu Gly Asp Ile Asn Leu Thr
485 490 495
Gly Ser His Ser Val Ser Gln Ala Gly Val Gln Trp Asp Tyr Leu Gly
500 505 510
Ser Leu Gln Pro Leu Pro Pro Ala Phe Arg
515 520
<210>104
<211>407
<212>PRT
<213>智人(Homo sapiens)
<400>104
Met Trp Pro Asn Gly Ser Ser Leu Gly Pro Cys Phe Arg Pro Thr Asn
1 5 10 15
Ile Thr Leu Glu Glu Arg Arg Leu Ile Ala Ser Pro Trp Phe Ala Ala
20 25 30
Ser Phe Cys Val Val Gly Leu Ala Ser Asn Leu Leu Ala Leu Ser Val
35 40 45
Leu Ala Gly Ala Arg Gln Gly Gly Ser His Thr Arg Ser Ser Phe Leu
50 55 60
Thr Phe Leu Cys Gly Leu Val Leu Thr Asp Phe Leu Gly Leu Leu Val
65 70 75 80
Thr Gly Thr Ile Val Val Ser Gln His Ala Ala Leu Phe Glu Trp His
85 90 95
Ala Val Asp Pro Gly Cys Arg Leu Cys Arg Phe Met Gly Val Val Met
100 105 110
Ile Phe Phe Gly Leu Ser Pro Leu Leu Leu Gly Ala Ala Met Ala Ser
115 120 125
Glu Arg Tyr Leu Gly Ile Thr Arg Pro Phe Ser Arg Pro Ala Val Ala
130 135 140
Ser Gln Arg Arg Ala Trp Ala Thr Val Gly Leu Val Trp Ala Ala Ala
145 150 155 160
Leu Ala Leu Gly Leu Leu Pro Leu Leu Gly Val Gly Arg Tyr Thr Val
165 170 175
Gln Tyr Pro Gly Ser Trp Cys Phe Leu Thr Leu Gly Ala Glu Ser Gly
180 185 190
Asp Val Ala Phe Gly Leu Leu Phe Ser Met Leu Gly Gly Leu Ser Val
195 200 205
Gly Leu Ser Phe Leu Leu Asn Thr Val Ser Val Ala Thr Leu Cys His
210 215 220
Val Tyr His Gly Gln Glu Ala Ala Gln Gln Arg Pro Arg Asp Ser Glu
225 230 235 240
Val Glu Met Met Ala Gln Leu Leu Gly Ile Met Val Val Ala Ser Val
245 250 255
Cys Trp Leu Pro Leu Leu Val Phe Ile Ala Gln Thr Val Leu Arg Asn
260 265 270
Pro Pro Ala Met Ser Pro Ala Gly Gln Leu Ser Arg Thr Thr Glu Lys
275 280 285
Glu Leu Leu Ile Tyr Leu Arg Val Ala Thr Trp Asn Gln Ile Leu Asp
290 295 300
Pro Trp Val Tyr Ile Leu Phe Arg Arg Ala Val Leu Arg Arg Leu Gln
305 310 315 320
Pro Arg Leu Ser Thr Arg Pro Arg Arg Ser Leu Thr Leu Trp Pro Ser
325 330 335
Leu Glu Tyr Ser Gly Thr Ile Ser Ala His Cys Asn Leu Arg Leu Pro
340 345 350
Gly Ser Ser Asp Ser Arg Ala Ser Ala Ser Arg Ala Ala Gly Ile Thr
355 360 365
Gly Val Ser His Cys Ala Arg Pro Cys Met Leu Phe Asp Pro Glu Phe
370 375 380
Asp Leu Leu Ala Gly Val Gln Leu Leu Pro Phe Glu Pro Pro Thr Gly
385 390 395 400
Lys Ala Leu Ser Arg Lys Asp
405
<210>105
<211>741
<212>PRT
<213>智人(Homo sapiens)
<400>105
Met Asp Ile Glu Asp Glu Glu Asn Met Ser Ser Ser Ser Thr Asp Val
1 5 10 15
Lys Glu Asn Arg Asn Leu Asp Asn Val Ser Pro Lys Asp Gly Ser Thr
20 25 30
Pro Gly Pro Gly Glu Gly Ser Gln Leu Ser Asn Gly Gly Gly Gly Gly
35 40 45
Pro Gly Arg Lys Arg Pro Leu Glu Glu Gly Ser Asn Gly His Ser Lys
50 55 60
Tyr Arg Leu Lys Lys Arg Arg Lys Thr Pro Gly Pro Val Leu Pro Lys
65 70 75 80
Asn Ala Leu Met Gln Leu Asn Glu Ile Lys Pro Gly Leu Gln Tyr Thr
85 90 95
Leu Leu Ser Gln Thr Gly Pro Val His Ala Pro Leu Phe Val Met Ser
100 105 110
Val Glu Val Asn Gly Gln Val Phe Glu Gly Ser Gly Pro Thr Lys Lys
115 120 125
Lys Ala Lys Leu His Ala Ala Glu Lys Ala Leu Arg Ser Phe Val Gln
130 135 140
Phe Pro Asn Ala Ser Glu Ala His Leu Ala Met Gly Arg Thr Leu Ser
145 150 155 160
Val Asn Thr Asp Phe Thr Ser Asp Gln Ala Asp Phe Pro Asp Thr Leu
165 170 175
Phe Asn Gly Phe Glu Thr Pro Asp Lys Ala Glu Pro Pro Phe Tyr Val
180 185 190
Gly Ser Asn Gly Asp Asp Ser Phe Ser Ser Ser Gly Asp Leu Ser Leu
195 200 205
Ser Ala Ser Pro Val Pro Ala Ser Leu Ala Gln Pro Pro Leu Pro Val
210 215 220
Leu Pro Pro Phe Pro Pro Pro Ser Gly Lys Asn Pro Val Met Ile Leu
225 230 235 240
Asn Glu Leu Arg Pro Gly Leu Lys Tyr Asp Phe Leu Ser Glu Ser Gly
245 250 255
Glu Ser His Ala Lys Ser Phe Val Met Ser Val Val Val Asp Gly Gln
260 265 270
Phe Phe Glu Gly Ser Gly Arg Asn Lys Lys Leu Ala Lys Ala Arg Ala
275 280 285
Ala Gln Ser Ala Leu Ala Ala Ile Phe Asn Leu His Leu Asp Gln Thr
290 295 300
Pro Ser Arg Gln Pro Ile Pro Ser Glu Gly Leu Gln Leu His Leu Pro
305 310 315 320
Gln Val Leu Ala Asp Ala Val Ser Arg Leu Val Leu Gly Lys Phe Gly
325 330 335
Asp Leu Thr Asp Asn Phe Ser Ser Pro His Ala Arg Arg Lys Val Leu
340 345 350
Ala Gly Val Val Met Thr Thr Gly Thr Asp Val Lys Asp Ala Lys Val
355 360 365
Ile Ser Val Ser Thr Gly Thr Lys Cys Ile Asn Gly Glu Tyr Met Ser
370 375 380
Asp Arg Gly Leu Ala Leu Asn Asp Cys His Ala Glu Ile Ile Ser Arg
385 390 395 400
Arg Ser Leu Leu Arg Phe Leu Tyr Thr Gln Leu Glu Leu Tyr Leu Asn
405 410 415
Asn Lys Asp Asp Gln Lys Arg Ser Ile Phe Gln Lys Ser Glu Arg Gly
420 425 430
Gly Phe Arg Leu Lys Glu Asn Val Gln Phe His Leu Tyr Ile Ser Thr
435 440 445
Ser Pro Cys Gly Asp Ala Arg Ile Phe Ser Pro His Glu Pro Ile Leu
450 455 460
Glu Gly Ser Arg Ser Tyr Thr Gln Ala Gly Val Gln Trp Cys Asn His
465 470 475 480
Gly Ser Leu Gln Pro Arg Pro Pro Gly Leu Leu Ser Asp Pro Ser Thr
485 490 495
Ser Thr Phe Gln Gly Ala Gly Thr Thr Glu Pro Ala Asp Arg His Pro
500 505 510
Asn Arg Lys Ala Arg Gly Gln Leu Arg Thr Lys Ile Glu Ser Gly Glu
515 520 525
Gly Thr Ile Pro Val Arg Ser Asn Ala Ser Ile Gln Thr Trp Asp Gly
530 535 540
Val Leu Gln Gly Glu Arg Leu Leu Thr Met Ser Cys Ser Asp Lys Ile
545 550 555 560
Ala Arg Trp Asn Val Val Gly Ile Gln Gly Ser Leu Leu Ser Ile Phe
565 570 575
Val Glu Pro Ile Tyr Phe Ser Ser Ile Ile Leu Gly Ser Leu Tyr His
580 585 590
Gly Asp His Leu Ser Arg Ala Met Tyr Gln Arg Ile Ser Asn Ile Glu
595 600 605
Asp Leu Pro Pro Leu Tyr Thr Leu Asn Lys Pro Leu Leu Ser Gly Ile
610 615 620
Ser Asn Ala Glu Ala Arg Gln Pro Gly Lys Ala Pro Asn Phe Ser Val
625 630 635 640
Asn Trp Thr Val Gly Asp Ser Ala Ile Glu Val Ile Asn Ala Thr Thr
645 650 655
Gly Lys Asp Glu Leu Gly Arg Ala Ser Arg Leu Cys Lys His Ala Leu
660 665 670
Tyr Cys Arg Trp Met Arg Val His Gly Lys Val Pro Ser His Leu Leu
675 680 685
Arg Ser Lys Ile Thr Lys Pro Asn Val Tyr His Glu Ser Lys Leu Ala
690 695 700
Ala Lys Glu Tyr Gln Ala Ala Lys Ala Arg Leu Phe Thr Ala Phe Ile
705 710 715 720
Lys Ala Gly Leu Gly Ala Trp Val Glu Lys Pro Thr Glu Gln Asp Gln
725 730 735
Phe Ser Leu Thr Pro
740
<210>106
<211>714
<212>PRT
<213>智人(Homo sapiens)
<400>106
Met Asp Ile Glu Asp Glu Glu Asn Met Ser Ser Ser Ser Thr Asp Val
1 5 10 15
Lys Glu Asn Arg Asn Leu Asp Asn Val Ser Pro Lys Asp Gly Ser Thr
20 25 30
Pro Gly Pro Gly Glu Gly Ser Gln Leu Ser Asn Gly Gly Gly Gly Gly
35 40 45
Pro Gly Arg Lys Arg Pro Leu Glu Glu Gly Ser Asn Gly His Ser Lys
50 55 60
Tyr Arg Leu Lys Lys Arg Arg Lys Thr Pro Gly Pro Val Leu Pro Lys
65 70 75 80
Asn Ala Leu Met Gln Leu Asn Glu Ile Lys Pro Gly Leu Gln Tyr Thr
85 90 95
Leu Leu Ser Gln Thr Gly Pro Val His Ala Pro Leu Phe Val Met Ser
100 105 110
Val Glu Val Asn Gly Gln Val Phe Glu Gly Ser Gly Pro Thr Lys Lys
115 120 125
Lys Ala Lys Leu His Ala Ala Glu Lys Ala Leu Arg Ser Phe Val Gln
130 135 140
Phe Pro Asn Ala Ser Glu Ala His Leu Ala Met Gly Arg Thr Leu Ser
145 150 155 160
Val Asn Thr Asp Phe Thr Ser Asp Gln Ala Asp Phe Pro Asp Thr Leu
165 170 175
Phe Asn Gly Phe Glu Thr Pro Asp Lys Ala Glu Pro Pro Phe Tyr Val
180 185 190
Gly Ser Asn Gly Asp Asp Ser Phe Ser Ser Ser Gly Asp Leu Ser Leu
195 200 205
Ser Ala Ser Pro Val Pro Ala Ser Leu Ala Gln Pro Pro Leu Pro Val
210 215 220
Leu Pro Pro Phe Pro Pro Pro Ser Gly Lys Asn Pro Val Met Ile Leu
225 230 235 240
Asn Glu Leu Arg Pro Gly Leu Lys Tyr Asp Phe Leu Ser Glu Ser Gly
245 250 255
Glu Ser His Ala Lys Ser Phe Val Met Ser Val Val Val Asp Gly Gln
260 265 270
Phe Phe Glu Gly Ser Gly Arg Asn Lys Lys Leu Ala Lys Ala Arg Ala
275 280 285
Ala Gln Ser Ala Leu Ala Ala Ile Phe Asn Leu His Leu Asp Gln Thr
290 295 300
Pro Ser Arg Gln Pro Ile Pro Ser Glu Gly Leu Gln Leu His Leu Pro
305 310 315 320
Gln Val Leu Ala Asp Ala Val Ser Arg Leu Val Leu Gly Lys Phe Gly
325 330 335
Asp Leu Thr Asp Asn Phe Ser Ser Pro His Ala Arg Arg Lys Val Leu
340 345 350
Ala Gly Val Val Met Thr Thr Gly Thr Asp Val Lys Asp Ala Lys Val
355 360 365
Ile Ser Val Ser Thr Gly Thr Lys Cys Ile Asn Gly Glu Tyr Met Ser
370 375 380
Asp Arg Gly Leu Ala Leu Asn Asp Cys His Ala Glu Ile Ile Ser Arg
385 390 395 400
Arg Ser Leu Leu Arg Phe Leu Tyr Thr Gln Leu Glu Leu Tyr Leu Asn
405 410 415
Asn Lys Asp Asp Gln Lys Arg Ser Ile Phe Gln Lys Ser Glu Arg Gly
420 425 430
Gly Phe Arg Leu Lys Glu Asn Val Gln Phe His Leu Tyr Ile Ser Thr
435 440 445
Ser Pro Cys Gly Asp Ala Arg Ile Phe Ser Pro His Glu Pro Ile Leu
450 455 460
Glu Gly Ser Arg Ser Tyr Thr Gln Ala Gly Val Gln Trp Cys Asn His
465 470 475 480
Gly Ser Leu Gln Pro Arg Pro Pro Gly Leu Leu Ser Asp Pro Ser Thr
485 490 495
Ser Thr Phe Gln Gly Ala Gly Thr Thr Glu Pro Ala Asp Arg His Pro
500 505 510
Asn Arg Lys Ala Arg Gly Gln Leu Arg Thr Lys Ile Glu Ser Gly Glu
515 520 525
Gly Thr Ile Pro Val Arg Ser Asn Ala Ser Ile Gln Thr Trp Asp Gly
530 535 540
Val Leu Gln Gly Glu Arg Leu Leu Thr Met Ser Cys Ser Asp Lys Ile
545 550 555 560
Ala Arg Trp Asn Val Val Gly Ile Gln Gly Ser Leu Leu Ser Ile Phe
565 570 575
Val Glu Pro Ile Tyr Phe Ser Ser Ile Ile Leu Gly Ser Leu Tyr His
580 585 590
Gly Asp His Leu Ser Arg Ala Met Tyr Gln Arg Ile Ser Asn Ile Glu
595 600 605
Asp Leu Pro Pro Leu Tyr Thr Leu Asn Lys Pro Leu Leu Ser Gly Ile
610 615 620
Ser Asn Ala Glu Ala Arg Gln Pro Gly Lys Ala Pro Asn Phe Ser Val
625 630 635 640
Asn Trp Thr Val Gly Asp Ser Ala Ile Glu Val Ile Asn Ala Thr Thr
645 650 655
Gly Lys Asp Glu Leu Gly Arg Ala Ser Arg Leu Cys Lys His Ala Leu
660 665 670
Tyr Cys Arg Trp Met Arg Val His Gly Lys Val Pro Ser His Leu Leu
675 680 685
Arg Ser Lys Ile Thr Lys Pro Asn Val Tyr His Glu Ser Lys Leu Ala
690 695 700
Ala Lys Glu Tyr Gln Ala Ala Lys Val His
705 710
<210>107
<211>76
<212>PRT
<213>智人(Homo sapiens)
<400>107
Met Glu Val Leu Leu Phe Leu Phe Ile Phe Glu Thr Glu Ser Cys Ser
1 5 10 15
Val Ile Arg Leu Glu Cys Ser Gly Ser Leu Gln Pro Pro Pro Pro Arg
20 25 30
Phe Lys Gln Phe Ser Cys Leu Ser Leu Pro Ser Ser Trp Asp Tyr Arg
35 40 45
Cys Pro Pro Pro Cys Pro Ile Asn Phe Cys Ile Phe Gly Thr Asp Arg
50 55 60
Val Ser Pro Cys Trp Pro Gly Trp Ser Arg Ser Arg
65 70 75
<210>108
<211>977
<212>PRT
<213>智人(Homo sapiens)
<400>108
Met Ala Gln Phe Tyr Tyr Lys Arg Asn Val Asn Ala Pro Tyr Arg Asp
1 5 10 15
Arg Ile Pro Leu Arg Ile Val Arg Ala Glu Ser Glu Leu Ser Pro Ser
20 25 30
Glu Lys Ala Tyr Leu Asn Ala Val Glu Lys Gly Asp Tyr Ala Ser Val
35 40 45
Lys Lys Ser Leu Glu Glu Ala Glu Ile Tyr Phe Lys Ile Asn Ile Asn
50 55 60
Cys Ile Asp Pro Leu Gly Arg Thr Ala Leu Leu Ile Ala Ile Glu Asn
65 70 75 80
Glu Asn Leu Glu Leu Ile Glu Leu Leu Leu Ser Phe Asn Val Tyr Val
85 90 95
Gly Asp Ala Leu Leu His Ala Ile Arg Lys Glu Val Val Gly Ala Val
100 105 110
Glu Leu Leu Leu Asn His Lys Lys Pro Ser Gly Glu Lys Gln Val Pro
115 120 125
Pro Ile Leu Leu Asp Lys Gln Phe Ser Glu Phe Thr Pro Asp Ile Thr
130 135 140
Pro Ile Ile Leu Ala Ala His Thr Asn Asn Tyr Glu Ile Ile Lys Leu
145 150 155 160
Leu Val Gln Lys Gly Val Ser Val Pro Arg Pro His Glu Val Arg Cys
165 170 175
Asn Cys Val Glu Cys Val Ser Ser Ser Asp Val Asp Ser Leu Arg His
180 185 190
Ser Arg Ser Arg Leu Asn Ile Tyr Lys Ala Leu Ala Ser Pro Ser Leu
195 200 205
Ile Ala Leu Ser Ser Glu Asp Pro Phe Leu Thr Ala Phe Gln Leu Ser
210 215 220
Trp Glu Leu Gln Glu Leu Ser Lys Val Glu Asn Glu Phe Lys Ser Glu
225 230 235 240
Tyr Glu Glu Leu Ser Arg Gln Cys Lys Gln Phe Ala Lys Asp Leu Leu
245 250 255
Asp Gln Thr Arg Ser Ser Arg Glu Leu Glu Ile Ile Leu Asn Tyr Arg
260 265 270
Asp Asp Asn Ser Leu Ile Glu Glu Gln Ser Gly Asn Asp Leu Ala Arg
275 280 285
Leu Lys Leu Ala Ile Lys Tyr Arg Gln Lys Glu Phe Val Ala Gln Pro
290 295 300
Asn Cys Gln Gln Leu Leu Ala Ser Arg Trp Tyr Asp Glu Phe Pro Gly
305 310 315 320
Trp Arg Arg Arg His Trp Ala Val Lys Met Val Thr Cys Phe Ile Ile
325 330 335
Gly Leu Leu Phe Pro Val Phe Ser Val Cys Tyr Leu Ile Ala Pro Lys
340 345 350
Ser Pro Leu Gly Leu Phe Ile Arg Lys Pro Phe Ile Lys Phe Ile Cys
355 360 365
His Thr Ala Ser Tyr Leu Thr Phe Leu Phe Leu Leu Leu Leu Ala Ser
370 375 380
Gln His Ile Asp Arg Ser Asp Leu Asn Arg Gln Gly Pro Pro Pro Thr
385 390 395 400
Ile Val Glu Trp Met Ile Leu Pro Trp Val Leu Gly Phe Ile Trp Gly
405 410 415
Glu Ile Lys Gln Met Trp Asp Gly Gly Leu Gln Asp Tyr Ile His Asp
420 425 430
Trp Trp Asn Leu Met Asp Phe Val Met Asn Ser Leu Tyr Leu Ala Thr
435 440 445
Ile Ser Leu Lys Ile Val Ala Phe Val Lys Tyr Ser Ala Leu Asn Pro
450 455 460
Arg Glu Ser Trp Asp Met Trp His Pro Thr Leu Val Ala Glu Ala Leu
465 470 475 480
Phe Ala Ile Ala Asn Ile Phe Ser Ser Leu Arg Leu Ile Ser Leu Phe
485 490 495
Thr Ala Asn Ser His Leu Gly Pro Leu Gln Ile Ser Leu Gly Arg Met
500 505 510
Leu Leu Asp Ile Leu Lys Phe Leu Phe Ile Tyr Cys Leu Val Leu Leu
515 520 525
Ala Phe Ala Asn Gly Leu Asn Gln Leu Tyr Phe Tyr Tyr Glu Glu Thr
530 535 540
Lys Gly Leu Thr Cys Lys Gly Ile Arg Cys Glu Lys Gln Asn Asn Ala
545 550 555 560
Phe Ser Thr Leu Phe Glu Thr Leu Gln Ser Leu Phe Trp Ser Ile Phe
565 570 575
Gly Leu Ile Asn Leu Tyr Val Thr Asn Val Lys Ala Gln His Glu Phe
580 585 590
Thr Glu Phe Val Gly Ala Thr Met Phe Gly Thr Tyr Asn Val Ile Ser
595 600 605
Leu Val Val Leu Leu Asn Met Leu Ile Ala Met Met Asn Asn Ser Tyr
610 615 620
Gln Leu Ile Ala Asp His Ala Asp Ile Glu Trp Lys Phe Ala Arg Thr
625 630 635 640
Lys Leu Trp Met Ser Tyr Phe Glu Glu Gly Gly Thr Leu Pro Thr Pro
645 650 655
Phe Asn Val Ile Pro Ser Pro Lys Ser Leu Trp Tyr Leu Ile Lys Trp
660 665 670
Ile Trp Thr His Leu Cys Lys Lys Lys Met Arg Arg Lys Pro Glu Ser
675 680 685
Phe Gly Thr Ile Gly Arg Arg Ala Ala Asp Asn Leu Arg Arg His His
690 695 700
Gln Tyr Gln Glu Val Met Arg Asn Leu Val Lys Arg Tyr Val Ala Ala
705 710 715 720
Met Ile Arg Asp Ala Lys Thr Glu Glu Gly Leu Thr Glu Glu Asn Phe
725 730 735
Lys Glu Leu Lys Gln Asp Ile Ser Ser Phe Arg Phe Glu Val Leu Gly
740 745 750
Leu Leu Arg Gly Ser Lys Leu Ser Thr Ile Gln Ser Ala Asn Ala Ser
755 760 765
Lys Glu Ser Ser Asn Ser Ala Asp Ser Asp Glu Lys Ser Asp Ser Glu
770 775 780
Gly Asn Ser Lys Asp Lys Lys Lys Asn Phe Ser Leu Phe Asp Leu Thr
785 790 795 800
Thr Leu Ile His Pro Arg Ser Ala Ala Ile Ala Ser Glu Arg His Asn
805 810 815
Ile Ser Asn Gly Ser Ala Leu Val Val Gln Glu Pro Pro Arg Glu Lys
820 825 830
Gln Arg Lys Val Asn Phe Val Thr Asp Ile Lys Asn Phe Gly Leu Phe
835 840 845
His Arg Arg Ser Lys Gln Asn Ala Ala Glu Gln Asn Ala Asn Gln Ile
850 855 860
Phe Ser Val Ser Glu Glu Val Ala Arg Gln Gln Ala Ala Gly Pro Leu
865 870 875 880
Glu Arg Asn Ile Gln Leu Glu Ser Arg Gly Leu Ala Ser Arg Gly Asp
885 890 895
Leu Ser Ile Pro Gly Leu Ser Glu Gln Cys Val Leu Val Asp His Arg
900 905 910
Glu Arg Asn Thr Asp Thr Leu Gly Leu Gln Val Gly Lys Arg Val Cys
915 920 925
Pro Phe Lys Ser Glu Lys Val Val Val Glu Asp Thr Val Pro Ile Ile
930 935 940
Pro Lys Glu Lys His Ala Lys Glu Glu Asp Ser Ser Ile Asp Tyr Asp
945 950 955 960
Leu Asn Leu Pro Asp Thr Val Thr His Glu Asp Tyr Val Thr Thr Arg
965 970 975
Leu
<210>109
<211>275
<212>PRT
<213>智人(Homo sapiens)
<400>109
Met Glu Ser Tyr Ser Val Thr Gln Ala Gly Val Gln Trp His Glu Leu
1 5 10 15
Cys Ser Leu Gln Pro Ser Pro Pro Arg Phe Arg Glu Met Cys Ile Glu
20 25 30
Gln Asp Gly Arg Val His Leu Thr Val Val Tyr Phe Gly Lys Glu Glu
35 40 45
Ile Asn Glu Val Lys Gly Val Leu Glu Asn Thr Ser Lys Ala Ala Asn
50 55 60
Phe Arg Asn Phe Thr Phe Ile Gln Leu Asn Gly Glu Phe Ser Arg Gly
65 70 75 80
Lys Gly Leu Asp Val Gly Ala Arg Phe Trp Lys Gly Ser Asn Val Leu
85 90 95
Leu Phe Phe Cys Asp Val Asp Ile Tyr Phe Thr Ser Glu Phe Leu Asn
100 105 110
Thr Cys Arg Leu Asn Thr Gln Pro Gly Lys Lys Val Phe Tyr Pro Val
115 120 125
Leu Phe Ser Gln Tyr Asn Pro Gly Ile Ile Tyr Gly His His Asp Ala
130 135 140
Val Pro Pro Leu Glu Gln Gln Leu Val Ile Lys Lys Glu Thr Gly Phe
145 150 155 160
Trp Arg Asp Phe Gly Phe Gly Met Thr Cys Gln Tyr Arg Ser Asp Phe
165 170 175
Ile Asn Ile Gly Gly Phe Asp Leu Asp Ile Lys Gly Trp Gly Gly Glu
180 185 190
Asp Val His Leu Tyr Arg Lys Tyr Leu His Ser Asn Leu Ile Val Val
195 200 205
Arg Thr Pro Val Arg Gly Leu Phe His Leu Trp His Glu Lys Arg Cys
210 215 220
Met Asp Glu Leu Thr Pro Glu Gln Tyr Lys Met Cys Met Gln Ser Lys
225 230 235 240
Ala Met Asn Glu Ala Ser His Gly Gln Leu Gly Met Leu Val Phe Arg
245 250 255
His Glu Ile Glu Ala His Leu Arg Lys Gln Lys Gln Lys Thr Ser Ser
260 265 270
Lys Lys Thr
275
<210>110
<211>1084
<212>PRT
<213>智人(Homo sapiens)
<400>110
Met Asp Ile Thr Leu Val Arg Lys Glu Leu Gln Glu Leu Gln Asn Leu
1 5 10 15
Tyr Lys Gln Asn Ser Thr His Thr Ala Gln Gln Ala Glu Leu Ile Gln
20 25 30
Gln Leu Gln Val Leu Asn Met Asp Thr Gln Lys Val Leu Arg Asn Gln
35 40 45
Glu Asp Val His Thr Ala Glu Ser Ile Ser Tyr Gln Lys Leu Tyr Asn
50 55 60
Glu Leu His Ile Cys Phe Glu Thr Thr Lys Ser Asn Glu Ala Met Leu
65 70 75 80
Arg Gln Ser Val Thr Asn Leu Gln Asp Gln Leu Leu Gln Lys Glu Gln
85 90 95
Glu Asn Ala Lys Leu Lys Glu Lys Leu Gln Glu Ser Gln Gly Ala Pro
100 105 110
Leu Pro Leu Pro Gln Glu Ser Asp Pro Asp Tyr Ser Ala Gln Val Pro
115 120 125
His Arg Pro Ser Leu Ser Ser Leu Glu Thr Leu Met Val Ser Gln Lys
130 135 140
Ser Glu Ile Glu Tyr Leu Gln Glu Lys Leu Lys Ile Ala Asn Glu Lys
145 150 155 160
Leu Ser Glu Asn Ile Ser Ala Asn Lys Gly Phe Ser Arg Lys Ser Ile
165 170 175
Met Thr Ser Ala Glu Gly Lys His Lys Glu Pro Pro Val Lys Arg Ser
180 185 190
Arg Ser Leu Ser Pro Lys Ser Ser Phe Thr Asp Ser Glu Glu Leu Gln
195 200 205
Lys Leu Arg Lys Ala Glu Arg Lys Ile Glu Asn Leu Glu Lys Ala Leu
210 215 220
Gln Leu Lys Ser Gln Glu Asn Asp Glu Leu Arg Asp Ala His Glu Lys
225 230 235 240
Arg Lys Glu Arg Leu Gln Met Leu Gln Thr Asn Tyr Arg Ala Val Lys
245 250 255
Glu Gln Leu Lys Gln Trp Glu Glu Gly Ser Gly Met Thr Glu Ile Arg
260 265 270
Lys Ile Lys Arg Ala Asp Pro Gln Gln Leu Arg Gln Glu Asp Ser Asp
275 280 285
Ala Val Trp Asn Glu Leu Ala Tyr Phe Lys Arg Glu Asn Gln Glu Leu
290 295 300
Met Ile Gln Lys Met Asn Leu Glu Glu Glu Leu Asp Glu Leu Lys Val
305 310 315 320
His Ile Ser Ile Asp Lys Ala Ala Ile Gln Glu Leu Asn Arg Cys Val
325 330 335
Ala Glu Arg Arg Glu Glu Gln Leu Phe Arg Ser Gly Glu Asp Asp Glu
340 345 350
Val Lys Arg Ser Thr Pro Glu Lys Asn Gly Lys Glu Met Leu Glu Gln
355 360 365
Thr Leu Gln Lys Val Ile Glu Leu Glu Asn Arg Leu Lys Ser Phe Glu
370 375 380
Lys Arg Ser Arg Lys Leu Lys Glu Gly Asn Lys Lys Leu Met Lys Glu
385 390 395 400
Asn Asp Phe Leu Lys Ser Leu Leu Lys Gln Gln Gln Glu Asp Thr Glu
405 410 415
Thr Arg Glu Lys Glu Leu Glu Gln Ile Ile Lys Gly Ser Lys Asp Val
420 425 430
Glu Lys Glu Asn Thr Glu Leu Gln Val Lys Ile Ser Glu Leu Glu Thr
435 440 445
Glu Val Thr Ser Leu Arg Arg Gln Val Ala Glu Ala Asn Ala Leu Arg
450 455 460
Asn Glu Asn Glu Glu Leu Ile Asn Pro Met Glu Lys Ser His Gln Ser
465 470 475 480
Ala Asp Arg Ala Lys Ser Glu Met Ala Thr Met Lys Val Arg Ser Gly
485 490 495
Arg Tyr Asp Cys Lys Thr Thr Met Thr Lys Val Lys Phe Lys Ala Ala
500 505 510
Lys Lys Asn Cys Ser Val Gly Arg His His Thr Val Leu Asn His Ser
515 520 525
Ile Lys Val Met Ser Asn Val Phe Glu Asn Leu Ser Lys Asp Gly Trp
530 535 540
Glu Asp Val Ser Glu Ser Ser Ser Asp Ser Glu Ala Gln Thr Ser Gln
545 550 555 560
Thr Leu Gly Thr Ile Ile Val Glu Thr Ser Gln Lys Ile Ser Pro Thr
565 570 575
Glu Asp Gly Lys Asp Gln Lys Glu Ser Asp Pro Thr Glu Asp Ser Gln
580 585 590
Thr Gln Gly Lys Glu Ile Val Gln Thr Tyr Leu Asn Ile Asp Gly Lys
595 600 605
Thr Pro Lys Asp Tyr Phe His Asp Lys Asn Ala Lys Lys Pro Thr Phe
610 615 620
Gln Lys Lys Asn Cys Lys Met Gln Lys Ser Ser His Thr Ala Val Pro
625 630 635 640
Thr Arg Val Asn Arg Glu Lys Tyr Lys Asn Ile Thr Ala Gln Lys Ser
645 650 655
Ser Ser Asn Ile Ile Leu Leu Arg Glu Arg Ile Ile Ser Leu Gln Gln
660 665 670
Gln Asn Ser Val Leu Gln Asn Ala Lys Lys Thr Ala Glu Leu Ser Val
675 680 685
Lys Glu Tyr Lys Glu Val Asn Glu Lys Leu Leu His Gln Gln Gln Val
690 695 700
Ser Asp Gln Arg Phe Gln Thr Ser Arg Gln Thr Ile Lys Lys Leu Asn
705 710 715 720
Leu Asp Leu Ala Gly Leu Arg Lys Glu Lys Glu Asp Leu Leu Lys Lys
725 730 735
Leu Glu Ser Ser Ser Glu Ile Thr Ser Leu Ala Glu Glu Asn Ser Gln
740 745 750
Val Thr Phe Pro Arg Ile Gln Val Thr Ser Leu Ser Pro Ser Arg Ser
755 760 765
Met Asp Leu Glu Met Lys Gln Leu Gln Tyr Lys Leu Lys Asn Ala Thr
770 775 780
Asn Glu Leu Thr Lys Gln Ser Ser Asn Val Lys Thr Leu Lys Phe Glu
785 790 795 800
Leu Leu Ala Lys Glu Glu His Ile Lys Glu Met His Glu Lys Ile Ser
805 810 815
Arg Met Glu Arg Asp Ile Thr Met Lys Arg His Leu Ile Glu Asp Leu
820 825 830
Lys Phe Arg Gln Lys Val Asn Leu Glu Ser Asn Lys Ser Phe Ser Glu
835 840 845
Met Leu Gln Asn Leu Asp Lys Lys Val Lys Thr Leu Thr Glu Glu Cys
850 855 860
Ser Asn Lys Lys Val Ser Ile Asp Ser Leu Lys Gln Arg Leu Asn Val
865 870 875 880
Ala Val Lys Glu Lys Ser Gln Tyr Glu Gln Met Tyr Gln Lys Ser Lys
885 890 895
Glu Glu Leu Glu Lys Lys Asp Leu Lys Leu Thr Leu Leu Val Ser Arg
900 905 910
Ile Ser Glu Thr Glu Ser Ala Met Ala Glu Ile Glu Thr Ala Ala Ser
915 920 925
Lys Gln Leu Gln Glu Leu Ala Leu Gln Ser Glu Gln Val Leu Glu Gly
930 935 940
Ala Gln Lys Thr Leu Leu Leu Ala Asn Glu Lys Val Glu Glu Phe Thr
945 950 955 960
Thr Phe Val Lys Ala Leu Ala Lys Glu Leu Gln Asn Asp Val His Val
965 970 975
Val Arg Arg Gln Ile Arg Glu Leu Lys Lys Met Lys Lys Asn Arg Asp
980 985 990
Ala Cys Lys Thr Ser Thr His Lys Ala Gln Thr Leu Ala Ala Ser Ile
995 1000 1005
Leu Asn Ile Ser Arg Ser Asp Leu Glu Glu Ile Leu Asp Thr Glu Asp
1010 1015 1020
Gln Val Glu Ile Glu Lys Thr Lys Ile Asp Ala Glu Asn Asp Lys Glu
1025 1030 1035 1040
Trp Met Leu Tyr Ile Gln Lys Leu Leu Glu Gly Gln Ser Leu Thr Leu
1045 1050 1055
Ser Pro Arg Leu Lys Cys Asn Gly Ala Ile Met Ala His Gln Asn Leu
1060 1065 1070
Arg Leu Pro Asp Ser Ser Ser Ser Ala Ser Ala Ser
1075 1080
<210>111
<211>687
<212>PRT
<213>智人(Homo sapiens)
<400>111
Met Lys Val Val Pro Glu Lys Asn Ala Val Arg Ile Leu Trp Gly Arg
1 5 10 15
Glu Arg Gly Ala Arg Ala Met Gly Ala Gln Arg Leu Leu Gln Glu Leu
20 25 30
Val Glu Asp Lys Thr Arg Trp Met Lys Trp Glu Gly Lys Arg Val Glu
35 40 45
Leu Pro Asp Ser Pro Arg Ser Thr Phe Leu Leu Ala Phe Ser Pro Asp
50 55 60
Arg Thr Leu Leu Ala Ser Thr His Val Asn His Asn Ile Tyr Ile Thr
65 70 75 80
Glu Val Lys Thr Gly Lys Cys Val His Ser Leu lle Gly His Arg Arg
85 90 95
Thr Pro Trp Cys Val Thr Phe His Pro Thr Ile Ser Gly Leu Ile Ala
100 105 110
Ser Gly Cys Leu Asp Gly Glu Val Arg Ile Trp Asp Leu His Gly Gly
115 120 125
Ser Glu Ser Trp Phe Thr Asp Ser Asn Asn Ala Ile Ala Ser Leu Ala
130 135 140
Phe His Pro Thr Ala Gln Leu Leu Leu Ile Ala Thr Ala Asn Glu Ile
145 150 155 160
His Phe Trp Asp Arg Ser Arg Arg Glu Pro Phe Ala Val Val Lys Thr
165 170 175
Ala Ser Glu Met Glu Arg Val Arg Leu Val Arg Phe Asp Pro Leu Gly
180 185 190
His Tyr Leu Leu Thr Ala Ile Val Asn Pro Ser Asn Gln Gln Gly Asp
195 200 205
Asp Glu Pro Glu Ile Pro Ile Asp Gly Thr Glu Leu Ser His Tyr Arg
210 215 220
Gln Arg Ala Leu Leu Gln Ser Gln Pro Val Arg Arg Thr Pro Leu Leu
225 230 235 240
His Asn Phe Leu His Met Leu Ser Ser Arg Ser Ser Gly Ile Gln Thr
245 250 255
Glu Pro Phe His Pro Pro Glu Gln Ala Ser Ser Thr Gln Gln Asp Gln
260 265 270
Gly Leu Leu Asn Arg Pro Ser Ala Phe Ser Thr Val Gln Ser Ser Thr
275 280 285
Ala Gly Asn Thr Leu Arg Asn Leu Ser Leu Gly Pro Thr Arg Arg Ser
290 295 300
Leu Gly Gly Pro Leu Ser Ser His Pro Ser Arg Tyr His Arg Glu Ile
305 310 315 320
Ala Pro Gly Leu Thr Gly Ser Glu Trp Thr Arg Thr Val Leu Ser Leu
325 330 335
Asn Ser Arg Ser Glu Ala Glu Ser Met Pro Pro Pro Arg Thr Ser Ala
340 345 350
Ser Ser Val Ser Leu Leu Ser Val Leu Arg Gln Gln Glu Gly Gly Ser
355 360 365
Gln Ala Ser Val Tyr Thr Ser Ala Thr Glu Gly Arg Gly Phe Pro Ala
370 375 380
Ser Gly Leu Ala Thr Glu Ser Asp Gly Gly Asn Gly Ser Ser Gln Asn
385 390 395 400
Asn Ser Gly Ser Ile Arg His Glu Leu Gln Cys Asp Leu Arg Arg Phe
405 410 415
Phe Leu Glu Tyr Asp Arg Leu Gln Glu Leu Asp Gln Ser Leu Ser Gly
420 425 430
Glu Ala Pro Gln Thr Gln Gln Ala Gln Glu Met Leu Asn Asn Asn Ile
435 440 445
Glu Ser Glu Arg Pro Gly Pro Ser His Gln Pro Thr Pro His Ser Ser
450 455 460
Glu Asn Asn Ser Asn Leu Ser Arg Gly His Leu Asn Arg Cys Arg Ala
465 470 475 480
Cys His Asn Leu Leu Thr Phe Asn Asn Asp Thr Leu Arg Trp Glu Arg
485 490 495
Thr Thr Pro Asn Tyr Ser Ser Gly Glu Ala Ser Ser Ser Trp Gln Val
500 505 510
Pro Ser Ser Phe Glu Ser Val Pro Ser Ser Gly Ser Gln Leu Pro Pro
515 520 525
Leu Glu Arg Thr Glu Gly Gln Thr Pro Ser Ser Ser Arg Leu Glu Leu
530 535 540
Ser Ser Ser Ala Ser Pro Gln Glu Glu Arg Thr Val Gly Val Ala Phe
545 550 555 560
Asn Gln Glu Thr Gly His Trp Glu Arg Ile Tyr Thr Gln Ser Ser Arg
565 570 575
Ser Gly Thr Val Ser Gln Glu Ala Leu His Gln Asp Met Pro Glu Glu
580 585 590
Ser Ser Glu Glu Asp Ser Leu Arg Arg Arg Ser Leu Ala Leu Ser Pro
595 600 605
Arg Leu Glu Tyr Ser Gly Ala Ile Leu Ala His Cys Lys Leu Arg Leu
610 615 620
Pro Gly Ser Cys His Ser Pro Ala Ser Ala Ser Gln Val Ala Gly Thr
625 630 635 640
Thr Gly Ala His His His Ala Arg Leu Ile Phe Ala Phe Leu Val Glu
645 650 655
Met Glu Phe His His Val Ser Gln Ala Gly Leu Glu Leu Leu Thr Ser
660 665 670
Gly Asp Leu Pro Thr Ser Ala Ser Gln Val Leu Gly Leu Gln Ala
675 680 685
<210>112
<211>152
<212>PRT
<213>智人(Homo sapiens)
<400>112
Met Val His Ser Pro Arg Ser Leu Val Ala Asn Pro Ser Gln Val Leu
1 5 10 15
Phe Phe Leu Ser Phe Leu Phe Phe Phe Phe Leu Arg Gln Ser Phe Ala
20 25 30
Leu Val Ala Gln Ala Gly Val Gln Trp Arg Asn Leu Gly Ser Leu Gln
35 40 45
Pro Pro Pro Pro Gly Phe Lys Gln Phe Ser Cys Leu Ser Leu Leu Ser
50 55 60
Ser Trp Asp Tyr Arg His Ala Pro Pro Cys Pro Ala Tyr Phe Val Phe
65 70 75 80
Leu Val Asp Met Gly Phe Pro His Val Gly Gln Thr Gly Leu Glu Leu
85 90 95
Leu Thr Ser Gly Asp Pro Pro Ala Ser Ala Ser Gln Ser Ala Gly Ile
100 105 110
Thr Gly Gly Ser His Arg Ala Gln Pro Thr Ser Ser Asn Pro Tyr Gly
115 120 125
Ile Val Phe Phe Phe Leu Pro Val Lys Thr Phe Ser Gly Met Ser Gln
130 135 140
Glu Ala Gly Asp Cys Arg Glu Thr
145 150
<210>113
<211>239
<212>PRT
<213>智人(Homo sapiens)
<400>113
Met Pro Thr Ala Thr Gly Leu Thr Leu Leu Thr Ser Ala Ser Ser Ala
1 5 10 15
Ile Ser Asp Pro Gly Gly Glu Val Ser Ala Pro Trp Gly Gly Leu Arg
20 25 30
Thr Trp Thr Gln Pro Leu Arg Cys Trp Glu Arg Leu Leu Pro Pro Pro
35 40 45
Gly Asp Pro Arg Thr Val Ala Glu Asn Thr Gln Gln Asp Glu Cys Gly
50 55 60
Leu Pro Gly Ser Cys Pro Ala Arg Pro Leu Ser Arg Lys Pro Glu Cys
65 70 75 80
Gly Arg Glu Gly Ile Leu Pro Cys Cys Ser Ser Ser Ala Trp Pro Glu
85 90 95
Gly Ser Phe Arg Pro Phe Gln Met Asn Leu Phe Ser Phe Leu Ser Phe
100 105 110
Phe Phe Leu Phe Phe Phe Phe Leu Arg Trp Ser Leu Thr Leu Ser Pro
115 120 125
Arg Leu Glu Cys Ser Ser Ala Ile 5er Ala His Cys Asn Leu Arg Leu
130 135 140
Pro Gly Ser Ser Asn Ser Pro Ala Leu Ala Ser Gln Val Ala Gly Ile
145 150 155 160
Thr Gly Ile Cys His His Ala Arg Gln Ile Phe Val Phe Leu Val Glu
165 170 175
Thr Gly Phe Cys His Val Gly Gln Ala Gly Leu Glu Leu Leu Ile Ser
180 185 190
Gly Asp Ser Pro Ala Ser Ala Phe Gln Ser Ala Gly Ile Ile Gly Val
195 200 205
Ser His Arg Ala Arg Pro Gly Ser Val Phe Leu Ala Arg Ser Glu Glu
210 215 220
Ser Leu Tyr Leu Arg Pro Gly Gln Gln Ser Gln Glu Val Lys Val
225 230 235
<210>114
<211>181
<212>PRT
<213>智人(Homo sapiens)
<400>114
Met Leu Leu Val Asp Ala Asp Gln Pro Glu Pro Met Arg Ser Gly Ala
1 5 10 15
Arg Glu Leu Ala Leu Phe Leu Thr Pro Glu Pro Gly Ala Glu Ala Lys
20 25 30
Glu Val Glu Glu Thr Ile Glu Gly Met Leu Leu Arg Leu Glu Glu Phe
35 40 45
Cys Ser Leu Ala Asp Leu Ile Arg Ser Asp Thr Ser Gln Ile Leu Glu
50 55 60
Glu Asn Ile Pro Val Leu Lys Ala Lys Leu Thr Glu Met Arg Gly Ile
65 70 75 80
Tyr Ala Lys Val Asp Arg Leu Glu Ala Phe Val Lys Met Val Gly His
85 90 95
His Val Ala Phe Leu Glu Ala Asp Val Leu Gln Ala Glu Arg Asp His
100 105 110
Gly Ala Phe Pro Gln Ala Leu Arg Arg Trp Leu Gly Ser Ala Gly Leu
115 120 125
Pro Ser Phe Arg Asn Val Glu Cys Ser Gly Thr Ile Pro Ala Arg Cys
130 135 140
Asn Leu Arg Leu Pro Gly Ser Ser Asp Ser Pro Ala Ser Ala Ser Gln
145 150 155 160
Val Ala Gly Ile Thr Glu Val Thr Cys Thr Gly Ala Arg Asp Val Arg
165 170 175
Ala Ala His Thr Val
180
<210>115
<211>208
<212>PRT
<213>智人(Homo sapiens)
<400>115
Met Ser Val Tyr Ser Gly Lys Val Leu Leu Gln Thr Thr Pro Pro His
1 5 10 15
Val Ile Gly Gln Leu Asp Lys Leu Ile Arg Glu Val Ser Thr Leu Asp
20 25 30
Gly Val Leu Glu Val Arg Asn Glu His Phe Trp Thr Leu Gly Phe Gly
35 40 45
Ser Leu Ala Gly Ser Val His Val Arg Ile Arg Arg Asp Ala Asn Glu
50 55 60
Gln Met Val Leu Ala His Val Thr Asn Arg Leu Tyr Thr Leu Val Ser
65 70 75 80
Thr Leu Thr Val Gln Ile Phe Lys Asp Asp Trp Ile Arg Pro Ala Leu
85 90 95
Leu Ser Gly Pro Val Ala Ala Asn Val Leu Asn Phe Ser Asp His His
100 105 110
Val Ile Pro Met Pro Leu Leu Lys Gly Thr Asp Gly Leu Asn Pro Tyr
115 120 125
Val His Phe Leu Trp Lys Ile Asn Phe Phe Leu Phe Phe Asp Met Glu
130 135 140
Ser Leu Ser Val Ala Gln Ala Gly Val Gln Trp His Asp Leu Gly Ser
145 150 155 160
Leu Gln Pro His Leu Pro Gly Ser Ser Asn Ser Ala Cys Leu Ser Leu
165 170 175
Pro Ser Ser Trp Asp Tyr Arg His Ala Pro Pro His Leu Pro Asn Phe
180 185 190
Cys Ile Ile Ser Lys Asp Gly Val Leu Pro Cys Trp Pro Cys Trp Ser
195 200 205
<210>116
<211>118
<212>PRT
<213>智人(Homo sapiens)
<400>116
Met Glu Ser Arg Ser Val Ala Gln Thr Gly Val His Trp His Asn Leu
1 5 10 15
Ser Ser Leu Gln Pro Leu Pro Pro Arg Phe Lys Gln Phe Ser Cys Leu
20 25 30
Ser Leu Arg Ser Ser Trp Asp Tyr Thr His Leu Pro Pro Cys Leu Ala
35 40 45
Asn Phe Phe Val Phe Leu Val Glu Thr Ala Phe Arg His Val Gly Gln
50 55 60
Ala Gly Leu Lys Leu Leu Thr Ser Gly Asp Gln Pro Thr Ser Ala Ser
65 70 75 80
Gln Ser Ala Gly Ile Thr Gly Ile Ser His Arg Thr Gln Pro Val Gly
85 90 95
Arg Phe Leu Ile Thr Asp Ser Ile Phe Leu Phe Val Thr Asp Leu Leu
100 105 110
Lys Phe Ser Ile Ser Ser
115
<210>117
<211>102
<212>PRT
<213>智人(Homo sapiens)
<400>117
Met Ser Lys Val Leu Gly Gly Pro Phe Ser Lys Gly His Thr Ala Ser
1 5 10 15
Asp Lys Tyr Phe Gln Ile Phe His Asn Ile Ser Phe Phe Glu Thr Glu
20 25 30
Ser Cys Ser Val Ala Gln Ala Gly Val Gln Trp Cys Asn Leu Gly Ser
35 40 45
Leu Gln Ala Leu Pro Pro Arg Phe Thr Pro Phe Ser Cys Leu Ser Leu
50 55 60
Pro Ser Ser Trp Asp Tyr Arg His Pro Pro Pro Cys Pro Asp Asn Val
65 70 75 80
Phe Val Phe Ser Val Glu Thr Gly Phe His Cys Val Ser Gln Asp Gly
85 90 95
Leu Asn Leu Leu Thr Leu
100
<210>118
<211>214
<212>PRT
<213>智人(Homo sapiens)
<400>118
Met Ala Gln Gly Thr Leu Ile Arg Val Thr Pro Glu Gln Pro Thr His
1 5 10 15
Ala Val Cys Val Leu Gly Thr Leu Thr Gln Leu Asp Ile Cys Ser Ser
20 25 30
Ala Pro Glu Asp Cys Thr Ser Phe Ser Ile Asn Ala Ser Pro Gly Val
35 40 45
Val Val Asp Ile Ala His Ser Pro Pro Ala Lys Lys Lys Ser Thr Gly
50 55 60
Ser Ser Thr Trp Pro Leu Asp Pro Gly Val Glu Val Thr Leu Thr Met
65 70 75 80
Lys Ala Ala Ser Gly Ser Thr Gly Asp Gln Lys Val Gln Ile Ser Tyr
85 90 95
Tyr Gly Pro Lys Thr Pro Pro Val Lys Ala Leu Leu Tyr Leu Thr Ala
100 105 110
Val Asp Gly Val Ser Pro Cys His Pro Gly Trp Ser Ala Met His Asp
115 120 125
Leu Ala His Cys Asn Leu Arg Leu Gln Val Gln Ala Ile Leu Cys Phe
130 135 140
Ser Val Pro Ser Ser Trp Thr Thr Gly Ala Cys His His Ala Trp Leu
145 150 155 160
Ile Phe Val Phe Leu Val Glu Met Glu Phe His His Val Gly Gln Ala
165 170 175
Gly Leu Glu Leu Leu Thr Ser Gly Asp Leu Pro Ala Ser Gly Ser Gln
180 185 190
Ser Ala Arg Ile Thr Gly Met Asn His Cys Ala Arg Pro Ser Ile Phe
195 200 205
Leu Ile Leu Lys Tyr Leu
210
<210>119
<211>876
<212>PRT
<213>智人(Homo sapiens)
<400>119
Met Ser Gln Ser Pro Ala Phe Gly Pro Arg Arg Gly Ser Ser Pro Arg
1 5 10 15
Gly Ala Ala Gly Ala Ala Ala Arg Arg Asn Glu Ser Gln Asp Tyr Leu
20 25 30
Leu Met Asp Ser Glu Leu Gly Glu Asp Gly Cys Pro Gln Ala Pro Leu
35 40 45
Pro Cys Tyr Gly Tyr Tyr Pro Cys Phe Arg Gly Ser Asp Asn Arg Leu
50 55 60
Ala His Arg Arg Gln Thr Val Leu Arg Glu Lys Gly Arg Arg Leu Ala
65 70 75 80
Asn Arg Gly Pro Ala Tyr Met Phe Ser Asp Arg Ser Thr Ser Leu Ser
85 90 95
Ile Glu Glu Glu Arg Phe Leu Asp Ala Ala Glu Tyr Gly Asn Ile Pro
100 105 110
Val Val Arg Lys Met Leu Glu Glu Cys His Ser Leu Asn Val Asn Cys
115 120 125
Val Asp Tyr Met Gly Gln Asn Ala Leu Gln Leu Ala Val Ala Asn Glu
130 135 140
His Leu Glu Ile Thr Glu Leu Leu Leu Lys Lys Glu Asn Leu Ser Arg
145 150 155 160
Val Gly Asp Ala Leu Leu Leu Ala Ile Ser Lys Gly Tyr Val Arg Ile
165 170 175
Val Glu Ala Ile Leu Ser His Pro Ala Phe Ala Glu Gly Lys Arg Leu
180 185 190
Ala Thr Ser Pro Ser Gln Ser Glu Leu Gln Gln Asp Asp Phe Tyr Ala
195 200 205
Tyr Asp Glu Asp Gly Thr Arg Phe Ser His Asp Val Thr Pro Ile Ile
210 215 220
Leu Ala Ala His Cys Gln Glu Tyr Glu Ile Val His Thr Leu Leu Arg
225 230 235 240
Lys Gly Ala Arg Ile Glu Arg Pro His Asp Tyr Phe Cys Lys Cys Asn
245 250 255
Asp Cys Asn Gln Lys Gln Lys His Asp Ser Phe Ser His Ser Arg Ser
260 265 270
Arg Ile Asn Ala Tyr Lys Gly Leu Ala Ser Pro Ala Tyr Leu Ser Leu
275 280 285
Ser Ser Glu Asp Pro Val Met Thr Ala Leu Glu Leu Ser Asn Glu Leu
290 295 300
Ala Val Leu Ala Asn Ile Glu Lys Glu Phe Lys Asn Asp Tyr Lys Lys
305 310 315 320
Leu Ser Met Gln Cys Lys Asp Phe Val Val Gly Leu Leu Asp Leu Arg
325 330 335
Arg Asn Thr Glu Glu Val Glu Ala Ile Leu Asn Gly Asp Val Glu Thr
340 345 350
Leu Gln Ser Gly Asp His Gly Arg Pro Asn Leu Ser Arg Leu Lys Leu
355 360 365
Ala Ile Lys Tyr Glu Val Lys Lys Met Gly Lys Ile Met Arg Gly Pro
370 375 380
Phe Met Lys Phe Val Ala His Ala Ala Ser Phe Thr Ile Phe Leu Gly
385 390 395 400
Leu Leu Val Met Asn Ala Ala Asp Arg Phe Glu Gly Thr Lys Leu Leu
405 410 415
Pro Asn Glu Thr Ser Thr Asp Asn Ala Lys Gln Leu Phe Arg Met Lys
420 425 430
Thr Ser Cys Phe Ser Trp Met Glu Met Leu Ile Ile Ser Trp Val Ile
435 440 445
Gly Met Ile Trp Ala Glu Cys Lys Glu Ile Trp Thr Gln Gly Pro Lys
450 455 460
Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu Asp Phe Gly Met Leu Ala
465 470 475 480
Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe Met Ala Phe Trp His Ala
485 490 495
Ser Lys Ala Gln Ser Ile Ile Asp Ala ASn Asp Thr Leu Lys Asp Leu
500 505 510
Thr Lys Val Thr Leu Gly Asp Asn Val Lys Tyr Tyr Asn Leu Ala Arg
515 520 525
Ile Lys Trp Asp Pro Ser Asp Pro Gln Ile Ile Ser Glu Gly Leu Tyr
530 535 540
Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Thr Leu Pro
545 550 555 560
Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr Val
565 570 575
Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val Phe Val Ala
580 585 590
Phe Met Ile Gly Met Phe Asn Leu Tyr Ser Tyr Tyr Ile Gly Ala Lys
595 600 605
Gln Asn Glu Ala Phe Thr Thr Val Glu Glu Ser Phe Lys Thr Leu Phe
610 615 620
Trp Ala Ile Phe Gly Leu Ser Glu Val Lys Ser Val Val Ile Asn Tyr
625 630 635 640
Asn His Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr Gly Val Tyr
645 650 655
Asn Val Thr Met Val Ile Val Leu Leu Asn Met Leu Ile Ala Met Ile
660 665 670
Asn Ser Ser Phe Gln Glu Ile Glu Asp Asp Ala Asp Val Glu Trp Lys
675 680 685
Phe Ala Arg Ala Lys Leu Trp Phe Ser Tyr Phe Glu Glu Gly Arg Thr
690 695 700
Leu Pro Val Pro Phe Asn Leu Val Pro Ser Pro Lys Ser Leu Phe Tyr
705 710 715 720
Leu Leu Leu Lys Leu Lys Lys Trp Ile Ser Glu Leu Phe Gln Gly His
725 730 735
Lys Lys Gly Phe Gln Glu Asp Ala Glu Met Asn Lys Ile Asn Glu Glu
740 745 750
Lys Lys Leu Gly Ile Leu Gly Ser His Glu Asp Leu Ser Lys Leu Ser
755 760 765
Leu Asp Lys Lys Gln Val Gly His Asn Lys Gln Pro Ser Ile Arg Ser
770 775 780
Ser Glu Asp Phe His Leu Asn Ser Phe Asn Asn Pro Pro Arg Gln Tyr
785 790 795 800
Gln Lys Ile Met Lys Arg Leu Ile Lys Arg Tyr Val Leu Gln Ala Gln
805 810 815
Ile Asp Lys Glu Ser Asp Glu Val Asn Glu Gly Glu Leu Lys Glu Ile
820 825 830
Lys Gln Asp Ile Ser Ser Leu Arg Tyr Glu Leu Leu Glu Glu Lys Ser
835 840 845
Gln Asn Thr Glu Asp Leu Ala Glu Leu Ile Arg Glu Leu Gly Glu Lys
850 855 860
Leu Ser Met Glu Pro Asn Gln Glu Glu Thr Asn Arg
865 870 875
<210>120
<211>862
<212>PRT
<213>智人(Homo sapiens)
<400>120
Met Leu Arg Asn Ser Thr Phe Lys Asn Met Gln Arg Arg His Thr Thr
1 5 10 15
Leu Arg Glu Lys Gly Arg Arg Gln Ala Ile Arg Gly Pro Ala Tyr Met
20 25 30
Phe Asn Glu Lys Gly Thr Ser Leu Thr Pro Glu Glu Glu Arg Phe Leu
35 40 45
Asp Ser Ala Glu Tyr Gly Asn Ile Pro Val Val Arg Lys Met Leu Glu
50 55 60
Glu Ser Lys Thr Leu Asn Phe Asn Cys Val Asp Tyr Met Gly Gln Asn
65 70 75 80
Ala Leu Gln Leu Ala Val Gly Asn Glu His Leu Glu Val Thr Glu Leu
85 90 95
Leu Leu Lys Lys Glu Asn Leu Ala Arg Val Gly Asp Ala Leu Leu Leu
100 105 110
Ala Ile Ser Lys Gly Tyr Val Arg Ile Val Glu Ala Ile Leu Asn His
115 120 125
Pro Ala Phe Ala Gln Gly Gln Arg Leu Thr Leu Ser Pro Leu Glu Gln
130 135 140
Glu Leu Arg Asp Asp Asp Phe Tyr Ala Tyr Asp Glu Asp Gly Thr Arg
145 150 155 160
Phe Ser His Asp Ile Thr Pro Ile Ile Leu Ala Ala His Cys Gln Glu
165 170 175
Tyr Glu Ile Val His Ile Leu Leu Leu Lys Gly Ala Arg Ile Glu Arg
180 185 190
Pro His Asp Tyr Phe Cys Lys Cys Asn Glu Cys Thr Glu Lys Gln Arg
195 200 205
Lys Asp Ser Phe Ser His Ser Arg Ser Arg Met Asn Ala Tyr Lys Gly
210 215 220
Leu Ala Ser Ala Ala Tyr Leu Ser Leu Ser Ser Glu Asp Pro Val Leu
225 230 235 240
Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala Arg Leu Ala Asn Ile Glu
245 250 255
Thr Glu Phe Lys Asn Asp Tyr Arg Lys Leu Ser Met Gln Cys Lys Asp
260 265 270
Phe Val Val Gly Val Leu Asp Leu Cys Arg Asp Thr Glu Glu Val Glu
275 280 285
Ala Ile Leu Asn Gly Asp Val Asn Phe Gln Val Trp Ser Asp His His
290 295 300
Arg Pro Ser Leu Ser Arg Ile Lys Leu Ala Ile Lys Tyr Glu Val Lys
305 310 315 320
Lys Phe Val Ala His Pro Asn Cys Gln Gln Gln Leu Leu Thr Met Trp
325 330 335
Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln Ser Ile Ala Val Lys Phe
340 345 350
Leu Ala Val Phe Gly Val Ser Ile Gly Leu Pro Phe Leu Ala Ile Ala
355 360 365
Tyr Trp Ile Ala Pro Cys Ser Lys Leu Gly Arg Thr Leu Arg Ser Pro
370 375 380
Phe Met Lys Phe Val Ala His Ala Val Ser Phe Thr Ile Phe Leu Gly
385 390 395 400
Leu Leu Val Val Asn Ala Ser Asp Arg Phe Glu Gly Val Lys Thr Leu
405 410 415
Pro Asn Glu Thr Phe Thr Asp Tyr Pro Lys Gln Ile Phe Arg Val Lys
420 425 430
Thr Thr Gln Phe Ser Trp Thr Glu Met Leu Ile Met Lys Trp Val Leu
435 440 445
Gly Met Ile Trp Ser Glu Cys Lys Glu Ile Trp Glu Glu Gly Pro Arg
450 455 460
Glu Tyr Val Leu His Leu Trp Asn Leu Leu Asp Phe Gly Met Leu Ser
465 470 475 480
Ile Phe Val Ala Ser Phe Thr Ala Arg Phe Met Ala Phe Leu Lys Ala
485 490 495
Thr Glu Ala Gln Leu Tyr Val Asp Gln His Val Gln Asp Asp Thr Leu
500 505 510
His Asn Val Ser Leu Pro Pro Glu Val Ala Tyr Phe Thr Tyr Ala Arg
515 520 525
Asp Lys Trp Trp Pro Ser Asp Pro Gln Ile Ile Ser Glu Gly Leu Tyr
530 535 540
Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Ile Leu Pro
545 550 555 560
Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr Val
565 570 575
Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val Phe Val Ala
580 585 590
Phe Met Ile Gly Met Phe Asn Leu Tyr Ser Tyr Tyr Arg Gly Ala Lys
595 600 605
Tyr Asn Pro Ala Phe Thr Thr Val Glu Glu Ser Phe Lys Thr Leu Phe
610 615 620
Trp Ser Ile Phe Gly Leu Ser Glu Val Ile Ser Val Val Leu Lys Tyr
625 630 635 640
Asp His Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr Gly Val Tyr
645 650 655
Asn Val Thr Met Val Val Val Leu Leu Asn Met Leu Ile Ala Met Ile
660 665 670
Asn Asn Ser Tyr Gln Glu Ile Glu Glu Asp Ala Asp Val Glu Trp Lys
675 680 685
Phe Ala Arg Ala Lys Leu Trp Leu Ser Tyr Phs Asp Glu Gly Arg Thr
690 695 700
Leu Pro Ala Pro Phe Asn Leu Val Pro Ser Pro Lys Ser Phe Tyr Tyr
705 710 715 720
Leu Ile Met Arg Ile Lys Met Cys Leu Ile Lys Leu Cys Lys Ser Lys
725 730 735
Ala Lys Ser Cys Glu Asn Asp Leu Glu Met Gly Met Leu Asn Ser Lys
740 745 750
Phe Lys Lys Thr Arg Tyr Gln Ala Gly Met Arg Asn Ser Glu Asn Leu
755 760 765
Thr Ala Asn Asn Thr Leu Ser Lys Pro Thr Arg Tyr Gln Lys Ile Met
770 775 780
Lys Arg Leu Ile Lys Arg Tyr Val Leu Lys Ala Gln Val Asp Arg Glu
785 790 795 800
Asn Asp Glu Val Asn Glu Gly Glu Leu Lys Glu Ile Lys Gln Asp Ile
805 810 815
Ser Ser Leu Arg Tyr Glu Leu Leu Glu Glu Lys Ser Gln Ala Thr Gly
820 825 830
Glu Leu Ala Asp Leu Ile Gln Gln Leu Ser Glu Lys Phe Gly Lys Asn
835 840 845
Leu Asn Lys Asp His Leu Arg Val Asn Lys Gly Lys Asp Ile
850 855 860
<210>121
<211>893
<212>PRT
<213>豚鼠(Cavia porcellus)
<400>121
Met Asp Asp Gly Cys Pro Gln Leu Pro Leu Pro Pro His Gly Tyr Tyr
1 5 10 15
Pro Ser Leu Arg Gly Thr Asp Asn Arg Leu Thr His Arg Arg Gln Thr
20 25 30
Val Leu Arg Glu Lys Gly Arg Arg Leu Ala Asn Arg Gly Pro Ala Tyr
35 40 45
Met Phe Asn Asp His Ser Thr Thr Leu Ser Ile Glu Glu Glu Arg Phe
50 55 60
Leu Asp Ala Ala Glu Tyr Gly Asn Ile Pro Val Val Arg Lys Met Leu
65 70 75 80
Glu Glu Cys Leu Ser Leu Asn Val Asn Cys Val Asp Tyr Met Gly Gln
85 90 95
Asn Ala Leu Gln Leu Ala Val Ala Asn Glu His Leu Glu Ile Thr Glu
100 105 110
Leu Leu Leu Lys Lys Glu Asn Leu Ser Arg Val Gly Asp Ala Leu Leu
115 120 125
Leu Ala Ile Ser Lys Gly Tyr Val Arg Ile Val Glu Ala Ile Leu Ser
130 135 140
His Pro Ala Phe Ala Glu Gly Lys Arg Leu Ala Thr Ser Pro Ser Gln
145 150 155 160
Ser Glu Leu Gln Gln Asp Asp Phe Tyr Ala Tyr Asp Glu Asp Gly Thr
165 170 175
Arg Phe Ser His Asp Val Thr Pro Ile Ile Leu Ala Ala His Cys Gln
180 185 190
Glu Tyr Glu Ile Val His Thr Leu Leu Arg Lys Gly Ala Arg Ile Glu
195 200 205
Arg Pro His Asp Tyr Phe Cys Lys Cys Ser Glu Cys Asn Gln Lys Gln
210 215 220
Lys His Asp Ser Phe Ser His Ser Arg Ser Arg Ile Asn Ala Tyr Lys
225 230 235 240
Gly Leu Ala Ser Pro Ala Tyr Leu Ser Leu Ser Ser Glu Asp Pro Val
245 250 255
Met Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala Val Leu Ala Asn Ile
260 265 270
Glu Lys Glu Phe Lys Asn Asp Tyr Lys Lys Leu Ser Met Gln Cys Lys
275 280 285
Asp Phe Val Val Gly Leu Leu Asp Leu Cys Arg Asn Thr Glu Glu Val
290 295 300
Glu Ala Ile Leu Asn Gly Asp Val Glu Thr Cys Gln Ser Gly Asp Gln
305 310 315 320
Gly Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala Ile Lys Tyr Glu Val
325 330 335
Lys Lys Phe Val Ala His Pro Asn Cys Gln Gln Gln Leu Leu Ser Ile
340 345 350
Trp Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln Thr Met Ala Val Lys
355 360 365
Phe Leu Val Val Leu Gly Val Ala Ile Gly Leu Pro Phe Leu Ala Leu
370 375 380
Ile Tyr Trp Cys Ala Pro Cys Ser Lys Met Gly Lys Ile Met Arg Gly
385 390 395 400
Pro Phe Met Lys Phe Val Ala His Ala Ala Ser Phe Thr Ile Phe Leu
405 410 415
Gly Leu Leu Val Met Asn Ala Ala Asp Arg Phe Glu Gly Thr Lys Leu
420 425 430
Arg Pro Asn Glu Thr Ser Thr Asp Asn Ala Lys Gln Leu Phe Arg Met
435 440 445
Lys Thr Ser Cys Phe Ser Trp Met Glu Met Leu Ile Ile Ser Trp Val
450 455 460
Ile Gly Met Ile Trp Ala Glu Cys Lys Glu Ile Trp Ala Gln Gly Pro
465 470 475 480
Lys Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu Asp Phe Gly Met Leu
485 490 495
Ala Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe Met Ala Phe Trp His
500 505 510
Ala Ser Lys Ala Gln Ser Ile Ile Asp Ala Asn Asp Thr Leu Lys Asp
515 520 525
Leu Thr Lys Val Thr Leu Gly Glu Asp Val Lys Tyr Tyr Asn Leu Ala
530 535 540
Arg Ile Lys Trp Asp Pro Ser Asp Pro Gln Ile Ile Ser Glu Gly Leu
545 550 555 560
Tyr Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Ile Leu
565 570 575
Pro Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr
580 585 590
Val Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val Phe Val
595 600 605
Ala Phe Met Ile Gly Met Phe Asn Leu Tyr Ser Tyr Tyr Ile Gly Ala
610 615 620
Lys Gln Asn Glu Ala Phe Thr Thr Val Glu Glu Ser Phe Lys Thr Leu
625 630 635 640
Phe Trp Ala Ile Phe Gly Leu Ser Glu Val Lys Ser Val Val Ile Asn
645 650 655
Tyr Asn His Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr Gly Val
660 665 670
Tyr Asn Val Thr Met Val Ile Val Leu Leu Asn Met Leu Ile Ala Met
675 680 685
Ile Asn Ser Ser Phe Gln Glu Ile Glu Asp Asp Ala Asp Val Glu Trp
690 695 700
Lys Phe Ala Arg Ala Lys Leu Trp Phe Ser Tyr Phe Glu Glu Gly Arg
705 710 715 720
Thr Leu Pro Val Pro Phe Asn Leu Val Pro Ser Pro Lys Ser Leu Leu
725 730 735
Tyr Leu Leu Leu Lys Phe Lys Lys Trp Gly Phe Glu Leu Phe Gln Gly
740 745 750
His Lys Lys Ala Phe Gln Glu Asp Ala Glu Met Asn Lys Arg Asn Glu
755 760 765
Glu Lys Lys Phe Gly Ile Leu Gly Ser His Glu Asp Leu Ser Lys Leu
770 775 780
Ser Val Asp Lys Lys Gln Leu Gly Gln Asn Lys Gln Ser Ser Ile Arg
785 790 795 800
Ser Ser Glu Asp Phe His Leu Asn Ser Phe Asn Asn Pro Pro Arg Gln
805 810 815
Tyr Gln Lys Ile Met Lys Arg Leu Ile Lys Arg Tyr Val Leu Gln Ala
820 825 830
Gln Ile Asp Lys Glu Ser Asp Glu Val Asn Glu Gly Glu Leu Lys Glu
835 840 845
Ile Lys Gln Asp Ile Ser Ser Leu Arg Tyr Glu Leu Leu Glu Glu Lys
850 855 860
Ser Gln Asn Thr Glu Asp Leu Ala Glu Leu Ile Arg Lys Leu Gly Glu
865 870 875 880
Lys Leu Ser Ser Glu Pro Lys Gln Glu Glu Ile Asn Arg
885 890
<210>122
<211>597
<212>PRT
<213>豚鼠(Cavia porcellus)
<400>122
Met Phe Asn Asp His Ser Thr Thr Leu Ser Ile Glu Glu Glu Arg Phe
1 5 10 15
Leu Asp Ala Ala Glu Tyr Gly Asn Ile Pro Val Val Arg Lys Met Leu
20 25 30
Glu Glu Cys Leu Ser Leu Asn Val Asn Cys Val Asp Tyr Met Gly Gln
35 40 45
Asn Ala Leu Gln Leu Ala Val Ala Asn Glu His Leu Glu Ile Thr Glu
50 55 60
Leu Leu Leu Lys Lys Glu Asn Leu Ser Arg Val Gly Asp Ala Leu Leu
65 70 75 80
Leu Ala Ile Ser Lys Gly Tyr Val Arg Ile Val Glu Ala Ile Leu Ser
85 90 95
His Pro Ala Phe Ala Glu Gly Lys Arg Leu Ala Thr Ser Leu Ser Gln
100 105 110
Ser Glu Leu Gln Gln Asp Asp Phe Tyr Ala Tyr Asp Glu Asp Gly Thr
115 120 125
Arg Phe Ser His Asp Val Thr Pro Ile Ile Leu Ala Ala His Cys Gln
130 135 140
Glu Tyr Glu Ile Val His Thr Leu Leu Arg Lys Gly Ala Arg Ile Glu
145 150 155 160
Arg Pro His Asp Tyr Phe Cys Lys Cys Ser Glu Cys Asn Gln Lys Gln
165 170 175
Lys His Asp Ser Phe Ser His Ser Arg Ser Arg Ile Asn Ala Tyr Lys
180 185 190
Gly Leu Ala Ser Pro Ala Tyr Leu Ser Leu Ser Ser Glu Asp Pro Val
195 200 205
Met Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala Val Leu Ala Asn Ile
210 215 220
Glu Lys Glu Phe Lys Asn Asp Tyr Lys Lys Leu Ser Met Gln Cys Lys
225 230 235 240
Asp Phe Val Val Gly Leu Leu Asp Leu Cys Arg Asn Thr Glu Glu Val
245 250 255
Glu Ala Ile Leu Asn Gly Asp Ile Glu Thr Cys Gln Pro Gly Asp Gln
260 265 270
Gly Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala Ile Lys Tyr Glu Val
275 280 285
Lys Lys Phe Val Ala His Pro Asn Cys Gln Gln Gln Leu Leu Ser Ile
290 295 300
Trp Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln Thr Met Ala Val Lys
305 310 315 320
Phe Leu Val Val Leu Gly Val Ala Ile Gly Leu Pro Phe Leu Ala Leu
325 330 335
Ile Tyr Trp Cys Ala Pro Cys Ser Lys Met Gly Lys Ile Met Arg Gly
340 345 350
Pro Phe Met Lys Phe Val Ala His Ala Ala Ser Phe Thr Ile Phe Leu
355 360 365
Gly Leu Leu Val Met Asn Ala Ala Asp Arg Phe Glu Gly Thr Lys Leu
370 375 380
Arg Pro Asn Glu Thr Ser Thr Asp Asn Ala Lys Gln Leu Phe Arg Met
385 390 395 400
Lys Thr Ser Cys Phe Ser Trp Met Glu Met Leu Ile Ile Ser Trp Val
405 410 415
Ile Gly Met Val Trp Ala Glu Cys Lys Glu Ile Trp Ala Gln Gly Pro
420 425 430
Lys Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu Asp Phe Gly Met Leu
435 440 445
Ala Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe Met Ala Phe Trp His
450 455 460
Ala Ser Lys Ala Gln Ser Ile Ile Asp Ala Asn Asp Thr Leu Lys Asp
465 470 475 480
Leu Thr Lys Val Thr Leu Gly Glu Asp Val Lys Tyr Tyr Asn Leu Ala
485 490 495
Arg Ile Lys Trp Asp Pro Ser Asp Pro Gln Ile Ile Ser Glu Gly Leu
500 505 510
Tyr Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Ile Leu
515 520 525
Pro Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr
530 535 540
Val Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val Phe Val
545 550 555 560
Ala Phe Met Ile Gly Met Phe Asn Leu Tyr Ser His Tyr Ile Gly Ala
565 570 575
Lys Gln Asn Glu Ala Phe Thr Thr Tyr Val Ile Ser Asp Val Leu Thr
580 585 590
Met Glu Ile Ala Asp
595
<210>123
<211>815
<212>PRT
<213>豚鼠(Cavia porcellus)
<400>123
Met Asp Asp Gly Cys Pro Gln Leu Pro Leu Pro Pro His Gly Tyr Tyr
1 5 10 15
Pro Ser Leu Arg Gly Thr Asp Asn Arg Leu Thr His Arg Arg Gln Thr
20 25 30
Val Leu Arg Glu Lys Gly Arg Arg Leu Ala Asn Arg Gly Pro Ala Tyr
35 40 45
Met Phe Asn Asp His Ser Thr Thr Leu Ser Ile Glu Glu Glu Arg Phe
50 55 60
Leu Asp Ala Ala Glu Tyr Gly Asn Ile Pro Val Val Arg Lys Met Leu
65 70 75 80
Glu Glu Cys Leu Ser Leu Asn Val Asn Cys Val Asp Tyr Met Gly Gln
85 90 95
Asn Ala Leu Gln Leu Ala Val Ala Asn Glu His Leu Glu Ile Thr Glu
100 105 110
Leu Leu Leu Lys Lys Glu Asn Leu Ser Arg Val Gly Asp Ala Leu Leu
115 120 125
Leu Ala Ile Ser Lys Gly Tyr Val Arg Ile Val Glu Ala Ile Leu Ser
130 135 140
His Pro Ala Phe Ala Glu Gly Lys Arg Leu Ala Thr Ser Pro Ser Gln
145 150 155 160
Ser Glu Leu Gln Gln Asp Asp Phe Tyr Ala Tyr Asp Glu Asp Gly Thr
165 170 175
Arg Phe Ser His Asp Val Thr Pro Ile Ile Leu Ala Ala His Cys Gln
180 185 190
Glu Tyr Glu Ile Val His Thr Leu Leu Arg Lys Gly Ala Arg Ile Glu
195 200 205
Arg Pro His Asp Tyr Phe Cys Glu Cys Ser Glu Cys Asn Gln Lys Gln
210 215 220
Lys His Asp Ser Phe Ser His Ser Arg Ser Arg Ile Asn Ala Tyr Lys
225 230 235 240
Gly Leu Ala Ser Pro Ala Tyr Leu Ser Leu Ser Ser Glu Asp Pro Val
245 250 255
Met Thr Ala Leu Glu Leu Ser Asn Glu Leu Ala Val Leu Ala Asn Ile
260 265 270
Glu Lys Glu Phe Lys Asn Asp Tyr Lys Lys Leu Ser Met Gln Cys Lys
275 280 285
Asp Phe Val Val Gly Leu Leu Asp Leu Cys Arg Asn Thr Glu Glu Val
290 295 300
Glu Ala Ile Leu Asn Gly Asp Val Glu Thr Cys Gln Pro Gly Asp Gln
305 310 315 320
Gly Arg Pro Asn Leu Ser Arg Leu Lys Leu Ala Ile Lys Tyr Glu Val
325 330 335
Lys Lys Phe Val Ala His Pro Asn Cys Gln Gln Gln Leu Leu Ser Ile
340 345 350
Trp Tyr Glu Asn Leu Ser Gly Leu Arg Gln Gln Thr Met Ala Val Lys
355 360 365
Phe Leu Val Val Leu Gly Val Ala Ile Gly Leu Pro Phe Leu Ala Leu
370 375 380
Ile Tyr Trp Cys Ala Pro Cys Ser Lys Met Gly Lys Ile Met Arg Gly
385 390 395 400
Pro Phe Met Lys Phe Val Ala His Ala Ala Ser Phe Thr Ile Phe Leu
405 410 415
Gly Leu Leu Val Met Asn Ala Ala Asp Arg Phe Glu Gly Thr Lys Leu
420 425 430
Arg Pro Asn Glu Thr Ser Thr Asp Asn Ala Lys Gln Leu Phe Arg Met
435 440 445
Lys Thr Ser Cys Phe Ser Trp Met Glu Met Leu Ile Ile Ser Trp Val
450 455 460
Ile Ala Arg Ile Lys Trp Asp Pro Ser Asp Pro Gln Ile Ile Ser Glu
465 470 475 480
Gly Leu Tyr Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr
485 490 495
Ile Leu Pro Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly
500 505 510
Arg Thr Val Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val
515 520 525
Phe Val Ala Phe Met Ile Gly Met Phe His Leu Tyr Ser Tyr Tyr Ile
530 535 540
Gly Ala Lys Gln Asn Glu Ala Phe Thr Thr Val Glu Glu Ser Phe Lys
545 550 555 560
Thr Leu Phe Trp Ala Ile Phe Gly Leu Ser Glu Val Lys Ser Val Val
565 570 575
Ile Asn Tyr Asn His Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr
580 585 590
Gly Val Tyr Asn Val Thr Met Val Ile Val Leu Leu Asn Met Leu Ile
595 600 605
Ala Met Ile Asn Ser Ser Phe Gln Glu Ile Glu Asp Asp Ala Asp Val
610 615 620
Glu Trp Lys Phe Ala Arg Ala Lys Leu Trp Phe Ser Tyr Phe Glu Glu
625 630 635 640
Gly Arg Thr Leu Pro Val Pro Phe Asn Leu Val Pro Ser Pro Lys Ser
645 650 655
Leu Leu Tyr Leu Leu Leu Lys Phe Lys Lys Trp Gly Phe Glu Leu Phe
660 665 670
Gln Gly His Lys Lys Ala Phe Gln Glu Asp Ala Glu Met Asn Lys Arg
675 680 685
Asn Glu Glu Lys Lys Phe Gly Ile Leu Gly Ser His Glu Asp Leu Ser
690 695 700
Lys Leu Ser Val Asp Lys Lys Gln Leu Gly Gln Asn Lys Gln Ser Ser
705 710 715 720
Ile Arg Ser Ser Glu Asp Phe His Leu Asn Ser Phe Asn Asn Pro Pro
725 730 735
Arg Gln Tyr Gln Lys Ile Met Lys Arg Leu Ile Lys Arg Tyr Val Leu
740 745 750
Gln Ala Gln Ile Asp Lys Glu Ser Asp Glu Val Asn Glu Gly Glu Leu
755 760 765
Lys Glu Ile Lys Gln Asp Ile Ser Ser Leu Arg Tyr Glu Leu Leu Glu
770 775 780
Glu Lys Ser Gln Asn Thr Glu Asp Leu Ala Glu Leu Ile Arg Lys Leu
785 790 795 800
Gly Glu Lys Leu Ser Ser Glu Pro Lys Gln Glu Glu Ile Asn Arg
805 810 815
<210>124
<211>876
<212>PRT
<213>智人(Homo sapiens)
<400>124
Met Ser Gln Ser Pro Ala Phe Gly Pro Arg Arg Gly Ser Ser Pro Arg
1 5 10 15
Gly Ala Ala Gly Ala Ala Ala Arg Arg Asn Glu Ser Gln Asp Tyr Leu
20 25 30
Leu Met Asp Ser Glu Leu Gly Glu Asp Gly Cys Pro Gln Ala Pro Leu
35 40 45
Pro Cys Tyr Gly Tyr Tyr Pro Cys Phe Arg Gly Ser Asp Asn Arg Leu
50 55 60
Ala His Arg Arg Gln Thr Val Leu Arg Glu Lys Gly Arg Arg Leu Ala
65 70 75 80
Asn Arg Gly Pro Ala Tyr Met Phe Ser Asp Arg Ser Thr Ser Leu Ser
85 90 95
Ile Glu Glu Glu Arg Phe Leu Asp Ala Ala Glu Tyr Gly Asn Ile Pro
100 105 110
Val Val Arg Lys Met Leu Glu Glu Cys His Ser Leu Asn Val Asn Cys
115 120 125
Val Asp Tyr Met Gly Gln Asn Ala Leu Gln Leu Ala Val Ala Asn Glu
130 135 140
His Leu Glu Ile Thr Glu Leu Leu Leu Lys Lys Glu Asn Leu Ser Arg
145 150 155 160
Val Gly Asp Ala Leu Leu Leu Ala Ile Ser Lys Gly Tyr Val Arg Ile
165 170 175
Val Glu Ala Ile Leu Ser His Pro Ala Phe Ala Glu Gly Lys Arg Leu
180 185 190
Ala Thr Ser Pro Ser Gln Ser Glu Leu Gln Gln Asp Asp Phe Tyr Ala
195 200 205
Tyr Asp Glu Asp Gly Thr Arg Phe Ser His Asp Val Thr Pro Ile Ile
210 215 220
Leu Ala Ala His Cys Gln Glu Tyr Glu Ile Val His Thr Leu Leu Arg
225 230 235 240
Lys Gly Ala Arg Ile Glu Arg Pro His Asp Tyr Phe Cys Lys Cys Asn
245 250 255
Asp Cys Asn Gln Lys Gln Lys His Asp Ser Phe Ser His Ser Arg Ser
260 265 270
Arg Ile Asn Ala Tyr Lys Gly Leu Ala Ser Pro Ala Tyr Leu Ser Leu
275 280 285
Ser Ser Glu Asp Pro Val Met Thr Ala Leu Glu Leu Ser Asn Glu Leu
290 295 300
Ala Val Leu Ala Asn Ile Glu Lys Glu Phe Lys Asn Asp Tyr Lys Lys
305 310 315 320
Leu Ser Met Gln Cys Lys Asp Phe Val Val Gly Leu Leu Asp Leu Arg
325 330 335
Arg Asn Thr Glu Glu Val Glu Ala Ile Leu Asn Gly Asp Val Glu Thr
340 345 350
Leu Gln Ser Gly Asp His Gly Arg Pro Asn Leu Ser Arg Leu Lys Leu
355 360 365
Ala Ile Lys Tyr Glu Val Lys Lys Met Gly Lys Ile Met Arg Gly Pro
370 375 380
Phe Met Lys Phe Val Ala His Ala Ala Ser Phe Thr Ile Phe Leu Gly
385 390 395 400
Leu Leu Val Met Asn Ala Ala Asp Arg Phe Glu Gly Thr Lys Leu Leu
405 410 415
Pro Asn Glu Thr Ser Thr Asp Asn Ala Lys Gln Leu Phe Arg Met Lys
420 425 430
Thr Ser Cys Phe Ser Trp Met Glu Met Leu Ile Ile Ser Trp Val Ile
435 440 445
Gly Met Ile Trp Ala Glu Cys Lys Glu Ile Trp Thr Gln Gly Pro Lys
450 455 460
Glu Tyr Leu Phe Glu Leu Trp Asn Met Leu Asp Phe Gly Met Leu Ala
465 470 475 480
Ile Phe Ala Ala Ser Phe Ile Ala Arg Phe Met Ala Phe Trp His Ala
485 490 495
Ser Lys Ala Gln Ser Ile Ile Asp Ala Asn Asp Thr Leu Lys Asp Leu
500 505 510
Thr Lys Val Thr Leu Gly Asp Asn Val Lys Tyr Tyr Asn Leu Ala Arg
515 520 525
Ile Lys Trp Asp Pro Ser Asp Pro Gln Ile Ile Ser Glu Gly Leu Tyr
530 535 540
Ala Ile Ala Val Val Leu Ser Phe Ser Arg Ile Ala Tyr Thr Leu Pro
545 550 555 560
Ala Asn Glu Ser Phe Gly Pro Leu Gln Ile Ser Leu Gly Arg Thr Val
565 570 575
Lys Asp Ile Phe Lys Phe Met Val Ile Phe Ile Met Val Phe Val Ala
580 585 590
Phe Met Ile Gly Met Phe Asn Leu Tyr Ser Tyr Tyr Ile Gly Ala Lys
595 600 605
Gln Asn Glu Ala Phe Thr Thr Val Glu Glu Ser Phe Lys Thr Leu Phe
610 615 620
Trp Ala Ile Phe Gly Leu Ser Glu Val Lys Ser Val Val Ile Asn Tyr
625 630 635 640
Asn His Lys Phe Ile Glu Asn Ile Gly Tyr Val Leu Tyr Gly Val Tyr
645 650 655
Asn Val Thr Met Val Ile Val Leu Leu Asn Met Leu Ile Ala Met Ile
660 665 670
Asn Ser Ser Phe Gln Glu Ile Glu Asp Asp Ala Asp Val Glu Trp Lys
675 680 685
Phe Ala Arg Ala Lys Leu Trp Phe Ser Tyr Phe Glu Glu Gly Arg Thr
690 695 700
Leu Pro Val Pro Phe Asn Leu Val Pro Ser Pro Lys Ser Leu Phe Tyr
705 710 715 720
Leu Leu Leu Lys Leu Lys Lys Trp Ile Ser Glu Leu Phe Gln Gly His
725 730 735
Lys Lys Gly Phe Gln Glu Asp Ala Glu Met Asn Lys Ile Asn Glu Glu
740 745 750
Lys Lys Leu Gly Ile Leu Gly Ser His Glu Asp Leu Ser Lys Leu Ser
755 760 765
Leu Asp Lys Lys Gln Val Gly His Asn Lys Gln Pro Ser Ile Arg Ser
770 775 780
Ser Glu Asp Phe His Leu Asn Ser Phe Asn Asn Pro Pro Arg Gln Tyr
785 790 795 800
Gln Lys Ile Met Lys Arg Leu Ile Lys Arg Tyr Val Leu Gln Ala Gln
805 810 815
Ile Asp Lys Glu Ser Asp Glu Val Asn Glu Gly Glu Leu Lys Glu Ile
820 825 830
Lys Gln Asp Ile Ser Ser Leu Arg Tyr Glu Leu Leu Glu Glu Lys Ser
835 840 845
Gln Asn Thr Glu Asp Leu Ala Glu Leu Ile Arg Glu Leu Gly Glu Lys
850 855 860
Leu Ser Met Glu Pro Asn Gln Glu Glu Thr Asn Arg
865 870 875
<210>125
<211>1442
<212>DNA
<213>智人(Homo sapiens)
<220>
<221>CDS
<222>(15)..(1139)
<400>125
tttttttttt tgag atg gag ttt tcg ctc ttg ttg ccc agg ctg gag tgc 50
Met Glu Phe Ser Leu Leu Leu Pro Arg Leu Glu Cys
1 5 10
aat ggc gca atc tca gct cac cgc aac ctc cgc ctc ccg ggt tca agc 98
Asn Gly Ala Ile Ser Ala His Arg Asn Leu Arg Leu Pro Gly Ser Ser
15 20 25
gat tct cct gcc tca gcc tcc cca gta gct ggg att aca ggc atg tgc 146
Asp Ser Pro Ala Ser Ala Ser Pro Val Ala Gly Ile Thr Gly Met Cys
30 35 40
acc cac gct cgg cta att ttg tat ttt ttt tta gta gag atg gag ttt 194
Thr His Ala Arg Leu Ile Leu Tyr Phe Phe Leu Val Glu Met Glu Phe
45 50 55 60
ctc cat gtt ggt cag gct ggt ctc gaa ctc ccg acc tca gat gat ccc 242
Leu His Val Gly Gln Ala Gly Leu Glu Leu Pro Thr Ser Asp Asp Pro
65 70 75
tcc gtc tcg gcc tcc caa agt gct aga tac agg act ggc cac cat gcc 290
Ser Val Ser Ala Ser Gln Ser Ala Arg Tyr Arg Thr Gly His His Ala
80 85 90
cgg ctc tgc ctg gct aat ttt tgt ggt aga aac agg gtt tca ctg atg 338
Arg Leu Cys Leu Ala Asn Phe Cys Gly Arg Asn Arg Val Ser Leu Met
95 100 105
tgc cca agc tgg tct cct gag ctc aag cag tcc acc tgc ctc agc ctc 386
Cys Pro Ser Trp Ser Pro Glu Leu Lys Gln Ser Thr Cys Leu Ser Leu
110 115 120
cca aag tgc tgg gat tac agg cgt gca gcc gtg cct ggc ctt ttt att 434
Pro Lys Cys Trp Asp Tyr Arg Arg Ala Ala Val Pro Gly Leu Phe Ile
125 130 135 140
tta ttt ttt tta aga cac agg tgt ccc act ctt acc cag gat gaa gtg 482
Leu Phe Phe Leu Arg His Arg Cys Pro Thr Leu Thr Gln Asp Glu Val
145 150 155
cag tgg tgt gat cac agc tca ctg cag cct tca act cct gag atc aag 530
Gln Trp Cys Asp His Ser Ser Leu Gln Pro Ser Thr Pro Glu Ile Lys
160 165 170
cat cct cct gcc tca gcc tcc caa gta gct ggg acc aaa gac atg cac 578
His Pro Pro Ala Ser Ala Ser Gln Val Ala Gly Thr Lys Asp Met His
175 180 185
cac tac acc tgg cta att ttt att ttt att ttt aat ttt ttg aga cag 626
His Tyr Thr Trp Leu Ile Phe Ile Phe Ile Phe Asn Phe Leu Arg Gln
190 195 200
agt ctc aac tct gtc acc cag gct gga gtg cag tgg cgc aat ctt ggc 674
Ser Leu Asn Ser Val Thr Gln Ala Gly Val Gln Trp Arg Asn Leu Gly
205 210 215 220
tca ctg caa cct ctg cct ccc ggg ttc aag tta ttc tcc tgc ccc agc 722
Ser Leu Gln Pro Leu Pro Pro Gly Phe Lys Leu Phe Ser Cys Pro Ser
225 230 235
ctc ctg agt agc tgg gac tac agg cgc cca cca cgc cta gct aat ttt 770
Leu Leu Ser Ser Trp Asp Tyr Arg Arg Pro Pro Arg Leu Ala Asn Phe
240 245 250
ttt gta ttt tta gta gag atg ggg ttc acc atg ttc gcc agg ttg atc 818
Phe Val Phe Leu Val Glu Met Gly Phe Thr Met Phe Ala Arg Leu Ile
255 260 265
ttg atc tct gga cct tgt gat ctg cct gcc tcg gcc tcc caa agt gct 866
Leu Ile Ser Gly Pro Cys Asp Leu Pro Ala Ser Ala Ser Gln Ser Ala
270 275 280
ggg att aca ggc gtg agc cac cac gcc cgg ctt att ttt aat ttt tgt 914
Gly Ile Thr Gly Val Ser His His Ala Arg Leu Ile Phe Asn Phe Cys
285 290 295 300
ttg ttt gaa atg gaa tct cac tct gtt acc cag gct gga gtg caa tgg 962
Leu Phe Glu Met Glu Ser His Ser Val Thr Gln Ala Gly Val Gln Trp
305 310 315
cca aat ctc ggc tca ctg caa cct ctg cct ccc ggg ctc aag cga ttc 1010
Pro Asn Leu Gly Ser Leu Gln Pro Leu Pro Pro Gly Leu Lys Arg Phe
320 325 330
tcc tgt ctc agc ctc cca agc agc tgg gat tac ggg cac ctg cca cca 1058
Ser Cys Leu Ser Leu Pro Ser Ser Trp Asp Tyr Gly His Leu Pro Pro
335 340 345
cac ccc gct aat ttt tgt att ttc att aga ggc ggg gtt tca cca tat 1106
His Pro Ala Asn Phe Cys Ile Phe Ile Arg Gly Gly Val Ser Pro Tyr
350 355 360
ttg tca ggc tgg tct caa act cct gac ctc agg tgacccacct gcctcagcct 1159
Leu Ser Gly Trp Ser Gln Thr Pro Asp Leu Arg
365 370 375
tccaaagtgc tgggattaca ggcgtgagcc acctcaccca gccggctaat ttagataaaa 1219
aaatatgtag caatgggggg tcttgctatg ttgcccaggc tggtctcaaa cttctggctt 1279
catgcaatcc ttccaaatga gccacaacac ccagccagtc acatttttta aacagttaca 1339
tctttatttt agtatactag aaagtaatac aataaacatg tcaaacctgc aaattcagta 1399
gtaacagagt tcttttataa cttttaaaca aagctttaga gca 1442
Claims (30)
1.一种选自SEQ ID NO:18、SEQ ID NO:68和SEQ ID NO:120中一种或多种的肽。
2.一种组合物,其特征在于,所述组合物含有一种或多种权利要求1所述的肽及其载体。
3.一种蛋白质,其特征在于,所述蛋白质包括权利要求1所述的肽,所述肽的3′或5′末端侧翼具有1到25个额外的氨基酸修饰。
4.一种蛋白质,其特征在于,所述蛋白质包含权利要求1所述的至少两个肽。
5.一种蛋白质,其特征在于,所述蛋白质包含权利要求1所述的至少两个肽的重复。
6.一种蛋白质,其特征在于,所述蛋白质包含与抗体、抗体片段或抗体样分子融合的权利要求1所述的肽。
7.一种核酸,其特征在于,所述核酸编码与权利要求1所述肽相对应的氨基酸序列。
8.一种组合物,其特征在于,所述组合物包含权利要求7所述的一种或多种核酸以及其药学上可接受的载体。
9.权利要求1、2、7和8任一所述的肽、核酸或组合物在制备用于治疗患者疾病的药物中的应用,所述疾病需要除去或破坏细胞。
10.如权利要求9所述的应用,其特征在于,所述疾病是选自以下组织的良性或恶性肿瘤:即肺、乳房、胃、胰、前列腺、膀胱、骨、卵巢、皮肤、肾、窦、结肠、肠、胃、直肠、食道、心、脾、唾液腺、血液、大脑和其覆盖物、脊髓和其覆盖物、肌肉、结缔组织、肾上腺、副甲状腺、甲状腺、子宫、睾丸、垂体、生殖器、肝脏、胆囊、眼、耳、鼻、喉、扁桃腺、口、淋巴结和淋巴组织。
11.如权利要求9所述的应用,其特征在于,所述疾病是选自以下组织的增生、肥大或过度生长:即肺、乳房、胃、胰、前列腺、膀胱、骨、卵巢、皮肤、肾、窦、结肠、肠、胃、直肠、食道、心、脾、唾液腺、血液、大脑和其覆盖物、脊髓和其覆盖物、肌肉、结缔组织、肾上腺、副甲状腺、甲状腺、子宫、睾丸、垂体、生殖器、肝脏、胆囊、眼、耳、鼻、喉、扁桃腺、口、淋巴结和淋巴组织。
12.如权利要求9所述的应用,其特征在于,所述疾病是受病毒、细菌或寄生虫改变的组织,这些组织选自肺、乳房、胃、胰、前列腺、膀胱、骨、卵巢、皮肤、肾、窦、结肠、肠、胃、直肠、食道、心、脾、唾液腺、血液、大脑和其覆盖物、脊髓和其覆盖物、肌肉、结缔组织、肾上腺、副甲状腺、甲状腺、子宫、睾丸、垂体、生殖器、肝脏、胆囊、眼、耳、鼻、喉、扁桃腺、口、淋巴结和淋巴组织。
13.如权利要求9所述的应用,其特征在于,所述疾病是选自以下组织的畸形:即肺、乳房、胃、胰、前列腺、膀胱、骨、卵巢、皮肤、肾、窦、结肠、肠、胃、直肠、食道、心、脾、唾液腺、血液、大脑和其覆盖物、脊髓和其覆盖物、肌肉、结缔组织、肾上腺、副甲状腺、甲状腺、子宫、睾丸、垂体、生殖器、肝脏、胆囊、眼、耳、鼻、喉、扁桃腺、口、淋巴结和淋巴组织。
14.如权利要求10所述的应用,其特征在于,所述组织是淋巴组织。
15.如权利要求9所述的应用,其特征在于,所述疾病是扁桃体肥大。
16.如权利要求9所述的应用,其特征在于,所述疾病是前列腺增生。
17.如权利要求9所述的应用,其特征在于,所述疾病是银屑病。
18.如权利要求9所述的应用,其特征在于,所述疾病是湿疹。
19.如权利要求9所述的应用,其特征在于,所述疾病是皮肤病。
20.如权利要求9所述的应用,其特征在于,所述疾病是对组织的整容修饰。
21.如权利要求10所述的应用,其特征在于,所述组织是皮肤、眼、耳、鼻、喉、口、肌肉、结缔组织和乳房。
22.如权利要求9所述的应用,其特征在于,所述疾病是血管病。
23.如权利要求9所述的应用,其特征在于,所述疾病是痔。
24.如权利要求9所述的应用,其特征在于,所述疾病是静脉曲张。
25.如权利要求22所述的应用,其特征在于,所述血管病是动脉粥样硬化或动脉硬化。
26.如权利要求9所述的应用,其特征在于,所述疾病选自炎性疾病、自身免疫疾病、代谢疾病、遗传疾病、创伤性疾病或身理损伤、营养缺乏性疾病、传染病、淀粉样变疾病、纤维变性病、贮积病、先天性畸形、酶缺乏性疾病、中毒、致醉、环境病、辐射病、内分泌疾病、变性疾病和机械性损伤疾病。
27.如权利要求9所述的应用,其特征在于,所述肽衍生自胰丝状蛋白的氨基酸序列。
28.如权利要求9所述的应用,其特征在于,所述肽偶联于、连接于或结合于选自抗体、抗体片段和抗体样结合分子的分子,其中所述分子与肿瘤或其它靶结合的亲和力高于与其它细胞结合的亲和力。
29.如权利要求9所述的应用,其特征在于,所述肽是一新克隆的重组分子的一部分,该重组分子由所述肽和选自抗体、抗体片段和抗体样结合分子的分子组成,其中所述分子与肿瘤或其它靶结合的亲和力高于与其它细胞结合的亲和力。
30.一种肽,其特征在于,所述肽含有具有SEQ ID NO:18:Gln-Gln-Ser-Ile-Ala-Val-Lys-Phe-Leu-Ala-Val-Phe-Gly-Val-Ser-Ile所代表的氨基酸序列的肽。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30615001P | 2001-07-19 | 2001-07-19 | |
US60/306,161 | 2001-07-19 | ||
US60/306,150 | 2001-07-19 | ||
US60/331,477 | 2001-11-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1714101A CN1714101A (zh) | 2005-12-28 |
CN100432103C true CN100432103C (zh) | 2008-11-12 |
Family
ID=34589902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028183320A Expired - Lifetime CN100432103C (zh) | 2001-07-19 | 2002-07-19 | 有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100432103C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009132231A2 (en) | 2008-04-24 | 2009-10-29 | Therimunex Pharmaceuticals, Inc. | Peptidyl diacylglycerides |
CN103966309B (zh) * | 2013-02-04 | 2016-01-27 | 中国科学院上海生命科学研究院 | 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆 |
US20160215031A1 (en) * | 2015-01-27 | 2016-07-28 | Nymox Pharnaceutical Corporation | Method of treating disorders requiring destruction or removal of cells |
US20160361380A1 (en) * | 2015-06-12 | 2016-12-15 | Nymox Corporation | Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations |
CN112625113B (zh) * | 2020-12-16 | 2022-03-29 | 熊猫乳品集团股份有限公司 | 一种生物活性肽agydveknnsriklglk及其制备方法和应用 |
CN112812150A (zh) * | 2021-01-29 | 2021-05-18 | 深圳海创生物科技有限公司 | 一种活性环肽、活性环肽组合物及其在制备具有抗氧化或抗炎作用的产品中的应用 |
-
2002
- 2002-07-19 CN CNB028183320A patent/CN100432103C/zh not_active Expired - Lifetime
Non-Patent Citations (2)
Title |
---|
"Efficient MHC Class I-Peptide I Required But Does NotEnsure MHC Class I-Restricted Immunogenicity. FELTKAMP MCW ET AL.MOLECULAR IMMUNOLOG,Vol.31 No.18. 1994 * |
"Immunodominant Mink Cell Focus-Inducing MurineLeukemia Virus (MuLV)-Encoded CTL Epitope, Identified byits MHC Class I-Binding Motif, Explains MuLV-TypeSpecificity of MCF-Directed Cytotoxic T Lymphocytes. SIJTS AJAM ET AL.JOURNAL OF IMMUNOLOGY,Vol.152 . 1994 * |
Also Published As
Publication number | Publication date |
---|---|
CN1714101A (zh) | 2005-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002342463B2 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
KR100966232B1 (ko) | 종양 및 세포의 제거 또는 파괴를 필요로 하는 다른질환의 치료에 효과적인 펩티드 | |
CA2448348C (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
AU2002319049A1 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
AU2002319050A1 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
AU2002256587A1 (en) | Peptides derived from neural thread proteins and their medical use | |
CN100432103C (zh) | 有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽 | |
EP1714979A2 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20081112 |